data_2omj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2omj _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.762 0.315 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.88 146.39 49.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -129.1 130.25 46.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -80.59 129.75 34.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 m -141.69 104.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.78 126.88 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 20' ' ' PHE . 26.4 mm -98.02 140.36 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.51 127.56 56.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.35 140.8 43.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.23 -171.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -31.64 70.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -90.32 -37.17 14.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 177.86 16.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.444 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' A' ' 13' ' ' ILE . 26.7 m-85 -60.09 123.84 18.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.68 -45.9 9.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.524 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -58.11 141.78 49.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.378 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.83 144.74 50.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.3 m -122.1 156.38 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.995 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -149.49 132.13 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.54 124.09 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.31 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.412 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 5.0 m-20 -74.97 -60.64 1.17 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 74.2 Cg_endo -75.33 -168.08 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.184 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 t -152.95 111.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.001 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.74 141.79 44.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.7 t -77.28 124.75 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -94.45 -42.54 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 p -122.85 153.25 39.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.44 142.62 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -68.69 99.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -69.0 129.77 40.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.83 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t0 60.05 32.7 21.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.65 -152.14 6.52 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.46 85.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.95 -47.31 72.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -36.3 81.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -31.09 62.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.21 -15.82 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.429 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.58 51.76 3.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.59 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.53 147.26 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -119.44 149.22 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.17 128.12 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.962 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.01 34.84 36.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.76 150.54 21.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -90.69 136.47 33.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 52' ' ' ILE . 18.5 mm -98.29 121.11 48.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.76 -49.21 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.76 161.56 34.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 m -120.33 111.28 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.94 41.33 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.66 73.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.529 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.982 0.42 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.42 -42.67 74.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.634 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.51 -43.97 97.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.277 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.85 -46.7 93.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.002 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.8 t -60.63 -45.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.254 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -64.47 -38.27 90.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.008 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -44.63 85.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.303 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.5 mt -68.96 -43.22 82.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.655 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.4 -12.97 60.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.369 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 p -44.35 -30.17 0.79 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.816 0.341 . . . . 0.0 111.597 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.23 156.88 27.01 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.547 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -57.09 -57.31 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -100.75 112.6 25.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -134.13 128.19 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.28 143.89 51.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tp -136.29 93.4 2.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.057 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.02 110.11 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.58 173.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.36 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -135.98 138.49 42.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.426 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.801 0.334 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -125.22 154.35 41.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.97 130.24 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 103.62 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.4 m -98.12 114.19 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.41 100.68 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -91.34 133.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -106.31 124.3 49.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.88 137.58 56.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -116.0 -171.47 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -60.2 -31.48 70.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -81.98 -36.97 27.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.72 166.48 22.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.423 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -60.33 109.27 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.07 -29.78 64.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.76 126.39 29.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.78 139.08 38.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.13 135.77 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.37 132.48 16.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.18 123.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.61 -76.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.311 . . . . 0.0 110.782 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -80.53 -60.56 0.46 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.823 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.0 Cg_endo -78.7 -168.05 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.56 2.173 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.8 t -145.89 96.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -125.51 145.11 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.46 120.2 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -49.23 8.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.49 143.97 46.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -136.42 136.18 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.59 114.45 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.709 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -97.27 40.79 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.42 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -176.36 34.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.683 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.65 -139.64 2.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.687 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.76 93.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.77 0.319 . . . . 0.0 111.324 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.38 85.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -41.8 95.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -71.94 -29.95 64.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.4 -15.87 61.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.11 33.77 35.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.712 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.22 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 111.024 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.72 163.21 14.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.56 126.52 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.728 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.88 29.06 35.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.372 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -80.2 141.08 35.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -93.82 134.62 35.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.0 mt -101.97 118.39 48.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.223 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.9 -43.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.63 148.2 28.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.38 118.55 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 57.74 48.01 14.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.72 28.2 72.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.3 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.767 0.318 . . . . 0.0 110.915 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.896 0.379 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.13 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.18 -44.13 97.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.386 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.4 t -64.08 -46.73 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.06 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.56 -43.64 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.22 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.97 -39.39 90.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.284 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -47.92 75.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.7 mt -68.97 -40.55 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -74.64 -19.68 60.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.1 t -50.9 -28.94 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.322 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.53 158.35 27.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -46.8 81.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.412 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.1 m-85 -95.76 112.72 24.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 p -116.46 123.52 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.66 111.18 18.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.84 133.87 50.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.4 m -79.33 116.29 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.0 m -113.55 175.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -132.69 130.88 40.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.528 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.714 0.293 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.3 154.71 33.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.12 134.99 33.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.3 135.27 33.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.59 142.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.6 mt -118.16 113.89 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 13' ' ' ILE . 27.6 pt -104.75 143.87 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.415 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 19.3 mt-30 -106.15 143.14 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 138.34 33.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -102.8 -168.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -58.51 -34.44 70.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.79 -35.47 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.62 -109.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CE2' HG23 ' A' ' 72' ' ' ILE . 32.0 m-85 -125.71 132.99 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -39.87 36.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.48 139.58 58.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.329 . . . . 0.0 111.043 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 m -103.22 130.77 50.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 65' ' ' HIS . 33.7 m -119.07 140.7 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.351 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.6 131.88 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.808 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.75 112.49 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.624 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.63 -74.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.17 -60.94 0.46 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.734 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.03 -169.46 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.161 . . . . 0.0 112.324 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.0 103.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.025 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -138.41 148.6 44.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.81 132.74 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -93.65 -34.81 13.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.051 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.87 152.27 40.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.98 135.38 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -59.8 113.88 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -92.46 44.12 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -177.15 35.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.99 -148.63 5.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.54 79.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.737 0.304 . . . . 0.0 111.244 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.42 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.233 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.7 tpt -69.9 -50.8 38.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -30.48 70.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.34 -15.82 62.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.38 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.06 28.93 32.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.445 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.4 t -84.79 151.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.71 145.19 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 t -69.25 131.43 44.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 30.28 36.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -93.81 149.36 21.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -96.43 142.52 28.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mt -106.75 125.56 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mt -92.43 -49.12 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.02 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -151.07 157.07 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.1 t -128.44 114.31 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.084 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.87 53.14 5.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.15 27.59 60.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.423 ' CE1' HG21 ' A' ' 24' ' ' VAL . 2.6 t-80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.715 0.293 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.84 -41.27 70.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.54 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -42.47 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.866 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 t -63.92 -46.63 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.212 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.19 -44.15 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.509 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -65.8 -38.41 88.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.475 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.01 -45.27 70.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.419 HG23 ' CE2' ' A' ' 20' ' ' PHE . 19.8 mt -69.69 -35.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -72.8 -29.33 63.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -64.7 80.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.55 144.32 6.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -54.45 14.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.3 m-85 -98.28 119.82 37.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.8 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.79 115.38 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.86 105.36 15.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.018 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.07 139.92 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.6 m -84.97 121.09 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.53 175.27 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -138.39 150.4 46.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.523 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.771 0.32 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -121.44 144.36 48.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -148.5 146.59 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 p -107.36 137.28 45.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.25 125.76 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -103.03 108.44 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.079 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.75 137.42 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.5 OUTLIER -109.76 139.97 44.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -72.67 143.05 48.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -110.91 -171.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.62 -31.43 71.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -96.05 -35.35 11.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.5 179.2 15.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.533 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -60.67 109.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.41 -36.66 69.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.538 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.5 132.68 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.019 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.63 134.09 49.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.51 148.21 18.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.9 t -148.7 138.69 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.24 115.98 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 -71.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.733 0.301 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -80.06 -60.0 0.51 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.783 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.48 -168.41 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.579 2.186 . . . . 0.0 112.355 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.33 95.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -123.13 148.37 45.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.22 126.63 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.004 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -95.29 -42.61 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -119.33 145.18 46.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.61 144.62 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -66.14 114.38 5.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.87 139.44 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t0 59.17 30.05 19.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.76 -158.7 8.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.23 85.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.08 -47.33 68.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.07 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -48.2 76.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -30.41 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.83 62.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.455 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.42 34.6 11.78 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.93 158.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -125.66 138.05 53.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.823 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 t -70.34 130.45 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.93 47.96 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.672 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -88.32 138.35 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.68 135.33 33.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.6 mt -94.31 125.24 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.9 mt -98.68 -34.97 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -142.99 142.02 31.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.13 117.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 59.41 30.77 20.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.5 27.3 67.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.547 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.096 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.757 0.313 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.82 -43.16 76.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.799 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -62.58 -44.1 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.401 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.16 -46.66 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.118 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 t -60.67 -43.23 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.137 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -65.71 -38.37 89.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.66 81.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.79 -36.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.739 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -74.27 -20.59 60.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -27.9 5.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.73 147.57 18.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.51 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 p -59.63 -43.65 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.4 m-85 -102.97 115.24 30.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.88 113.42 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.181 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.1 104.46 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.11 134.03 54.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.997 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -84.65 122.63 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 m -116.81 169.19 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.294 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -135.43 134.63 39.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.755 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.647 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.833 0.349 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -122.45 154.3 37.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.846 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -139.49 130.28 26.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.0 108.11 19.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.97 143.66 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 12' ' ' ILE . 21.7 mm -119.27 95.42 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.053 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mt -86.34 130.01 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.35 127.36 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.838 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -65.26 131.64 47.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -102.5 -169.1 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.814 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -59.5 -29.87 68.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.22 -29.97 15.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.24 -118.66 3.33 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.447 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CE2' HG12 ' A' ' 72' ' ' ILE . 48.0 m-85 -116.42 115.54 26.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.56 -44.19 73.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.596 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -59.73 139.43 57.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -112.58 137.4 50.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.31 142.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.258 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -149.49 132.02 15.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.11 140.46 4.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.605 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -73.7 -74.21 0.19 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.778 0.323 . . . . 0.0 110.805 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.24 -56.79 0.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.691 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.03 -168.15 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.571 2.18 . . . . 0.0 112.176 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -155.71 106.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -127.69 154.85 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.19 120.34 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -89.42 -31.08 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 144.33 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.35 139.36 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -62.54 107.82 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -73.46 130.53 40.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.69 30.42 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.1 -157.42 8.85 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -39.33 89.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.02 -47.35 74.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.6 tpt -69.33 -41.74 76.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -67.95 -29.69 68.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.4 -15.92 60.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.324 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.37 46.24 3.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.491 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 t -106.92 143.84 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.832 0.348 . . . . 0.0 111.042 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.06 163.14 13.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 116.98 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.24 37.13 11.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.598 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.83 154.02 17.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -95.42 137.31 34.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.7 117.48 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.082 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.69 -42.5 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 147.06 30.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.77 111.64 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.96 41.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.83 73.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 pp -55.24 -43.07 74.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.766 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -44.02 97.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.993 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.78 -46.67 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.114 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 t -61.7 -44.13 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.564 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.9 -39.74 90.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -45.9 73.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.424 HG12 ' CE2' ' A' ' 20' ' ' PHE . 20.5 tt -68.76 -35.76 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -70.43 -32.37 69.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.76 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.8 t -71.59 73.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.82 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.75 144.34 4.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.539 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.22 -30.78 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -108.85 132.99 53.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -129.94 112.43 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.45 103.48 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.07 124.76 45.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.3 m -79.24 126.93 31.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.59 169.71 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.33 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -142.8 144.05 32.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.59 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.824 0.345 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.32 129.96 50.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -127.82 137.96 52.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.28 143.33 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.43 126.4 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.97 107.23 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.04 138.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -102.07 124.8 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -71.58 133.59 45.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -99.51 -170.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.67 -31.56 69.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -88.58 -44.23 10.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.63 -158.54 23.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.509 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.416 ' CD2' HG12 ' A' ' 72' ' ' ILE . 68.7 m-85 -86.72 118.13 25.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.51 -26.98 58.21 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 pp -58.47 138.95 56.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -107.0 134.26 50.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.41 ' O ' ' CD2' ' A' ' 65' ' ' HIS . 30.8 t -115.61 135.55 55.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.402 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 37.3 t -149.42 132.17 15.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.04 125.41 0.92 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.94 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -78.78 -61.06 0.54 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.3 Cg_endo -76.61 -167.9 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.86 110.84 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 23.1 p90 -136.39 150.25 48.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.11 120.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -72.34 -58.97 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 t -122.59 157.97 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.4 m -135.04 145.33 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -56.84 98.95 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 140.09 54.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.59 29.89 14.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.5 -160.12 8.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.689 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.4 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.532 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.29 -47.71 63.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.634 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -70.6 -34.73 72.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -31.81 70.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.72 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.375 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 27.29 11.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.52 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t -88.54 144.51 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 111.046 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.71 158.02 19.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.68 122.06 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.21 43.24 39.97 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.407 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -98.79 156.76 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.7 mt -103.47 124.4 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.8 -32.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -137.68 141.91 41.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 m -124.59 104.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 61.03 43.98 10.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.81 28.21 69.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.18 -179.763 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 24' ' ' VAL . 11.1 t-80 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.78 0.324 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 3.0 mt -55.46 -43.03 75.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -66.08 -38.8 89.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.0 t -66.9 -46.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.502 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.8 p -66.16 -41.43 89.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.167 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -66.33 -39.46 89.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.366 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.9 -46.94 67.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.553 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.416 HG12 ' CD2' ' A' ' 20' ' ' PHE . 2.3 tt -67.97 -35.67 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.893 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 59.9 p -66.62 78.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.73 145.97 6.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -71.04 -46.66 61.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -95.76 121.11 37.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.14 141.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.83 117.82 14.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.2 pp -135.98 134.35 38.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.8 m -75.75 123.94 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.3 m -123.45 175.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.216 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -142.81 135.6 27.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.554 179.968 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -120.6 152.29 38.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 130.3 41.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.89 103.3 13.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -93.66 129.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.87 106.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.61 129.4 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HB3' ' CE1' ' A' ' 77' ' ' TYR . 3.5 pt20 -97.0 127.42 42.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.791 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -65.27 132.34 48.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -96.25 -170.92 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -60.7 -32.36 71.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -92.99 -36.54 12.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.0 -105.75 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.502 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CE2' HG22 ' A' ' 72' ' ' ILE . 94.9 m-85 -129.78 111.4 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.375 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.76 68.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.61 140.42 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 m -101.31 137.5 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 m -134.14 138.43 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.07 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.2 t -148.76 132.62 17.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.86 117.55 0.56 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.23 -77.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-80 -79.33 -61.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.7 Cg_endo -76.42 -168.34 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.543 2.162 . . . . 0.0 112.326 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 t -145.53 110.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -138.27 154.09 49.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.174 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 t -95.92 139.14 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.06 -35.27 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.12 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -133.75 153.81 51.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.069 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 m -136.37 139.86 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 117.49 3.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.55 126.46 29.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t0 55.34 30.37 14.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.37 -149.23 7.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -37.55 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 111.17 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.13 -47.51 57.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.315 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.04 -44.6 96.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -31.36 72.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.49 -15.88 60.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.479 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.48 33.06 40.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.14 158.99 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.036 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -123.06 119.61 30.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.748 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.81 131.15 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 30.99 56.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.515 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -94.38 152.36 18.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -97.03 134.07 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 mt -101.3 123.92 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.038 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mt -97.84 -38.65 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -129.07 149.3 50.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.026 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.18 112.29 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.039 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.46 38.56 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.86 27.0 73.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.336 . . . . 0.0 110.956 -179.896 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.769 0.319 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.27 -43.21 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -44.26 94.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.82 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.127 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.73 -45.23 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.192 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -62.66 -38.3 89.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.129 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -42.71 74.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 HG22 ' CE2' ' A' ' 20' ' ' PHE . 15.2 mt -68.96 -36.02 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.773 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -31.45 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.693 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.78 78.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.91 145.43 5.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -78.09 -44.87 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -106.93 112.74 25.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.91 136.66 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.12 106.43 10.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.073 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 mp -106.64 127.32 53.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.1 m -75.1 112.85 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.9 m -112.91 175.74 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -142.67 141.49 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.513 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.879 0.371 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -124.52 149.61 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.06 135.57 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.47 131.99 34.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.1 115.83 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.96 119.17 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG23 ' CE1' ' A' ' 20' ' ' PHE . 3.8 mt -89.53 135.35 26.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.082 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -113.15 121.4 44.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -72.34 145.07 48.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.24 -168.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.814 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.65 -30.52 65.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -87.51 -32.72 19.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.06 -175.71 25.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' A' ' 13' ' ' ILE . 27.0 m-85 -62.43 103.61 0.42 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.28 79.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.607 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 pp -59.58 133.92 56.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 129.14 47.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.3 141.69 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.9 m -149.34 132.15 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.38 119.5 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -58.99 -74.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.29 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -79.96 -61.49 0.45 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.941 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -76.28 -168.3 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.459 2.106 . . . . 0.0 112.246 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 t -150.46 100.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.033 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -123.37 144.03 49.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.22 123.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -86.37 -48.48 8.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -130.11 155.9 45.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.3 m -136.39 137.53 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 113.42 3.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.76 134.89 47.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 58.43 28.55 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.19 -162.1 10.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.425 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.83 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.46 56.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.218 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -34.73 63.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.45 -31.39 65.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.25 -15.82 60.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.401 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.06 26.91 11.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.61 148.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.704 0.288 . . . . 0.0 111.059 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -125.81 147.66 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -67.22 131.04 44.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.25 38.54 33.97 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.538 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.67 27.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.65 130.34 38.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.4 mt -94.21 121.87 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mt -88.07 -48.32 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -136.72 161.98 34.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.36 109.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 61.56 49.28 5.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.427 . . . . 0.0 110.774 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.59 26.52 59.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.888 0.375 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.1 -42.73 73.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.617 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -61.72 -44.03 97.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.082 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.32 -46.62 95.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.087 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.86 -44.49 97.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.41 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -38.35 88.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.327 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -47.59 70.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.489 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.4 tt -68.15 -35.95 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.684 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -71.64 -29.32 64.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -64.37 80.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.989 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.64 146.66 7.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.529 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -69.76 -54.14 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.15 129.86 43.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.856 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.3 p -147.12 118.48 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.34 142.79 35.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mp -143.69 108.04 4.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -77.36 112.21 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.588 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.58 165.82 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.463 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -142.81 150.48 40.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.34 145.07 47.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.9 ttm-85 -142.44 133.0 25.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.73 120.91 24.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.41 119.46 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.067 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mt -106.92 105.61 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 20' ' ' PHE . 3.5 mt -87.89 132.35 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -67.52 149.97 49.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.28 -172.78 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.86 -31.28 69.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.71 -49.04 7.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.88 176.0 14.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.422 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 13' ' ' ILE . 16.2 m-85 -64.43 108.04 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.346 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.87 -37.37 94.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.499 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.46 142.08 53.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.802 0.334 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.56 140.62 49.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.78 148.48 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 4.7 t -149.39 132.04 15.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.56 122.33 0.6 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.482 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.3 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.951 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.66 -60.34 0.88 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.851 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.4 -169.48 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.286 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -150.57 115.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.998 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 4.7 p90 -136.06 144.61 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.18 120.83 28.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -89.31 -45.85 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -126.75 151.85 47.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.42 129.89 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.54 99.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.35 130.76 44.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 58.46 36.75 25.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.67 -144.78 4.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.455 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.84 93.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.116 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.55 -47.39 84.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -29.85 70.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.79 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -72.24 -37.79 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.05 -15.78 61.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.389 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.31 27.45 33.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.16 147.11 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.704 0.287 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -113.45 164.65 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -79.75 126.63 31.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 38.45 27.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 152.74 20.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 134.35 39.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.8 mt -107.01 114.42 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.7 -47.13 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 150.86 43.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.76 111.6 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 60.35 28.86 18.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.03 24.3 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.662 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.454 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.857 0.36 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.767 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.13 -44.14 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.13 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -62.74 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.199 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.454 ' CG2' ' CE1' ' A' ' 65' ' ' HIS . 31.8 t -62.09 -44.63 99.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.214 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -63.21 -38.43 91.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.222 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.57 -36.38 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.562 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.2 mt -73.55 -41.86 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -74.24 -25.96 59.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.43 77.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.925 0.393 . . . . 0.0 110.888 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.93 153.46 8.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.545 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -78.44 -36.3 45.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -106.05 141.45 37.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -137.26 125.81 34.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.065 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 111.09 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.09 124.72 22.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.4 m -74.51 124.49 26.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.27 175.59 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.64 138.81 39.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.391 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.769 0.318 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.51 126.37 52.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.89 148.75 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.59 159.57 26.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.18 108.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.075 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.08 111.89 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -89.24 144.44 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -109.37 128.41 55.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 12.7 ttmt -82.46 115.32 21.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -90.33 -168.22 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.775 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.51 -30.33 65.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.21 -46.81 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.33 -118.08 1.73 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.554 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 39.6 m-85 -124.29 113.73 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.61 60.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -53.81 122.37 9.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 m -101.31 122.28 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.46 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.1 149.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.373 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -149.33 132.08 15.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.86 111.69 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.587 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.3 -73.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -74.65 -60.68 1.26 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 73.8 Cg_endo -75.51 -168.13 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.55 2.166 . . . . 0.0 112.102 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 p -159.46 104.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -134.25 154.24 51.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.03 137.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.59 -52.2 2.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.8 t -122.48 149.43 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.41 153.39 31.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 94.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.842 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.13 139.3 58.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 58.29 30.98 20.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.15 -147.76 5.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.498 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.86 96.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.03 -47.43 80.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.044 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.34 -35.12 79.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -74.21 -31.49 62.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.53 -15.71 59.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.22 52.6 3.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 t -92.45 160.55 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -128.9 114.78 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.694 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.91 131.13 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.23 30.82 58.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.627 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -97.8 154.21 17.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 110.976 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -92.21 142.46 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.711 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 52' ' ' ILE . 36.3 mt -106.86 115.4 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.27 -47.3 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 144.57 32.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.93 111.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.15 30.0 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.06 -24.71 30.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -43.19 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.741 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -62.62 -44.1 97.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.343 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.05 -46.5 93.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.114 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.92 -44.43 97.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -65.69 -38.35 88.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.099 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mt -66.55 -47.29 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.521 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -35.93 72.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.819 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -29.32 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.41 80.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.38 153.59 11.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.601 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -67.8 -42.21 81.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.64 150.27 25.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.947 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.88 122.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.5 109.49 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.03 139.95 53.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m -90.34 124.21 34.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.92 172.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -142.83 136.37 28.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.815 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.549 -179.921 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.91 0.385 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -122.69 133.39 54.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.778 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 136.56 21.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.158 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.42 142.91 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 m -142.85 134.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.277 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.1 mt -96.1 117.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.037 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG23 ' CD1' ' A' ' 20' ' ' PHE . 20.8 mt -86.32 127.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.23 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -101.9 130.31 48.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.74 150.06 44.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.32 -168.13 1.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.734 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -30.03 65.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -100.58 -35.72 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.83 -137.27 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.519 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 13' ' ' ILE . 24.1 m-85 -95.42 97.31 9.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.44 -27.86 63.97 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.93 133.69 53.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.964 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -103.33 137.54 41.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.4 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 27.0 m -132.5 142.92 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -149.52 132.13 15.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.56 112.93 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.83 -54.78 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.444 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 6.4 m-20 -98.46 -63.9 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -79.99 -166.42 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.437 2.092 . . . . 0.0 112.278 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.4 t -143.55 110.55 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.059 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.06 155.03 48.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.022 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.2 t -92.56 120.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.057 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -31.07 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.48 148.46 39.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.0 m -136.49 148.51 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.023 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.16 105.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.36 135.3 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 62.05 25.37 15.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.09 -150.08 6.29 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.3 95.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.81 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.02 84.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ttp85 -62.03 -33.39 74.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.968 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.35 -15.88 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 31.75 19.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.546 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.38 157.21 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -122.8 145.53 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 123.73 25.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 34.31 22.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.24 147.53 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.788 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -90.94 140.47 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.8 mt -104.93 130.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -102.94 -49.11 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.066 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -125.03 142.08 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.68 107.33 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.181 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.94 43.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.52 27.96 71.81 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.96 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 24' ' ' VAL . 10.8 t-160 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.838 0.352 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.8 mt -55.08 -43.09 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.731 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.91 -44.11 97.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.123 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.77 -46.75 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.128 0.489 . . . . 0.0 110.102 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.1 t -60.07 -44.5 95.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.25 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -65.85 -38.47 88.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.185 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.2 -47.7 75.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.5 mt -68.04 -42.38 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.617 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -74.64 -14.9 60.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 p -48.22 -28.22 2.9 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.678 0.275 . . . . 0.0 111.402 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.99 150.02 20.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.621 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 p -64.23 -51.24 64.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.835 0.35 . . . . 0.0 110.78 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.7 112.62 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.618 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.26 129.49 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.354 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.91 103.46 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.05 128.76 55.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.07 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -79.74 121.84 25.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.6 172.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -141.93 137.84 31.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.513 -179.949 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.794 0.33 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 129.64 52.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -120.93 137.66 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 t -82.7 123.94 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.0 126.9 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.3 mt -98.13 104.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.89 116.09 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.069 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.41 135.9 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 146.41 54.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -112.48 -174.19 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.82 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -60.05 -30.66 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.78 -42.55 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.2 72.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 63.21 144.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.81 -27.15 3.61 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.557 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.3 138.41 57.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.2 m -102.9 126.4 50.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.43 137.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 p -149.45 132.16 15.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.52 126.97 1.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.525 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.82 -77.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.446 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -88.21 -52.3 0.39 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.582 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 6.9 Cg_exo -73.21 -166.75 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.826 2.35 . . . . 0.0 111.846 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.8 t -154.29 95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -119.95 146.8 45.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.47 120.67 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -79.37 -55.15 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -126.6 157.91 37.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.33 139.86 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tptp -59.74 109.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.81 131.73 44.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t70 59.92 31.45 20.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.27 -150.67 6.23 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.517 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.95 87.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.816 0.341 . . . . 0.0 111.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.29 -47.26 71.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.151 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.9 tpt -64.32 -49.07 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -31.58 70.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.24 -15.77 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.492 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.1 158.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -125.31 141.99 51.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.04 128.1 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.61 48.4 56.64 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.2 p30 -100.92 174.67 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.58 133.31 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.1 mt -105.68 114.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.144 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.16 -30.09 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -135.82 143.1 44.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.71 107.18 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.2 t30 60.4 32.54 20.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.85 26.25 71.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.145 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.888 0.375 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.32 -43.07 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.136 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.61 -46.57 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.988 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 t -61.45 -46.88 95.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.339 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -62.24 -38.3 88.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 tt -68.32 -41.83 80.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.437 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.7 mt -70.63 -35.99 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.803 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -27.52 62.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.32 80.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.19 147.21 7.14 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.403 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.0 m -59.53 -61.39 2.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.81 128.47 56.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -113.09 140.23 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.29 101.77 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.78 126.89 55.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.6 m -71.49 112.8 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.771 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.48 159.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -132.48 144.46 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.502 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.63 133.34 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.4 ttp85 -144.82 130.89 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.3 m -80.57 144.36 32.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.17 137.46 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.6 mp -116.59 117.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.73 143.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -112.92 128.71 56.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -65.45 143.84 57.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.02 -170.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -59.69 -29.21 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.999 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.06 -50.17 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.29 -128.07 2.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 62.0 m-85 -117.34 114.13 23.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.44 -29.96 65.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.418 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 mp -55.52 113.45 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 111.058 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 m -101.2 122.35 43.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.14 141.5 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.188 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -149.34 135.67 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.43 138.89 3.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.71 -79.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.29 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -78.2 -61.26 0.59 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.4 Cg_endo -76.4 -167.43 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.126 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 m -157.53 104.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.214 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -123.05 136.71 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.677 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.3 t -81.98 120.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -87.27 -29.29 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 148.32 51.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.242 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.67 153.48 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -68.73 116.56 9.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.9 134.9 35.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 55.76 32.97 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.975 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -137.17 -144.63 4.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.68 97.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.078 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.4 -47.28 79.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -38.66 91.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -71.22 -30.75 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.18 -15.82 60.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.415 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.12 38.85 12.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.582 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 p -96.32 153.99 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 110.95 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -120.19 141.44 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -60.97 132.39 53.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.34 47.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.188 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.53 146.92 26.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -92.15 132.5 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.08 123.86 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.105 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mt -91.94 -42.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.026 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -148.42 142.99 26.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.83 118.87 58.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.78 32.62 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.16 26.87 69.71 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.651 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.721 0.296 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.458 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.7 pp -55.38 -43.61 75.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.101 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.5 -39.34 91.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.279 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.2 t -65.62 -46.84 88.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.1 p -65.39 -41.42 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.197 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -66.06 -40.46 90.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.261 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.66 -47.48 69.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.2 tt -68.48 -35.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.869 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -73.24 -28.81 62.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 p -68.83 72.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.819 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.14 144.01 7.71 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.0 p -70.15 -30.92 68.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.98 117.39 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.89 133.24 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.82 113.1 10.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 pp -126.32 133.59 51.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.8 m -76.02 126.08 30.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.7 m -127.1 175.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -134.17 132.54 39.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -97.53 138.26 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.791 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -141.41 139.38 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.1 m -106.62 142.6 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.8 m -128.17 137.05 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.153 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.3 mt -128.08 92.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -86.33 142.76 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -112.99 137.46 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.89 135.44 45.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -103.7 -163.15 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.603 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.47 56.1 2.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.795 0.331 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 174.8 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.59 -169.28 24.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.444 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -79.04 130.5 35.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.9 -33.77 23.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.6 148.63 28.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -112.19 122.94 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 11.2 p -118.58 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.7 132.1 15.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.64 99.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.677 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.88 -69.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.409 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.409 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 t-20 -82.71 -55.12 0.55 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.182 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.6 Cg_endo -86.87 -164.66 0.22 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.818 2.345 . . . . 0.0 111.909 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.92 97.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 110.94 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -133.75 149.26 51.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.9 120.2 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.35 -67.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.7 m -134.71 171.4 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.099 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.91 153.47 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.011 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.34 123.25 22.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -75.3 146.62 40.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 55.08 24.05 5.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.81 -161.17 11.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.26 92.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.319 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.0 -47.71 67.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.093 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -63.4 -39.28 94.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 0.0 110.712 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -69.88 -31.88 69.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.01 -15.77 62.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.453 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.12 29.07 26.45 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.537 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.05 149.9 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -110.03 163.01 13.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.82 123.77 29.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.22 44.64 65.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.536 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -93.71 146.51 23.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.738 0.304 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 23.6 mtp85 -84.48 138.45 32.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.6 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.5 mt -100.93 114.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.171 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.71 -42.01 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -156.32 142.07 17.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.43 125.56 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.199 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 59.81 37.01 22.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.21 27.93 63.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.585 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.403 ' CE1' ' O ' ' A' ' 24' ' ' VAL . 3.4 t-160 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.35 -43.13 74.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.562 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.1 -43.97 97.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.174 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 t -62.15 -46.69 95.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.047 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.0 t -62.18 -46.2 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.322 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.42 75.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.456 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 mt -69.71 -36.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.844 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -31.53 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -67.88 80.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 173.37 13.42 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -98.51 -42.73 7.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.86 120.54 39.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.0 p -116.36 120.46 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.96 104.91 10.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 pp -120.65 132.87 55.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.811 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.6 m -79.97 122.86 27.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 51' ' ' ARG . 26.8 m -116.11 169.09 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.03 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.83 142.78 46.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.875 0.369 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -131.98 133.8 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.72 130.18 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -88.99 118.07 28.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.27 108.28 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 130.63 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -108.36 137.36 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.062 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 13.9 mt-30 -110.31 134.42 52.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -67.82 123.82 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -86.93 -169.93 2.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -59.46 -31.18 69.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.52 1.72 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.348 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.33 -160.27 14.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.545 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 72' ' ' ILE . 14.0 m-85 -80.06 114.62 19.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.719 0.295 . . . . 0.0 110.855 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -29.77 75.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.604 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.18 137.54 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.38 136.78 40.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.36 134.05 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -149.4 137.0 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.41 130.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.523 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.6 -71.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.405 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.9 m-20 -82.6 -61.86 0.32 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.786 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 80.1 Cg_endo -77.64 -167.99 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.542 2.161 . . . . 0.0 112.151 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.2 p -152.96 104.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -130.89 155.64 46.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -92.17 120.87 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -31.43 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -135.28 147.8 49.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.89 145.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 105.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.48 133.12 44.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 60.22 30.94 20.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.77 -147.8 5.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.48 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.76 -47.37 78.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 tpt -63.1 -41.59 99.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -36.99 86.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.83 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 36.51 25.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.593 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.08 149.05 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 111.072 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -112.11 153.3 27.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -69.04 130.6 43.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.57 31.94 43.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.405 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -84.24 138.55 32.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.72 141.4 28.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.655 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -102.77 137.77 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mm -113.32 -38.79 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -137.63 157.77 45.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 m -139.48 104.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.89 43.57 17.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.68 26.79 66.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.504 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.414 ' HA ' HG13 ' A' ' 68' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.952 0.406 . . . . 0.0 110.886 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -38.68 88.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.222 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.22 -44.34 79.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.717 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 65' ' ' HIS . 7.5 p -68.29 -41.63 83.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.13 -43.77 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.929 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -65.99 -41.18 91.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.2 mt -65.34 -50.41 65.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.416 HG22 ' CE2' ' A' ' 20' ' ' PHE . 26.5 mt -65.51 -35.89 76.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.573 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.55 -25.68 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -63.92 80.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.11 144.13 10.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.438 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.99 -42.96 89.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.399 . . . . 0.0 111.022 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.0 m-85 -102.54 113.73 27.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.12 127.77 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.209 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.81 148.55 22.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.65 116.32 8.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.081 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -79.47 115.22 18.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.8 m -115.18 170.53 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -131.9 140.95 49.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.568 -179.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.743 0.306 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.16 151.87 29.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -148.52 146.49 28.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.3 m -90.19 132.86 35.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.43 100.35 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.93 108.81 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.24 124.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.46 134.35 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.795 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -65.35 131.48 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.09 -170.83 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -30.71 69.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -103.07 -34.36 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.38 -160.36 24.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.53 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 72' ' ' ILE . 59.4 m-85 -81.53 121.72 26.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.973 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.61 -30.94 42.42 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.545 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -60.04 134.97 57.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -104.57 137.0 43.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 m -129.4 136.53 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 t -149.42 132.12 15.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.012 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.92 117.41 0.61 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.05 -74.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 110.816 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.7 m120 -81.75 -61.48 0.37 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 71.7 Cg_endo -77.06 -168.05 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.52 2.146 . . . . 0.0 112.317 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -144.08 111.99 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 31' ' ' PHE . 2.7 p90 -139.6 152.97 47.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -92.75 120.99 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.036 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -73.09 -67.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.98 163.03 17.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.32 140.04 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -59.28 120.41 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.73 131.08 39.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.3 30.82 20.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.45 -152.35 7.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.538 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.81 87.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.187 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.64 -47.37 66.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -63.67 -48.76 75.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -34.41 72.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.982 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.68 -15.95 62.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.432 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.99 40.73 13.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.456 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 t -90.36 140.16 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.81 148.04 26.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.25 119.8 13.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 44.98 12.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -93.38 161.99 14.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.788 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -98.72 137.88 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.479 HG21 HD12 ' A' ' 52' ' ' ILE . 25.4 mm -96.21 138.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.019 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.61 -48.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.059 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -136.07 141.96 44.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -125.71 112.36 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 59.25 38.19 23.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.013 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 24.31 71.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.783 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.26 -179.943 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.749 0.309 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.441 ' HA ' HG13 ' A' ' 69' ' ' VAL . 2.9 mm? -55.46 -43.3 75.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.652 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.37 -39.14 91.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.304 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.26 -46.79 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.599 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 66' ' ' LEU . 7.2 p -65.98 -41.22 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.194 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.82 -38.32 88.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.56 -43.22 77.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.305 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.42 HG23 ' CE2' ' A' ' 20' ' ' PHE . 19.4 mt -71.32 -41.67 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -74.43 -18.87 60.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.103 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -28.62 6.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.48 161.64 29.03 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 p -68.56 -48.2 64.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -95.8 114.75 26.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.408 ' CG2' ' CD1' ' A' ' 80' ' ' LEU . 12.8 p -128.52 139.47 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.01 114.31 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.883 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.408 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 7.8 mp -119.27 119.74 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -77.78 113.62 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.39 172.95 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.586 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -135.49 137.09 41.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.765 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.956 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.781 0.324 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -128.61 138.96 52.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -135.51 149.8 49.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.6 p -99.37 104.9 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.52 115.49 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -88.11 99.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.442 ' CG2' ' CD1' ' A' ' 20' ' ' PHE . 28.8 mt -86.42 112.65 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.414 ' HG3' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -102.16 131.52 48.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.96 119.61 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.43 -168.96 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -30.71 66.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 -38.39 13.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.61 178.43 20.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.442 ' CD1' ' CG2' ' A' ' 13' ' ' ILE . 25.1 m-85 -60.05 112.78 2.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.5 8.41 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -50.74 146.84 5.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 111.19 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 148.78 41.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.804 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.34 140.07 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 t -149.51 132.09 15.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.27 109.95 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -57.61 -68.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.437 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 2.0 t30 -89.51 -51.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 2.2 Cg_endo -84.61 -161.37 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.98 2.453 . . . . 0.0 112.19 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.1 t -150.4 97.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -133.8 149.73 51.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.147 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.7 t -83.65 128.36 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -92.64 -49.49 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.68 158.02 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.6 m -136.49 153.11 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -81.79 111.69 18.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.2 138.01 39.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t0 58.58 30.62 20.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.6 -158.99 8.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.554 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.79 72.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.31 -47.36 57.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.214 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tpt -67.42 -42.24 83.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -32.72 74.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.75 58.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.461 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 52.95 3.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.479 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.59 158.95 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.13 115.86 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.32 130.83 36.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 32.67 45.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.434 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -94.68 147.71 23.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.926 0.393 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.56 142.61 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.707 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.1 mt -98.51 115.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.0 mt -78.72 -47.09 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.001 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -156.86 161.91 39.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.002 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG2' ' CD2' ' A' ' 80' ' ' LEU . 9.4 p -121.13 114.79 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.181 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 56.6 55.56 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.91 27.5 62.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.546 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.842 -179.957 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mp -55.32 -43.19 74.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.29 -43.97 96.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.192 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.32 -46.56 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.053 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.55 -45.08 99.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -38.42 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.17 -45.48 73.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.707 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.1 mt -70.14 -36.09 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -74.37 -28.88 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.9 p -64.29 80.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.932 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.68 143.94 5.41 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.578 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 m -71.68 -55.7 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.414 ' CE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 m-85 -96.06 116.17 28.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.05 145.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.203 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.83 112.38 16.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' CD2' ' CG2' ' A' ' 55' ' ' VAL . 3.3 mt -112.96 116.67 30.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.5 m -77.47 111.15 12.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.688 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.4 m -117.43 175.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.325 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.96 130.04 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.67 -179.81 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.782 0.325 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -105.47 139.88 39.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -148.49 137.93 21.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.98 107.25 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.07 143.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.1 105.21 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 pt -105.06 137.76 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.254 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -106.61 119.18 38.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 21.2 ttpp -67.31 145.5 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -112.99 -169.34 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -60.37 -31.18 70.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -41.27 13.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 -155.45 20.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 57.4 m-85 -88.85 111.08 21.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.97 -38.67 96.38 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.605 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -54.59 136.81 44.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -101.25 131.64 47.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.0 m -129.64 134.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 p -147.67 132.16 17.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.23 119.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.28 -77.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -84.28 -48.25 0.68 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -84.65 -168.81 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.538 2.159 . . . . 0.0 112.476 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.4 102.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -132.2 153.3 50.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.4 t -88.78 124.81 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.0 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -34.85 22.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.62 158.81 43.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 m -136.08 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.156 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -55.93 122.56 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.1 mt-10 -77.33 151.43 34.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.974 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.28 29.85 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.04 -166.65 10.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.35 -44.72 65.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.777 0.322 . . . . 0.0 111.405 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.61 85.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.415 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -67.26 -50.96 58.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -59.14 -31.95 69.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.03 -15.82 62.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.399 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.55 35.51 28.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.544 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.9 t -85.08 141.21 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.282 . . . . 0.0 111.115 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -105.77 156.83 17.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.88 125.14 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.23 30.59 45.48 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -80.7 145.49 31.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.04 133.89 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.27 133.93 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.098 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mt -110.77 -47.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -122.02 156.5 33.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.66 104.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.089 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 t30 59.0 41.44 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.15 73.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.587 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.851 0.358 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.25 -43.26 74.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.97 -44.12 96.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -62.74 -46.51 96.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 72' ' ' ILE . 24.9 t -62.31 -44.3 99.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 13.9 mtpp -66.09 -38.37 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.794 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -40.48 70.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -73.93 -36.87 46.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.038 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.55 -20.57 59.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -68.6 72.14 0.22 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.879 0.371 . . . . 0.0 110.8 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 150.24 7.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.438 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -46.67 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 114.39 26.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.728 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -131.47 144.47 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.66 111.35 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.18 134.34 53.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.6 m -82.64 113.78 20.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -112.59 169.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -142.78 128.0 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.647 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.774 -179.891 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.872 0.368 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -128.62 143.65 50.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -143.51 140.52 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 128.75 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.2 114.72 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.19 114.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.41 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 12.0 mt -98.09 145.05 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.13 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -114.97 126.2 54.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -66.13 120.4 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -87.57 -173.05 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -29.82 67.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.12 -30.38 14.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.94 -161.67 12.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.514 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 13' ' ' ILE . 4.3 m-85 -79.38 94.49 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.48 -32.12 80.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -59.87 131.39 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 m -102.22 132.92 47.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.88 143.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.54 132.51 17.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.02 132.26 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.365 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -58.03 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.672 0.272 . . . . 0.0 110.839 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 7.6 m-20 -85.24 -61.49 0.27 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.766 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 92.1 Cg_endo -80.07 -167.44 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.524 2.149 . . . . 0.0 112.194 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.64 120.72 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 2.9 t80 -128.42 135.39 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.6 t -93.75 122.99 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.956 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -97.0 -49.83 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.281 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.54 148.66 42.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.191 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.46 145.56 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.99 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.89 121.06 15.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.008 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.02 138.94 31.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t0 59.11 30.73 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.34 -149.66 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.78 -45.55 91.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.76 0.314 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.7 -47.41 85.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.82 85.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -32.72 73.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.25 -15.72 62.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.404 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.3 26.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.567 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.4 t -78.8 158.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.731 0.301 . . . . 0.0 110.992 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -132.3 144.65 50.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.42 125.11 23.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 78.32 46.6 8.88 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.429 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.7 139.65 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -92.05 152.08 20.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.973 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.406 ' CD1' ' CG1' ' A' ' 82' ' ' VAL . 13.4 mm -106.94 133.37 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.0 mm -107.45 -33.82 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.2 157.28 42.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 m -140.62 110.46 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 60.75 41.98 14.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.958 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 26.25 71.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.87 0.367 . . . . 0.0 110.952 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.827 0.346 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 tp -55.29 -43.47 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.87 -40.14 94.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.256 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -65.68 -46.78 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.609 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.2 p -65.02 -41.29 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.019 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -38.37 87.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.102 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -47.39 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.453 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.4 HG21 ' HA ' ' A' ' 69' ' ' VAL . 2.0 tt -68.7 -37.89 78.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.64 -26.6 59.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.023 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 t -64.23 80.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.96 144.56 9.13 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 m -69.8 -49.26 54.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 120.49 36.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.06 133.87 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.93 117.44 30.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.03 127.56 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -70.02 131.23 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 27.0 m -126.86 169.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -140.61 127.87 21.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.627 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.835 0.35 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.74 138.58 40.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.7 154.17 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.33 139.75 37.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.79 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.4 m -134.05 144.29 35.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.3 mm -113.67 107.32 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 20' ' ' PHE . 15.9 pt -106.02 126.07 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.41 139.35 38.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 128.67 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -103.99 -169.59 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.81 -36.35 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.29 -43.84 66.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.14 76.06 1.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.561 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 13' ' ' ILE . 8.8 m-85 61.39 115.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.11 -44.97 4.91 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.553 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 142.79 36.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.337 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m -101.32 122.26 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.401 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 10.0 p -118.97 137.18 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.8 p -149.53 132.03 15.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.26 120.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.461 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.7 -73.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.5 t-20 -84.66 -53.04 0.5 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 86.2 Cg_endo -84.27 -167.49 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.725 2.284 . . . . 0.0 112.378 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -145.49 94.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.006 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -127.31 141.02 51.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.92 128.69 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.05 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.73 -30.33 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.17 146.25 47.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.951 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.6 129.71 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -66.92 110.55 3.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.806 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -91.81 44.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.43 35.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.591 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.47 -145.82 4.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.849 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.88 87.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.726 0.298 . . . . 0.0 111.401 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.47 85.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.8 tpt -72.42 -43.14 64.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.801 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -30.8 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.51 -15.85 47.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.73 56.96 3.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.6 t -98.39 158.5 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -118.88 148.68 42.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.04 129.11 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 33.42 32.8 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.586 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.95 133.93 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.846 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mt -96.89 124.41 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.69 -43.85 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.181 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -138.29 150.36 46.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.955 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.19 106.19 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.173 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.29 43.6 10.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.803 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.98 27.56 70.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.495 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 24' ' ' VAL . 19.2 t-80 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.806 0.336 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 mt -55.2 -42.91 73.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.662 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.57 -44.04 97.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.1 t -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.69 -43.72 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -65.43 -38.41 89.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.342 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -41.87 79.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.9 mt -71.61 -38.04 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -74.49 -27.13 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 85.2 p -63.33 80.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.44 144.41 4.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.584 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.7 p -71.63 -54.02 11.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -95.75 118.77 33.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.86 123.42 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.282 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.27 101.82 9.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.812 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 137.43 51.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.022 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 m -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.59 170.05 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.261 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -130.0 143.9 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.588 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -114.23 160.0 19.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.358 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.2 m80 60.34 167.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.59 -75.03 0.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.37 -43.75 97.86 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 tp 60.2 30.74 20.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.895 0.378 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.24 130.69 54.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.88 146.39 49.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -129.1 130.25 46.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -80.59 129.75 34.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 m -141.69 104.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.78 126.88 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 20' ' ' PHE . 26.4 mm -98.02 140.36 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.51 127.56 56.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.35 140.8 43.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.23 -171.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -31.64 70.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -90.32 -37.17 14.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 177.86 16.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.444 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' A' ' 13' ' ' ILE . 26.7 m-85 -60.09 123.84 18.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.68 -45.9 9.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.524 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -58.11 141.78 49.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.378 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.83 144.74 50.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.3 m -122.1 156.38 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.995 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -149.49 132.13 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.54 124.09 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.31 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.412 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 5.0 m-20 -74.97 -60.64 1.17 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 74.2 Cg_endo -75.33 -168.08 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.184 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 t -152.95 111.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.001 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.74 141.79 44.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.7 t -77.28 124.75 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -94.45 -42.54 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 p -122.85 153.25 39.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.44 142.62 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -68.69 99.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -69.0 129.77 40.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.83 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t0 60.05 32.7 21.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.65 -152.14 6.52 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.46 85.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.95 -47.31 72.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -36.3 81.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -31.09 62.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.21 -15.82 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.429 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.58 51.76 3.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.59 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.53 147.26 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -119.44 149.22 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.17 128.12 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.962 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.01 34.84 36.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.76 150.54 21.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -90.69 136.47 33.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 52' ' ' ILE . 18.5 mm -98.29 121.11 48.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.76 -49.21 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.76 161.56 34.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.3 m -120.33 111.28 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 t30 59.94 41.33 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.66 73.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.529 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.2 m -134.38 115.14 13.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mp -60.71 148.95 36.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.815 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 t -107.33 111.78 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.3 p -114.74 179.14 4.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 61.78 152.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.24 108.66 21.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.35 103.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -59.6 -38.64 81.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.819 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.42 -42.67 74.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.634 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.51 -43.97 97.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.277 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.85 -46.7 93.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.002 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.8 t -60.63 -45.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.254 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -64.47 -38.27 90.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.008 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -44.63 85.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.303 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.5 mt -68.96 -43.22 82.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.655 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.4 -12.97 60.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.369 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 p -44.35 -30.17 0.79 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.816 0.341 . . . . 0.0 111.597 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.23 156.88 27.01 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.547 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -57.09 -57.31 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -100.75 112.6 25.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -134.13 128.19 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.28 143.89 51.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tp -136.29 93.4 2.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.057 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.02 110.11 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.58 173.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.36 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -135.98 138.49 42.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.91 135.45 2.13 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.426 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -105.92 115.74 60.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.531 0.205 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -51.88 171.25 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.415 2.077 . . . . 0.0 112.348 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.17 175.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.551 2.167 . . . . 0.0 112.241 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.35 27.89 3.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.526 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.938 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -61.38 93.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.77 0.319 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -155.81 107.16 2.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.793 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 37.1 mtt -70.28 -55.38 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.7 54.76 13.61 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.15 36.59 4.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.79 0.329 . . . . 0.0 110.79 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -108.58 146.56 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.23 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -125.22 154.35 41.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.97 130.24 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 103.62 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.4 m -98.12 114.19 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.41 100.68 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -91.34 133.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -106.31 124.3 49.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.88 137.58 56.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -116.0 -171.47 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -60.2 -31.48 70.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -81.98 -36.97 27.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.72 166.48 22.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.423 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -60.33 109.27 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.07 -29.78 64.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.76 126.39 29.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.78 139.08 38.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.13 135.77 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.37 132.48 16.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.18 123.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.61 -76.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.311 . . . . 0.0 110.782 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -80.53 -60.56 0.46 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.823 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.0 Cg_endo -78.7 -168.05 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.56 2.173 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.8 t -145.89 96.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -125.51 145.11 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -76.46 120.2 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -49.23 8.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.49 143.97 46.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.4 m -136.42 136.18 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.59 114.45 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.709 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -97.27 40.79 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.42 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -176.36 34.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.683 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.65 -139.64 2.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.687 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.76 93.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.77 0.319 . . . . 0.0 111.324 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.38 85.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -41.8 95.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -71.94 -29.95 64.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.4 -15.87 61.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.11 33.77 35.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.712 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.22 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 111.024 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.72 163.21 14.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.56 126.52 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.728 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.88 29.06 35.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.372 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -80.2 141.08 35.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -93.82 134.62 35.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.0 mt -101.97 118.39 48.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.223 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.9 -43.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.63 148.2 28.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.38 118.55 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 57.74 48.01 14.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.72 28.2 72.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.3 m -134.27 104.19 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.767 0.318 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.91 170.28 2.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.6 p -103.63 145.79 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.97 -47.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.36 31.22 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.5 m -89.69 126.95 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -96.65 -173.11 2.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -57.49 -52.58 64.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.13 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.18 -44.13 97.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.386 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.4 t -64.08 -46.73 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.06 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.56 -43.64 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.22 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.97 -39.39 90.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.284 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -47.92 75.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.7 mt -68.97 -40.55 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -74.64 -19.68 60.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.1 t -50.9 -28.94 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.322 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.53 158.35 27.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -46.8 81.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.412 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.1 m-85 -95.76 112.72 24.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 p -116.46 123.52 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.201 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.66 111.18 18.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.84 133.87 50.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.4 m -79.33 116.29 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.0 m -113.55 175.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -132.69 130.88 40.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 155.79 163.51 12.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.528 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 144.38 31.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.551 0.215 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.54 129.64 12.98 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.497 2.131 . . . . 0.0 112.258 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.53 133.14 21.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.344 2.029 . . . . 0.0 112.414 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.69 41.28 2.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.802 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.62 179.1 4.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.759 0.314 . . . . 0.0 110.833 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -117.99 -40.71 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.3 mtm 60.85 82.34 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.56 -88.25 2.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp -164.84 94.17 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.4 m -133.22 118.09 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.3 154.71 33.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.12 134.99 33.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.3 135.27 33.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.59 142.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.6 mt -118.16 113.89 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 13' ' ' ILE . 27.6 pt -104.75 143.87 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.415 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 19.3 mt-30 -106.15 143.14 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 138.34 33.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -102.8 -168.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -58.51 -34.44 70.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.79 -35.47 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.62 -109.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.419 ' CE2' HG23 ' A' ' 72' ' ' ILE . 32.0 m-85 -125.71 132.99 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -39.87 36.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.48 139.58 58.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.329 . . . . 0.0 111.043 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 m -103.22 130.77 50.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 65' ' ' HIS . 33.7 m -119.07 140.7 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.351 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.6 131.88 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.808 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.75 112.49 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.624 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.63 -74.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.17 -60.94 0.46 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.734 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.03 -169.46 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.161 . . . . 0.0 112.324 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 t -144.0 103.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.025 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -138.41 148.6 44.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.81 132.74 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -93.65 -34.81 13.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.051 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.87 152.27 40.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 m -135.98 135.38 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.4 tptp -59.8 113.88 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -92.46 44.12 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -177.15 35.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.99 -148.63 5.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.54 79.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.737 0.304 . . . . 0.0 111.244 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.42 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.233 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.7 tpt -69.9 -50.8 38.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -30.48 70.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.34 -15.82 62.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.38 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.06 28.93 32.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.445 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.4 t -84.79 151.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.98 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.71 145.19 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 t -69.25 131.43 44.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 30.28 36.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -93.81 149.36 21.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -96.43 142.52 28.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mt -106.75 125.56 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mt -92.43 -49.12 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.02 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -151.07 157.07 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.1 t -128.44 114.31 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.084 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.87 53.14 5.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.15 27.59 60.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.35 128.84 8.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -170.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.1 m -98.45 34.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.9 m 67.63 -70.21 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -176.8 -65.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.006 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.8 m -142.16 -163.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 69.95 111.86 0.05 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.423 ' CE1' HG21 ' A' ' 24' ' ' VAL . 2.6 t-80 -65.57 -36.13 82.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.84 -41.27 70.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.54 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -42.47 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.866 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 t -63.92 -46.63 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.212 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.19 -44.15 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.509 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -65.8 -38.41 88.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.475 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.01 -45.27 70.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.419 HG23 ' CE2' ' A' ' 20' ' ' PHE . 19.8 mt -69.69 -35.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -72.8 -29.33 63.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -64.7 80.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.55 144.32 6.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -54.45 14.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.3 m-85 -98.28 119.82 37.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.8 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.0 p -124.79 115.38 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.86 105.36 15.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.018 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.07 139.92 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.6 m -84.97 121.09 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.53 175.27 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -138.39 150.4 46.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.71 136.26 2.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.523 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.81 127.95 26.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.554 0.216 . . . . 0.0 110.884 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.48 107.16 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.563 2.176 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.0 -61.39 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.521 2.147 . . . . 0.0 112.276 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.43 27.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.558 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.922 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 t -124.58 155.0 39.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -72.61 65.26 0.67 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.2 ttm -113.76 -35.57 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.07 -32.88 0.15 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.85 112.73 13.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 0.0 110.87 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.26 111.95 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -121.44 144.36 48.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -148.5 146.59 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 p -107.36 137.28 45.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.25 125.76 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -103.03 108.44 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.079 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.75 137.42 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.5 OUTLIER -109.76 139.97 44.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -72.67 143.05 48.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -110.91 -171.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.62 -31.43 71.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -96.05 -35.35 11.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.5 179.2 15.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.533 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -60.67 109.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.41 -36.66 69.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.538 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.5 132.68 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.019 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.63 134.09 49.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.51 148.21 18.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.9 t -148.7 138.69 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.24 115.98 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 -71.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.733 0.301 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -80.06 -60.0 0.51 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.783 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.48 -168.41 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.579 2.186 . . . . 0.0 112.355 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 t -148.33 95.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -123.13 148.37 45.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.22 126.63 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.004 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -95.29 -42.61 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -119.33 145.18 46.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.61 144.62 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -66.14 114.38 5.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.87 139.44 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t0 59.17 30.05 19.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.76 -158.7 8.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.23 85.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.08 -47.33 68.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.07 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -48.2 76.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -30.41 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.83 62.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.455 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.42 34.6 11.78 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.93 158.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -125.66 138.05 53.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.823 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 t -70.34 130.45 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.93 47.96 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.672 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -88.32 138.35 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.68 135.33 33.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.6 mt -94.31 125.24 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.9 mt -98.68 -34.97 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -142.99 142.02 31.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.13 117.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 59.41 30.77 20.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.5 27.3 67.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.547 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.5 m -121.12 23.24 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.096 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 49.05 -168.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.234 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -159.3 115.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.998 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 p -97.75 -67.0 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.78 130.39 4.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.991 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -162.8 156.29 20.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.19 178.89 7.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -59.53 -49.88 76.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.82 -43.16 76.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.799 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -62.58 -44.1 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.401 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.5 t -64.16 -46.66 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.118 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 t -60.67 -43.23 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.137 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -65.71 -38.37 89.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.66 81.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.4 mt -70.79 -36.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.739 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -74.27 -20.59 60.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -27.9 5.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.73 147.57 18.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.51 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 p -59.63 -43.65 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.4 m-85 -102.97 115.24 30.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.88 113.42 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.181 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.1 104.46 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 pp -123.11 134.03 54.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.997 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -84.65 122.63 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 m -116.81 169.19 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.294 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -135.43 134.63 39.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.755 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.86 -51.47 9.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.647 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 62.54 143.0 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.637 0.256 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.47 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 44.7 Cg_exo -55.15 -49.07 17.7 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.535 2.156 . . . . 0.0 112.673 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 73.0 Cg_endo -75.99 -174.52 2.09 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.253 1.969 . . . . 0.0 112.419 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -100.53 -38.14 3.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.525 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.878 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -140.06 104.28 4.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.881 0.372 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.83 32.81 20.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.6 mtm -116.46 99.9 7.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 153.76 -64.32 0.35 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.13 87.82 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 110.766 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m -107.3 123.74 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.217 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -122.45 154.3 37.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.846 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -139.49 130.28 26.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.0 108.11 19.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.97 143.66 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 12' ' ' ILE . 21.7 mm -119.27 95.42 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.053 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mt -86.34 130.01 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.35 127.36 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.838 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -65.26 131.64 47.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -102.5 -169.1 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.814 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -59.5 -29.87 68.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.22 -29.97 15.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.24 -118.66 3.33 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.447 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CE2' HG12 ' A' ' 72' ' ' ILE . 48.0 m-85 -116.42 115.54 26.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.56 -44.19 73.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.596 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -59.73 139.43 57.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -112.58 137.4 50.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.31 142.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.258 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -149.49 132.02 15.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.11 140.46 4.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.605 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -73.7 -74.21 0.19 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.778 0.323 . . . . 0.0 110.805 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.24 -56.79 0.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.691 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.03 -168.15 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.571 2.18 . . . . 0.0 112.176 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -155.71 106.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -127.69 154.85 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.19 120.34 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -89.42 -31.08 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 144.33 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.35 139.36 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -62.54 107.82 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -73.46 130.53 40.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.69 30.42 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.1 -157.42 8.85 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -39.33 89.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.02 -47.35 74.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.6 tpt -69.33 -41.74 76.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -67.95 -29.69 68.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.4 -15.92 60.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.324 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.37 46.24 3.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.491 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 t -106.92 143.84 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.832 0.348 . . . . 0.0 111.042 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -110.06 163.14 13.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 116.98 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.24 37.13 11.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.598 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.83 154.02 17.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -95.42 137.31 34.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.7 117.48 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.082 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.69 -42.5 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 147.06 30.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.77 111.64 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.96 41.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.83 73.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.3 m -128.09 90.8 3.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.74 -49.33 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.3 m -75.01 -177.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.062 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.12 -165.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.1 m80 61.99 151.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.4 p -168.88 -43.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -97.33 155.15 17.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.92 -36.45 83.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 pp -55.24 -43.07 74.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.766 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.42 -44.02 97.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.993 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.78 -46.67 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.114 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 t -61.7 -44.13 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.564 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.9 -39.74 90.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -45.9 73.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.424 HG12 ' CE2' ' A' ' 20' ' ' PHE . 20.5 tt -68.76 -35.76 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -70.43 -32.37 69.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.76 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.8 t -71.59 73.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.82 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.75 144.34 4.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.539 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.22 -30.78 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -108.85 132.99 53.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -129.94 112.43 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.45 103.48 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.07 124.76 45.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.3 m -79.24 126.93 31.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.59 169.71 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.33 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -142.8 144.05 32.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.29 117.13 0.73 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.59 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.424 ' CB ' ' HD3' ' A' ' 86' ' ' PRO . 3.2 ttp180 -94.23 -53.89 0.24 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.563 0.221 . . . . 0.0 111.159 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.442 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 31.5 Cg_exo -57.74 -47.31 21.69 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.499 2.133 . . . . 0.0 112.656 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 86' ' ' PRO . 96.2 Cg_endo -80.89 177.15 8.27 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.327 2.018 . . . . 0.0 112.438 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.59 0.54 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.565 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.951 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.98 31.46 2.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.805 0.336 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.54 31.66 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.924 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mtm -128.14 159.09 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 -24.6 29.79 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.554 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.7 29.8 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.95 115.33 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.054 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.32 129.96 50.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -127.82 137.96 52.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.28 143.33 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.43 126.4 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.97 107.23 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.04 138.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -102.07 124.8 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -71.58 133.59 45.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -99.51 -170.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.67 -31.56 69.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -88.58 -44.23 10.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.63 -158.54 23.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.509 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' CD2' HG12 ' A' ' 72' ' ' ILE . 68.7 m-85 -86.72 118.13 25.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.51 -26.98 58.21 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 pp -58.47 138.95 56.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -107.0 134.26 50.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.41 ' O ' ' CD2' ' A' ' 65' ' ' HIS . 30.8 t -115.61 135.55 55.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.402 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 37.3 t -149.42 132.17 15.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.04 125.41 0.92 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.94 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -78.78 -61.06 0.54 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.3 Cg_endo -76.61 -167.9 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.86 110.84 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 23.1 p90 -136.39 150.25 48.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.11 120.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -72.34 -58.97 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 t -122.59 157.97 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.4 m -135.04 145.33 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -56.84 98.95 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 140.09 54.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.59 29.89 14.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.5 -160.12 8.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.689 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.4 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.532 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.29 -47.71 63.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.634 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -70.6 -34.73 72.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.908 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -31.81 70.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.72 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.375 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 27.29 11.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.52 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t -88.54 144.51 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 111.046 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.71 158.02 19.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.68 122.06 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.21 43.24 39.97 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.407 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -98.79 156.76 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.7 mt -103.47 124.4 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.8 -32.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 59' ' ' LEU . 26.2 ttpt -137.68 141.91 41.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.3 m -124.59 104.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 61.03 43.98 10.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.81 28.21 69.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.6 m -133.62 84.5 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.18 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 54' ' ' LYS . 1.4 pt? -94.87 27.61 3.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.3 158.86 38.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.258 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.4 m 60.56 99.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -70.69 155.24 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.927 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.02 178.46 7.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.59 -175.15 3.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 24' ' ' VAL . 11.1 t-80 -59.53 -45.1 92.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HA ' HG12 ' A' ' 69' ' ' VAL . 3.0 mt -55.46 -43.03 75.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -66.08 -38.8 89.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.0 t -66.9 -46.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.502 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.8 p -66.16 -41.43 89.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.167 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -66.33 -39.46 89.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.366 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.9 -46.94 67.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.553 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.416 HG12 ' CD2' ' A' ' 20' ' ' PHE . 2.3 tt -67.97 -35.67 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.893 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 59.9 p -66.62 78.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.73 145.97 6.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -71.04 -46.66 61.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -95.76 121.11 37.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.14 141.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.83 117.82 14.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.2 pp -135.98 134.35 38.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.8 m -75.75 123.94 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.3 m -123.45 175.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.216 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -142.81 135.6 27.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.28 -96.97 0.1 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.554 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.32 78.43 0.3 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.297 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.3 169.9 21.17 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.554 2.17 . . . . 0.0 112.28 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.0 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.511 2.14 . . . . 0.0 112.343 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.06 -43.99 2.37 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.483 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.93 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.3 p -99.19 31.54 3.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.99 78.4 1.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttt -150.26 153.93 37.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.17 78.57 0.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.496 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 mt 60.78 104.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 0.0 110.84 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.99 121.28 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -120.6 152.29 38.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 130.3 41.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.89 103.3 13.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -93.66 129.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.87 106.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.61 129.4 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HB3' ' CE1' ' A' ' 77' ' ' TYR . 3.5 pt20 -97.0 127.42 42.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.791 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -65.27 132.34 48.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -96.25 -170.92 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -60.7 -32.36 71.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -92.99 -36.54 12.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.0 -105.75 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.502 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.421 ' CE2' HG22 ' A' ' 72' ' ' ILE . 94.9 m-85 -129.78 111.4 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.375 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.76 68.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.61 140.42 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 m -101.31 137.5 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 m -134.14 138.43 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.07 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.2 t -148.76 132.62 17.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.86 117.55 0.56 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.23 -77.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-80 -79.33 -61.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.7 Cg_endo -76.42 -168.34 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.543 2.162 . . . . 0.0 112.326 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.7 t -145.53 110.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -138.27 154.09 49.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.174 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 t -95.92 139.14 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.06 -35.27 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.12 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -133.75 153.81 51.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.069 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 m -136.37 139.86 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 117.49 3.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.55 126.46 29.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t0 55.34 30.37 14.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.37 -149.23 7.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -37.55 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 111.17 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.13 -47.51 57.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.315 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.04 -44.6 96.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -31.36 72.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.49 -15.88 60.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.479 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.48 33.06 40.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.14 158.99 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.036 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -123.06 119.61 30.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.748 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.81 131.15 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 30.99 56.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.515 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -94.38 152.36 18.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -97.03 134.07 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 mt -101.3 123.92 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.038 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 mt -97.84 -38.65 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -129.07 149.3 50.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.026 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.18 112.29 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.039 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.46 38.56 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.86 27.0 73.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 m -133.31 115.03 14.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.336 . . . . 0.0 110.956 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.21 -175.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.03 142.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 t -152.39 152.44 32.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -84.85 165.95 17.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 p -98.03 36.87 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -140.61 129.81 23.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -60.96 -39.23 88.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.27 -43.21 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -44.26 94.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.82 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.127 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 t -61.73 -45.23 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.192 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -62.66 -38.3 89.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.129 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -42.71 74.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 HG22 ' CE2' ' A' ' 20' ' ' PHE . 15.2 mt -68.96 -36.02 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.773 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -31.45 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.693 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.78 78.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.91 145.43 5.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -78.09 -44.87 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -106.93 112.74 25.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.91 136.66 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.12 106.43 10.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.073 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 mp -106.64 127.32 53.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.1 m -75.1 112.85 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.9 m -112.91 175.74 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -142.67 141.49 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.46 101.07 1.26 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.513 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.14 82.13 30.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 2.9 Cg_endo -42.06 -57.46 1.54 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.973 2.449 . . . . 0.0 112.68 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 42.0 Cg_endo -67.68 158.6 56.46 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.238 1.959 . . . . 0.0 112.167 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.55 66.05 3.85 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.542 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.862 179.949 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -168.86 -44.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.819 0.342 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -154.03 105.96 2.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.7 ttt -122.06 2.66 9.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.402 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.38 24.84 7.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.611 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mp -146.63 75.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.769 0.319 . . . . 0.0 110.766 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.62 127.27 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.19 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -124.52 149.61 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.06 135.57 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.47 131.99 34.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.1 115.83 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.96 119.17 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG23 ' CE1' ' A' ' 20' ' ' PHE . 3.8 mt -89.53 135.35 26.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.082 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -113.15 121.4 44.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -72.34 145.07 48.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.24 -168.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.814 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.65 -30.52 65.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -87.51 -32.72 19.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.06 -175.71 25.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' A' ' 13' ' ' ILE . 27.0 m-85 -62.43 103.61 0.42 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.28 79.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.607 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 pp -59.58 133.92 56.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 129.14 47.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.3 141.69 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.9 m -149.34 132.15 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.38 119.5 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -58.99 -74.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.29 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -79.96 -61.49 0.45 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.941 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -76.28 -168.3 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.459 2.106 . . . . 0.0 112.246 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 t -150.46 100.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.033 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -123.37 144.03 49.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.22 123.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -86.37 -48.48 8.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -130.11 155.9 45.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.3 m -136.39 137.53 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 113.42 3.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.76 134.89 47.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 58.43 28.55 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.19 -162.1 10.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.425 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.83 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.46 56.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.218 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -34.73 63.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.45 -31.39 65.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.25 -15.82 60.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.401 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.06 26.91 11.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -86.61 148.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.704 0.288 . . . . 0.0 111.059 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -125.81 147.66 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -67.22 131.04 44.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.25 38.54 33.97 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.538 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.67 27.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.65 130.34 38.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.4 mt -94.21 121.87 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.0 mt -88.07 -48.32 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -136.72 161.98 34.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.36 109.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 61.56 49.28 5.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.427 . . . . 0.0 110.774 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.59 26.52 59.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 m -148.21 119.87 8.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.86 -30.19 65.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.23 144.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.6 t -61.17 124.25 20.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.772 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -65.38 -177.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 t 62.34 159.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.002 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.68 97.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.138 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -66.07 -36.27 82.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.722 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.1 -42.73 73.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.617 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -61.72 -44.03 97.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.082 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.32 -46.62 95.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.087 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.86 -44.49 97.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.41 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -38.35 88.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.327 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.14 -47.59 70.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.489 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.4 tt -68.15 -35.95 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.684 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -71.64 -29.32 64.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -64.37 80.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.989 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.64 146.66 7.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.529 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -69.76 -54.14 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.15 129.86 43.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.856 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.3 p -147.12 118.48 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.34 142.79 35.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mp -143.69 108.04 4.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -77.36 112.21 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.588 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.58 165.82 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.463 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -142.81 150.48 40.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.58 175.42 45.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.0 mtp-105 -136.74 112.57 9.81 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.507 0.194 . . . . 0.0 110.699 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.79 104.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.627 2.218 . . . . 0.0 112.582 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.72 -178.68 4.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.65 2.233 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.09 56.43 25.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.603 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.87 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -103.32 -179.99 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -154.26 -173.58 4.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.822 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -81.59 -31.71 32.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.22 -28.76 1.81 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.547 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 tp -103.11 97.5 7.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 m -116.31 124.43 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.34 145.07 47.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.9 ttm-85 -142.44 133.0 25.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.73 120.91 24.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.41 119.46 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.067 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mt -106.92 105.61 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.411 HG21 ' CD1' ' A' ' 20' ' ' PHE . 3.5 mt -87.89 132.35 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -67.52 149.97 49.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.28 -172.78 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.86 -31.28 69.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.71 -49.04 7.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.88 176.0 14.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.422 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 13' ' ' ILE . 16.2 m-85 -64.43 108.04 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.346 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.87 -37.37 94.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.499 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.46 142.08 53.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.802 0.334 . . . . 0.0 110.913 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.56 140.62 49.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.78 148.48 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 4.7 t -149.39 132.04 15.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.56 122.33 0.6 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.482 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.3 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.951 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.66 -60.34 0.88 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.851 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.4 -169.48 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.286 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -150.57 115.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.998 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 4.7 p90 -136.06 144.61 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.18 120.83 28.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -89.31 -45.85 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -126.75 151.85 47.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.42 129.89 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.54 99.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.35 130.76 44.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 58.46 36.75 25.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.67 -144.78 4.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.455 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -45.84 93.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.116 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.55 -47.39 84.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.121 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -29.85 70.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.79 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -72.24 -37.79 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.05 -15.78 61.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.389 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.31 27.45 33.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.16 147.11 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.704 0.287 . . . . 0.0 111.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -113.45 164.65 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -79.75 126.63 31.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 38.45 27.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 152.74 20.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 134.35 39.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.8 mt -107.01 114.42 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.7 -47.13 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 150.86 43.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.76 111.6 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 60.35 28.86 18.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.03 24.3 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.662 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.23 100.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.19 33.04 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.88 157.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.014 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.88 81.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.949 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.85 175.45 10.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 96.1 p -145.84 -173.79 4.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.21 105.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.454 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.8 OUTLIER -61.23 -38.23 85.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.767 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.13 -44.14 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.13 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -62.74 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.199 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.454 ' CG2' ' CE1' ' A' ' 65' ' ' HIS . 31.8 t -62.09 -44.63 99.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.214 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -63.21 -38.43 91.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.222 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.57 -36.38 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.562 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.2 mt -73.55 -41.86 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -74.24 -25.96 59.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.43 77.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.925 0.393 . . . . 0.0 110.888 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.93 153.46 8.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.545 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -78.44 -36.3 45.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -106.05 141.45 37.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -137.26 125.81 34.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.065 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 111.09 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.09 124.72 22.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.4 m -74.51 124.49 26.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.27 175.59 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -137.64 138.81 39.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.83 133.09 5.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.391 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.94 141.14 11.79 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.542 0.211 . . . . 0.0 110.818 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 45.5 Cg_exo -54.72 -49.11 17.89 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.35 2.033 . . . . 0.0 112.616 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 73.5 Cg_endo -75.66 164.19 32.58 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.282 1.988 . . . . 0.0 112.298 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.7 -46.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.56 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.882 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -165.52 -65.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.28 -68.9 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.3 mmt 60.19 101.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.919 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.74 -77.63 0.19 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.01 52.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 0.0 110.834 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.68 118.93 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.175 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.51 126.37 52.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.89 148.75 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.59 159.57 26.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.18 108.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.075 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.08 111.89 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -89.24 144.44 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -109.37 128.41 55.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 12.7 ttmt -82.46 115.32 21.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -90.33 -168.22 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.775 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.51 -30.33 65.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.21 -46.81 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.33 -118.08 1.73 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.554 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 39.6 m-85 -124.29 113.73 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.61 60.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -53.81 122.37 9.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 m -101.31 122.28 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.46 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.1 149.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.373 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -149.33 132.08 15.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.86 111.69 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.587 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.3 -73.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -74.65 -60.68 1.26 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 73.8 Cg_endo -75.51 -168.13 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.55 2.166 . . . . 0.0 112.102 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 p -159.46 104.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -134.25 154.24 51.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 t -92.03 137.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.59 -52.2 2.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.8 t -122.48 149.43 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.41 153.39 31.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 94.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.842 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.13 139.3 58.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 58.29 30.98 20.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.15 -147.76 5.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.498 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.86 96.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.03 -47.43 80.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.044 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.34 -35.12 79.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -74.21 -31.49 62.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.53 -15.71 59.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.22 52.6 3.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 t -92.45 160.55 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -128.9 114.78 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.694 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.91 131.13 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.23 30.82 58.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.627 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -97.8 154.21 17.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 110.976 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -92.21 142.46 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.711 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 52' ' ' ILE . 36.3 mt -106.86 115.4 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.27 -47.3 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 144.57 32.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.93 111.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.15 30.0 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.06 -24.71 30.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.68 85.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.32 -23.4 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -53.88 148.59 2.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.403 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 t -126.93 101.19 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.53 38.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.02 -169.62 2.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -120.09 -173.13 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.08 -37.71 80.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -43.19 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.741 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -62.62 -44.1 97.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.343 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.05 -46.5 93.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.114 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -60.92 -44.43 97.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -65.69 -38.35 88.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.099 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mt -66.55 -47.29 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.521 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.61 -35.93 72.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.819 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -29.32 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.41 80.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.38 153.59 11.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.601 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -67.8 -42.21 81.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.64 150.27 25.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.947 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.88 122.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.5 109.49 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.03 139.95 53.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m -90.34 124.21 34.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.92 172.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -142.83 136.37 28.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.815 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.76 32.85 6.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.549 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -96.76 109.06 46.75 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.539 0.209 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.63 118.96 5.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.43 2.087 . . . . 0.0 112.278 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.95 -50.73 13.03 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.457 2.105 . . . . 0.0 112.312 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.88 -69.9 3.15 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.444 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.92 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.7 m -117.67 31.55 6.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -125.9 121.22 32.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.2 95.96 10.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.47 25.64 11.99 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.604 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.1 mt 65.18 -73.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.791 0.329 . . . . 0.0 111.204 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.01 112.67 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -122.69 133.39 54.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.778 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 136.56 21.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.158 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.42 142.91 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 m -142.85 134.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.277 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.1 mt -96.1 117.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.037 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG23 ' CD1' ' A' ' 20' ' ' PHE . 20.8 mt -86.32 127.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.23 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -101.9 130.31 48.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.74 150.06 44.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.32 -168.13 1.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.734 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -30.03 65.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -100.58 -35.72 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.83 -137.27 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.519 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.418 ' CD1' HG23 ' A' ' 13' ' ' ILE . 24.1 m-85 -95.42 97.31 9.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.44 -27.86 63.97 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -63.93 133.69 53.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.964 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -103.33 137.54 41.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.4 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 27.0 m -132.5 142.92 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -149.52 132.13 15.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.56 112.93 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.83 -54.78 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.444 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 6.4 m-20 -98.46 -63.9 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -79.99 -166.42 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.437 2.092 . . . . 0.0 112.278 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.4 t -143.55 110.55 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.059 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.06 155.03 48.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.022 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.2 t -92.56 120.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.057 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -31.07 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.48 148.46 39.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.0 m -136.49 148.51 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.023 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.16 105.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.36 135.3 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 62.05 25.37 15.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.09 -150.08 6.29 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.3 95.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.5 -46.81 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.02 84.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ttp85 -62.03 -33.39 74.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.968 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.35 -15.88 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 31.75 19.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.546 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.38 157.21 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -122.8 145.53 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 123.73 25.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 34.31 22.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.24 147.53 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.788 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -90.94 140.47 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.8 mt -104.93 130.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -102.94 -49.11 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.066 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -125.03 142.08 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -114.68 107.33 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.181 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.94 43.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.52 27.96 71.81 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 m -136.24 114.11 11.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.83 79.78 3.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.828 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.65 140.07 42.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.111 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 t -109.56 -24.99 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.02 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 61.8 178.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.775 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.0 m -100.68 -75.34 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -74.14 146.35 43.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.062 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 24' ' ' VAL . 10.8 t-160 -63.65 -36.37 83.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.857 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.8 mt -55.08 -43.09 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.731 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.91 -44.11 97.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.123 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.77 -46.75 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.128 0.489 . . . . 0.0 110.102 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.1 t -60.07 -44.5 95.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.25 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -65.85 -38.47 88.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.185 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.2 -47.7 75.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.5 mt -68.04 -42.38 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.617 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -74.64 -14.9 60.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 p -48.22 -28.22 2.9 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.678 0.275 . . . . 0.0 111.402 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.99 150.02 20.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.621 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 p -64.23 -51.24 64.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.835 0.35 . . . . 0.0 110.78 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.7 112.62 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.618 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.26 129.49 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.354 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.91 103.46 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.05 128.76 55.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.07 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -79.74 121.84 25.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.6 172.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -141.93 137.84 31.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -107.13 104.19 2.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.513 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.66 91.72 4.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 51.8 Cg_exo -53.09 -45.02 44.09 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.434 2.089 . . . . 0.0 112.564 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 86' ' ' PRO . 23.8 Cg_exo -63.82 -160.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.405 2.07 . . . . 0.0 112.182 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -120.53 47.04 1.06 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.382 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.997 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.32 33.68 20.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 110.945 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -121.92 -43.1 2.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.0 mtp -90.93 -61.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.23 65.25 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.432 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tp -137.44 47.13 2.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.25 115.33 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.168 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 129.64 52.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -120.93 137.66 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 t -82.7 123.94 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.0 126.9 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.3 mt -98.13 104.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.89 116.09 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.069 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.41 135.9 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 146.41 54.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -112.48 -174.19 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.82 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -60.05 -30.66 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.78 -42.55 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.2 72.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 63.21 144.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.81 -27.15 3.61 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.557 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.3 138.41 57.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.2 m -102.9 126.4 50.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.43 137.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 p -149.45 132.16 15.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.52 126.97 1.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.525 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.82 -77.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.446 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -88.21 -52.3 0.39 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.582 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 6.9 Cg_exo -73.21 -166.75 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.826 2.35 . . . . 0.0 111.846 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.8 t -154.29 95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -119.95 146.8 45.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.47 120.67 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -79.37 -55.15 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -126.6 157.91 37.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.33 139.86 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tptp -59.74 109.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.81 131.73 44.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t70 59.92 31.45 20.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.27 -150.67 6.23 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.517 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.95 87.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.816 0.341 . . . . 0.0 111.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.29 -47.26 71.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.151 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.9 tpt -64.32 -49.07 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -31.58 70.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.24 -15.77 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.492 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.1 158.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -125.31 141.99 51.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.04 128.1 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.61 48.4 56.64 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.2 p30 -100.92 174.67 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.58 133.31 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.1 mt -105.68 114.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.144 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.16 -30.09 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -135.82 143.1 44.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.71 107.18 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.2 t30 60.4 32.54 20.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.85 26.25 71.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -123.04 23.6 9.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.145 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.84 173.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.108 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.6 m -117.76 64.09 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.072 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.36 31.12 3.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -108.6 -178.08 3.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.6 p -147.15 -50.34 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.52 126.03 25.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -60.06 -41.3 92.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.772 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.32 -43.07 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.136 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.61 -46.57 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.988 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 t -61.45 -46.88 95.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.339 179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -62.24 -38.3 88.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.2 tt -68.32 -41.83 80.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.437 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.7 mt -70.63 -35.99 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.803 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -27.52 62.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.32 80.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.19 147.21 7.14 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.403 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.0 m -59.53 -61.39 2.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.81 128.47 56.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 p -113.09 140.23 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.29 101.77 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.78 126.89 55.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.6 m -71.49 112.8 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.771 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.48 159.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -132.48 144.46 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.13 120.19 3.17 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.502 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -140.8 139.14 19.2 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.611 0.244 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.55 109.99 3.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.468 2.112 . . . . 0.0 112.292 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.77 154.14 73.94 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.466 2.11 . . . . 0.0 112.296 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -96.42 29.15 10.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.573 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.019 179.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m -121.91 171.31 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -35.82 32.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.8 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.6 tpt -63.11 83.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.63 -50.76 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mp -144.88 113.59 6.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.39 123.87 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.63 133.34 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.4 ttp85 -144.82 130.89 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.3 m -80.57 144.36 32.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.17 137.46 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.6 mp -116.59 117.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.73 143.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -112.92 128.71 56.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -65.45 143.84 57.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.02 -170.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -59.69 -29.21 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.999 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.06 -50.17 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.29 -128.07 2.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 62.0 m-85 -117.34 114.13 23.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.44 -29.96 65.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.418 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.9 mp -55.52 113.45 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 111.058 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 m -101.2 122.35 43.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 p -130.14 141.5 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.188 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -149.34 135.67 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.43 138.89 3.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.71 -79.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.29 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -78.2 -61.26 0.59 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.4 Cg_endo -76.4 -167.43 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.126 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 m -157.53 104.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.214 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -123.05 136.71 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.677 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.3 t -81.98 120.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -87.27 -29.29 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 148.32 51.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.242 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.67 153.48 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -68.73 116.56 9.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.9 134.9 35.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 55.76 32.97 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.975 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -137.17 -144.63 4.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.68 97.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.078 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.4 -47.28 79.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -38.66 91.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -71.22 -30.75 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.18 -15.82 60.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.415 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.12 38.85 12.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.582 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 p -96.32 153.99 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 110.95 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -120.19 141.44 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -60.97 132.39 53.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.34 47.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.188 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.53 146.92 26.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -92.15 132.5 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.08 123.86 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.105 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mt -91.94 -42.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.026 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -148.42 142.99 26.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.83 118.87 58.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.78 32.62 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.16 26.87 69.71 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.651 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t -143.52 104.39 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.1 tp -109.9 152.18 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.26 172.28 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -44.95 48.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -117.65 124.97 49.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.858 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.7 p -142.13 -58.35 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.018 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t30 73.86 -178.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.937 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -66.0 -42.54 89.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.412 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.458 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.7 pp -55.38 -43.61 75.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.101 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -65.5 -39.34 91.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.279 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.2 t -65.62 -46.84 88.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.1 p -65.39 -41.42 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.197 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -66.06 -40.46 90.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.261 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -67.66 -47.48 69.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.2 tt -68.48 -35.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.869 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -73.24 -28.81 62.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 p -68.83 72.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.819 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.14 144.01 7.71 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.0 p -70.15 -30.92 68.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.98 117.39 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.89 133.24 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.82 113.1 10.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 pp -126.32 133.59 51.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.8 m -76.02 126.08 30.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.7 m -127.1 175.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -134.17 132.54 39.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.43 105.44 0.56 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -176.3 96.58 0.25 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.572 0.225 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.92 171.49 11.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.419 2.079 . . . . 0.0 112.135 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.5 172.84 7.3 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.549 2.166 . . . . 0.0 112.208 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -100.1 19.66 52.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.647 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.012 179.891 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m -129.0 -64.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -89.43 167.62 12.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.5 ttm 61.65 152.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.64 68.52 0.85 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.549 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.19 35.83 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.346 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t -108.3 112.24 39.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.107 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -97.53 138.26 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.791 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -141.41 139.38 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.1 m -106.62 142.6 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.8 m -128.17 137.05 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.153 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.3 mt -128.08 92.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -86.33 142.76 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -112.99 137.46 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.89 135.44 45.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -103.7 -163.15 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.603 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.47 56.1 2.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.795 0.331 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 174.8 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.59 -169.28 24.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.444 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -79.04 130.5 35.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.9 -33.77 23.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.6 148.63 28.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -112.19 122.94 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 11.2 p -118.58 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.7 132.1 15.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.64 99.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.677 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.88 -69.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.409 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.409 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 t-20 -82.71 -55.12 0.55 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.182 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.6 Cg_endo -86.87 -164.66 0.22 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.818 2.345 . . . . 0.0 111.909 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.92 97.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 110.94 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -133.75 149.26 51.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.9 120.2 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.35 -67.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.7 m -134.71 171.4 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.099 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.91 153.47 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.011 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.34 123.25 22.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.409 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -75.3 146.62 40.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 55.08 24.05 5.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.81 -161.17 11.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -40.26 92.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.319 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.0 -47.71 67.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.093 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.409 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -63.4 -39.28 94.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 0.0 110.712 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -69.88 -31.88 69.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.01 -15.77 62.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.453 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.12 29.07 26.45 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.537 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.05 149.9 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -110.03 163.01 13.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.82 123.77 29.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.22 44.64 65.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.536 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -93.71 146.51 23.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.738 0.304 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 23.6 mtp85 -84.48 138.45 32.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.6 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.5 mt -100.93 114.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.171 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.71 -42.01 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -156.32 142.07 17.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.43 125.56 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.199 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 59.81 37.01 22.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.21 27.93 63.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.585 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -145.37 103.44 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.7 mp -63.8 163.8 11.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.004 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -136.21 109.04 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 t -98.4 138.49 35.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.3 t60 60.16 39.49 19.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.3 m -111.79 174.71 5.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -125.26 -179.82 4.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.403 ' CE1' ' O ' ' A' ' 24' ' ' VAL . 3.4 t-160 -61.58 -37.39 83.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.965 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.35 -43.13 74.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.562 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.1 -43.97 97.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.174 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 t -62.15 -46.69 95.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.047 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.0 t -62.18 -46.2 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.322 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.42 75.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.456 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 mt -69.71 -36.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.844 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.75 -31.53 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.922 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -67.88 80.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 173.37 13.42 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -98.51 -42.73 7.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.86 120.54 39.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.0 p -116.36 120.46 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.96 104.91 10.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 pp -120.65 132.87 55.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.811 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 63.6 m -79.97 122.86 27.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 51' ' ' ARG . 26.8 m -116.11 169.09 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.03 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.83 142.78 46.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.76 159.71 27.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 29.9 ptt85 -158.57 149.94 16.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.704 0.287 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.97 175.18 9.46 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.593 2.195 . . . . 0.0 112.322 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.18 -170.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.518 2.145 . . . . 0.0 112.227 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.43 -36.25 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.46 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.97 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -132.93 -175.84 3.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -74.63 -12.55 60.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.263 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.37 105.39 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 110.996 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.5 61.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 tt -104.45 -46.56 4.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.319 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.2 p -119.39 116.9 52.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -131.98 133.8 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.72 130.18 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -88.99 118.07 28.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.27 108.28 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 130.63 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -108.36 137.36 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.062 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 13.9 mt-30 -110.31 134.42 52.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -67.82 123.82 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -86.93 -169.93 2.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -59.46 -31.18 69.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.52 1.72 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.348 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.33 -160.27 14.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.545 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 72' ' ' ILE . 14.0 m-85 -80.06 114.62 19.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.719 0.295 . . . . 0.0 110.855 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -29.77 75.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.604 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.18 137.54 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.38 136.78 40.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.3 p -133.36 134.05 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -149.4 137.0 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.41 130.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.523 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.6 -71.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.405 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.9 m-20 -82.6 -61.86 0.32 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.786 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 80.1 Cg_endo -77.64 -167.99 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.542 2.161 . . . . 0.0 112.151 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.2 p -152.96 104.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -130.89 155.64 46.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -92.17 120.87 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -31.43 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -135.28 147.8 49.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.89 145.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 105.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.48 133.12 44.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 60.22 30.94 20.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.77 -147.8 5.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.48 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.76 -47.37 78.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 tpt -63.1 -41.59 99.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -36.99 86.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.83 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 36.51 25.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.593 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.08 149.05 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 111.072 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -112.11 153.3 27.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -69.04 130.6 43.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.57 31.94 43.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.405 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -84.24 138.55 32.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.72 141.4 28.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.655 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -102.77 137.77 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mm -113.32 -38.79 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -137.63 157.77 45.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 m -139.48 104.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.89 43.57 17.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.68 26.79 66.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.504 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.0 m -124.74 94.46 4.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.83 104.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.59 135.25 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 t -130.66 -48.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.77 97.05 3.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.835 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.3 m -145.25 -178.53 6.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.07 173.69 6.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.414 ' HA ' HG13 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -62.36 -40.92 97.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -38.68 88.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.222 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.22 -44.34 79.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.717 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 65' ' ' HIS . 7.5 p -68.29 -41.63 83.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.13 -43.77 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.929 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -65.99 -41.18 91.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.2 mt -65.34 -50.41 65.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.416 HG22 ' CE2' ' A' ' 20' ' ' PHE . 26.5 mt -65.51 -35.89 76.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.573 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.55 -25.68 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -63.92 80.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.11 144.13 10.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.438 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.99 -42.96 89.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.399 . . . . 0.0 111.022 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.0 m-85 -102.54 113.73 27.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.12 127.77 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.209 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.81 148.55 22.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.65 116.32 8.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.081 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -79.47 115.22 18.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.8 m -115.18 170.53 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -131.9 140.95 49.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.39 76.1 0.25 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.568 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.39 94.1 25.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.625 0.25 . . . . 0.0 110.809 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.13 171.24 12.91 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.476 2.117 . . . . 0.0 112.245 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.69 -168.28 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.571 2.181 . . . . 0.0 112.316 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -96.5 37.24 3.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.893 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p -157.95 38.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.816 0.341 . . . . 0.0 110.933 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 60.75 33.89 20.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.97 122.16 22.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.0 -80.26 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mp 58.68 27.54 16.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.348 . . . . 0.0 110.991 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m -123.67 112.14 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.16 151.87 29.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -148.52 146.49 28.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.3 m -90.19 132.86 35.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.43 100.35 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.93 108.81 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.24 124.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.46 134.35 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.795 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -65.35 131.48 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.09 -170.83 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -30.71 69.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -103.07 -34.36 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.38 -160.36 24.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.53 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 72' ' ' ILE . 59.4 m-85 -81.53 121.72 26.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.973 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.61 -30.94 42.42 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.545 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -60.04 134.97 57.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -104.57 137.0 43.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 m -129.4 136.53 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 t -149.42 132.12 15.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.012 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.92 117.41 0.61 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.05 -74.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 110.816 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.7 m120 -81.75 -61.48 0.37 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 71.7 Cg_endo -77.06 -168.05 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.52 2.146 . . . . 0.0 112.317 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -144.08 111.99 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 31' ' ' PHE . 2.7 p90 -139.6 152.97 47.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -92.75 120.99 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.036 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -73.09 -67.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.98 163.03 17.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.32 140.04 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -59.28 120.41 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.73 131.08 39.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.3 30.82 20.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.45 -152.35 7.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.538 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.81 87.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.187 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.64 -47.37 66.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -63.67 -48.76 75.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -34.41 72.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.982 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.68 -15.95 62.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.432 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.99 40.73 13.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.456 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 t -90.36 140.16 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.81 148.04 26.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.25 119.8 13.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 44.98 12.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -93.38 161.99 14.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.788 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -98.72 137.88 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.479 HG21 HD12 ' A' ' 52' ' ' ILE . 25.4 mm -96.21 138.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.019 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.8 mt -113.61 -48.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.059 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -136.07 141.96 44.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -125.71 112.36 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 59.25 38.19 23.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.013 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 24.31 71.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.783 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.4 p -131.77 88.14 2.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.26 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pp -47.48 169.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.295 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.1 132.05 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.8 p -140.14 -68.3 0.42 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.47 88.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.3 m -151.68 146.56 25.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -96.36 -174.44 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.916 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.34 -45.17 84.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' HA ' HG13 ' A' ' 69' ' ' VAL . 2.9 mm? -55.46 -43.3 75.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.652 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.37 -39.14 91.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.304 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.8 t -66.26 -46.79 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.599 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 66' ' ' LEU . 7.2 p -65.98 -41.22 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.194 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.82 -38.32 88.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.56 -43.22 77.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.305 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.42 HG23 ' CE2' ' A' ' 20' ' ' PHE . 19.4 mt -71.32 -41.67 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -74.43 -18.87 60.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.103 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -28.62 6.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.48 161.64 29.03 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 p -68.56 -48.2 64.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -95.8 114.75 26.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.408 ' CG2' ' CD1' ' A' ' 80' ' ' LEU . 12.8 p -128.52 139.47 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.01 114.31 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.883 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.408 ' CD1' ' CG2' ' A' ' 78' ' ' VAL . 7.8 mp -119.27 119.74 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -77.78 113.62 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.39 172.95 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.586 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -135.49 137.09 41.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.765 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.91 134.27 1.61 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -92.05 136.6 25.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.507 0.194 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 142.18 55.99 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.398 2.065 . . . . 0.0 112.197 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.1 -175.91 2.4 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.432 2.088 . . . . 0.0 112.296 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.6 -28.17 57.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.433 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.866 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 m -129.76 33.91 4.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 110.969 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.74 83.0 1.03 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -162.58 -47.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.98 -54.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -114.52 109.68 18.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.759 0.314 . . . . 0.0 110.984 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m -107.52 134.18 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -128.61 138.96 52.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -135.51 149.8 49.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.6 p -99.37 104.9 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.52 115.49 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -88.11 99.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.442 ' CG2' ' CD1' ' A' ' 20' ' ' PHE . 28.8 mt -86.42 112.65 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.414 ' HG3' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -102.16 131.52 48.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.96 119.61 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.43 -168.96 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -30.71 66.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 -38.39 13.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.61 178.43 20.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.442 ' CD1' ' CG2' ' A' ' 13' ' ' ILE . 25.1 m-85 -60.05 112.78 2.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.5 8.41 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -50.74 146.84 5.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 111.19 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 148.78 41.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.804 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.34 140.07 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 t -149.51 132.09 15.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.27 109.95 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -57.61 -68.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.437 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 2.0 t30 -89.51 -51.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 2.2 Cg_endo -84.61 -161.37 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.98 2.453 . . . . 0.0 112.19 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.1 t -150.4 97.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -133.8 149.73 51.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.147 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.7 t -83.65 128.36 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -92.64 -49.49 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.68 158.02 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.6 m -136.49 153.11 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -81.79 111.69 18.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.2 138.01 39.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t0 58.58 30.62 20.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.6 -158.99 8.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.554 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.79 72.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.31 -47.36 57.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.214 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tpt -67.42 -42.24 83.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -32.72 74.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.75 58.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.461 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 52.95 3.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.479 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -88.59 158.95 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.13 115.86 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.32 130.83 36.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 32.67 45.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.434 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -94.68 147.71 23.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.926 0.393 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.56 142.61 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.707 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.1 mt -98.51 115.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.0 mt -78.72 -47.09 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.001 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -156.86 161.91 39.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.002 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG2' ' CD2' ' A' ' 80' ' ' LEU . 9.4 p -121.13 114.79 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.181 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 56.6 55.56 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.91 27.5 62.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.546 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -129.78 118.03 21.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.842 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -85.2 57.17 4.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.39 141.0 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.07 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 m -112.17 -66.49 1.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 57.9 -171.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.15 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -147.86 115.89 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -60.4 -40.28 90.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mp -55.32 -43.19 74.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.29 -43.97 96.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.192 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.32 -46.56 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.053 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.55 -45.08 99.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -38.42 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.17 -45.48 73.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.707 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.1 mt -70.14 -36.09 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -74.37 -28.88 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.9 p -64.29 80.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.932 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.68 143.94 5.41 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.578 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 m -71.68 -55.7 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.414 ' CE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 m-85 -96.06 116.17 28.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.05 145.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.203 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.83 112.38 16.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' CD2' ' CG2' ' A' ' 55' ' ' VAL . 3.3 mt -112.96 116.67 30.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.5 m -77.47 111.15 12.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.688 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.4 m -117.43 175.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.325 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.96 130.04 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.01 -149.33 24.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.67 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 63.78 65.34 1.22 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.14 137.73 80.96 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.56 2.173 . . . . 0.0 112.137 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.35 134.42 15.61 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.423 2.082 . . . . 0.0 112.414 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.97 -54.08 4.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.565 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.29 -69.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.801 0.334 . . . . 0.0 110.975 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -95.65 -39.96 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -98.55 32.66 2.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.65 -50.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.575 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.7 mt -134.56 101.34 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 110.937 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.5 m -101.57 119.15 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -105.47 139.88 39.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -148.49 137.93 21.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.98 107.25 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.07 143.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.1 105.21 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.7 pt -105.06 137.76 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.254 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -106.61 119.18 38.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 21.2 ttpp -67.31 145.5 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -112.99 -169.34 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -60.37 -31.18 70.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -41.27 13.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 -155.45 20.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 57.4 m-85 -88.85 111.08 21.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.97 -38.67 96.38 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.605 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -54.59 136.81 44.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -101.25 131.64 47.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.0 m -129.64 134.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 p -147.67 132.16 17.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.23 119.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.28 -77.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -84.28 -48.25 0.68 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -84.65 -168.81 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.538 2.159 . . . . 0.0 112.476 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -149.4 102.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -132.2 153.3 50.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.4 t -88.78 124.81 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.0 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -34.85 22.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.62 158.81 43.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 m -136.08 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.156 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -55.93 122.56 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.1 mt-10 -77.33 151.43 34.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.974 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.28 29.85 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.04 -166.65 10.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.35 -44.72 65.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.777 0.322 . . . . 0.0 111.405 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.61 85.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.415 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -67.26 -50.96 58.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -59.14 -31.95 69.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.03 -15.82 62.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.399 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.55 35.51 28.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.544 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.9 t -85.08 141.21 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.282 . . . . 0.0 111.115 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -105.77 156.83 17.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.88 125.14 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.23 30.59 45.48 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -80.7 145.49 31.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.04 133.89 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mt -101.27 133.93 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.098 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mt -110.77 -47.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -122.02 156.5 33.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.66 104.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.089 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 t30 59.0 41.44 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.15 73.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.587 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.58 84.33 1.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.71 152.13 23.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.4 p -132.85 158.3 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.4 p -99.11 -58.95 1.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -177.15 138.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.973 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.8 m -158.79 -78.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -179.33 162.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -59.3 -38.6 80.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.25 -43.26 74.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.97 -44.12 96.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -62.74 -46.51 96.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.407 ' HA ' HG22 ' A' ' 72' ' ' ILE . 24.9 t -62.31 -44.3 99.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 13.9 mtpp -66.09 -38.37 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.794 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -40.48 70.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -73.93 -36.87 46.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.038 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.55 -20.57 59.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -68.6 72.14 0.22 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.879 0.371 . . . . 0.0 110.8 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 150.24 7.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.438 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -46.67 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 114.39 26.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.728 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -131.47 144.47 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.66 111.35 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.18 134.34 53.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.6 m -82.64 113.78 20.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -112.59 169.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -142.78 128.0 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.647 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.25 174.95 20.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.774 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.74 78.05 0.31 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.836 0.35 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.18 112.18 3.43 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.671 2.247 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.39 -160.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.511 2.141 . . . . 0.0 112.196 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.85 -46.08 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.423 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.5 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.91 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 p 50.08 88.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.68 0.276 . . . . 0.0 111.225 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -123.79 146.57 48.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 35.3 mtp 60.33 78.99 0.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.81 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.82 -49.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.53 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 mt -118.21 104.78 11.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.08 147.46 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -128.62 143.65 50.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -143.51 140.52 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 128.75 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.4 p -126.2 114.72 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.19 114.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.41 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 12.0 mt -98.09 145.05 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.13 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -114.97 126.2 54.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -66.13 120.4 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -87.57 -173.05 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -29.82 67.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.12 -30.38 14.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.94 -161.67 12.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.514 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 13' ' ' ILE . 4.3 m-85 -79.38 94.49 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.48 -32.12 80.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 pp -59.87 131.39 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 m -102.22 132.92 47.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.88 143.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.54 132.51 17.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.02 132.26 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.365 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -58.03 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.672 0.272 . . . . 0.0 110.839 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 7.6 m-20 -85.24 -61.49 0.27 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.766 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 92.1 Cg_endo -80.07 -167.44 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.524 2.149 . . . . 0.0 112.194 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.64 120.72 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 2.9 t80 -128.42 135.39 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.6 t -93.75 122.99 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.956 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -97.0 -49.83 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.281 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.54 148.66 42.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.191 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -136.46 145.56 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.99 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.89 121.06 15.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.008 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.02 138.94 31.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t0 59.11 30.73 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.34 -149.66 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.78 -45.55 91.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.76 0.314 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.7 -47.41 85.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.82 85.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -32.72 73.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.25 -15.72 62.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.404 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.3 26.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.567 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.4 t -78.8 158.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.731 0.301 . . . . 0.0 110.992 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -132.3 144.65 50.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.42 125.11 23.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 78.32 46.6 8.88 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.429 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.7 139.65 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -92.05 152.08 20.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.973 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.406 ' CD1' ' CG1' ' A' ' 82' ' ' VAL . 13.4 mm -106.94 133.37 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.0 mm -107.45 -33.82 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.2 157.28 42.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 m -140.62 110.46 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 60.75 41.98 14.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.958 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 26.25 71.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p -139.32 116.45 11.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.87 0.367 . . . . 0.0 110.952 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.72 -75.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.62 112.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.9 m -120.42 32.12 6.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -169.44 106.79 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.913 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 t -171.48 161.74 6.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -92.21 168.36 11.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -59.41 -42.23 91.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.453 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 tp -55.29 -43.47 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.87 -40.14 94.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.256 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -65.68 -46.78 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.609 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.2 p -65.02 -41.29 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.019 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -38.37 87.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.102 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -47.39 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.453 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.4 HG21 ' HA ' ' A' ' 69' ' ' VAL . 2.0 tt -68.7 -37.89 78.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.64 -26.6 59.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.023 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 t -64.23 80.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.96 144.56 9.13 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 m -69.8 -49.26 54.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 120.49 36.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.06 133.87 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.93 117.44 30.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.03 127.56 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -70.02 131.23 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.406 ' CG1' ' CD1' ' A' ' 52' ' ' ILE . 27.0 m -126.86 169.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -140.61 127.87 21.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.96 -169.26 11.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.627 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.27 92.27 3.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.39 110.42 2.03 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.487 2.124 . . . . 0.0 112.343 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.41 -44.9 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.415 2.077 . . . . 0.0 112.369 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.87 49.36 0.85 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.617 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 112.379 -0.288 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -107.17 46.7 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.921 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -156.44 31.19 0.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.4 ttm -65.9 -32.18 73.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.73 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.65 -80.64 0.25 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.468 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.28 -76.37 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 110.762 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.72 131.14 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.135 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.74 138.58 40.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.7 154.17 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.33 139.75 37.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.79 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.4 m -134.05 144.29 35.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.3 mm -113.67 107.32 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 20' ' ' PHE . 15.9 pt -106.02 126.07 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.41 139.35 38.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 128.67 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -103.99 -169.59 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.81 -36.35 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.29 -43.84 66.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.14 76.06 1.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.561 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 13' ' ' ILE . 8.8 m-85 61.39 115.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.11 -44.97 4.91 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.553 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 142.79 36.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.337 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m -101.32 122.26 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.401 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 10.0 p -118.97 137.18 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.8 p -149.53 132.03 15.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.26 120.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.461 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.7 -73.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.5 t-20 -84.66 -53.04 0.5 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 86.2 Cg_endo -84.27 -167.49 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.725 2.284 . . . . 0.0 112.378 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -145.49 94.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.006 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -127.31 141.02 51.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.92 128.69 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.05 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.73 -30.33 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.17 146.25 47.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.951 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.6 129.71 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -66.92 110.55 3.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.806 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -91.81 44.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.43 35.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.591 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.47 -145.82 4.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.849 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.88 87.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.726 0.298 . . . . 0.0 111.401 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.47 85.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.8 tpt -72.42 -43.14 64.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.801 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -30.8 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.51 -15.85 47.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.73 56.96 3.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.6 t -98.39 158.5 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -118.88 148.68 42.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.04 129.11 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 33.42 32.8 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.586 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.95 133.93 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.846 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.3 mt -96.89 124.41 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.69 -43.85 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.181 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -138.29 150.36 46.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.955 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.19 106.19 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.173 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.29 43.6 10.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.803 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.98 27.56 70.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.495 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.42 79.66 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -30.56 70.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.12 151.59 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.133 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -134.64 171.72 13.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -119.51 178.54 4.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.99 -30.16 21.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.72 122.89 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 24' ' ' VAL . 19.2 t-80 -66.02 -36.5 83.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.834 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 mt -55.2 -42.91 73.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.662 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.57 -44.04 97.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.1 t -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.69 -43.72 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -65.43 -38.41 89.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.342 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -41.87 79.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.9 mt -71.61 -38.04 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -74.49 -27.13 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 85.2 p -63.33 80.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.44 144.41 4.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.584 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.7 p -71.63 -54.02 11.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -95.75 118.77 33.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.86 123.42 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.282 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.27 101.82 9.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.812 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 137.43 51.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.022 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 m -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.59 170.05 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.261 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -130.0 143.9 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.43 -178.11 42.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.588 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -137.92 119.17 10.53 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.612 0.244 . . . . 0.0 110.799 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.481 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 42.0 Cg_exo -55.79 -45.37 39.51 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.499 2.132 . . . . 0.0 112.428 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 86' ' ' PRO . 44.6 Cg_exo -56.44 164.5 5.41 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.397 2.065 . . . . 0.0 112.23 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.71 -64.35 3.87 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.522 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.898 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.762 0.315 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.88 146.39 49.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -129.1 130.25 46.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -80.59 129.75 34.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 45' ' ' GLY . 5.1 m -141.69 104.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.78 126.88 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.442 HG22 ' CE1' ' A' ' 20' ' ' PHE . 26.4 mm -98.02 140.36 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.51 127.56 56.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.35 140.8 43.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.23 -171.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -31.64 70.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -90.32 -37.17 14.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 177.86 16.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.444 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 72' ' ' ILE . 26.7 m-85 -60.09 123.84 18.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.68 -45.9 9.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.524 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 22' ' ' LEU . 4.0 pp -58.11 141.78 49.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.378 . . . . 0.0 110.967 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.83 144.74 50.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.795 HG12 ' HA ' ' A' ' 32' ' ' VAL . 30.3 m -122.1 156.38 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.995 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -149.49 132.13 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.54 124.09 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.31 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.412 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 5.0 m-20 -74.97 -60.64 1.17 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 74.2 Cg_endo -75.33 -168.08 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.184 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.533 HG12 HG13 ' A' ' 52' ' ' ILE . 30.4 t -152.95 111.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.001 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.74 141.79 44.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.839 HG23 HD11 ' A' ' 52' ' ' ILE . 23.7 t -77.28 124.75 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.526 ' O ' HG22 ' A' ' 48' ' ' THR . 24.4 pt20 -94.45 -42.54 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.978 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 p -122.85 153.25 39.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.44 142.62 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -68.69 99.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -69.0 129.77 40.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.83 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t0 60.05 32.7 21.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.65 -152.14 6.52 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.46 85.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.95 -47.31 72.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -36.3 81.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -31.09 62.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 13' ' ' ILE . . . -78.21 -15.82 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' HG11 ' A' ' 11' ' ' VAL . . . 85.58 51.76 3.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.59 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.53 147.26 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -119.44 149.22 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -73.17 128.12 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.962 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.01 34.84 36.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.76 150.54 21.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -90.69 136.47 33.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.903 HD13 HG12 ' A' ' 82' ' ' VAL . 18.5 mm -98.29 121.11 48.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.76 -49.21 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.76 161.56 34.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 80' ' ' LEU . 5.3 m -120.33 111.28 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 1.9 t30 59.94 41.33 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.66 73.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.529 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.78 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 t-80 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.982 0.42 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -55.42 -42.67 74.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.634 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.51 -43.97 97.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.277 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.659 HG12 HD11 ' A' ' 72' ' ' ILE . 24.5 t -63.85 -46.7 93.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 65' ' ' HIS . 29.8 t -60.63 -45.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.254 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HG3' HD23 ' A' ' 66' ' ' LEU . 5.5 mtmp? -64.47 -38.27 90.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.008 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -44.63 85.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.303 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.659 HD11 HG12 ' A' ' 68' ' ' VAL . 15.5 mt -68.96 -43.22 82.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.655 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.4 -12.97 60.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.369 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 p -44.35 -30.17 0.79 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.816 0.341 . . . . 0.0 111.597 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.23 156.88 27.01 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.547 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -57.09 -57.31 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -100.75 112.6 25.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -134.13 128.19 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 56' ' ' ASN . . . -70.28 143.89 51.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.61 HD12 HG12 ' A' ' 55' ' ' VAL . 4.1 tp -136.29 93.4 2.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.02 110.11 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.903 HG12 HD13 ' A' ' 52' ' ' ILE . 27.5 m -112.58 173.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.36 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -135.98 138.49 42.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.426 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.801 0.334 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 53' ' ' ILE . 1.4 mt-30 -125.22 154.35 41.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.97 130.24 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 103.62 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 11' ' ' VAL . 31.4 m -98.12 114.19 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.41 100.68 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.424 HG22 ' CE1' ' A' ' 20' ' ' PHE . 3.6 mp -91.34 133.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -106.31 124.3 49.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.88 137.58 56.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -116.0 -171.47 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -60.2 -31.48 70.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -81.98 -36.97 27.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.72 166.48 22.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.423 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 72' ' ' ILE . 23.8 m-85 -60.33 109.27 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.07 -29.78 64.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.76 126.39 29.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.78 139.08 38.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 32' ' ' VAL . 25.2 m -119.13 135.77 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.37 132.48 16.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.18 123.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.61 -76.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.311 . . . . 0.0 110.782 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -80.53 -60.56 0.46 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.823 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.0 Cg_endo -78.7 -168.05 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.56 2.173 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.81 HG12 HD12 ' A' ' 52' ' ' ILE . 19.8 t -145.89 96.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -125.51 145.11 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 24' ' ' VAL . 12.1 t -76.46 120.2 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -49.23 8.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.49 143.97 46.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 46' ' ' VAL . 28.4 m -136.42 136.18 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' CB ' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -64.59 114.45 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.709 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -97.27 40.79 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.42 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -176.36 34.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.683 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.65 -139.64 2.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.687 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.76 93.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.77 0.319 . . . . 0.0 111.324 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.778 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -59.29 -47.38 85.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -41.8 95.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -71.94 -29.95 64.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.4 -15.87 61.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.11 33.77 35.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.712 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 41' ' ' ALA . 12.2 p -90.22 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 111.024 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.72 163.21 14.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.56 126.52 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.728 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.88 29.06 35.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.372 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -80.2 141.08 35.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -93.82 134.62 35.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.81 HD12 HG12 ' A' ' 30' ' ' VAL . 25.0 mt -101.97 118.39 48.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.223 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.8 mp -85.9 -43.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.63 148.2 28.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.763 HG12 ' CB ' ' A' ' 80' ' ' LEU . 29.3 m -125.38 118.55 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 57.74 48.01 14.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.72 28.2 72.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.3 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.767 0.318 . . . . 0.0 110.915 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.894 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.8 t-80 . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.896 0.379 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.13 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.18 -44.13 97.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.386 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.698 HG12 HD11 ' A' ' 72' ' ' ILE . 34.4 t -64.08 -46.73 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.06 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 65' ' ' HIS . 19.1 t -60.56 -43.64 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.22 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.97 -39.39 90.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.284 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -47.92 75.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.698 HD11 HG12 ' A' ' 68' ' ' VAL . 14.7 mt -68.97 -40.55 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -74.64 -19.68 60.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.1 t -50.9 -28.94 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.322 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.53 158.35 27.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -46.8 81.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.1 m-85 -95.76 112.72 24.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.592 HG11 HG23 ' A' ' 72' ' ' ILE . 12.6 p -116.46 123.52 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.66 111.18 18.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.763 ' CB ' HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.84 133.87 50.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.4 m -79.33 116.29 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 52' ' ' ILE . 28.0 m -113.55 175.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.707 ' HB2' HD11 ' A' ' 53' ' ' ILE . 35.0 tt0 -132.69 130.88 40.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.528 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 7' ' ' VAL . 22.4 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.714 0.293 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.3 154.71 33.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.12 134.99 33.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.3 135.27 33.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.59 142.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 ' HB2' ' A' ' 79' ' ' ALA . 22.6 mt -118.16 113.89 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.14 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.515 HG22 ' CB ' ' A' ' 44' ' ' ALA . 27.6 pt -104.75 143.87 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 19.3 mt-30 -106.15 143.14 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 138.34 33.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -102.8 -168.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -58.51 -34.44 70.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.79 -35.47 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.62 -109.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 72' ' ' ILE . 32.0 m-85 -125.71 132.99 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -39.87 36.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.48 139.58 58.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.329 . . . . 0.0 111.043 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 m -103.22 130.77 50.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 32' ' ' VAL . 33.7 m -119.07 140.7 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.351 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.6 131.88 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.808 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.75 112.49 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.624 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.63 -74.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -80.17 -60.94 0.46 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.734 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 85.8 Cg_endo -78.03 -169.46 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.161 . . . . 0.0 112.324 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.991 HG12 HD12 ' A' ' 52' ' ' ILE . 21.7 t -144.0 103.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.025 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -138.41 148.6 44.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 24' ' ' VAL . 25.2 t -84.81 132.74 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -93.65 -34.81 13.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.051 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.87 152.27 40.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 46' ' ' VAL . 30.4 m -135.98 135.38 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.4 tptp -59.8 113.88 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -92.46 44.12 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -177.15 35.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.99 -148.63 5.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.54 79.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.737 0.304 . . . . 0.0 111.244 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . . . -59.7 -47.42 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.7 tpt -69.9 -50.8 38.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -30.48 70.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' A' ' 13' ' ' ILE . . . -71.34 -15.82 62.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.06 28.93 32.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.445 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 35' ' ' VAL . 9.4 t -84.79 151.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.71 145.19 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 48' ' ' THR . 1.3 t -69.25 131.43 44.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 30.28 36.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -93.81 149.36 21.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -96.43 142.52 28.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.991 HD12 HG12 ' A' ' 30' ' ' VAL . 32.2 mt -106.75 125.56 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 81' ' ' THR . 4.0 mt -92.43 -49.12 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.02 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -151.07 157.07 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 80' ' ' LEU . 30.1 t -128.44 114.31 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.87 53.14 5.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.15 27.59 60.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.684 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.6 t-80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.715 0.293 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.84 -41.27 70.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.54 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -42.47 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.866 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.78 HG12 ' CD1' ' A' ' 72' ' ' ILE . 31.4 t -63.92 -46.63 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.212 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.9 t -63.19 -44.15 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.509 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -65.8 -38.41 88.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.475 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.01 -45.27 70.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.78 ' CD1' HG12 ' A' ' 68' ' ' VAL . 19.8 mt -69.69 -35.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -72.8 -29.33 63.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -64.7 80.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.55 144.32 6.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -54.45 14.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.3 m-85 -98.28 119.82 37.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.8 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.0 p -124.79 115.38 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB2' HG12 ' A' ' 12' ' ' ILE . . . -105.86 105.36 15.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -112.07 139.92 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.57 HG22 HD12 ' A' ' 53' ' ' ILE . 63.6 m -84.97 121.09 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 52' ' ' ILE . 4.2 m -114.53 175.27 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.539 ' HB2' HD11 ' A' ' 53' ' ' ILE . 25.3 tt0 -138.39 150.4 46.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.523 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.771 0.32 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -121.44 144.36 48.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -148.5 146.59 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 p -107.36 137.28 45.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.25 125.76 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -103.03 108.44 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.079 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.75 137.42 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.441 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.5 OUTLIER -109.76 139.97 44.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -72.67 143.05 48.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -110.91 -171.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.62 -31.43 71.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -96.05 -35.35 11.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.5 179.2 15.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.533 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.512 ' CE2' HG22 ' A' ' 72' ' ' ILE . 36.5 m-85 -60.67 109.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 110.926 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.41 -36.66 69.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.538 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.5 132.68 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.019 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.63 134.09 49.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.794 HG12 HG22 ' A' ' 32' ' ' VAL . 29.2 m -115.51 148.21 18.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.9 t -148.7 138.69 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.24 115.98 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 -71.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.733 0.301 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.402 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -80.06 -60.0 0.51 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.783 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -78.48 -168.41 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.579 2.186 . . . . 0.0 112.355 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.927 HG12 HD12 ' A' ' 52' ' ' ILE . 21.5 t -148.33 95.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -123.13 148.37 45.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.794 HG22 HG12 ' A' ' 24' ' ' VAL . 19.6 t -90.22 126.63 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.004 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -95.29 -42.61 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -119.33 145.18 46.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.61 144.62 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 37.9 tttt -66.14 114.38 5.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.87 139.44 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t0 59.17 30.05 19.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.76 -158.7 8.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.23 85.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.758 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.08 -47.33 68.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.07 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -48.2 76.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -30.41 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.83 62.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.455 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.42 34.6 11.78 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 41' ' ' ALA . 14.0 p -79.93 158.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 46' ' ' VAL . 14.9 mt-30 -125.66 138.05 53.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.823 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 t -70.34 130.45 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.93 47.96 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.672 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -88.32 138.35 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.68 135.33 33.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.927 HD12 HG12 ' A' ' 30' ' ' VAL . 18.6 mt -94.31 125.24 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 83' ' ' GLN . 33.9 mt -98.68 -34.97 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -142.99 142.02 31.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 52' ' ' ILE . 21.4 t -125.13 117.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 59.41 30.77 20.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.5 27.3 67.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.547 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 58' ' ' THR . 8.5 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.096 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.81 ' O ' HG23 ' A' ' 69' ' ' VAL . 34.0 t-80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.757 0.313 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.82 -43.16 76.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.799 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -62.58 -44.1 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.401 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.846 HG12 HD11 ' A' ' 72' ' ' ILE . 25.5 t -64.16 -46.66 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.118 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 65' ' ' HIS . 35.2 t -60.67 -43.23 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.137 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -65.71 -38.37 89.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.66 81.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.846 HD11 HG12 ' A' ' 68' ' ' VAL . 9.4 mt -70.79 -36.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.739 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -74.27 -20.59 60.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -27.9 5.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.73 147.57 18.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.51 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 p -59.63 -43.65 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.4 m-85 -102.97 115.24 30.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 78' ' ' VAL . 12.7 p -114.88 113.42 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.181 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.1 104.46 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD12 HG13 ' A' ' 82' ' ' VAL . 3.6 pp -123.11 134.03 54.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -84.65 122.63 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' A' ' 52' ' ' ILE . 12.7 m -116.81 169.19 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.294 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.714 ' HB2' HD11 ' A' ' 53' ' ' ILE . 6.6 tt0 -135.43 134.63 39.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.647 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.833 0.349 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -122.45 154.3 37.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.846 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -139.49 130.28 26.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.0 108.11 19.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.014 HG21 HG22 ' A' ' 46' ' ' VAL . 9.3 p -96.97 143.66 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.7 mm -119.27 95.42 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.053 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.608 HD13 HD21 ' A' ' 22' ' ' LEU . 3.3 mt -86.34 130.01 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.35 127.36 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.838 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -65.26 131.64 47.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -102.5 -169.1 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.814 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -59.5 -29.87 68.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.22 -29.97 15.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.24 -118.66 3.33 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.447 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 72' ' ' ILE . 48.0 m-85 -116.42 115.54 26.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.56 -44.19 73.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.596 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.608 HD21 HD13 ' A' ' 13' ' ' ILE . 4.1 pp -59.73 139.43 57.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -112.58 137.4 50.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.838 HG12 ' HA ' ' A' ' 32' ' ' VAL . 30.1 m -129.31 142.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.258 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -149.49 132.02 15.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.11 140.46 4.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.605 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -73.7 -74.21 0.19 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.778 0.323 . . . . 0.0 110.805 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.24 -56.79 0.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.691 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.03 -168.15 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.571 2.18 . . . . 0.0 112.176 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.813 HG13 ' HB ' ' A' ' 52' ' ' ILE . 8.6 p -155.71 106.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -127.69 154.85 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.838 ' HA ' HG12 ' A' ' 24' ' ' VAL . 4.5 t -91.19 120.34 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -89.42 -31.08 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 144.33 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 46' ' ' VAL . 31.2 m -132.35 139.36 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -62.54 107.82 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -73.46 130.53 40.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.69 30.42 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.1 -157.42 8.85 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -39.33 89.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -66.02 -47.35 74.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.6 tpt -69.33 -41.74 76.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -67.95 -29.69 68.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.689 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -75.4 -15.92 60.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.324 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.37 46.24 3.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.491 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.014 HG22 HG21 ' A' ' 11' ' ' VAL . 16.2 t -106.92 143.84 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.832 0.348 . . . . 0.0 111.042 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -110.06 163.14 13.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 116.98 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.24 37.13 11.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.598 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.574 ' OD2' HG11 ' A' ' 82' ' ' VAL . 8.9 p-10 -96.83 154.02 17.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -95.42 137.31 34.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.813 ' HB ' HG13 ' A' ' 30' ' ' VAL . 12.8 mt -99.7 117.48 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.082 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.69 -42.5 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 147.06 30.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 52' ' ' ILE . 21.5 t -118.77 111.64 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.96 41.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.83 73.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.729 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 67' ' ' GLU . 3.0 pp -55.24 -43.07 74.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.766 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.42 -44.02 97.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.993 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 72' ' ' ILE . 24.9 t -62.78 -46.67 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.114 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.9 t -61.7 -44.13 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.564 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.9 -39.74 90.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -45.9 73.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.462 HG13 HG21 ' A' ' 78' ' ' VAL . 20.5 tt -68.76 -35.76 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -70.43 -32.37 69.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.76 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.8 t -71.59 73.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.82 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.75 144.34 4.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.539 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.22 -30.78 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -108.85 132.99 53.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.4 p -129.94 112.43 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.45 103.48 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.62 HD12 HG13 ' A' ' 82' ' ' VAL . 3.1 pp -121.07 124.76 45.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.3 m -79.24 126.93 31.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.62 HG13 HD12 ' A' ' 80' ' ' LEU . 30.6 m -118.59 169.71 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.33 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -142.8 144.05 32.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.59 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.824 0.345 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.32 129.96 50.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -127.82 137.96 52.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.28 143.33 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.505 HG21 HG22 ' A' ' 46' ' ' VAL . 25.5 m -133.43 126.4 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.97 107.23 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.49 HD12 ' H ' ' A' ' 13' ' ' ILE . 4.0 mp -94.04 138.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 3.1 mp0 -102.07 124.8 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -71.58 133.59 45.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -99.51 -170.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.67 -31.56 69.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -88.58 -44.23 10.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.63 -158.54 23.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.509 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.43 ' CD2' HG12 ' A' ' 72' ' ' ILE . 68.7 m-85 -86.72 118.13 25.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.51 -26.98 58.21 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 pp -58.47 138.95 56.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -107.0 134.26 50.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 68' ' ' VAL . 30.8 t -115.61 135.55 55.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.402 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 37.3 t -149.42 132.17 15.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.04 125.41 0.92 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.94 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -78.78 -61.06 0.54 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.3 Cg_endo -76.61 -167.9 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.848 HG12 HD12 ' A' ' 52' ' ' ILE . 21.4 t -140.86 110.84 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 23.1 p90 -136.39 150.25 48.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.644 ' CG2' HD11 ' A' ' 52' ' ' ILE . 21.5 t -91.11 120.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -72.34 -58.97 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 t -122.59 157.97 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.681 HG11 HG12 ' A' ' 46' ' ' VAL . 32.4 m -135.04 145.33 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.0 ttpm? -56.84 98.95 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 140.09 54.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER 55.59 29.89 14.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -136.5 -160.12 8.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.689 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.4 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.532 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . . . -69.29 -47.71 63.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.634 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 39' ' ' GLY . 2.4 ppp? -70.6 -34.73 72.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -31.81 70.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.72 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.375 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 27.29 11.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.52 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.681 HG12 HG11 ' A' ' 35' ' ' VAL . 16.3 t -88.54 144.51 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 111.046 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.71 158.02 19.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.68 122.06 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.21 43.24 39.97 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.407 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -98.79 156.76 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.848 HD12 HG12 ' A' ' 30' ' ' VAL . 19.7 mt -103.47 124.4 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.5 mp -97.8 -32.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -137.68 141.91 41.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 55' ' ' VAL . 26.3 m -124.59 104.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.516 ' OD1' HG23 ' A' ' 78' ' ' VAL . 97.8 m-20 61.03 43.98 10.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.81 28.21 69.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.18 -179.763 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 24' ' ' VAL . 11.1 t-80 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.78 0.324 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 69' ' ' VAL . 3.0 mt -55.46 -43.03 75.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.741 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.0 mm-40 -66.08 -38.8 89.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 24' ' ' VAL . 30.0 t -66.9 -46.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.502 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.505 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.8 p -66.16 -41.43 89.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.167 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 69' ' ' VAL . 14.1 ttmm -66.33 -39.46 89.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.366 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.8 mm? -68.9 -46.94 67.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.553 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 68' ' ' VAL . 2.3 tt -67.97 -35.67 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.893 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 59.9 p -66.62 78.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.73 145.97 6.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -71.04 -46.66 61.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CZ ' ' HG2' ' A' ' 14' ' ' GLN . 2.4 m-85 -95.76 121.11 37.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.516 HG23 ' OD1' ' A' ' 56' ' ' ASN . 11.6 p -117.14 141.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.83 117.82 14.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.2 pp -135.98 134.35 38.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.8 m -75.75 123.94 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 52' ' ' ILE . 10.3 m -123.45 175.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.216 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.656 ' HB2' HD11 ' A' ' 53' ' ' ILE . 36.6 tt0 -142.81 135.6 27.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.554 179.968 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -120.6 152.29 38.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 130.3 41.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.89 103.3 13.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -93.66 129.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.87 106.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.61 129.4 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 77' ' ' TYR . 3.5 pt20 -97.0 127.42 42.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.791 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -65.27 132.34 48.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -96.25 -170.92 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -60.7 -32.36 71.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -92.99 -36.54 12.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.0 -105.75 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.502 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 72' ' ' ILE . 94.9 m-85 -129.78 111.4 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.375 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.76 68.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.61 140.42 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 m -101.31 137.5 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.471 HG12 HG22 ' A' ' 32' ' ' VAL . 20.3 m -134.14 138.43 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.07 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.2 t -148.76 132.62 17.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.86 117.55 0.56 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.23 -77.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-80 -79.33 -61.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.7 Cg_endo -76.42 -168.34 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.543 2.162 . . . . 0.0 112.326 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.559 HG12 HD12 ' A' ' 52' ' ' ILE . 14.7 t -145.53 110.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -138.27 154.09 49.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.174 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 24' ' ' VAL . 15.5 t -95.92 139.14 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.06 -35.27 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.12 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -133.75 153.81 51.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.069 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 14.2 m -136.37 139.86 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -56.21 117.49 3.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.55 126.46 29.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t0 55.34 30.37 14.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.37 -149.23 7.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 14' ' ' GLN . . . -60.97 -37.55 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -71.13 -47.51 57.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.315 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.04 -44.6 96.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -31.36 72.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.49 -15.88 60.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.479 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.48 33.06 40.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 47' ' ' GLN . 21.7 t -71.14 158.99 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.036 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' HG12 ' A' ' 46' ' ' VAL . 2.2 mt-30 -123.06 119.61 30.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.748 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.81 131.15 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 30.99 56.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.515 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -94.38 152.36 18.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -97.03 134.07 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.57 ' CG1' HG12 ' A' ' 82' ' ' VAL . 5.9 mt -101.3 123.92 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 83' ' ' GLN . 2.3 mt -97.84 -38.65 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -129.07 149.3 50.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.026 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.917 HG12 HD23 ' A' ' 80' ' ' LEU . 29.9 m -119.18 112.29 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.039 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.46 38.56 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.86 27.0 73.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.336 . . . . 0.0 110.956 -179.896 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.807 ' O ' HG23 ' A' ' 69' ' ' VAL . 20.3 t-80 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.769 0.319 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.27 -43.21 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -44.26 94.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.826 HG12 HD11 ' A' ' 72' ' ' ILE . 27.3 t -62.82 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.127 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.5 t -61.73 -45.23 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.192 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -62.66 -38.3 89.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.129 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -42.71 74.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 HG12 ' A' ' 68' ' ' VAL . 15.2 mt -68.96 -36.02 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.773 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -31.45 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.693 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.78 78.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.91 145.43 5.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -78.09 -44.87 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -106.93 112.74 25.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.91 136.66 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.12 106.43 10.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.073 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.917 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -106.64 127.32 53.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.1 m -75.1 112.85 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.57 HG12 ' CG1' ' A' ' 52' ' ' ILE . 29.9 m -112.91 175.74 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.653 ' HB2' HD11 ' A' ' 53' ' ' ILE . 6.0 tt0 -142.67 141.49 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.513 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.879 0.371 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -124.52 149.61 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.06 135.57 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.47 131.99 34.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 44' ' ' ALA . 4.4 m -135.1 115.83 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.96 119.17 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -89.53 135.35 26.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.082 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -113.15 121.4 44.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -72.34 145.07 48.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.24 -168.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.814 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.65 -30.52 65.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -87.51 -32.72 19.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.06 -175.71 25.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -62.43 103.61 0.42 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.28 79.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.607 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.2 pp -59.58 133.92 56.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 129.14 47.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.3 141.69 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.9 m -149.34 132.15 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.38 119.5 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -58.99 -74.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.29 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -79.96 -61.49 0.45 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.941 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -76.28 -168.3 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.459 2.106 . . . . 0.0 112.246 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.857 HG12 HD12 ' A' ' 52' ' ' ILE . 6.3 t -150.46 100.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.033 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -123.37 144.03 49.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.22 123.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -86.37 -48.48 8.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -130.11 155.9 45.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 46' ' ' VAL . 22.3 m -136.39 137.53 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 113.42 3.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.76 134.89 47.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 58.43 28.55 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.19 -162.1 10.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.425 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.83 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.46 56.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.218 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -34.73 63.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.45 -31.39 65.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -74.25 -15.82 60.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.401 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.06 26.91 11.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 35' ' ' VAL . 17.1 t -86.61 148.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.704 0.288 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -125.81 147.66 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 48' ' ' THR . 1.2 t -67.22 131.04 44.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.25 38.54 33.97 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.538 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.67 27.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.65 130.34 38.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.857 HD12 HG12 ' A' ' 30' ' ' VAL . 13.4 mt -94.21 121.87 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.991 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.694 HD11 ' HB2' ' A' ' 83' ' ' GLN . 31.0 mt -88.07 -48.32 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -136.72 161.98 34.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 80' ' ' LEU . 25.5 t -136.36 109.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 61.56 49.28 5.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.427 . . . . 0.0 110.774 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.59 26.52 59.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.772 ' O ' HG23 ' A' ' 69' ' ' VAL . 8.9 t-80 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.888 0.375 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.1 -42.73 73.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.617 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -61.72 -44.03 97.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.082 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.32 -46.62 95.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.087 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.1 t -60.86 -44.49 97.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.41 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -38.35 88.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.327 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -67.14 -47.59 70.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.489 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.53 HG13 HG11 ' A' ' 78' ' ' VAL . 16.4 tt -68.15 -35.95 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.684 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE2' HG12 ' A' ' 69' ' ' VAL . 6.0 mttm -71.64 -29.32 64.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -64.37 80.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.989 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.64 146.66 7.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.529 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -69.76 -54.14 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.15 129.86 43.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.856 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.53 HG11 HG13 ' A' ' 72' ' ' ILE . 10.3 p -147.12 118.48 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.34 142.79 35.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.73 HD23 HG21 ' A' ' 52' ' ' ILE . 2.1 mp -143.69 108.04 4.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -77.36 112.21 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.588 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 52' ' ' ILE . 30.5 m -112.58 165.82 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.463 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.694 ' HB2' HD11 ' A' ' 53' ' ' ILE . 25.1 tt0 -142.81 150.48 40.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.34 145.07 47.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.9 ttm-85 -142.44 133.0 25.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.73 120.91 24.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 44' ' ' ALA . 12.4 p -114.41 119.46 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.067 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mt -106.92 105.61 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.591 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . 3.5 mt -87.89 132.35 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -67.52 149.97 49.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -115.28 -172.78 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.82 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.86 -31.28 69.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.71 -49.04 7.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.88 176.0 14.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.422 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CE1' HG22 ' A' ' 13' ' ' ILE . 16.2 m-85 -64.43 108.04 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.346 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.87 -37.37 94.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.499 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -59.46 142.08 53.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.802 0.334 . . . . 0.0 110.913 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.56 140.62 49.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.78 148.48 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 4.7 t -149.39 132.04 15.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.56 122.33 0.6 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.482 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.3 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.951 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.66 -60.34 0.88 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.851 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.4 -169.48 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.286 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.562 HG12 HD12 ' A' ' 52' ' ' ILE . 4.2 t -150.57 115.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 4.7 p90 -136.06 144.61 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.18 120.83 28.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -89.31 -45.85 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -126.75 151.85 47.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.42 129.89 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.54 99.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.35 130.76 44.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 58.46 36.75 25.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.67 -144.78 4.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.455 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . . . -60.97 -45.84 93.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.116 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.746 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -62.55 -47.39 84.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.121 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -29.85 70.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.79 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -72.24 -37.79 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -74.05 -15.78 61.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.389 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.31 27.45 33.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 41' ' ' ALA . 11.4 p -85.16 147.11 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.704 0.287 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -113.45 164.65 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -79.75 126.63 31.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 38.45 27.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 152.74 20.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 134.35 39.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.562 HD12 HG12 ' A' ' 30' ' ' VAL . 7.8 mt -107.01 114.42 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 83' ' ' GLN . 4.1 mp -78.7 -47.13 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 150.86 43.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG12 ' CB ' ' A' ' 80' ' ' LEU . 4.5 m -132.76 111.6 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 60.35 28.86 18.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.03 24.3 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.662 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.749 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.857 0.36 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.767 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.13 -44.14 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.13 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 72' ' ' ILE . 4.4 t -62.74 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.199 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 65' ' ' HIS . 31.8 t -62.09 -44.63 99.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.214 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -63.21 -38.43 91.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.222 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.57 -36.38 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.562 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 68' ' ' VAL . 55.2 mt -73.55 -41.86 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -74.24 -25.96 59.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.43 77.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.925 0.393 . . . . 0.0 110.888 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.93 153.46 8.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.545 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -78.44 -36.3 45.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -106.05 141.45 37.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.1 p -137.26 125.81 34.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.065 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 111.09 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.7 HD12 HG13 ' A' ' 82' ' ' VAL . 2.5 pp -137.09 124.72 22.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.4 m -74.51 124.49 26.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 80' ' ' LEU . 30.5 m -117.27 175.59 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.755 ' HB2' HD11 ' A' ' 53' ' ' ILE . 5.7 tt0 -137.64 138.81 39.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.391 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.769 0.318 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.51 126.37 52.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.89 148.75 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.59 159.57 26.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.901 HG21 HG22 ' A' ' 46' ' ' VAL . 10.4 p -146.18 108.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.075 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.08 111.89 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 22' ' ' LEU . 6.5 mt -89.24 144.44 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -109.37 128.41 55.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 12.7 ttmt -82.46 115.32 21.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -90.33 -168.22 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.775 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.51 -30.33 65.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.21 -46.81 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.33 -118.08 1.73 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.554 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 39.6 m-85 -124.29 113.73 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.61 60.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.774 HD23 HG12 ' A' ' 35' ' ' VAL . 4.7 mp -53.81 122.37 9.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 m -101.31 122.28 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.46 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 32' ' ' VAL . 35.7 m -124.1 149.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.373 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -149.33 132.08 15.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.86 111.69 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.587 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.3 -73.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -74.65 -60.68 1.26 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 73.8 Cg_endo -75.51 -168.13 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.55 2.166 . . . . 0.0 112.102 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 HD12 ' A' ' 52' ' ' ILE . 4.9 p -159.46 104.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -134.25 154.24 51.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.782 ' HA ' HG12 ' A' ' 24' ' ' VAL . 10.5 t -92.03 137.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.59 -52.2 2.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.8 t -122.48 149.43 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.774 HG12 HD23 ' A' ' 22' ' ' LEU . 27.2 m -136.41 153.39 31.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 94.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.842 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.13 139.3 58.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 58.29 30.98 20.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.15 -147.76 5.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.498 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.86 96.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -64.03 -47.43 80.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.044 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.34 -35.12 79.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -74.21 -31.49 62.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.53 -15.71 59.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.22 52.6 3.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.901 HG22 HG21 ' A' ' 11' ' ' VAL . 8.8 t -92.45 160.55 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 110.972 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 46' ' ' VAL . 14.2 mp0 -128.9 114.78 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.694 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.91 131.13 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.23 30.82 58.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.627 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -97.8 154.21 17.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 110.976 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -92.21 142.46 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.711 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 30' ' ' VAL . 36.3 mt -106.86 115.4 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.657 HD11 ' HG3' ' A' ' 83' ' ' GLN . 3.2 mp -80.27 -47.3 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 144.57 32.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 71' ' ' LEU . 6.9 m -121.93 111.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' OD1' HG23 ' A' ' 78' ' ' VAL . 0.8 OUTLIER 60.15 30.0 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.895 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.06 -24.71 30.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.845 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -43.19 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.741 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -62.62 -44.1 97.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.343 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.05 -46.5 93.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.114 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 65' ' ' HIS . 22.0 t -60.92 -44.43 97.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -65.69 -38.35 88.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.099 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.493 HD13 ' CG2' ' A' ' 55' ' ' VAL . 3.8 mt -66.55 -47.29 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.529 ' CD1' HG11 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -68.61 -35.93 72.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.819 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -29.32 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.41 80.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.38 153.59 11.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.601 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -67.8 -42.21 81.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.64 150.27 25.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.947 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 72' ' ' ILE . 11.4 p -145.88 122.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.5 109.49 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -125.03 139.95 53.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m -90.34 124.21 34.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.634 HG12 HG12 ' A' ' 52' ' ' ILE . 30.0 m -118.92 172.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.657 ' HG3' HD11 ' A' ' 53' ' ' ILE . 21.5 mt-30 -142.83 136.37 28.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.549 -179.921 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.91 0.385 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -122.69 133.39 54.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.778 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 136.56 21.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.158 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.42 142.91 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 m -142.85 134.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.277 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 79' ' ' ALA . 21.1 mt -96.1 117.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.037 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.885 HD13 HD21 ' A' ' 22' ' ' LEU . 20.8 mt -86.32 127.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.23 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -101.9 130.31 48.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.74 150.06 44.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.32 -168.13 1.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.734 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -30.03 65.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -100.58 -35.72 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.83 -137.27 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.519 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.42 97.31 9.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.44 -27.86 63.97 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 13' ' ' ILE . 3.6 pp -63.93 133.69 53.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -103.33 137.54 41.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 32' ' ' VAL . 27.0 m -132.5 142.92 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -149.52 132.13 15.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.56 112.93 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.83 -54.78 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 6.4 m-20 -98.46 -63.9 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -79.99 -166.42 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.437 2.092 . . . . 0.0 112.278 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.931 HG12 HD12 ' A' ' 52' ' ' ILE . 18.4 t -143.55 110.55 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.06 155.03 48.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.022 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.787 ' HA ' HG12 ' A' ' 24' ' ' VAL . 23.2 t -92.56 120.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -31.07 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.48 148.46 39.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.581 HG11 ' CG1' ' A' ' 46' ' ' VAL . 18.0 m -136.49 148.51 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.023 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -61.16 105.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.36 135.3 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 62.05 25.37 15.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.09 -150.08 6.29 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.3 95.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -61.5 -46.81 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.093 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.02 84.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ttp85 -62.03 -33.39 74.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.968 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.35 -15.88 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 31.75 19.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.546 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.581 ' CG1' HG11 ' A' ' 35' ' ' VAL . 21.3 t -82.38 157.21 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' N ' HG12 ' A' ' 46' ' ' VAL . 7.3 mt-30 -122.8 145.53 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 123.73 25.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 34.31 22.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.24 147.53 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.788 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -90.94 140.47 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.931 HD12 HG12 ' A' ' 30' ' ' VAL . 29.8 mt -104.93 130.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -102.94 -49.11 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.066 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -125.03 142.08 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.898 HG12 HD23 ' A' ' 80' ' ' LEU . 27.5 m -114.68 107.33 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.181 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' CG ' HG13 ' A' ' 78' ' ' VAL . 3.7 t-20 59.94 43.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.52 27.96 71.81 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.96 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.787 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.8 t-160 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.838 0.352 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.8 mt -55.08 -43.09 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.731 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.91 -44.11 97.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.123 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.469 HG12 HD11 ' A' ' 72' ' ' ILE . 23.3 t -63.77 -46.75 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.128 0.489 . . . . 0.0 110.102 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 65' ' ' HIS . 32.1 t -60.07 -44.5 95.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.25 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -65.85 -38.47 88.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.185 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.2 -47.7 75.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.602 ' O ' HG21 ' A' ' 78' ' ' VAL . 32.5 mt -68.04 -42.38 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.617 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -74.64 -14.9 60.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 p -48.22 -28.22 2.9 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.678 0.275 . . . . 0.0 111.402 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.99 150.02 20.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.621 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 p -64.23 -51.24 64.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.835 0.35 . . . . 0.0 110.78 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.7 112.62 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.618 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 72' ' ' ILE . 21.7 t -131.26 129.49 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.354 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.576 ' HB2' HG12 ' A' ' 12' ' ' ILE . . . -110.91 103.46 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.898 HD23 HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -110.05 128.76 55.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.07 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -79.74 121.84 25.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.438 HG12 HG12 ' A' ' 52' ' ' ILE . 15.9 m -112.6 172.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -141.93 137.84 31.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.513 -179.949 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.794 0.33 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 129.64 52.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -120.93 137.66 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 t -82.7 123.94 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 44' ' ' ALA . 17.4 m -112.0 126.9 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.3 mt -98.13 104.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.758 HG21 HD21 ' A' ' 22' ' ' LEU . 18.5 mt -86.89 116.09 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.41 135.9 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 146.41 54.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -112.48 -174.19 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.82 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -60.05 -30.66 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -93.78 -42.55 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.2 72.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 63.21 144.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.81 -27.15 3.61 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.557 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -59.3 138.41 57.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.2 m -102.9 126.4 50.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 31' ' ' PHE . 12.3 p -125.43 137.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 p -149.45 132.16 15.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.52 126.97 1.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.525 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.82 -77.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.449 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -88.21 -52.3 0.39 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.582 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 6.9 Cg_exo -73.21 -166.75 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.826 2.35 . . . . 0.0 111.846 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.838 HG12 HD12 ' A' ' 52' ' ' ILE . 21.8 t -154.29 95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 24' ' ' VAL . 7.6 p90 -119.95 146.8 45.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.409 ' CG2' HD11 ' A' ' 52' ' ' ILE . 21.2 t -90.47 120.67 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.421 ' O ' HG22 ' A' ' 48' ' ' THR . 3.0 tt0 -79.37 -55.15 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -126.6 157.91 37.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.657 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 18.2 m -136.33 139.86 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tptp -59.74 109.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.81 131.73 44.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t70 59.92 31.45 20.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.27 -150.67 6.23 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.517 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.95 87.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.816 0.341 . . . . 0.0 111.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -67.29 -47.26 71.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.151 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.9 tpt -64.32 -49.07 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -31.58 70.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.514 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -72.24 -15.77 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.45 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.492 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.491 HG22 HG21 ' A' ' 11' ' ' VAL . 20.5 t -79.1 158.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' HG12 ' A' ' 46' ' ' VAL . 10.8 mp0 -125.31 141.99 51.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.04 128.1 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.61 48.4 56.64 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.2 p30 -100.92 174.67 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.58 133.31 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.838 HD12 HG12 ' A' ' 30' ' ' VAL . 31.1 mt -105.68 114.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.16 -30.09 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -135.82 143.1 44.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.559 HG12 HD23 ' A' ' 80' ' ' LEU . 16.6 m -126.71 107.18 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.783 ' CG ' HG23 ' A' ' 78' ' ' VAL . 15.2 t30 60.4 32.54 20.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.85 26.25 71.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.145 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.759 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 t-80 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.888 0.375 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.32 -43.07 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.136 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.777 HG12 HD11 ' A' ' 72' ' ' ILE . 25.3 t -62.61 -46.57 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.9 t -61.45 -46.88 95.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.339 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -62.24 -38.3 88.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 71' ' ' LEU . 6.2 tt -68.32 -41.83 80.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.437 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.777 HD11 HG12 ' A' ' 68' ' ' VAL . 15.7 mt -70.63 -35.99 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.803 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -27.52 62.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.32 80.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.19 147.21 7.14 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.403 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.0 m -59.53 -61.39 2.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.81 128.47 56.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.853 HG13 HD11 ' A' ' 80' ' ' LEU . 10.4 p -113.09 140.23 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.29 101.77 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.853 HD11 HG13 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -113.78 126.89 55.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.6 m -71.49 112.8 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.771 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 83' ' ' GLN . 11.9 p -113.48 159.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 82' ' ' VAL . 48.4 tt0 -132.48 144.46 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.502 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.63 133.34 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.4 ttp85 -144.82 130.89 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.3 m -80.57 144.36 32.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.17 137.46 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.6 mp -116.59 117.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.73 143.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.576 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 31.5 mt-30 -112.92 128.71 56.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -65.45 143.84 57.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.02 -170.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -59.69 -29.21 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.999 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.06 -50.17 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.29 -128.07 2.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 62.0 m-85 -117.34 114.13 23.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.44 -29.96 65.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.418 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 41' ' ' ALA . 1.9 mp -55.52 113.45 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 m -101.2 122.35 43.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 31' ' ' PHE . 9.2 p -130.14 141.5 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -149.34 135.67 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.43 138.89 3.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.71 -79.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.29 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -78.2 -61.26 0.59 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' O ' HG13 ' A' ' 30' ' ' VAL . 72.4 Cg_endo -76.4 -167.43 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.126 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.754 HG23 ' HB ' ' A' ' 52' ' ' ILE . 3.0 m -157.53 104.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.214 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.762 ' O ' HG23 ' A' ' 24' ' ' VAL . 18.0 p90 -123.05 136.71 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 22' ' ' LEU . 26.3 t -81.98 120.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -87.27 -29.29 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 148.32 51.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.242 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.433 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 31.6 m -136.67 153.48 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 7.9 tttp -68.73 116.56 9.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.9 134.9 35.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 55.76 32.97 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.975 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -137.17 -144.63 4.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -61.04 -44.68 97.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.776 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -64.4 -47.28 79.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -38.66 91.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -71.22 -30.75 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . -75.18 -15.82 60.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.415 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' O ' ' NE2' ' A' ' 47' ' ' GLN . . . 82.12 38.85 12.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.582 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 41' ' ' ALA . 11.5 p -96.32 153.99 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 110.95 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 45' ' ' GLY . 19.7 mp0 -120.19 141.44 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -60.97 132.39 53.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.34 47.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.188 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.53 146.92 26.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -92.15 132.5 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.787 ' HA ' HG12 ' A' ' 82' ' ' VAL . 4.0 mt -97.08 123.86 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.105 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 81' ' ' THR . 4.3 mt -91.94 -42.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.026 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HG3' HG22 ' A' ' 53' ' ' ILE . 25.1 mttp -148.42 142.99 26.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.83 118.87 58.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.78 32.62 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.16 26.87 69.71 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.651 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.721 0.296 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.7 pp -55.38 -43.61 75.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.101 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.45 ' N ' HD12 ' A' ' 66' ' ' LEU . 3.0 tp10 -65.5 -39.34 91.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.279 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 72' ' ' ILE . 30.2 t -65.62 -46.84 88.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.1 p -65.39 -41.42 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.197 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 2.5 mptp? -66.06 -40.46 90.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.261 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' HG3' ' A' ' 67' ' ' GLU . 2.3 mm? -67.66 -47.48 69.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 68' ' ' VAL . 7.2 tt -68.48 -35.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.869 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -73.24 -28.81 62.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 p -68.83 72.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.819 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.14 144.01 7.71 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.0 p -70.15 -30.92 68.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -95.98 117.39 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.89 133.24 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.82 113.1 10.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.746 HD12 HG13 ' A' ' 82' ' ' VAL . 3.3 pp -126.32 133.59 51.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.433 HG22 HD12 ' A' ' 53' ' ' ILE . 60.8 m -76.02 126.08 30.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 52' ' ' ILE . 14.7 m -127.1 175.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -134.17 132.54 39.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -97.53 138.26 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.791 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -141.41 139.38 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.1 m -106.62 142.6 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.668 ' CG1' HG22 ' A' ' 46' ' ' VAL . 15.8 m -128.17 137.05 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.529 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 32.3 mt -128.08 92.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.995 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 22' ' ' LEU . 4.0 mt -86.33 142.76 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.626 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 21.1 mt-30 -112.99 137.46 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.89 135.44 45.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -103.7 -163.15 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.603 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.47 56.1 2.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.795 0.331 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 174.8 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.59 -169.28 24.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.444 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.47 ' CE2' HG22 ' A' ' 72' ' ' ILE . 63.2 m-85 -79.04 130.5 35.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.9 -33.77 23.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' CD2' HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -58.6 148.63 28.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -112.19 122.94 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 11.2 p -118.58 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.7 132.1 15.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.64 99.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.677 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.88 -69.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.409 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.421 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 t-20 -82.71 -55.12 0.55 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.182 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.6 Cg_endo -86.87 -164.66 0.22 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.818 2.345 . . . . 0.0 111.909 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.058 HG22 HD12 ' A' ' 52' ' ' ILE . 5.6 p -147.92 97.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 110.94 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -133.75 149.26 51.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.9 120.2 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.35 -67.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG23 ' A' ' 48' ' ' THR . 30.7 m -134.71 171.4 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.099 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.616 HG11 ' CG1' ' A' ' 46' ' ' VAL . 5.9 m -135.91 153.47 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.34 123.25 22.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -75.3 146.62 40.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 55.08 24.05 5.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.81 -161.17 11.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.626 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -60.99 -40.26 92.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.319 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.707 ' HB3' ' HG2' ' A' ' 36' ' ' LYS . . . -68.0 -47.71 67.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.093 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -63.4 -39.28 94.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 0.0 110.712 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -69.88 -31.88 69.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.529 ' HB1' ' H ' ' A' ' 12' ' ' ILE . . . -71.01 -15.77 62.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.453 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.12 29.07 26.45 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.537 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.668 HG22 ' CG1' ' A' ' 11' ' ' VAL . 11.9 t -78.05 149.9 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -110.03 163.01 13.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -82.82 123.77 29.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.22 44.64 65.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.536 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -93.71 146.51 23.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.738 0.304 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -84.48 138.45 32.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.6 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.058 HD12 HG22 ' A' ' 30' ' ' VAL . 29.5 mt -100.93 114.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.171 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 83' ' ' GLN . 7.2 mt -78.71 -42.01 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.028 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -156.32 142.07 17.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 80' ' ' LEU . 21.4 t -108.43 125.56 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.199 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 59.81 37.01 22.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.21 27.93 63.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.585 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.767 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.4 t-160 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.35 -43.13 74.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.562 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.1 -43.97 97.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.174 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.758 HG12 HD11 ' A' ' 72' ' ' ILE . 6.3 t -62.15 -46.69 95.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.047 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.0 t -62.18 -46.2 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.322 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.42 75.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.456 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.758 HD11 HG12 ' A' ' 68' ' ' VAL . 20.3 mt -69.71 -36.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.844 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HD3' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -73.75 -31.53 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.922 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -67.88 80.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 173.37 13.42 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -98.51 -42.73 7.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.86 120.54 39.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 72' ' ' ILE . 12.0 p -116.36 120.46 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.96 104.91 10.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.737 HD12 HG13 ' A' ' 82' ' ' VAL . 2.9 pp -120.65 132.87 55.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.811 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.458 HG22 HD12 ' A' ' 53' ' ' ILE . 63.6 m -79.97 122.86 27.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.737 HG13 HD12 ' A' ' 80' ' ' LEU . 26.8 m -116.11 169.09 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.03 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.619 ' HB2' HD11 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -134.83 142.78 46.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.2 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.875 0.369 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -131.98 133.8 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.72 130.18 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -88.99 118.07 28.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 11' ' ' VAL . 24.5 m -128.27 108.28 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 130.63 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 46' ' ' VAL . 23.6 mm -108.36 137.36 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.062 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 13.9 mt-30 -110.31 134.42 52.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -67.82 123.82 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -86.93 -169.93 2.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -59.46 -31.18 69.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.52 1.72 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.348 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.33 -160.27 14.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.545 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.434 ' CE2' HG22 ' A' ' 72' ' ' ILE . 14.0 m-85 -80.06 114.62 19.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.719 0.295 . . . . 0.0 110.855 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -29.77 75.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.604 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.18 137.54 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.38 136.78 40.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 31' ' ' PHE . 12.3 p -133.36 134.05 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -149.4 137.0 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.41 130.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.523 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.6 -71.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.417 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 3.9 m-20 -82.6 -61.86 0.32 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.786 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 80.1 Cg_endo -77.64 -167.99 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.542 2.161 . . . . 0.0 112.151 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.813 HG22 HD12 ' A' ' 52' ' ' ILE . 8.2 p -152.96 104.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.743 ' O ' HG23 ' A' ' 24' ' ' VAL . 47.0 p90 -130.89 155.64 46.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -92.17 120.87 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -31.43 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -135.28 147.8 49.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.608 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 15.8 m -129.89 145.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 105.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.48 133.12 44.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 60.22 30.94 20.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.77 -147.8 5.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.48 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.608 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -64.76 -47.37 78.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 tpt -63.1 -41.59 99.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -36.99 86.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.83 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 36.51 25.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.593 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 13' ' ' ILE . 18.5 t -88.08 149.05 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 111.072 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -112.11 153.3 27.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -69.04 130.6 43.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.57 31.94 43.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.405 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' HG11 ' A' ' 82' ' ' VAL . 3.4 p30 -84.24 138.55 32.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.72 141.4 28.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.655 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.813 HD12 HG22 ' A' ' 30' ' ' VAL . 17.0 mt -102.77 137.77 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mm -113.32 -38.79 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -137.63 157.77 45.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 55' ' ' VAL . 18.5 m -139.48 104.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.89 43.57 17.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.68 26.79 66.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.504 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 55' ' ' VAL . 16.0 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.952 0.406 . . . . 0.0 110.886 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -38.68 88.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.222 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.22 -44.34 79.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.717 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 72' ' ' ILE . 7.5 p -68.29 -41.63 83.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 65' ' ' HIS . 95.1 t -65.13 -43.77 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.929 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -65.99 -41.18 91.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.2 mt -65.34 -50.41 65.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.763 ' CD1' HG22 ' A' ' 68' ' ' VAL . 26.5 mt -65.51 -35.89 76.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.573 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.55 -25.68 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -63.92 80.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.11 144.13 10.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.438 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.99 -42.96 89.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.399 . . . . 0.0 111.022 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.0 m-85 -102.54 113.73 27.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -137.12 127.77 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.209 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.81 148.55 22.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -143.65 116.32 8.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.081 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -79.47 115.22 18.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 ' OD1' ' A' ' 50' ' ' ASP . 17.8 m -115.18 170.53 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 7' ' ' VAL . 3.9 mt-30 -131.9 140.95 49.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.66 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.442 ' O ' HG11 ' A' ' 7' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.568 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.743 0.306 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.16 151.87 29.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -148.52 146.49 28.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.3 m -90.19 132.86 35.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 11' ' ' VAL . 29.6 m -130.43 100.35 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.552 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.9 mp -84.93 108.81 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.24 124.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HG2' ' CD1' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -101.46 134.35 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.795 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -65.35 131.48 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.09 -170.83 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -30.71 69.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -103.07 -34.36 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.38 -160.36 24.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.53 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 72' ' ' ILE . 59.4 m-85 -81.53 121.72 26.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.973 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.61 -30.94 42.42 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.545 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -60.04 134.97 57.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -104.57 137.0 43.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 32' ' ' VAL . 6.7 m -129.4 136.53 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 t -149.42 132.12 15.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.012 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.92 117.41 0.61 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.05 -74.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 110.816 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.7 m120 -81.75 -61.48 0.37 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 71.7 Cg_endo -77.06 -168.05 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.52 2.146 . . . . 0.0 112.317 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.607 HG12 HG13 ' A' ' 52' ' ' ILE . 25.5 t -144.08 111.99 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 2.7 p90 -139.6 152.97 47.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.716 ' HA ' HG12 ' A' ' 24' ' ' VAL . 11.2 t -92.75 120.99 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.036 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -73.09 -67.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.98 163.03 17.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.652 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 23.3 m -136.32 140.04 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -59.28 120.41 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.73 131.08 39.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.3 30.82 20.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.45 -152.35 7.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.538 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.81 87.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.187 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -68.64 -47.37 66.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -63.67 -48.76 75.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -34.41 72.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.982 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.553 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -71.68 -15.95 62.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.432 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.99 40.73 13.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.456 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.446 ' CG1' HG11 ' A' ' 35' ' ' VAL . 19.2 t -90.36 140.16 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.81 148.04 26.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.25 119.8 13.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 44.98 12.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 32' ' ' VAL . 57.0 p30 -93.38 161.99 14.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -98.72 137.88 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.023 HD13 HG12 ' A' ' 82' ' ' VAL . 25.4 mm -96.21 138.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.019 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 83' ' ' GLN . 5.8 mt -113.61 -48.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.059 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -136.07 141.96 44.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.631 HG23 HD11 ' A' ' 80' ' ' LEU . 9.7 p -125.71 112.36 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.643 ' OD1' HG23 ' A' ' 78' ' ' VAL . 54.6 m-20 59.25 38.19 23.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.013 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 24.31 71.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.783 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.26 -179.943 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.749 0.309 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.9 mm? -55.46 -43.3 75.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.652 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.753 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.9 mp0 -65.37 -39.14 91.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.304 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.655 HG12 HD11 ' A' ' 72' ' ' ILE . 22.8 t -66.26 -46.79 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.599 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.2 p -65.98 -41.22 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.194 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.82 -38.32 88.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.6 mm? -68.56 -43.22 77.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.305 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.737 HG23 HG11 ' A' ' 78' ' ' VAL . 19.4 mt -71.32 -41.67 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -74.43 -18.87 60.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.103 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -28.62 6.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.48 161.64 29.03 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 p -68.56 -48.2 64.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 14' ' ' GLN . 57.4 m-85 -95.8 114.75 26.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 72' ' ' ILE . 12.8 p -128.52 139.47 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.01 114.31 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.883 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.642 ' CD1' HG22 ' A' ' 78' ' ' VAL . 7.8 mp -119.27 119.74 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -77.78 113.62 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.023 HG12 HD13 ' A' ' 52' ' ' ILE . 34.1 m -112.39 172.95 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.586 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.792 ' HB2' HD11 ' A' ' 53' ' ' ILE . 23.0 tt0 -135.49 137.09 41.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.765 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.956 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.781 0.324 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -128.61 138.96 52.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -135.51 149.8 49.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.6 p -99.37 104.9 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 11' ' ' VAL . 12.9 p -85.52 115.49 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -88.11 99.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.702 HG22 ' CD1' ' A' ' 20' ' ' PHE . 28.8 mt -86.42 112.65 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -102.16 131.52 48.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.96 119.61 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.43 -168.96 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -30.71 66.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 -38.39 13.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.61 178.43 20.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.702 ' CD1' HG22 ' A' ' 13' ' ' ILE . 25.1 m-85 -60.05 112.78 2.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.5 8.41 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.636 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -50.74 146.84 5.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 111.19 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 148.78 41.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.804 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.629 HG12 HG22 ' A' ' 32' ' ' VAL . 30.9 m -135.34 140.07 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 t -149.51 132.09 15.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.27 109.95 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -57.61 -68.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 2.0 t30 -89.51 -51.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 2.2 Cg_endo -84.61 -161.37 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.98 2.453 . . . . 0.0 112.19 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.029 HG12 HD12 ' A' ' 52' ' ' ILE . 10.1 t -150.4 97.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -133.8 149.73 51.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.147 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.629 HG22 HG12 ' A' ' 24' ' ' VAL . 25.7 t -83.65 128.36 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -92.64 -49.49 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.68 158.02 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HB ' HG11 ' A' ' 46' ' ' VAL . 17.6 m -136.49 153.11 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -81.79 111.69 18.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.2 138.01 39.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t0 58.58 30.62 20.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.6 -158.99 8.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.554 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.79 72.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB1' HG11 ' A' ' 46' ' ' VAL . . . -71.31 -47.36 57.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.214 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tpt -67.42 -42.24 83.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -32.72 74.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.75 58.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.461 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 52.95 3.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.479 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.611 HG11 ' HB1' ' A' ' 41' ' ' ALA . 14.9 p -88.59 158.95 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -128.13 115.86 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.867 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.32 130.83 36.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 32.67 45.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.434 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -94.68 147.71 23.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.926 0.393 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.56 142.61 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.707 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.029 HD12 HG12 ' A' ' 30' ' ' VAL . 39.1 mt -98.51 115.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.763 HD12 HG22 ' A' ' 81' ' ' THR . 20.0 mt -78.72 -47.09 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -156.86 161.91 39.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.002 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.937 HG23 ' CD2' ' A' ' 80' ' ' LEU . 9.4 p -121.13 114.79 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.181 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 56.6 55.56 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.91 27.5 62.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.546 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.842 -179.957 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.814 ' O ' HG23 ' A' ' 69' ' ' VAL . 12.0 t-80 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 66' ' ' LEU . 6.5 mp -55.32 -43.19 74.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.29 -43.97 96.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.192 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.822 HG12 HD11 ' A' ' 72' ' ' ILE . 6.4 t -63.32 -46.56 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.053 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 65' ' ' HIS . 23.4 t -62.55 -45.08 99.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -38.42 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.492 HD23 HG11 ' A' ' 55' ' ' VAL . 5.9 tp -68.17 -45.48 73.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.707 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.822 HD11 HG12 ' A' ' 68' ' ' VAL . 18.1 mt -70.14 -36.09 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -74.37 -28.88 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.9 p -64.29 80.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.932 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.68 143.94 5.41 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.578 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 m -71.68 -55.7 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 m-85 -96.06 116.17 28.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.05 145.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.203 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.83 112.38 16.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.937 ' CD2' HG23 ' A' ' 55' ' ' VAL . 3.3 mt -112.96 116.67 30.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.763 HG22 HD12 ' A' ' 53' ' ' ILE . 89.5 m -77.47 111.15 12.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.688 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 52' ' ' ILE . 12.4 m -117.43 175.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.325 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.96 130.04 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.67 -179.81 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.782 0.325 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -105.47 139.88 39.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -148.49 137.93 21.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.98 107.25 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.07 143.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.1 105.21 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.713 HD11 HD11 ' A' ' 72' ' ' ILE . 32.7 pt -105.06 137.76 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.254 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.51 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 8.2 tt0 -106.61 119.18 38.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.754 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -67.31 145.5 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -112.99 -169.34 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -60.37 -31.18 70.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -41.27 13.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 -155.45 20.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -88.85 111.08 21.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.97 -38.67 96.38 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.605 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -54.59 136.81 44.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -101.25 131.64 47.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 32' ' ' VAL . 29.0 m -129.64 134.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 p -147.67 132.16 17.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.23 119.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.28 -77.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.4 m120 -84.28 -48.25 0.68 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -84.65 -168.81 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.538 2.159 . . . . 0.0 112.476 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.702 HG12 HD12 ' A' ' 52' ' ' ILE . 21.3 t -149.4 102.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -132.2 153.3 50.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 24' ' ' VAL . 24.4 t -88.78 124.81 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.0 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -34.85 22.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.62 158.81 43.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 46' ' ' VAL . 8.9 m -136.08 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.156 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 13.3 ptmt -55.93 122.56 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.1 mt-10 -77.33 151.43 34.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.974 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.28 29.85 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HE2' ' A' ' 36' ' ' LYS . . . -141.04 -166.65 10.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -52.35 -44.72 65.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.777 0.322 . . . . 0.0 111.405 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -59.9 -47.61 85.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -67.26 -50.96 58.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -59.14 -31.95 69.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.03 -15.82 62.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.399 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.55 35.51 28.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.544 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.693 ' HB ' HG11 ' A' ' 35' ' ' VAL . 17.9 t -85.08 141.21 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.282 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -105.77 156.83 17.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.88 125.14 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.23 30.59 45.48 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -80.7 145.49 31.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.04 133.89 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.702 HD12 HG12 ' A' ' 30' ' ' VAL . 5.6 mt -101.27 133.93 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mt -110.77 -47.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -122.02 156.5 33.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.58 HG13 ' CD2' ' A' ' 80' ' ' LEU . 22.1 t -133.66 104.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 t30 59.0 41.44 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.15 73.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.587 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.786 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.1 t-80 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.851 0.358 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.25 -43.26 74.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.97 -44.12 96.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 72' ' ' ILE . 17.4 t -62.74 -46.51 96.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.9 t -62.31 -44.3 99.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 13.9 mtpp -66.09 -38.37 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.794 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -40.48 70.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.888 HD12 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -73.93 -36.87 46.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.038 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.55 -20.57 59.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -68.6 72.14 0.22 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.879 0.371 . . . . 0.0 110.8 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 150.24 7.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.438 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -46.67 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 114.39 26.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.728 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -131.47 144.47 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.66 111.35 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -112.18 134.34 53.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.6 m -82.64 113.78 20.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -112.59 169.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -142.78 128.0 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.647 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.774 -179.891 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.872 0.368 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -128.62 143.65 50.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -143.51 140.52 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 128.75 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 44' ' ' ALA . 12.4 p -126.2 114.72 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.19 114.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.758 HD13 HD21 ' A' ' 22' ' ' LEU . 12.0 mt -98.09 145.05 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.13 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -114.97 126.2 54.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -66.13 120.4 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 33.9 m-20 -87.57 -173.05 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -29.82 67.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.12 -30.38 14.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.94 -161.67 12.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.514 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 72' ' ' ILE . 4.3 m-85 -79.38 94.49 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.48 -32.12 80.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 13' ' ' ILE . 4.2 pp -59.87 131.39 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 m -102.22 132.92 47.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 HG22 ' A' ' 32' ' ' VAL . 31.3 m -116.88 143.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.54 132.51 17.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.02 132.26 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.365 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -58.03 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.672 0.272 . . . . 0.0 110.839 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.439 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 7.6 m-20 -85.24 -61.49 0.27 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.766 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 92.1 Cg_endo -80.07 -167.44 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.524 2.149 . . . . 0.0 112.194 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.64 120.72 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 2.9 t80 -128.42 135.39 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.702 HG22 HG12 ' A' ' 24' ' ' VAL . 20.6 t -93.75 122.99 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -97.0 -49.83 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.281 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.54 148.66 42.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.191 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.603 HG11 HG12 ' A' ' 46' ' ' VAL . 29.4 m -136.46 145.56 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.99 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.89 121.06 15.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.008 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.02 138.94 31.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t0 59.11 30.73 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.34 -149.66 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . . . -59.78 -45.55 91.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.76 0.314 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . -61.7 -47.41 85.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.82 85.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -32.72 73.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -71.25 -15.72 62.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.404 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.3 26.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.567 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.603 HG12 HG11 ' A' ' 35' ' ' VAL . 24.4 t -78.8 158.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.731 0.301 . . . . 0.0 110.992 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.482 ' N ' HG12 ' A' ' 46' ' ' VAL . 13.2 mt-30 -132.3 144.65 50.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.42 125.11 23.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 78.32 46.6 8.88 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.429 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.7 139.65 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -92.05 152.08 20.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.973 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.808 HD13 HG12 ' A' ' 82' ' ' VAL . 13.4 mm -106.94 133.37 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.0 mm -107.45 -33.82 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.2 157.28 42.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.752 HG12 ' HB3' ' A' ' 80' ' ' LEU . 4.7 m -140.62 110.46 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.496 HD21 HG23 ' A' ' 78' ' ' VAL . 84.4 m-20 60.75 41.98 14.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 26.25 71.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.87 0.367 . . . . 0.0 110.952 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.827 0.346 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.468 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 tp -55.29 -43.47 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.87 -40.14 94.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.256 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 72' ' ' ILE . 22.6 t -65.68 -46.78 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.2 p -65.02 -41.29 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.019 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -38.37 87.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.102 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -47.39 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.453 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.513 HD11 ' CE2' ' A' ' 20' ' ' PHE . 2.0 tt -68.7 -37.89 78.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.64 -26.6 59.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.023 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 t -64.23 80.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.96 144.56 9.13 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 m -69.8 -49.26 54.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 120.49 36.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG23 HD21 ' A' ' 56' ' ' ASN . 11.1 p -136.06 133.87 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.93 117.44 30.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.752 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -131.03 127.56 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -70.02 131.23 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.808 HG12 HD13 ' A' ' 52' ' ' ILE . 27.0 m -126.86 169.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -140.61 127.87 21.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.627 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.835 0.35 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.74 138.58 40.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.7 154.17 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.33 139.75 37.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.79 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.4 m -134.05 144.29 35.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 79' ' ' ALA . 24.3 mm -113.67 107.32 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.691 HD11 HD21 ' A' ' 80' ' ' LEU . 15.9 pt -106.02 126.07 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.41 139.35 38.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 128.67 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.703 ' OD2' ' HB2' ' A' ' 40' ' ' ALA . 18.0 m-20 -103.99 -169.59 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.81 -36.35 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.29 -43.84 66.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.14 76.06 1.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.561 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.641 ' CE2' HD12 ' A' ' 13' ' ' ILE . 8.8 m-85 61.39 115.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.11 -44.97 4.91 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.553 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 142.79 36.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.337 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m -101.32 122.26 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.401 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 10.0 p -118.97 137.18 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.8 p -149.53 132.03 15.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.26 120.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.461 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.7 -73.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.5 t-20 -84.66 -53.04 0.5 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 86.2 Cg_endo -84.27 -167.49 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.725 2.284 . . . . 0.0 112.378 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.098 HG12 HD12 ' A' ' 52' ' ' ILE . 19.5 t -145.49 94.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.006 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -127.31 141.02 51.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.92 128.69 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.05 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.73 -30.33 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.17 146.25 47.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.951 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.61 HG13 ' HB1' ' A' ' 41' ' ' ALA . 40.4 t -134.6 129.71 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -66.92 110.55 3.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.806 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.4 pm0 -91.81 44.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.43 35.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.591 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.47 -145.82 4.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.849 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . . . -60.99 -38.88 87.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.726 0.298 . . . . 0.0 111.401 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -59.29 -47.47 85.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.416 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 3.8 tpt -72.42 -43.14 64.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.801 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -30.8 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 13' ' ' ILE . . . -83.51 -15.85 47.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.73 56.96 3.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 47' ' ' GLN . 24.6 t -98.39 158.5 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.481 ' N ' HG12 ' A' ' 46' ' ' VAL . 1.5 mp0 -118.88 148.68 42.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.04 129.11 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 33.42 32.8 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.586 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.95 133.93 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.846 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.098 HD12 HG12 ' A' ' 30' ' ' VAL . 24.3 mt -96.89 124.41 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.69 -43.85 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.181 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -138.29 150.36 46.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.955 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 80' ' ' LEU . 5.2 m -136.19 106.19 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.173 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.29 43.6 10.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.803 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.98 27.56 70.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.495 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.727 ' O ' HG23 ' A' ' 69' ' ' VAL . 19.2 t-80 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.806 0.336 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 mt -55.2 -42.91 73.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.662 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.57 -44.04 97.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 HD11 ' A' ' 72' ' ' ILE . 21.1 t -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.8 t -61.69 -43.72 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -65.43 -38.41 89.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.342 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -41.87 79.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.785 HD11 HG12 ' A' ' 68' ' ' VAL . 14.9 mt -71.61 -38.04 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -74.49 -27.13 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 85.2 p -63.33 80.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.44 144.41 4.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.584 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.7 p -71.63 -54.02 11.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -95.75 118.77 33.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 72' ' ' ILE . 20.5 t -125.86 123.42 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.282 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -115.27 101.82 9.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.691 HD21 HD11 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -113.31 137.43 51.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.022 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 m -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 80' ' ' LEU . 5.8 m -112.59 170.05 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -130.0 143.9 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.588 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -114.23 160.0 19.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.358 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.2 m80 60.34 167.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.59 -75.03 0.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.37 -43.75 97.86 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 tp 60.2 30.74 20.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.895 0.378 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.24 130.69 54.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.88 146.39 49.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -129.1 130.25 46.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -80.59 129.75 34.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 45' ' ' GLY . 5.1 m -141.69 104.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.78 126.88 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.442 HG22 ' CE1' ' A' ' 20' ' ' PHE . 26.4 mm -98.02 140.36 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.51 127.56 56.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.35 140.8 43.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.23 -171.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -31.64 70.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -90.32 -37.17 14.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 177.86 16.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.444 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 72' ' ' ILE . 26.7 m-85 -60.09 123.84 18.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.68 -45.9 9.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.524 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 22' ' ' LEU . 4.0 pp -58.11 141.78 49.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.378 . . . . 0.0 110.967 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.83 144.74 50.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.795 HG12 ' HA ' ' A' ' 32' ' ' VAL . 30.3 m -122.1 156.38 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.995 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -149.49 132.13 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.54 124.09 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.31 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.412 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 5.0 m-20 -74.97 -60.64 1.17 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 74.2 Cg_endo -75.33 -168.08 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.184 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.533 HG12 HG13 ' A' ' 52' ' ' ILE . 30.4 t -152.95 111.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.001 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.74 141.79 44.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.839 HG23 HD11 ' A' ' 52' ' ' ILE . 23.7 t -77.28 124.75 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.526 ' O ' HG22 ' A' ' 48' ' ' THR . 24.4 pt20 -94.45 -42.54 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.978 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 p -122.85 153.25 39.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.44 142.62 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -68.69 99.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -69.0 129.77 40.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.83 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t0 60.05 32.7 21.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.65 -152.14 6.52 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.46 85.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.95 -47.31 72.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -36.3 81.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -31.09 62.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 13' ' ' ILE . . . -78.21 -15.82 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' HG11 ' A' ' 11' ' ' VAL . . . 85.58 51.76 3.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.59 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.53 147.26 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -119.44 149.22 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -73.17 128.12 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.962 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.01 34.84 36.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.76 150.54 21.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -90.69 136.47 33.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.903 HD13 HG12 ' A' ' 82' ' ' VAL . 18.5 mm -98.29 121.11 48.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.76 -49.21 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.76 161.56 34.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 80' ' ' LEU . 5.3 m -120.33 111.28 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 1.9 t30 59.94 41.33 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.66 73.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.529 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.2 m -134.38 115.14 13.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mp -60.71 148.95 36.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.815 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 t -107.33 111.78 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.3 p -114.74 179.14 4.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 61.78 152.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.24 108.66 21.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.35 103.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.78 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 t-80 -59.6 -38.64 81.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.819 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -55.42 -42.67 74.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.634 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.51 -43.97 97.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.277 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.659 HG12 HD11 ' A' ' 72' ' ' ILE . 24.5 t -63.85 -46.7 93.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 65' ' ' HIS . 29.8 t -60.63 -45.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.254 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HG3' HD23 ' A' ' 66' ' ' LEU . 5.5 mtmp? -64.47 -38.27 90.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.008 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -44.63 85.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.303 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.659 HD11 HG12 ' A' ' 68' ' ' VAL . 15.5 mt -68.96 -43.22 82.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.655 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.4 -12.97 60.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.369 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 p -44.35 -30.17 0.79 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.816 0.341 . . . . 0.0 111.597 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.23 156.88 27.01 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.547 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -57.09 -57.31 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -100.75 112.6 25.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -134.13 128.19 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 56' ' ' ASN . . . -70.28 143.89 51.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.61 HD12 HG12 ' A' ' 55' ' ' VAL . 4.1 tp -136.29 93.4 2.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.02 110.11 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.903 HG12 HD13 ' A' ' 52' ' ' ILE . 27.5 m -112.58 173.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.36 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -135.98 138.49 42.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.91 135.45 2.13 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.426 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -105.92 115.74 60.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.531 0.205 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -51.88 171.25 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.415 2.077 . . . . 0.0 112.348 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.17 175.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.551 2.167 . . . . 0.0 112.241 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.35 27.89 3.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.526 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.938 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -61.38 93.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.77 0.319 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -155.81 107.16 2.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.793 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 37.1 mtt -70.28 -55.38 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.7 54.76 13.61 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.15 36.59 4.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.79 0.329 . . . . 0.0 110.79 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -108.58 146.56 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.23 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 53' ' ' ILE . 1.4 mt-30 -125.22 154.35 41.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.97 130.24 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 103.62 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 11' ' ' VAL . 31.4 m -98.12 114.19 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.41 100.68 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.424 HG22 ' CE1' ' A' ' 20' ' ' PHE . 3.6 mp -91.34 133.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -106.31 124.3 49.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.88 137.58 56.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -116.0 -171.47 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -60.2 -31.48 70.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -81.98 -36.97 27.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.72 166.48 22.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.423 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 72' ' ' ILE . 23.8 m-85 -60.33 109.27 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.07 -29.78 64.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.76 126.39 29.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.78 139.08 38.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 32' ' ' VAL . 25.2 m -119.13 135.77 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.37 132.48 16.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.18 123.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.61 -76.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.311 . . . . 0.0 110.782 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -80.53 -60.56 0.46 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.823 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.0 Cg_endo -78.7 -168.05 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.56 2.173 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.81 HG12 HD12 ' A' ' 52' ' ' ILE . 19.8 t -145.89 96.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -125.51 145.11 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 24' ' ' VAL . 12.1 t -76.46 120.2 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -49.23 8.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.49 143.97 46.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 46' ' ' VAL . 28.4 m -136.42 136.18 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' CB ' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -64.59 114.45 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.709 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -97.27 40.79 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.42 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -176.36 34.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.683 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.65 -139.64 2.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.687 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.76 93.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.77 0.319 . . . . 0.0 111.324 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.778 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -59.29 -47.38 85.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -41.8 95.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -71.94 -29.95 64.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.4 -15.87 61.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.11 33.77 35.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.712 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 41' ' ' ALA . 12.2 p -90.22 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 111.024 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.72 163.21 14.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.56 126.52 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.728 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.88 29.06 35.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.372 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -80.2 141.08 35.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -93.82 134.62 35.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.81 HD12 HG12 ' A' ' 30' ' ' VAL . 25.0 mt -101.97 118.39 48.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.223 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.8 mp -85.9 -43.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.63 148.2 28.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.763 HG12 ' CB ' ' A' ' 80' ' ' LEU . 29.3 m -125.38 118.55 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 57.74 48.01 14.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.72 28.2 72.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.3 m -134.27 104.19 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.767 0.318 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 59' ' ' LEU . 0.3 OUTLIER -61.91 170.28 2.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG21 HG23 ' A' ' 30' ' ' VAL . 9.6 p -103.63 145.79 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.97 -47.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.36 31.22 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.5 m -89.69 126.95 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.839 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.7 t-20 -96.65 -173.11 2.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.894 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.8 t-80 -57.49 -52.58 64.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.13 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.18 -44.13 97.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.386 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 64' ' ' ASN . 34.4 t -64.08 -46.73 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.06 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 65' ' ' HIS . 19.1 t -60.56 -43.64 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.22 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.97 -39.39 90.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.284 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -47.92 75.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.698 HD11 HG12 ' A' ' 68' ' ' VAL . 14.7 mt -68.97 -40.55 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -74.64 -19.68 60.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.1 t -50.9 -28.94 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.322 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.53 158.35 27.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -46.8 81.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.1 m-85 -95.76 112.72 24.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.592 HG11 HG23 ' A' ' 72' ' ' ILE . 12.6 p -116.46 123.52 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.66 111.18 18.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.763 ' CB ' HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.84 133.87 50.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.4 m -79.33 116.29 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 52' ' ' ILE . 28.0 m -113.55 175.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.707 ' HB2' HD11 ' A' ' 53' ' ' ILE . 35.0 tt0 -132.69 130.88 40.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 155.79 163.51 12.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.528 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 144.38 31.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.551 0.215 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.54 129.64 12.98 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.497 2.131 . . . . 0.0 112.258 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.53 133.14 21.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.344 2.029 . . . . 0.0 112.414 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.69 41.28 2.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.802 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.62 179.1 4.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.759 0.314 . . . . 0.0 110.833 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -117.99 -40.71 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.3 mtm 60.85 82.34 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.56 -88.25 2.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp -164.84 94.17 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 7' ' ' VAL . 22.4 m -133.22 118.09 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.3 154.71 33.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.12 134.99 33.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.3 135.27 33.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.59 142.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 ' HB2' ' A' ' 79' ' ' ALA . 22.6 mt -118.16 113.89 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.14 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.515 HG22 ' CB ' ' A' ' 44' ' ' ALA . 27.6 pt -104.75 143.87 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 19.3 mt-30 -106.15 143.14 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 138.34 33.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -102.8 -168.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -58.51 -34.44 70.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.79 -35.47 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.62 -109.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 72' ' ' ILE . 32.0 m-85 -125.71 132.99 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -39.87 36.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.48 139.58 58.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.329 . . . . 0.0 111.043 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 m -103.22 130.77 50.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 32' ' ' VAL . 33.7 m -119.07 140.7 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.351 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.6 131.88 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.808 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.75 112.49 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.624 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.63 -74.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -80.17 -60.94 0.46 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.734 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 85.8 Cg_endo -78.03 -169.46 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.161 . . . . 0.0 112.324 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.991 HG12 HD12 ' A' ' 52' ' ' ILE . 21.7 t -144.0 103.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.025 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -138.41 148.6 44.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 24' ' ' VAL . 25.2 t -84.81 132.74 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -93.65 -34.81 13.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.051 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.87 152.27 40.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 46' ' ' VAL . 30.4 m -135.98 135.38 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.4 tptp -59.8 113.88 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -92.46 44.12 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -177.15 35.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.99 -148.63 5.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.54 79.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.737 0.304 . . . . 0.0 111.244 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . . . -59.7 -47.42 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.7 tpt -69.9 -50.8 38.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -30.48 70.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' A' ' 13' ' ' ILE . . . -71.34 -15.82 62.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.06 28.93 32.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.445 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 35' ' ' VAL . 9.4 t -84.79 151.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.71 145.19 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 48' ' ' THR . 1.3 t -69.25 131.43 44.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 30.28 36.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -93.81 149.36 21.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -96.43 142.52 28.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.991 HD12 HG12 ' A' ' 30' ' ' VAL . 32.2 mt -106.75 125.56 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 81' ' ' THR . 4.0 mt -92.43 -49.12 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.02 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -151.07 157.07 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 80' ' ' LEU . 30.1 t -128.44 114.31 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.87 53.14 5.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.15 27.59 60.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.35 128.84 8.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -170.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.912 HG21 ' CG2' ' A' ' 30' ' ' VAL . 16.1 m -98.45 34.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.9 m 67.63 -70.21 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -176.8 -65.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.006 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.8 m -142.16 -163.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 69.95 111.86 0.05 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.684 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.6 t-80 -65.57 -36.13 82.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.84 -41.27 70.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.54 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -42.47 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.866 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.78 HG12 ' CD1' ' A' ' 72' ' ' ILE . 31.4 t -63.92 -46.63 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.212 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.9 t -63.19 -44.15 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.509 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -65.8 -38.41 88.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.475 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.01 -45.27 70.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.78 ' CD1' HG12 ' A' ' 68' ' ' VAL . 19.8 mt -69.69 -35.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -72.8 -29.33 63.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -64.7 80.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.55 144.32 6.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -54.45 14.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.3 m-85 -98.28 119.82 37.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.8 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.0 p -124.79 115.38 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB2' HG12 ' A' ' 12' ' ' ILE . . . -105.86 105.36 15.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -112.07 139.92 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.57 HG22 HD12 ' A' ' 53' ' ' ILE . 63.6 m -84.97 121.09 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 52' ' ' ILE . 4.2 m -114.53 175.27 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.539 ' HB2' HD11 ' A' ' 53' ' ' ILE . 25.3 tt0 -138.39 150.4 46.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.71 136.26 2.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.523 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.81 127.95 26.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.554 0.216 . . . . 0.0 110.884 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.48 107.16 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.563 2.176 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.0 -61.39 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.521 2.147 . . . . 0.0 112.276 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.43 27.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.558 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.922 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 t -124.58 155.0 39.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -72.61 65.26 0.67 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.2 ttm -113.76 -35.57 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.07 -32.88 0.15 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.85 112.73 13.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 0.0 110.87 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.26 111.95 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -121.44 144.36 48.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -148.5 146.59 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 p -107.36 137.28 45.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.25 125.76 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -103.03 108.44 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.079 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.75 137.42 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.441 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.5 OUTLIER -109.76 139.97 44.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -72.67 143.05 48.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -110.91 -171.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.62 -31.43 71.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -96.05 -35.35 11.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.5 179.2 15.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.533 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.512 ' CE2' HG22 ' A' ' 72' ' ' ILE . 36.5 m-85 -60.67 109.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 110.926 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.41 -36.66 69.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.538 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.5 132.68 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.019 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.63 134.09 49.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.794 HG12 HG22 ' A' ' 32' ' ' VAL . 29.2 m -115.51 148.21 18.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.9 t -148.7 138.69 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.24 115.98 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 -71.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.733 0.301 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.402 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -80.06 -60.0 0.51 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.783 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -78.48 -168.41 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.579 2.186 . . . . 0.0 112.355 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.927 HG12 HD12 ' A' ' 52' ' ' ILE . 21.5 t -148.33 95.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -123.13 148.37 45.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.794 HG22 HG12 ' A' ' 24' ' ' VAL . 19.6 t -90.22 126.63 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.004 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -95.29 -42.61 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -119.33 145.18 46.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.61 144.62 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 37.9 tttt -66.14 114.38 5.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.87 139.44 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t0 59.17 30.05 19.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.76 -158.7 8.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.23 85.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.758 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.08 -47.33 68.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.07 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -48.2 76.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -30.41 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.83 62.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.455 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.42 34.6 11.78 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 41' ' ' ALA . 14.0 p -79.93 158.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 46' ' ' VAL . 14.9 mt-30 -125.66 138.05 53.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.823 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 t -70.34 130.45 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.93 47.96 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.672 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -88.32 138.35 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.68 135.33 33.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.927 HD12 HG12 ' A' ' 30' ' ' VAL . 18.6 mt -94.31 125.24 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 83' ' ' GLN . 33.9 mt -98.68 -34.97 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -142.99 142.02 31.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 52' ' ' ILE . 21.4 t -125.13 117.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 59.41 30.77 20.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.5 27.3 67.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.547 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 58' ' ' THR . 8.5 m -121.12 23.24 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 49.05 -168.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.234 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 60' ' ' VAL . 11.0 p -159.3 115.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.998 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 p -97.75 -67.0 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.78 130.39 4.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.991 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -162.8 156.29 20.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.808 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.8 m-80 -86.19 178.89 7.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.81 ' O ' HG23 ' A' ' 69' ' ' VAL . 34.0 t-80 -59.53 -49.88 76.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.82 -43.16 76.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.799 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -62.58 -44.1 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.401 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.846 HG12 HD11 ' A' ' 72' ' ' ILE . 25.5 t -64.16 -46.66 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.118 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 65' ' ' HIS . 35.2 t -60.67 -43.23 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.137 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -65.71 -38.37 89.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.66 81.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.846 HD11 HG12 ' A' ' 68' ' ' VAL . 9.4 mt -70.79 -36.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.739 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -74.27 -20.59 60.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -27.9 5.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.73 147.57 18.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.51 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 p -59.63 -43.65 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.4 m-85 -102.97 115.24 30.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 78' ' ' VAL . 12.7 p -114.88 113.42 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.181 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.1 104.46 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD12 HG13 ' A' ' 82' ' ' VAL . 3.6 pp -123.11 134.03 54.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -84.65 122.63 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' A' ' 52' ' ' ILE . 12.7 m -116.81 169.19 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.294 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.714 ' HB2' HD11 ' A' ' 53' ' ' ILE . 11.7 tt0 -135.43 134.63 39.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.86 -51.47 9.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.647 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 62.54 143.0 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.637 0.256 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.491 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 44.7 Cg_exo -55.15 -49.07 17.7 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.535 2.156 . . . . 0.0 112.673 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 73.0 Cg_endo -75.99 -174.52 2.09 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.253 1.969 . . . . 0.0 112.419 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -100.53 -38.14 3.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.525 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.878 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -140.06 104.28 4.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.881 0.372 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.83 32.81 20.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.6 mtm -116.46 99.9 7.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 153.76 -64.32 0.35 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.13 87.82 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 110.766 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m -107.3 123.74 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.217 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -122.45 154.3 37.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.846 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -139.49 130.28 26.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.0 108.11 19.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.014 HG21 HG22 ' A' ' 46' ' ' VAL . 9.3 p -96.97 143.66 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.7 mm -119.27 95.42 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.053 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.608 HD13 HD21 ' A' ' 22' ' ' LEU . 3.3 mt -86.34 130.01 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.35 127.36 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.838 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -65.26 131.64 47.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -102.5 -169.1 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.814 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -59.5 -29.87 68.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.22 -29.97 15.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.24 -118.66 3.33 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.447 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 72' ' ' ILE . 48.0 m-85 -116.42 115.54 26.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.56 -44.19 73.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.596 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.608 HD21 HD13 ' A' ' 13' ' ' ILE . 4.1 pp -59.73 139.43 57.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -112.58 137.4 50.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.838 HG12 ' HA ' ' A' ' 32' ' ' VAL . 30.1 m -129.31 142.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.258 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -149.49 132.02 15.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.11 140.46 4.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.605 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -73.7 -74.21 0.19 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.778 0.323 . . . . 0.0 110.805 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.24 -56.79 0.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.691 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.03 -168.15 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.571 2.18 . . . . 0.0 112.176 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.813 HG13 ' HB ' ' A' ' 52' ' ' ILE . 8.6 p -155.71 106.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -127.69 154.85 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.838 ' HA ' HG12 ' A' ' 24' ' ' VAL . 4.5 t -91.19 120.34 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -89.42 -31.08 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 144.33 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 46' ' ' VAL . 31.2 m -132.35 139.36 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -62.54 107.82 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -73.46 130.53 40.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.69 30.42 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.1 -157.42 8.85 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -39.33 89.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -66.02 -47.35 74.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.6 tpt -69.33 -41.74 76.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -67.95 -29.69 68.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.689 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -75.4 -15.92 60.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.324 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.37 46.24 3.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.491 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.014 HG22 HG21 ' A' ' 11' ' ' VAL . 16.2 t -106.92 143.84 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.832 0.348 . . . . 0.0 111.042 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -110.06 163.14 13.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 116.98 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.24 37.13 11.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.598 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.574 ' OD2' HG11 ' A' ' 82' ' ' VAL . 8.9 p-10 -96.83 154.02 17.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -95.42 137.31 34.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.813 ' HB ' HG13 ' A' ' 30' ' ' VAL . 12.8 mt -99.7 117.48 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.082 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.69 -42.5 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 147.06 30.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 52' ' ' ILE . 21.5 t -118.77 111.64 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.96 41.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.83 73.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.3 m -128.09 90.8 3.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.74 -49.33 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.3 m -75.01 -177.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.062 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 62' ' ' HIS . 0.2 OUTLIER 63.12 -165.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.407 ' H ' HG22 ' A' ' 61' ' ' THR . 50.1 m80 61.99 151.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.4 p -168.88 -43.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -97.33 155.15 17.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.729 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -62.92 -36.45 83.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 67' ' ' GLU . 3.0 pp -55.24 -43.07 74.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.766 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.42 -44.02 97.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.993 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 72' ' ' ILE . 24.9 t -62.78 -46.67 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.114 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.9 t -61.7 -44.13 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.564 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.9 -39.74 90.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -45.9 73.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG13 HG21 ' A' ' 78' ' ' VAL . 20.5 tt -68.76 -35.76 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -70.43 -32.37 69.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.76 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.8 t -71.59 73.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.82 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.75 144.34 4.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.539 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.22 -30.78 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -108.85 132.99 53.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.4 p -129.94 112.43 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.45 103.48 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.62 HD12 HG13 ' A' ' 82' ' ' VAL . 3.1 pp -121.07 124.76 45.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.3 m -79.24 126.93 31.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.62 HG13 HD12 ' A' ' 80' ' ' LEU . 30.6 m -118.59 169.71 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.33 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -142.8 144.05 32.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.29 117.13 0.73 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.59 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.432 ' CB ' ' HD3' ' A' ' 86' ' ' PRO . 3.2 ttp180 -94.23 -53.89 0.24 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.563 0.221 . . . . 0.0 111.159 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.446 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 31.5 Cg_exo -57.74 -47.31 21.69 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.499 2.133 . . . . 0.0 112.656 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 96.2 Cg_endo -80.89 177.15 8.27 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.327 2.018 . . . . 0.0 112.438 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.59 0.54 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.565 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.951 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.98 31.46 2.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.805 0.336 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.54 31.66 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.924 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mtm -128.14 159.09 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 -24.6 29.79 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.554 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.7 29.8 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG21 ' CD ' ' A' ' 85' ' ' ARG . 5.4 m -122.95 115.33 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.054 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.32 129.96 50.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -127.82 137.96 52.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.28 143.33 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.505 HG21 HG22 ' A' ' 46' ' ' VAL . 25.5 m -133.43 126.4 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.97 107.23 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.49 HD12 ' H ' ' A' ' 13' ' ' ILE . 4.0 mp -94.04 138.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 3.1 mp0 -102.07 124.8 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -71.58 133.59 45.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -99.51 -170.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.67 -31.56 69.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -88.58 -44.23 10.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.63 -158.54 23.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.509 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.43 ' CD2' HG12 ' A' ' 72' ' ' ILE . 68.7 m-85 -86.72 118.13 25.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.51 -26.98 58.21 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 pp -58.47 138.95 56.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -107.0 134.26 50.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 68' ' ' VAL . 30.8 t -115.61 135.55 55.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.402 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 37.3 t -149.42 132.17 15.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.04 125.41 0.92 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.94 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -78.78 -61.06 0.54 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.3 Cg_endo -76.61 -167.9 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.848 HG12 HD12 ' A' ' 52' ' ' ILE . 21.4 t -140.86 110.84 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 23.1 p90 -136.39 150.25 48.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.644 ' CG2' HD11 ' A' ' 52' ' ' ILE . 21.5 t -91.11 120.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -72.34 -58.97 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 t -122.59 157.97 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.681 HG11 HG12 ' A' ' 46' ' ' VAL . 32.4 m -135.04 145.33 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.0 ttpm? -56.84 98.95 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 140.09 54.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER 55.59 29.89 14.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -136.5 -160.12 8.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.689 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.4 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.532 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . . . -69.29 -47.71 63.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.634 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 39' ' ' GLY . 2.4 ppp? -70.6 -34.73 72.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -31.81 70.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.72 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.375 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 27.29 11.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.52 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.681 HG12 HG11 ' A' ' 35' ' ' VAL . 16.3 t -88.54 144.51 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 111.046 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.71 158.02 19.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.68 122.06 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.21 43.24 39.97 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.407 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -98.79 156.76 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.848 HD12 HG12 ' A' ' 30' ' ' VAL . 19.7 mt -103.47 124.4 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.5 mp -97.8 -32.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 59' ' ' LEU . 26.2 ttpt -137.68 141.91 41.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 55' ' ' VAL . 26.3 m -124.59 104.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.516 ' OD1' HG23 ' A' ' 78' ' ' VAL . 97.8 m-20 61.03 43.98 10.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.81 28.21 69.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.6 m -133.62 84.5 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.18 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.4 pt? -94.87 27.61 3.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 61' ' ' THR . 21.3 t -136.3 158.86 38.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.258 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 60' ' ' VAL . 8.4 m 60.56 99.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -70.69 155.24 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.927 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.02 178.46 7.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.733 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.3 t-20 -94.59 -175.15 3.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 24' ' ' VAL . 11.1 t-80 -59.53 -45.1 92.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 69' ' ' VAL . 3.0 mt -55.46 -43.03 75.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.741 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.0 mm-40 -66.08 -38.8 89.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 64' ' ' ASN . 30.0 t -66.9 -46.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.502 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.505 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.8 p -66.16 -41.43 89.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.167 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 69' ' ' VAL . 14.1 ttmm -66.33 -39.46 89.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.366 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.8 mm? -68.9 -46.94 67.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.553 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 68' ' ' VAL . 2.3 tt -67.97 -35.67 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.893 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 59.9 p -66.62 78.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.73 145.97 6.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -71.04 -46.66 61.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CZ ' ' HG2' ' A' ' 14' ' ' GLN . 2.4 m-85 -95.76 121.11 37.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG23 ' OD1' ' A' ' 56' ' ' ASN . 11.6 p -117.14 141.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.83 117.82 14.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.2 pp -135.98 134.35 38.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.8 m -75.75 123.94 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 52' ' ' ILE . 10.3 m -123.45 175.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.216 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.656 ' HB2' HD11 ' A' ' 53' ' ' ILE . 36.6 tt0 -142.81 135.6 27.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.28 -96.97 0.1 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.554 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.457 ' CD ' HG21 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 62.32 78.43 0.3 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.297 . . . . 0.0 110.87 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.3 169.9 21.17 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.554 2.17 . . . . 0.0 112.28 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.0 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.511 2.14 . . . . 0.0 112.343 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.06 -43.99 2.37 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.483 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.93 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.3 p -99.19 31.54 3.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 78.4 1.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttt -150.26 153.93 37.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.17 78.57 0.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.496 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.436 HD23 ' OE1' ' A' ' 83' ' ' GLN . 9.2 mt 60.78 104.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 0.0 110.84 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.99 121.28 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -120.6 152.29 38.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 130.3 41.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.89 103.3 13.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -93.66 129.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.87 106.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.61 129.4 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 77' ' ' TYR . 3.5 pt20 -97.0 127.42 42.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.791 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -65.27 132.34 48.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -96.25 -170.92 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -60.7 -32.36 71.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -92.99 -36.54 12.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.0 -105.75 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.502 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 72' ' ' ILE . 94.9 m-85 -129.78 111.4 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.375 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.76 68.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.61 140.42 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 m -101.31 137.5 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.471 HG12 HG22 ' A' ' 32' ' ' VAL . 20.3 m -134.14 138.43 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.07 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.2 t -148.76 132.62 17.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.86 117.55 0.56 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.23 -77.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-80 -79.33 -61.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.7 Cg_endo -76.42 -168.34 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.543 2.162 . . . . 0.0 112.326 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.559 HG12 HD12 ' A' ' 52' ' ' ILE . 14.7 t -145.53 110.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -138.27 154.09 49.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.174 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 24' ' ' VAL . 15.5 t -95.92 139.14 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.06 -35.27 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.12 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -133.75 153.81 51.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.069 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 14.2 m -136.37 139.86 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -56.21 117.49 3.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.55 126.46 29.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t0 55.34 30.37 14.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.37 -149.23 7.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 14' ' ' GLN . . . -60.97 -37.55 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -71.13 -47.51 57.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.315 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.04 -44.6 96.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -31.36 72.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.49 -15.88 60.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.479 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.48 33.06 40.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 47' ' ' GLN . 21.7 t -71.14 158.99 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.036 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' HG12 ' A' ' 46' ' ' VAL . 2.2 mt-30 -123.06 119.61 30.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.748 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.81 131.15 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 30.99 56.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.515 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -94.38 152.36 18.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -97.03 134.07 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.57 ' CG1' HG12 ' A' ' 82' ' ' VAL . 5.9 mt -101.3 123.92 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 83' ' ' GLN . 2.3 mt -97.84 -38.65 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.64 ' HG2' HD12 ' A' ' 59' ' ' LEU . 23.4 mtmt -129.07 149.3 50.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.026 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.917 HG12 HD23 ' A' ' 80' ' ' LEU . 29.9 m -119.18 112.29 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.039 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.46 38.56 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.86 27.0 73.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 m -133.31 115.03 14.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.336 . . . . 0.0 110.956 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD12 ' HG2' ' A' ' 54' ' ' LYS . 1.3 tp -64.21 -175.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.03 142.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 t -152.39 152.44 32.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -84.85 165.95 17.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 p -98.03 36.87 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.1 m120 -140.61 129.81 23.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.807 ' O ' HG23 ' A' ' 69' ' ' VAL . 20.3 t-80 -60.96 -39.23 88.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.27 -43.21 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -44.26 94.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.826 HG12 HD11 ' A' ' 72' ' ' ILE . 27.3 t -62.82 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.127 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.5 t -61.73 -45.23 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.192 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -62.66 -38.3 89.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.129 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -42.71 74.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 HG12 ' A' ' 68' ' ' VAL . 15.2 mt -68.96 -36.02 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.773 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -31.45 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.693 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.78 78.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.91 145.43 5.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -78.09 -44.87 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -106.93 112.74 25.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.91 136.66 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.12 106.43 10.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.073 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.917 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -106.64 127.32 53.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.1 m -75.1 112.85 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.57 HG12 ' CG1' ' A' ' 52' ' ' ILE . 29.9 m -112.91 175.74 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.653 ' HB2' HD11 ' A' ' 53' ' ' ILE . 6.0 tt0 -142.67 141.49 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.46 101.07 1.26 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.513 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.14 82.13 30.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.436 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 2.9 Cg_endo -42.06 -57.46 1.54 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.973 2.449 . . . . 0.0 112.68 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 42.0 Cg_endo -67.68 158.6 56.46 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.238 1.959 . . . . 0.0 112.167 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.55 66.05 3.85 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.542 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.862 179.949 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -168.86 -44.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.819 0.342 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -154.03 105.96 2.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.7 ttt -122.06 2.66 9.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.402 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.38 24.84 7.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.611 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mp -146.63 75.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.769 0.319 . . . . 0.0 110.766 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.62 127.27 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.19 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -124.52 149.61 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.06 135.57 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.47 131.99 34.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 44' ' ' ALA . 4.4 m -135.1 115.83 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.96 119.17 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -89.53 135.35 26.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.082 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -113.15 121.4 44.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -72.34 145.07 48.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.24 -168.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.814 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.65 -30.52 65.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -87.51 -32.72 19.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.06 -175.71 25.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -62.43 103.61 0.42 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.28 79.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.607 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.2 pp -59.58 133.92 56.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 129.14 47.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.3 141.69 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.9 m -149.34 132.15 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.38 119.5 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -58.99 -74.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.29 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -79.96 -61.49 0.45 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.941 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -76.28 -168.3 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.459 2.106 . . . . 0.0 112.246 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.857 HG12 HD12 ' A' ' 52' ' ' ILE . 6.3 t -150.46 100.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.033 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -123.37 144.03 49.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.22 123.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -86.37 -48.48 8.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -130.11 155.9 45.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 46' ' ' VAL . 22.3 m -136.39 137.53 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 113.42 3.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.76 134.89 47.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 58.43 28.55 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.19 -162.1 10.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.425 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.83 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.46 56.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.218 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -34.73 63.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.45 -31.39 65.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -74.25 -15.82 60.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.401 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.06 26.91 11.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 35' ' ' VAL . 17.1 t -86.61 148.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.704 0.288 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -125.81 147.66 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 48' ' ' THR . 1.2 t -67.22 131.04 44.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.25 38.54 33.97 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.538 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.67 27.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.65 130.34 38.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.857 HD12 HG12 ' A' ' 30' ' ' VAL . 13.4 mt -94.21 121.87 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.991 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.694 HD11 ' HB2' ' A' ' 83' ' ' GLN . 31.0 mt -88.07 -48.32 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -136.72 161.98 34.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 80' ' ' LEU . 25.5 t -136.36 109.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 61.56 49.28 5.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.427 . . . . 0.0 110.774 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.59 26.52 59.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 60' ' ' VAL . 9.9 m -148.21 119.87 8.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.86 -30.19 65.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 58' ' ' THR . 21.5 t 64.23 144.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.6 t -61.17 124.25 20.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.772 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -65.38 -177.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 t 62.34 159.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.002 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.68 97.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.138 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.772 ' O ' HG23 ' A' ' 69' ' ' VAL . 8.9 t-80 -66.07 -36.27 82.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.722 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.1 -42.73 73.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.617 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -61.72 -44.03 97.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.082 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.32 -46.62 95.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.087 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.1 t -60.86 -44.49 97.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.41 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -38.35 88.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.327 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -67.14 -47.59 70.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.489 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.53 HG13 HG11 ' A' ' 78' ' ' VAL . 16.4 tt -68.15 -35.95 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.684 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE2' HG12 ' A' ' 69' ' ' VAL . 6.0 mttm -71.64 -29.32 64.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -64.37 80.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.989 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.64 146.66 7.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.529 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -69.76 -54.14 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.15 129.86 43.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.856 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG11 HG13 ' A' ' 72' ' ' ILE . 10.3 p -147.12 118.48 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.34 142.79 35.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.73 HD23 HG21 ' A' ' 52' ' ' ILE . 2.1 mp -143.69 108.04 4.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -77.36 112.21 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.588 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 52' ' ' ILE . 30.5 m -112.58 165.82 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.463 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.694 ' HB2' HD11 ' A' ' 53' ' ' ILE . 25.1 tt0 -142.81 150.48 40.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.58 175.42 45.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 85' ' ' ARG . 9.0 mtp-105 -136.74 112.57 9.81 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.507 0.194 . . . . 0.0 110.699 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.79 104.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.627 2.218 . . . . 0.0 112.582 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.72 -178.68 4.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.65 2.233 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.09 56.43 25.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.603 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.87 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -103.32 -179.99 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -154.26 -173.58 4.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.822 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -81.59 -31.71 32.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.22 -28.76 1.81 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.547 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 tp -103.11 97.5 7.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 m -116.31 124.43 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.34 145.07 47.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.9 ttm-85 -142.44 133.0 25.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.73 120.91 24.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 44' ' ' ALA . 12.4 p -114.41 119.46 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.067 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mt -106.92 105.61 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.591 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . 3.5 mt -87.89 132.35 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -67.52 149.97 49.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -115.28 -172.78 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.82 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.86 -31.28 69.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.71 -49.04 7.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.88 176.0 14.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.422 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CE1' HG22 ' A' ' 13' ' ' ILE . 16.2 m-85 -64.43 108.04 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.346 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.87 -37.37 94.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.499 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -59.46 142.08 53.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.802 0.334 . . . . 0.0 110.913 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.56 140.62 49.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.78 148.48 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 4.7 t -149.39 132.04 15.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.56 122.33 0.6 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.482 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.3 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.951 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.66 -60.34 0.88 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.851 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.4 -169.48 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.286 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.562 HG12 HD12 ' A' ' 52' ' ' ILE . 4.2 t -150.57 115.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 4.7 p90 -136.06 144.61 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.18 120.83 28.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -89.31 -45.85 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -126.75 151.85 47.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.42 129.89 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.54 99.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.35 130.76 44.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 58.46 36.75 25.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.67 -144.78 4.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.455 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . . . -60.97 -45.84 93.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.116 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.746 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -62.55 -47.39 84.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.121 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -29.85 70.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.79 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -72.24 -37.79 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -74.05 -15.78 61.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.389 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.31 27.45 33.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 41' ' ' ALA . 11.4 p -85.16 147.11 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.704 0.287 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -113.45 164.65 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -79.75 126.63 31.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 38.45 27.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 152.74 20.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 134.35 39.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.562 HD12 HG12 ' A' ' 30' ' ' VAL . 7.8 mt -107.01 114.42 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 83' ' ' GLN . 4.1 mp -78.7 -47.13 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 150.86 43.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG12 ' CB ' ' A' ' 80' ' ' LEU . 4.5 m -132.76 111.6 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 60.35 28.86 18.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.03 24.3 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.662 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.23 100.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 59' ' ' LEU . 1.9 pp -114.19 33.04 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 61' ' ' THR . 11.1 p -117.88 157.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.014 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -63.88 81.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.949 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.85 175.45 10.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 96.1 p -145.84 -173.79 4.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.9 OUTLIER 63.21 105.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.749 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -61.23 -38.23 85.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.767 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.13 -44.14 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.13 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 64' ' ' ASN . 4.4 t -62.74 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.199 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 65' ' ' HIS . 31.8 t -62.09 -44.63 99.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.214 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -63.21 -38.43 91.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.222 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.57 -36.38 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.562 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 68' ' ' VAL . 55.2 mt -73.55 -41.86 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -74.24 -25.96 59.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.43 77.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.925 0.393 . . . . 0.0 110.888 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.93 153.46 8.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.545 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -78.44 -36.3 45.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -106.05 141.45 37.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.1 p -137.26 125.81 34.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.065 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 111.09 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.7 HD12 HG13 ' A' ' 82' ' ' VAL . 2.5 pp -137.09 124.72 22.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.4 m -74.51 124.49 26.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 80' ' ' LEU . 30.5 m -117.27 175.59 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.755 ' HB2' HD11 ' A' ' 53' ' ' ILE . 5.7 tt0 -137.64 138.81 39.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.83 133.09 5.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.391 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.94 141.14 11.79 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.542 0.211 . . . . 0.0 110.818 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.478 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 45.5 Cg_exo -54.72 -49.11 17.89 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.35 2.033 . . . . 0.0 112.616 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 73.5 Cg_endo -75.66 164.19 32.58 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.282 1.988 . . . . 0.0 112.298 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.7 -46.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.56 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.882 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -165.52 -65.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.28 -68.9 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.3 mmt 60.19 101.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.919 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.74 -77.63 0.19 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.01 52.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 0.0 110.834 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.68 118.93 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.175 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.51 126.37 52.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.89 148.75 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.59 159.57 26.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.901 HG21 HG22 ' A' ' 46' ' ' VAL . 10.4 p -146.18 108.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.075 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.08 111.89 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 22' ' ' LEU . 6.5 mt -89.24 144.44 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -109.37 128.41 55.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 12.7 ttmt -82.46 115.32 21.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -90.33 -168.22 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.775 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.51 -30.33 65.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.21 -46.81 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.33 -118.08 1.73 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.554 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 39.6 m-85 -124.29 113.73 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.61 60.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.774 HD23 HG12 ' A' ' 35' ' ' VAL . 4.7 mp -53.81 122.37 9.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 m -101.31 122.28 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.46 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 32' ' ' VAL . 35.7 m -124.1 149.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.373 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -149.33 132.08 15.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.86 111.69 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.587 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.3 -73.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -74.65 -60.68 1.26 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 73.8 Cg_endo -75.51 -168.13 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.55 2.166 . . . . 0.0 112.102 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 HD12 ' A' ' 52' ' ' ILE . 4.9 p -159.46 104.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -134.25 154.24 51.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.782 ' HA ' HG12 ' A' ' 24' ' ' VAL . 10.5 t -92.03 137.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.59 -52.2 2.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.8 t -122.48 149.43 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.774 HG12 HD23 ' A' ' 22' ' ' LEU . 27.2 m -136.41 153.39 31.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 94.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.842 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.13 139.3 58.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 58.29 30.98 20.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.15 -147.76 5.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.498 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.86 96.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -64.03 -47.43 80.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.044 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.34 -35.12 79.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -74.21 -31.49 62.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.53 -15.71 59.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.22 52.6 3.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.901 HG22 HG21 ' A' ' 11' ' ' VAL . 8.8 t -92.45 160.55 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 110.972 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 46' ' ' VAL . 14.2 mp0 -128.9 114.78 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.694 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.91 131.13 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.23 30.82 58.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.627 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -97.8 154.21 17.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 110.976 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -92.21 142.46 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.711 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 30' ' ' VAL . 36.3 mt -106.86 115.4 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.657 HD11 ' HG3' ' A' ' 83' ' ' GLN . 3.2 mp -80.27 -47.3 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 144.57 32.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 71' ' ' LEU . 6.9 m -121.93 111.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' OD1' HG23 ' A' ' 78' ' ' VAL . 0.8 OUTLIER 60.15 30.0 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.895 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.61 ' O ' HD23 ' A' ' 59' ' ' LEU . . . 101.06 -24.71 30.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.639 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.68 85.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 57' ' ' GLY . 0.4 OUTLIER -83.32 -23.4 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -53.88 148.59 2.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.403 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 61' ' ' THR . 3.8 t -126.93 101.19 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.53 38.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.02 -169.62 2.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -120.09 -173.13 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.845 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -60.08 -37.71 80.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -43.19 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.741 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -62.62 -44.1 97.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.343 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.05 -46.5 93.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.114 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 65' ' ' HIS . 22.0 t -60.92 -44.43 97.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -65.69 -38.35 88.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.099 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.493 HD13 ' CG2' ' A' ' 55' ' ' VAL . 3.8 mt -66.55 -47.29 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.529 ' CD1' HG11 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -68.61 -35.93 72.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.819 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -29.32 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.41 80.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.38 153.59 11.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.601 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -67.8 -42.21 81.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.64 150.27 25.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.947 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 72' ' ' ILE . 11.4 p -145.88 122.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.5 109.49 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -125.03 139.95 53.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m -90.34 124.21 34.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.634 HG12 HG12 ' A' ' 52' ' ' ILE . 30.0 m -118.92 172.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.657 ' HG3' HD11 ' A' ' 53' ' ' ILE . 21.5 mt-30 -142.83 136.37 28.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.76 32.85 6.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.549 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -96.76 109.06 46.75 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.539 0.209 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.63 118.96 5.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.43 2.087 . . . . 0.0 112.278 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.95 -50.73 13.03 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.457 2.105 . . . . 0.0 112.312 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.88 -69.9 3.15 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.444 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.92 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.7 m -117.67 31.55 6.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -125.9 121.22 32.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.2 95.96 10.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.47 25.64 11.99 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.604 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.705 HD12 ' HD3' ' A' ' 85' ' ' ARG . 74.1 mt 65.18 -73.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.791 0.329 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.01 112.67 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -122.69 133.39 54.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.778 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 136.56 21.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.158 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.42 142.91 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 m -142.85 134.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.277 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 79' ' ' ALA . 21.1 mt -96.1 117.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.037 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.885 HD13 HD21 ' A' ' 22' ' ' LEU . 20.8 mt -86.32 127.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.23 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -101.9 130.31 48.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.74 150.06 44.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.32 -168.13 1.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.734 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -30.03 65.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -100.58 -35.72 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.83 -137.27 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.519 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.42 97.31 9.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.44 -27.86 63.97 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 13' ' ' ILE . 3.6 pp -63.93 133.69 53.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -103.33 137.54 41.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 32' ' ' VAL . 27.0 m -132.5 142.92 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -149.52 132.13 15.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.56 112.93 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.83 -54.78 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 6.4 m-20 -98.46 -63.9 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -79.99 -166.42 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.437 2.092 . . . . 0.0 112.278 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.931 HG12 HD12 ' A' ' 52' ' ' ILE . 18.4 t -143.55 110.55 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.06 155.03 48.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.022 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.787 ' HA ' HG12 ' A' ' 24' ' ' VAL . 23.2 t -92.56 120.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -31.07 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.48 148.46 39.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.581 HG11 ' CG1' ' A' ' 46' ' ' VAL . 18.0 m -136.49 148.51 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.023 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -61.16 105.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.36 135.3 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 62.05 25.37 15.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.09 -150.08 6.29 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.3 95.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -61.5 -46.81 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.093 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.02 84.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ttp85 -62.03 -33.39 74.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.968 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.35 -15.88 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 31.75 19.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.546 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.581 ' CG1' HG11 ' A' ' 35' ' ' VAL . 21.3 t -82.38 157.21 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' N ' HG12 ' A' ' 46' ' ' VAL . 7.3 mt-30 -122.8 145.53 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 123.73 25.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 34.31 22.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.24 147.53 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.788 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -90.94 140.47 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.931 HD12 HG12 ' A' ' 30' ' ' VAL . 29.8 mt -104.93 130.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -102.94 -49.11 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.066 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -125.03 142.08 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.898 HG12 HD23 ' A' ' 80' ' ' LEU . 27.5 m -114.68 107.33 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.181 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' CG ' HG13 ' A' ' 78' ' ' VAL . 3.7 t-20 59.94 43.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.52 27.96 71.81 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 m -136.24 114.11 11.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.83 79.78 3.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.828 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.65 140.07 42.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.111 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 t -109.56 -24.99 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.02 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' A' ' 71' ' ' LEU . 31.0 m-70 61.8 178.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.775 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.0 m -100.68 -75.34 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -74.14 146.35 43.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.062 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.787 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.8 t-160 -63.65 -36.37 83.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.857 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.8 mt -55.08 -43.09 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.731 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.91 -44.11 97.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.123 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 62' ' ' HIS . 23.3 t -63.77 -46.75 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.128 0.489 . . . . 0.0 110.102 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 65' ' ' HIS . 32.1 t -60.07 -44.5 95.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.25 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -65.85 -38.47 88.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.185 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.633 HD13 ' CE1' ' A' ' 62' ' ' HIS . 1.0 OUTLIER -65.2 -47.7 75.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.602 ' O ' HG21 ' A' ' 78' ' ' VAL . 32.5 mt -68.04 -42.38 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.617 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -74.64 -14.9 60.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 p -48.22 -28.22 2.9 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.678 0.275 . . . . 0.0 111.402 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.99 150.02 20.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.621 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 p -64.23 -51.24 64.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.835 0.35 . . . . 0.0 110.78 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.7 112.62 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.618 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 72' ' ' ILE . 21.7 t -131.26 129.49 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.354 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.576 ' HB2' HG12 ' A' ' 12' ' ' ILE . . . -110.91 103.46 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.898 HD23 HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -110.05 128.76 55.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.07 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -79.74 121.84 25.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.438 HG12 HG12 ' A' ' 52' ' ' ILE . 15.9 m -112.6 172.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -141.93 137.84 31.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -107.13 104.19 2.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.513 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.705 ' HD3' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.66 91.72 4.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.907 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 51.8 Cg_exo -53.09 -45.02 44.09 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.434 2.089 . . . . 0.0 112.564 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 86' ' ' PRO . 23.8 Cg_exo -63.82 -160.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.405 2.07 . . . . 0.0 112.182 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -120.53 47.04 1.06 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.382 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.997 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.32 33.68 20.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 110.945 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -121.92 -43.1 2.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.0 mtp -90.93 -61.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.23 65.25 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.432 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tp -137.44 47.13 2.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.25 115.33 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.168 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 129.64 52.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -120.93 137.66 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 t -82.7 123.94 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 44' ' ' ALA . 17.4 m -112.0 126.9 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.3 mt -98.13 104.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.758 HG21 HD21 ' A' ' 22' ' ' LEU . 18.5 mt -86.89 116.09 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.41 135.9 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 146.41 54.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -112.48 -174.19 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.82 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -60.05 -30.66 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -93.78 -42.55 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.2 72.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 63.21 144.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.81 -27.15 3.61 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.557 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -59.3 138.41 57.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.2 m -102.9 126.4 50.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 31' ' ' PHE . 12.3 p -125.43 137.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 p -149.45 132.16 15.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.52 126.97 1.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.525 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.82 -77.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.449 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -88.21 -52.3 0.39 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.582 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 6.9 Cg_exo -73.21 -166.75 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.826 2.35 . . . . 0.0 111.846 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.838 HG12 HD12 ' A' ' 52' ' ' ILE . 21.8 t -154.29 95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 24' ' ' VAL . 7.6 p90 -119.95 146.8 45.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.409 ' CG2' HD11 ' A' ' 52' ' ' ILE . 21.2 t -90.47 120.67 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.421 ' O ' HG22 ' A' ' 48' ' ' THR . 3.0 tt0 -79.37 -55.15 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -126.6 157.91 37.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.657 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 18.2 m -136.33 139.86 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tptp -59.74 109.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.81 131.73 44.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t70 59.92 31.45 20.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.27 -150.67 6.23 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.517 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.95 87.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.816 0.341 . . . . 0.0 111.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -67.29 -47.26 71.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.151 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.9 tpt -64.32 -49.07 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -31.58 70.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.514 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -72.24 -15.77 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.45 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.492 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.491 HG22 HG21 ' A' ' 11' ' ' VAL . 20.5 t -79.1 158.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' HG12 ' A' ' 46' ' ' VAL . 10.8 mp0 -125.31 141.99 51.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.04 128.1 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.61 48.4 56.64 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.2 p30 -100.92 174.67 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.58 133.31 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.838 HD12 HG12 ' A' ' 30' ' ' VAL . 31.1 mt -105.68 114.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.485 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.7 mp -95.16 -30.09 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -135.82 143.1 44.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 59' ' ' LEU . 16.6 m -126.71 107.18 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.783 ' CG ' HG23 ' A' ' 78' ' ' VAL . 15.2 t30 60.4 32.54 20.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.85 26.25 71.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -123.04 23.6 9.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.145 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.645 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER 54.84 173.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.108 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.528 HG12 HG13 ' A' ' 55' ' ' VAL . 23.6 m -117.76 64.09 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.072 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.36 31.12 3.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -108.6 -178.08 3.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.6 p -147.15 -50.34 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.4 m120 -60.52 126.03 25.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.759 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 t-80 -60.06 -41.3 92.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.772 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.32 -43.07 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.136 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.777 HG12 HD11 ' A' ' 72' ' ' ILE . 25.3 t -62.61 -46.57 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.9 t -61.45 -46.88 95.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.339 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -62.24 -38.3 88.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 71' ' ' LEU . 6.2 tt -68.32 -41.83 80.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.437 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.777 HD11 HG12 ' A' ' 68' ' ' VAL . 15.7 mt -70.63 -35.99 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.803 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -27.52 62.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.32 80.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.19 147.21 7.14 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.403 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.0 m -59.53 -61.39 2.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.81 128.47 56.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.853 HG13 HD11 ' A' ' 80' ' ' LEU . 10.4 p -113.09 140.23 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.29 101.77 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.853 HD11 HG13 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -113.78 126.89 55.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.6 m -71.49 112.8 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.771 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 83' ' ' GLN . 11.9 p -113.48 159.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 82' ' ' VAL . 48.4 tt0 -132.48 144.46 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.13 120.19 3.17 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.502 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -140.8 139.14 19.2 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.611 0.244 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.55 109.99 3.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.468 2.112 . . . . 0.0 112.292 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.77 154.14 73.94 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.466 2.11 . . . . 0.0 112.296 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -96.42 29.15 10.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.573 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.019 179.939 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m -121.91 171.31 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -35.82 32.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.8 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.6 tpt -63.11 83.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.63 -50.76 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mp -144.88 113.59 6.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.39 123.87 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.63 133.34 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.4 ttp85 -144.82 130.89 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.3 m -80.57 144.36 32.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.17 137.46 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.6 mp -116.59 117.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.73 143.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.576 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 31.5 mt-30 -112.92 128.71 56.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -65.45 143.84 57.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.02 -170.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -59.69 -29.21 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.999 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.06 -50.17 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.29 -128.07 2.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 62.0 m-85 -117.34 114.13 23.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.44 -29.96 65.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.418 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 41' ' ' ALA . 1.9 mp -55.52 113.45 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 m -101.2 122.35 43.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 31' ' ' PHE . 9.2 p -130.14 141.5 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -149.34 135.67 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.43 138.89 3.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.71 -79.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.29 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -78.2 -61.26 0.59 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' O ' HG13 ' A' ' 30' ' ' VAL . 72.4 Cg_endo -76.4 -167.43 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.126 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.754 HG23 ' HB ' ' A' ' 52' ' ' ILE . 3.0 m -157.53 104.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.214 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.762 ' O ' HG23 ' A' ' 24' ' ' VAL . 18.0 p90 -123.05 136.71 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 22' ' ' LEU . 26.3 t -81.98 120.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -87.27 -29.29 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 148.32 51.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.242 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.433 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 31.6 m -136.67 153.48 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 7.9 tttp -68.73 116.56 9.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.9 134.9 35.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 55.76 32.97 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.975 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -137.17 -144.63 4.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -61.04 -44.68 97.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.776 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -64.4 -47.28 79.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -38.66 91.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -71.22 -30.75 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . -75.18 -15.82 60.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.415 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' O ' ' NE2' ' A' ' 47' ' ' GLN . . . 82.12 38.85 12.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.582 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 41' ' ' ALA . 11.5 p -96.32 153.99 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 110.95 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 45' ' ' GLY . 19.7 mp0 -120.19 141.44 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -60.97 132.39 53.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.34 47.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.188 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.53 146.92 26.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -92.15 132.5 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.787 ' HA ' HG12 ' A' ' 82' ' ' VAL . 4.0 mt -97.08 123.86 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.105 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 81' ' ' THR . 4.3 mt -91.94 -42.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.026 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HG3' HG22 ' A' ' 53' ' ' ILE . 25.1 mttp -148.42 142.99 26.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.83 118.87 58.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.78 32.62 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.16 26.87 69.71 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.651 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t -143.52 104.39 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 53' ' ' ILE . 32.1 tp -109.9 152.18 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.26 172.28 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -44.95 48.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -117.65 124.97 49.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.858 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.7 p -142.13 -58.35 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.018 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.78 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.5 t30 73.86 -178.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.937 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -66.0 -42.54 89.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.412 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.7 pp -55.38 -43.61 75.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.101 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.45 ' N ' HD12 ' A' ' 66' ' ' LEU . 3.0 tp10 -65.5 -39.34 91.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.279 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 64' ' ' ASN . 30.2 t -65.62 -46.84 88.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.1 p -65.39 -41.42 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.197 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 2.5 mptp? -66.06 -40.46 90.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.261 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' HG3' ' A' ' 67' ' ' GLU . 2.3 mm? -67.66 -47.48 69.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 68' ' ' VAL . 7.2 tt -68.48 -35.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.869 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -73.24 -28.81 62.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 p -68.83 72.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.819 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.14 144.01 7.71 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.0 p -70.15 -30.92 68.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -95.98 117.39 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.89 133.24 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.82 113.1 10.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.746 HD12 HG13 ' A' ' 82' ' ' VAL . 3.3 pp -126.32 133.59 51.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.433 HG22 HD12 ' A' ' 53' ' ' ILE . 60.8 m -76.02 126.08 30.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 52' ' ' ILE . 14.7 m -127.1 175.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -134.17 132.54 39.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.43 105.44 0.56 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -176.3 96.58 0.25 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.572 0.225 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.92 171.49 11.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.419 2.079 . . . . 0.0 112.135 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.5 172.84 7.3 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.549 2.166 . . . . 0.0 112.208 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -100.1 19.66 52.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.647 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.012 179.891 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m -129.0 -64.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -89.43 167.62 12.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.5 ttm 61.65 152.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.64 68.52 0.85 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.549 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.19 35.83 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.346 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t -108.3 112.24 39.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.107 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -97.53 138.26 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.791 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -141.41 139.38 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.1 m -106.62 142.6 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.668 ' CG1' HG22 ' A' ' 46' ' ' VAL . 15.8 m -128.17 137.05 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.529 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 32.3 mt -128.08 92.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.995 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 22' ' ' LEU . 4.0 mt -86.33 142.76 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.626 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 21.1 mt-30 -112.99 137.46 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.89 135.44 45.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -103.7 -163.15 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.603 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.47 56.1 2.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.795 0.331 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 174.8 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.59 -169.28 24.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.444 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.47 ' CE2' HG22 ' A' ' 72' ' ' ILE . 63.2 m-85 -79.04 130.5 35.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.9 -33.77 23.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' CD2' HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -58.6 148.63 28.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -112.19 122.94 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 11.2 p -118.58 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.7 132.1 15.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.64 99.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.677 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.88 -69.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.409 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.421 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 t-20 -82.71 -55.12 0.55 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.182 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.6 Cg_endo -86.87 -164.66 0.22 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.818 2.345 . . . . 0.0 111.909 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.058 HG22 HD12 ' A' ' 52' ' ' ILE . 5.6 p -147.92 97.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 110.94 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -133.75 149.26 51.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.9 120.2 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.35 -67.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG23 ' A' ' 48' ' ' THR . 30.7 m -134.71 171.4 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.099 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.616 HG11 ' CG1' ' A' ' 46' ' ' VAL . 5.9 m -135.91 153.47 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.34 123.25 22.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -75.3 146.62 40.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 55.08 24.05 5.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.81 -161.17 11.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.626 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -60.99 -40.26 92.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.319 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.707 ' HB3' ' HG2' ' A' ' 36' ' ' LYS . . . -68.0 -47.71 67.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.093 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -63.4 -39.28 94.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 0.0 110.712 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -69.88 -31.88 69.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' HB1' ' H ' ' A' ' 12' ' ' ILE . . . -71.01 -15.77 62.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.453 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.12 29.07 26.45 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.537 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.668 HG22 ' CG1' ' A' ' 11' ' ' VAL . 11.9 t -78.05 149.9 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -110.03 163.01 13.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -82.82 123.77 29.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.22 44.64 65.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.536 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -93.71 146.51 23.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.738 0.304 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -84.48 138.45 32.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.6 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.058 HD12 HG22 ' A' ' 30' ' ' VAL . 29.5 mt -100.93 114.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.171 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 83' ' ' GLN . 7.2 mt -78.71 -42.01 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.028 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -156.32 142.07 17.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 80' ' ' LEU . 21.4 t -108.43 125.56 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.199 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 59.81 37.01 22.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.21 27.93 63.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.585 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -145.37 103.44 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.7 mp -63.8 163.8 11.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.004 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -136.21 109.04 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 t -98.4 138.49 35.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.3 t60 60.16 39.49 19.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.3 m -111.79 174.71 5.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 68' ' ' VAL . 57.9 m-20 -125.26 -179.82 4.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.767 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.4 t-160 -61.58 -37.39 83.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.965 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.35 -43.13 74.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.562 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.1 -43.97 97.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.174 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.758 HG12 HD11 ' A' ' 72' ' ' ILE . 6.3 t -62.15 -46.69 95.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.047 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.0 t -62.18 -46.2 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.322 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.42 75.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.456 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.758 HD11 HG12 ' A' ' 68' ' ' VAL . 20.3 mt -69.71 -36.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.844 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HD3' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -73.75 -31.53 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.922 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -67.88 80.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 173.37 13.42 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -98.51 -42.73 7.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.86 120.54 39.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 72' ' ' ILE . 12.0 p -116.36 120.46 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.96 104.91 10.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.737 HD12 HG13 ' A' ' 82' ' ' VAL . 2.9 pp -120.65 132.87 55.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.811 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.458 HG22 HD12 ' A' ' 53' ' ' ILE . 63.6 m -79.97 122.86 27.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.737 HG13 HD12 ' A' ' 80' ' ' LEU . 26.8 m -116.11 169.09 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.03 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.619 ' HB2' HD11 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -134.83 142.78 46.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.76 159.71 27.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 29.9 ptt85 -158.57 149.94 16.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.704 0.287 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.97 175.18 9.46 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.593 2.195 . . . . 0.0 112.322 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.18 -170.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.518 2.145 . . . . 0.0 112.227 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.43 -36.25 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.46 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.97 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -132.93 -175.84 3.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -74.63 -12.55 60.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.263 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.37 105.39 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 110.996 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.5 61.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 tt -104.45 -46.56 4.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.319 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.2 p -119.39 116.9 52.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -131.98 133.8 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.72 130.18 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -88.99 118.07 28.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 11' ' ' VAL . 24.5 m -128.27 108.28 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 130.63 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 46' ' ' VAL . 23.6 mm -108.36 137.36 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.062 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 13.9 mt-30 -110.31 134.42 52.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -67.82 123.82 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -86.93 -169.93 2.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -59.46 -31.18 69.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.52 1.72 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.348 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.33 -160.27 14.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.545 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.434 ' CE2' HG22 ' A' ' 72' ' ' ILE . 14.0 m-85 -80.06 114.62 19.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.719 0.295 . . . . 0.0 110.855 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -29.77 75.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.604 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.18 137.54 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.38 136.78 40.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 31' ' ' PHE . 12.3 p -133.36 134.05 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -149.4 137.0 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.41 130.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.523 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.6 -71.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.417 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 3.9 m-20 -82.6 -61.86 0.32 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.786 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 80.1 Cg_endo -77.64 -167.99 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.542 2.161 . . . . 0.0 112.151 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.813 HG22 HD12 ' A' ' 52' ' ' ILE . 8.2 p -152.96 104.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.743 ' O ' HG23 ' A' ' 24' ' ' VAL . 47.0 p90 -130.89 155.64 46.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -92.17 120.87 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -31.43 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -135.28 147.8 49.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.608 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 15.8 m -129.89 145.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 105.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.48 133.12 44.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 60.22 30.94 20.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.77 -147.8 5.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.48 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.608 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -64.76 -47.37 78.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 tpt -63.1 -41.59 99.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -36.99 86.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.83 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 36.51 25.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.593 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 13' ' ' ILE . 18.5 t -88.08 149.05 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 111.072 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -112.11 153.3 27.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -69.04 130.6 43.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.57 31.94 43.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.405 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' HG11 ' A' ' 82' ' ' VAL . 3.4 p30 -84.24 138.55 32.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.72 141.4 28.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.655 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.813 HD12 HG22 ' A' ' 30' ' ' VAL . 17.0 mt -102.77 137.77 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mm -113.32 -38.79 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -137.63 157.77 45.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 55' ' ' VAL . 18.5 m -139.48 104.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.89 43.57 17.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.68 26.79 66.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.504 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 55' ' ' VAL . 16.0 m -124.74 94.46 4.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.83 104.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 58' ' ' THR . 21.5 t -93.59 135.25 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 t -130.66 -48.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.77 97.05 3.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.835 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.3 m -145.25 -178.53 6.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.07 173.69 6.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -62.36 -40.92 97.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -38.68 88.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.222 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.22 -44.34 79.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.717 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 72' ' ' ILE . 7.5 p -68.29 -41.63 83.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 65' ' ' HIS . 95.1 t -65.13 -43.77 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.929 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -65.99 -41.18 91.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.2 mt -65.34 -50.41 65.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.763 ' CD1' HG22 ' A' ' 68' ' ' VAL . 26.5 mt -65.51 -35.89 76.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.573 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.55 -25.68 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -63.92 80.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.11 144.13 10.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.438 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.99 -42.96 89.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.399 . . . . 0.0 111.022 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.0 m-85 -102.54 113.73 27.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -137.12 127.77 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.209 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.81 148.55 22.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -143.65 116.32 8.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.081 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -79.47 115.22 18.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 ' OD1' ' A' ' 50' ' ' ASP . 17.8 m -115.18 170.53 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.445 ' NE2' ' O ' ' A' ' 7' ' ' VAL . 3.9 mt-30 -131.9 140.95 49.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.66 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.442 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -114.39 76.1 0.25 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.568 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.39 94.1 25.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.625 0.25 . . . . 0.0 110.809 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.13 171.24 12.91 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.476 2.117 . . . . 0.0 112.245 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.69 -168.28 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.571 2.181 . . . . 0.0 112.316 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -96.5 37.24 3.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.893 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p -157.95 38.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.816 0.341 . . . . 0.0 110.933 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 60.75 33.89 20.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.97 122.16 22.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.0 -80.26 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mp 58.68 27.54 16.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.348 . . . . 0.0 110.991 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.478 HG21 ' HG3' ' A' ' 85' ' ' ARG . 5.0 m -123.67 112.14 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.16 151.87 29.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -148.52 146.49 28.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.3 m -90.19 132.86 35.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 11' ' ' VAL . 29.6 m -130.43 100.35 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.552 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.9 mp -84.93 108.81 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.24 124.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HG2' ' CD1' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -101.46 134.35 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.795 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -65.35 131.48 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.09 -170.83 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -30.71 69.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -103.07 -34.36 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.38 -160.36 24.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.53 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 72' ' ' ILE . 59.4 m-85 -81.53 121.72 26.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.973 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.61 -30.94 42.42 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.545 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -60.04 134.97 57.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -104.57 137.0 43.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 32' ' ' VAL . 6.7 m -129.4 136.53 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 t -149.42 132.12 15.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.012 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.92 117.41 0.61 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.05 -74.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 110.816 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.7 m120 -81.75 -61.48 0.37 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 71.7 Cg_endo -77.06 -168.05 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.52 2.146 . . . . 0.0 112.317 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.607 HG12 HG13 ' A' ' 52' ' ' ILE . 25.5 t -144.08 111.99 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 2.7 p90 -139.6 152.97 47.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.716 ' HA ' HG12 ' A' ' 24' ' ' VAL . 11.2 t -92.75 120.99 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.036 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -73.09 -67.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.98 163.03 17.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.652 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 23.3 m -136.32 140.04 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -59.28 120.41 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.73 131.08 39.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.3 30.82 20.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.45 -152.35 7.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.538 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.81 87.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.187 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -68.64 -47.37 66.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -63.67 -48.76 75.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -34.41 72.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.982 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -71.68 -15.95 62.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.432 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.99 40.73 13.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.456 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.446 ' CG1' HG11 ' A' ' 35' ' ' VAL . 19.2 t -90.36 140.16 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.81 148.04 26.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.25 119.8 13.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 44.98 12.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 32' ' ' VAL . 57.0 p30 -93.38 161.99 14.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -98.72 137.88 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.023 HD13 HG12 ' A' ' 82' ' ' VAL . 25.4 mm -96.21 138.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.019 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 83' ' ' GLN . 5.8 mt -113.61 -48.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.059 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 19.3 ttmt -136.07 141.96 44.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.631 HG23 HD11 ' A' ' 80' ' ' LEU . 9.7 p -125.71 112.36 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.643 ' OD1' HG23 ' A' ' 78' ' ' VAL . 54.6 m-20 59.25 38.19 23.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.013 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 24.31 71.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.783 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.4 p -131.77 88.14 2.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.26 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 60' ' ' VAL . 2.5 pp -47.48 169.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.295 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.739 ' O ' HD12 ' A' ' 59' ' ' LEU . 21.5 t -60.1 132.05 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.8 p -140.14 -68.3 0.42 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.47 88.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.3 m -151.68 146.56 25.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.723 ' O ' HG23 ' A' ' 68' ' ' VAL . 54.2 m-20 -96.36 -174.44 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.916 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.34 -45.17 84.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.9 mm? -55.46 -43.3 75.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.652 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.753 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.9 mp0 -65.37 -39.14 91.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.304 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 64' ' ' ASN . 22.8 t -66.26 -46.79 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.599 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.2 p -65.98 -41.22 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.194 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.82 -38.32 88.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.6 mm? -68.56 -43.22 77.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.305 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.737 HG23 HG11 ' A' ' 78' ' ' VAL . 19.4 mt -71.32 -41.67 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -74.43 -18.87 60.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.103 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -28.62 6.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.48 161.64 29.03 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 p -68.56 -48.2 64.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 14' ' ' GLN . 57.4 m-85 -95.8 114.75 26.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 72' ' ' ILE . 12.8 p -128.52 139.47 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.01 114.31 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.883 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.642 ' CD1' HG22 ' A' ' 78' ' ' VAL . 7.8 mp -119.27 119.74 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -77.78 113.62 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.023 HG12 HD13 ' A' ' 52' ' ' ILE . 34.1 m -112.39 172.95 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.586 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.792 ' HB2' HD11 ' A' ' 53' ' ' ILE . 23.0 tt0 -135.49 137.09 41.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.765 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.91 134.27 1.61 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.478 ' HG3' HG21 ' A' ' 7' ' ' VAL . 4.0 ttp180 -92.05 136.6 25.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.507 0.194 . . . . 0.0 110.846 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 142.18 55.99 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.398 2.065 . . . . 0.0 112.197 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.1 -175.91 2.4 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.432 2.088 . . . . 0.0 112.296 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.6 -28.17 57.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.433 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.866 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.417 ' C ' HG12 ' A' ' 7' ' ' VAL . 32.5 m -129.76 33.91 4.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.74 83.0 1.03 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -162.58 -47.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.98 -54.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -114.52 109.68 18.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.759 0.314 . . . . 0.0 110.984 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG12 ' C ' ' A' ' 2' ' ' SER . 31.1 m -107.52 134.18 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -128.61 138.96 52.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -135.51 149.8 49.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.6 p -99.37 104.9 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 11' ' ' VAL . 12.9 p -85.52 115.49 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -88.11 99.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.702 HG22 ' CD1' ' A' ' 20' ' ' PHE . 28.8 mt -86.42 112.65 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -102.16 131.52 48.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.96 119.61 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.43 -168.96 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -30.71 66.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 -38.39 13.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.61 178.43 20.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.702 ' CD1' HG22 ' A' ' 13' ' ' ILE . 25.1 m-85 -60.05 112.78 2.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.5 8.41 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.636 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -50.74 146.84 5.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 111.19 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 148.78 41.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.804 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.629 HG12 HG22 ' A' ' 32' ' ' VAL . 30.9 m -135.34 140.07 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 t -149.51 132.09 15.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.27 109.95 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -57.61 -68.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 2.0 t30 -89.51 -51.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 2.2 Cg_endo -84.61 -161.37 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.98 2.453 . . . . 0.0 112.19 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.029 HG12 HD12 ' A' ' 52' ' ' ILE . 10.1 t -150.4 97.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -133.8 149.73 51.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.147 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.629 HG22 HG12 ' A' ' 24' ' ' VAL . 25.7 t -83.65 128.36 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -92.64 -49.49 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.68 158.02 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HB ' HG11 ' A' ' 46' ' ' VAL . 17.6 m -136.49 153.11 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -81.79 111.69 18.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.2 138.01 39.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t0 58.58 30.62 20.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.6 -158.99 8.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.554 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.79 72.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB1' HG11 ' A' ' 46' ' ' VAL . . . -71.31 -47.36 57.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.214 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tpt -67.42 -42.24 83.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -32.72 74.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.75 58.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.461 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 52.95 3.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.479 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.611 HG11 ' HB1' ' A' ' 41' ' ' ALA . 14.9 p -88.59 158.95 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -128.13 115.86 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.867 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.32 130.83 36.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 32.67 45.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.434 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -94.68 147.71 23.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.926 0.393 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.56 142.61 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.707 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.029 HD12 HG12 ' A' ' 30' ' ' VAL . 39.1 mt -98.51 115.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.763 HD12 HG22 ' A' ' 81' ' ' THR . 20.0 mt -78.72 -47.09 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.64 ' HB3' HD23 ' A' ' 59' ' ' LEU . 5.1 pttt -156.86 161.91 39.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.002 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.937 HG23 ' CD2' ' A' ' 80' ' ' LEU . 9.4 p -121.13 114.79 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.181 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 56.6 55.56 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.91 27.5 62.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.546 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -129.78 118.03 21.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.842 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 54' ' ' LYS . 4.7 mt -85.2 57.17 4.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 55' ' ' VAL . 12.1 p -87.39 141.0 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.07 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 m -112.17 -66.49 1.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 57.9 -171.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.15 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 68' ' ' VAL . 24.2 m-20 -147.86 115.89 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.814 ' O ' HG23 ' A' ' 69' ' ' VAL . 12.0 t-80 -60.4 -40.28 90.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 66' ' ' LEU . 6.5 mp -55.32 -43.19 74.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.29 -43.97 96.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.192 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.822 HG12 HD11 ' A' ' 72' ' ' ILE . 6.4 t -63.32 -46.56 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.053 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 65' ' ' HIS . 23.4 t -62.55 -45.08 99.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -38.42 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.492 HD23 HG11 ' A' ' 55' ' ' VAL . 5.9 tp -68.17 -45.48 73.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.707 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.822 HD11 HG12 ' A' ' 68' ' ' VAL . 18.1 mt -70.14 -36.09 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -74.37 -28.88 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.9 p -64.29 80.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.932 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.68 143.94 5.41 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.578 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 m -71.68 -55.7 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 m-85 -96.06 116.17 28.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.05 145.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.203 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.83 112.38 16.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.937 ' CD2' HG23 ' A' ' 55' ' ' VAL . 3.3 mt -112.96 116.67 30.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.763 HG22 HD12 ' A' ' 53' ' ' ILE . 89.5 m -77.47 111.15 12.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.688 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 52' ' ' ILE . 12.4 m -117.43 175.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.325 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.96 130.04 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.01 -149.33 24.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.67 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 63.78 65.34 1.22 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.14 137.73 80.96 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.56 2.173 . . . . 0.0 112.137 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.35 134.42 15.61 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.423 2.082 . . . . 0.0 112.414 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.97 -54.08 4.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.565 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.29 -69.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.801 0.334 . . . . 0.0 110.975 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -95.65 -39.96 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -98.55 32.66 2.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.65 -50.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.575 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.623 HD22 HE21 ' A' ' 83' ' ' GLN . 32.7 mt -134.56 101.34 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.5 m -101.57 119.15 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -105.47 139.88 39.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -148.49 137.93 21.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.98 107.25 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.07 143.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.1 105.21 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.713 HD11 HD11 ' A' ' 72' ' ' ILE . 32.7 pt -105.06 137.76 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.254 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.51 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 8.2 tt0 -106.61 119.18 38.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.754 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -67.31 145.5 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -112.99 -169.34 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -60.37 -31.18 70.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -41.27 13.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 -155.45 20.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -88.85 111.08 21.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.97 -38.67 96.38 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.605 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -54.59 136.81 44.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -101.25 131.64 47.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 32' ' ' VAL . 29.0 m -129.64 134.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 p -147.67 132.16 17.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.23 119.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.28 -77.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.4 m120 -84.28 -48.25 0.68 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -84.65 -168.81 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.538 2.159 . . . . 0.0 112.476 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.702 HG12 HD12 ' A' ' 52' ' ' ILE . 21.3 t -149.4 102.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -132.2 153.3 50.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 24' ' ' VAL . 24.4 t -88.78 124.81 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.0 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -34.85 22.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.62 158.81 43.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 46' ' ' VAL . 8.9 m -136.08 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.156 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 13.3 ptmt -55.93 122.56 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.1 mt-10 -77.33 151.43 34.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.974 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.28 29.85 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HE2' ' A' ' 36' ' ' LYS . . . -141.04 -166.65 10.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -52.35 -44.72 65.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.777 0.322 . . . . 0.0 111.405 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -59.9 -47.61 85.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -67.26 -50.96 58.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -59.14 -31.95 69.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.03 -15.82 62.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.399 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.55 35.51 28.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.544 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.693 ' HB ' HG11 ' A' ' 35' ' ' VAL . 17.9 t -85.08 141.21 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.282 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -105.77 156.83 17.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.88 125.14 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.23 30.59 45.48 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -80.7 145.49 31.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.04 133.89 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.702 HD12 HG12 ' A' ' 30' ' ' VAL . 5.6 mt -101.27 133.93 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mt -110.77 -47.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -122.02 156.5 33.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.58 HG13 ' CD2' ' A' ' 80' ' ' LEU . 22.1 t -133.66 104.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 t30 59.0 41.44 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.15 73.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.587 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.58 84.33 1.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.71 152.13 23.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 61' ' ' THR . 9.4 p -132.85 158.3 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.482 ' N ' HG22 ' A' ' 60' ' ' VAL . 73.4 p -99.11 -58.95 1.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -177.15 138.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.973 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.8 m -158.79 -78.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -179.33 162.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.786 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.1 t-80 -59.3 -38.6 80.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.25 -43.26 74.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.97 -44.12 96.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 72' ' ' ILE . 17.4 t -62.74 -46.51 96.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.9 t -62.31 -44.3 99.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 13.9 mtpp -66.09 -38.37 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.794 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -40.48 70.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.888 HD12 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -73.93 -36.87 46.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.038 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.55 -20.57 59.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -68.6 72.14 0.22 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.879 0.371 . . . . 0.0 110.8 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 150.24 7.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.438 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -46.67 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 114.39 26.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.728 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -131.47 144.47 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.66 111.35 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -112.18 134.34 53.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.6 m -82.64 113.78 20.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -112.59 169.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.623 HE21 HD22 ' A' ' 6' ' ' LEU . 1.2 tt0 -142.78 128.0 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.647 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.25 174.95 20.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.774 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.74 78.05 0.31 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.836 0.35 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.18 112.18 3.43 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.671 2.247 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.39 -160.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.511 2.141 . . . . 0.0 112.196 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.85 -46.08 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.423 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.5 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.91 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 p 50.08 88.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.68 0.276 . . . . 0.0 111.225 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -123.79 146.57 48.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 35.3 mtp 60.33 78.99 0.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.81 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.82 -49.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.53 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 mt -118.21 104.78 11.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.08 147.46 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -128.62 143.65 50.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -143.51 140.52 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 128.75 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 44' ' ' ALA . 12.4 p -126.2 114.72 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.19 114.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.758 HD13 HD21 ' A' ' 22' ' ' LEU . 12.0 mt -98.09 145.05 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.13 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -114.97 126.2 54.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -66.13 120.4 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 33.9 m-20 -87.57 -173.05 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -29.82 67.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.12 -30.38 14.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.94 -161.67 12.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.514 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 72' ' ' ILE . 4.3 m-85 -79.38 94.49 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.48 -32.12 80.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 13' ' ' ILE . 4.2 pp -59.87 131.39 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 m -102.22 132.92 47.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 HG22 ' A' ' 32' ' ' VAL . 31.3 m -116.88 143.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.54 132.51 17.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.02 132.26 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.365 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -58.03 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.672 0.272 . . . . 0.0 110.839 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 7.6 m-20 -85.24 -61.49 0.27 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.766 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 92.1 Cg_endo -80.07 -167.44 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.524 2.149 . . . . 0.0 112.194 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.64 120.72 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 2.9 t80 -128.42 135.39 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.702 HG22 HG12 ' A' ' 24' ' ' VAL . 20.6 t -93.75 122.99 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -97.0 -49.83 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.281 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.54 148.66 42.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.191 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.603 HG11 HG12 ' A' ' 46' ' ' VAL . 29.4 m -136.46 145.56 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.99 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.89 121.06 15.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.008 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.02 138.94 31.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t0 59.11 30.73 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.34 -149.66 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . . . -59.78 -45.55 91.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.76 0.314 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . -61.7 -47.41 85.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.82 85.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -32.72 73.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -71.25 -15.72 62.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.404 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.3 26.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.567 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.603 HG12 HG11 ' A' ' 35' ' ' VAL . 24.4 t -78.8 158.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.731 0.301 . . . . 0.0 110.992 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.482 ' N ' HG12 ' A' ' 46' ' ' VAL . 13.2 mt-30 -132.3 144.65 50.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.42 125.11 23.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 78.32 46.6 8.88 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.429 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.7 139.65 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -92.05 152.08 20.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.973 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.808 HD13 HG12 ' A' ' 82' ' ' VAL . 13.4 mm -106.94 133.37 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.0 mm -107.45 -33.82 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.2 157.28 42.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.752 HG12 ' HB3' ' A' ' 80' ' ' LEU . 4.7 m -140.62 110.46 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.496 HD21 HG23 ' A' ' 78' ' ' VAL . 84.4 m-20 60.75 41.98 14.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 26.25 71.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p -139.32 116.45 11.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.87 0.367 . . . . 0.0 110.952 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.72 -75.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.62 112.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 61' ' ' THR . 16.9 m -120.42 32.12 6.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -169.44 106.79 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.913 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 t -171.48 161.74 6.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.619 ' O ' HG23 ' A' ' 68' ' ' VAL . 18.3 t-20 -92.21 168.36 11.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -59.41 -42.23 91.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.468 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 tp -55.29 -43.47 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.87 -40.14 94.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.256 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 64' ' ' ASN . 22.6 t -65.68 -46.78 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.2 p -65.02 -41.29 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.019 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -38.37 87.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.102 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -47.39 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.453 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.513 HD11 ' CE2' ' A' ' 20' ' ' PHE . 2.0 tt -68.7 -37.89 78.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.64 -26.6 59.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.023 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 t -64.23 80.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.96 144.56 9.13 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 m -69.8 -49.26 54.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 120.49 36.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG23 HD21 ' A' ' 56' ' ' ASN . 11.1 p -136.06 133.87 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.93 117.44 30.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.752 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -131.03 127.56 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -70.02 131.23 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.808 HG12 HD13 ' A' ' 52' ' ' ILE . 27.0 m -126.86 169.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -140.61 127.87 21.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.96 -169.26 11.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.627 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.27 92.27 3.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.39 110.42 2.03 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.487 2.124 . . . . 0.0 112.343 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.41 -44.9 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.415 2.077 . . . . 0.0 112.369 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.87 49.36 0.85 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.617 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 112.379 -0.288 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -107.17 46.7 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.921 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -156.44 31.19 0.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.4 ttm -65.9 -32.18 73.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.73 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.65 -80.64 0.25 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.468 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.28 -76.37 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 110.762 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.72 131.14 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.135 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.74 138.58 40.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.7 154.17 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.33 139.75 37.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.79 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.4 m -134.05 144.29 35.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 79' ' ' ALA . 24.3 mm -113.67 107.32 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.691 HD11 HD21 ' A' ' 80' ' ' LEU . 15.9 pt -106.02 126.07 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.41 139.35 38.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 128.67 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.703 ' OD2' ' HB2' ' A' ' 40' ' ' ALA . 18.0 m-20 -103.99 -169.59 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.81 -36.35 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.29 -43.84 66.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.14 76.06 1.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.561 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.641 ' CE2' HD12 ' A' ' 13' ' ' ILE . 8.8 m-85 61.39 115.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.11 -44.97 4.91 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.553 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 142.79 36.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.337 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m -101.32 122.26 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.401 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 10.0 p -118.97 137.18 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.8 p -149.53 132.03 15.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.26 120.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.461 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.7 -73.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.5 t-20 -84.66 -53.04 0.5 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 86.2 Cg_endo -84.27 -167.49 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.725 2.284 . . . . 0.0 112.378 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.098 HG12 HD12 ' A' ' 52' ' ' ILE . 19.5 t -145.49 94.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.006 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -127.31 141.02 51.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.92 128.69 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.05 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.73 -30.33 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.17 146.25 47.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.951 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.61 HG13 ' HB1' ' A' ' 41' ' ' ALA . 40.4 t -134.6 129.71 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -66.92 110.55 3.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.806 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.4 pm0 -91.81 44.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.43 35.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.591 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.47 -145.82 4.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.849 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . . . -60.99 -38.88 87.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.726 0.298 . . . . 0.0 111.401 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -59.29 -47.47 85.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.416 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 3.8 tpt -72.42 -43.14 64.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.801 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -30.8 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 13' ' ' ILE . . . -83.51 -15.85 47.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.73 56.96 3.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 47' ' ' GLN . 24.6 t -98.39 158.5 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.481 ' N ' HG12 ' A' ' 46' ' ' VAL . 1.5 mp0 -118.88 148.68 42.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.04 129.11 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 33.42 32.8 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.586 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.95 133.93 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.846 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.098 HD12 HG12 ' A' ' 30' ' ' VAL . 24.3 mt -96.89 124.41 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.69 -43.85 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.181 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -138.29 150.36 46.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.955 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 80' ' ' LEU . 5.2 m -136.19 106.19 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.173 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.29 43.6 10.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.803 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.98 27.56 70.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.495 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.42 79.66 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -61.68 -30.56 70.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.12 151.59 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.133 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -134.64 171.72 13.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -119.51 178.54 4.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.99 -30.16 21.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.72 122.89 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.727 ' O ' HG23 ' A' ' 69' ' ' VAL . 19.2 t-80 -66.02 -36.5 83.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.834 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 mt -55.2 -42.91 73.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.662 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.57 -44.04 97.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 HD11 ' A' ' 72' ' ' ILE . 21.1 t -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.8 t -61.69 -43.72 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -65.43 -38.41 89.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.342 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -41.87 79.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.785 HD11 HG12 ' A' ' 68' ' ' VAL . 14.9 mt -71.61 -38.04 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -74.49 -27.13 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 85.2 p -63.33 80.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.44 144.41 4.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.584 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.7 p -71.63 -54.02 11.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -95.75 118.77 33.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 72' ' ' ILE . 20.5 t -125.86 123.42 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.282 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -115.27 101.82 9.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.691 HD21 HD11 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -113.31 137.43 51.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.022 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 m -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 80' ' ' LEU . 5.8 m -112.59 170.05 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -130.0 143.9 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.43 -178.11 42.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.588 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -137.92 119.17 10.53 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.612 0.244 . . . . 0.0 110.799 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.481 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 42.0 Cg_exo -55.79 -45.37 39.51 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.499 2.132 . . . . 0.0 112.428 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 86' ' ' PRO . 44.6 Cg_exo -56.44 164.5 5.41 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.397 2.065 . . . . 0.0 112.23 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.71 -64.35 3.87 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.522 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.898 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.762 0.315 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.88 146.39 49.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -129.1 130.25 46.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -80.59 129.75 34.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 45' ' ' GLY . 5.1 m -141.69 104.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.78 126.88 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.442 HG22 ' CE1' ' A' ' 20' ' ' PHE . 26.4 mm -98.02 140.36 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.51 127.56 56.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.35 140.8 43.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.23 -171.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -31.64 70.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -90.32 -37.17 14.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 177.86 16.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.444 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 72' ' ' ILE . 26.7 m-85 -60.09 123.84 18.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.68 -45.9 9.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.524 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 22' ' ' LEU . 4.0 pp -58.11 141.78 49.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.378 . . . . 0.0 110.967 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.83 144.74 50.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.795 HG12 ' HA ' ' A' ' 32' ' ' VAL . 30.3 m -122.1 156.38 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.995 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -149.49 132.13 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.54 124.09 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.31 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.412 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 5.0 m-20 -74.97 -60.64 1.17 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 74.2 Cg_endo -75.33 -168.08 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.184 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.533 HG12 HG13 ' A' ' 52' ' ' ILE . 30.4 t -152.95 111.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.001 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.74 141.79 44.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.839 HG23 HD11 ' A' ' 52' ' ' ILE . 23.7 t -77.28 124.75 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.526 ' O ' HG22 ' A' ' 48' ' ' THR . 24.4 pt20 -94.45 -42.54 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.978 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 p -122.85 153.25 39.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.44 142.62 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -68.69 99.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -69.0 129.77 40.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.83 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t0 60.05 32.7 21.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.65 -152.14 6.52 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.46 85.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.95 -47.31 72.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -36.3 81.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -31.09 62.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 13' ' ' ILE . . . -78.21 -15.82 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' HG11 ' A' ' 11' ' ' VAL . . . 85.58 51.76 3.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.59 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.53 147.26 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -119.44 149.22 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -73.17 128.12 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.962 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.01 34.84 36.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.76 150.54 21.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -90.69 136.47 33.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.903 HD13 HG12 ' A' ' 82' ' ' VAL . 18.5 mm -98.29 121.11 48.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.76 -49.21 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.76 161.56 34.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 80' ' ' LEU . 5.3 m -120.33 111.28 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 1.9 t30 59.94 41.33 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.66 73.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.529 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.78 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 t-80 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.982 0.42 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -55.42 -42.67 74.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.634 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.51 -43.97 97.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.277 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.659 HG12 HD11 ' A' ' 72' ' ' ILE . 24.5 t -63.85 -46.7 93.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 65' ' ' HIS . 29.8 t -60.63 -45.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.254 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HG3' HD23 ' A' ' 66' ' ' LEU . 5.5 mtmp? -64.47 -38.27 90.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.008 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -44.63 85.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.303 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.659 HD11 HG12 ' A' ' 68' ' ' VAL . 15.5 mt -68.96 -43.22 82.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.655 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.4 -12.97 60.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.369 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 p -44.35 -30.17 0.79 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.816 0.341 . . . . 0.0 111.597 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.23 156.88 27.01 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.547 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -57.09 -57.31 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -100.75 112.6 25.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -134.13 128.19 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 56' ' ' ASN . . . -70.28 143.89 51.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.61 HD12 HG12 ' A' ' 55' ' ' VAL . 4.1 tp -136.29 93.4 2.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.02 110.11 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.903 HG12 HD13 ' A' ' 52' ' ' ILE . 27.5 m -112.58 173.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.36 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -135.98 138.49 42.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.429 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.426 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.801 0.334 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 53' ' ' ILE . 1.4 mt-30 -125.22 154.35 41.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.97 130.24 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 103.62 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 11' ' ' VAL . 31.4 m -98.12 114.19 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.41 100.68 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.424 HG22 ' CE1' ' A' ' 20' ' ' PHE . 3.6 mp -91.34 133.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -106.31 124.3 49.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.88 137.58 56.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -116.0 -171.47 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -60.2 -31.48 70.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -81.98 -36.97 27.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.72 166.48 22.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.423 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 72' ' ' ILE . 23.8 m-85 -60.33 109.27 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.07 -29.78 64.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.76 126.39 29.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.78 139.08 38.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 32' ' ' VAL . 25.2 m -119.13 135.77 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.37 132.48 16.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.18 123.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.61 -76.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.311 . . . . 0.0 110.782 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -80.53 -60.56 0.46 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.823 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.0 Cg_endo -78.7 -168.05 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.56 2.173 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.81 HG12 HD12 ' A' ' 52' ' ' ILE . 19.8 t -145.89 96.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -125.51 145.11 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 24' ' ' VAL . 12.1 t -76.46 120.2 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -49.23 8.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.49 143.97 46.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 46' ' ' VAL . 28.4 m -136.42 136.18 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' CB ' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -64.59 114.45 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.709 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -97.27 40.79 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.42 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -176.36 34.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.683 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.65 -139.64 2.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.687 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.76 93.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.77 0.319 . . . . 0.0 111.324 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.778 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -59.29 -47.38 85.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -41.8 95.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -71.94 -29.95 64.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.4 -15.87 61.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.11 33.77 35.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.712 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 41' ' ' ALA . 12.2 p -90.22 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 111.024 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.72 163.21 14.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.56 126.52 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.728 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.88 29.06 35.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.372 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -80.2 141.08 35.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -93.82 134.62 35.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.81 HD12 HG12 ' A' ' 30' ' ' VAL . 25.0 mt -101.97 118.39 48.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.223 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.8 mp -85.9 -43.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.63 148.2 28.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.763 HG12 ' CB ' ' A' ' 80' ' ' LEU . 29.3 m -125.38 118.55 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 57.74 48.01 14.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.72 28.2 72.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.3 m . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.767 0.318 . . . . 0.0 110.915 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.894 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.8 t-80 . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.896 0.379 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.13 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.18 -44.13 97.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.386 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.698 HG12 HD11 ' A' ' 72' ' ' ILE . 34.4 t -64.08 -46.73 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.06 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 65' ' ' HIS . 19.1 t -60.56 -43.64 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.22 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.97 -39.39 90.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.284 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -47.92 75.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.698 HD11 HG12 ' A' ' 68' ' ' VAL . 14.7 mt -68.97 -40.55 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -74.64 -19.68 60.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.1 t -50.9 -28.94 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.322 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.53 158.35 27.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -46.8 81.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.1 m-85 -95.76 112.72 24.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.592 HG11 HG23 ' A' ' 72' ' ' ILE . 12.6 p -116.46 123.52 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.66 111.18 18.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.763 ' CB ' HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.84 133.87 50.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.4 m -79.33 116.29 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 52' ' ' ILE . 28.0 m -113.55 175.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.707 ' HB2' HD11 ' A' ' 53' ' ' ILE . 35.0 tt0 -132.69 130.88 40.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.528 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 7' ' ' VAL . 22.4 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.714 0.293 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.3 154.71 33.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.12 134.99 33.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.3 135.27 33.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.59 142.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 ' HB2' ' A' ' 79' ' ' ALA . 22.6 mt -118.16 113.89 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.14 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.515 HG22 ' CB ' ' A' ' 44' ' ' ALA . 27.6 pt -104.75 143.87 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 19.3 mt-30 -106.15 143.14 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 138.34 33.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -102.8 -168.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -58.51 -34.44 70.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.79 -35.47 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.62 -109.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 72' ' ' ILE . 32.0 m-85 -125.71 132.99 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -39.87 36.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.48 139.58 58.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.329 . . . . 0.0 111.043 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 m -103.22 130.77 50.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 32' ' ' VAL . 33.7 m -119.07 140.7 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.351 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.6 131.88 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.808 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.75 112.49 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.624 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.63 -74.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -80.17 -60.94 0.46 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.734 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 85.8 Cg_endo -78.03 -169.46 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.161 . . . . 0.0 112.324 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.991 HG12 HD12 ' A' ' 52' ' ' ILE . 21.7 t -144.0 103.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.025 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -138.41 148.6 44.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 24' ' ' VAL . 25.2 t -84.81 132.74 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -93.65 -34.81 13.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.051 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.87 152.27 40.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 46' ' ' VAL . 30.4 m -135.98 135.38 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.4 tptp -59.8 113.88 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -92.46 44.12 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -177.15 35.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.99 -148.63 5.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.54 79.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.737 0.304 . . . . 0.0 111.244 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . . . -59.7 -47.42 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.7 tpt -69.9 -50.8 38.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -30.48 70.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' A' ' 13' ' ' ILE . . . -71.34 -15.82 62.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.06 28.93 32.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.445 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 35' ' ' VAL . 9.4 t -84.79 151.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.71 145.19 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 48' ' ' THR . 1.3 t -69.25 131.43 44.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 30.28 36.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -93.81 149.36 21.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -96.43 142.52 28.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.991 HD12 HG12 ' A' ' 30' ' ' VAL . 32.2 mt -106.75 125.56 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 81' ' ' THR . 4.0 mt -92.43 -49.12 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.02 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -151.07 157.07 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 80' ' ' LEU . 30.1 t -128.44 114.31 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.87 53.14 5.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.15 27.59 60.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.684 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.6 t-80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.715 0.293 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.84 -41.27 70.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.54 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -42.47 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.866 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.78 HG12 ' CD1' ' A' ' 72' ' ' ILE . 31.4 t -63.92 -46.63 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.212 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.9 t -63.19 -44.15 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.509 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -65.8 -38.41 88.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.475 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.01 -45.27 70.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.78 ' CD1' HG12 ' A' ' 68' ' ' VAL . 19.8 mt -69.69 -35.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -72.8 -29.33 63.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -64.7 80.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.55 144.32 6.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -54.45 14.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.3 m-85 -98.28 119.82 37.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.8 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.0 p -124.79 115.38 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB2' HG12 ' A' ' 12' ' ' ILE . . . -105.86 105.36 15.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -112.07 139.92 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.57 HG22 HD12 ' A' ' 53' ' ' ILE . 63.6 m -84.97 121.09 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 52' ' ' ILE . 4.2 m -114.53 175.27 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.539 ' HB2' HD11 ' A' ' 53' ' ' ILE . 25.3 tt0 -138.39 150.4 46.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.523 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.771 0.32 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -121.44 144.36 48.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -148.5 146.59 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 p -107.36 137.28 45.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.25 125.76 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -103.03 108.44 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.079 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.75 137.42 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.441 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.5 OUTLIER -109.76 139.97 44.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -72.67 143.05 48.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -110.91 -171.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.62 -31.43 71.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -96.05 -35.35 11.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.5 179.2 15.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.533 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.512 ' CE2' HG22 ' A' ' 72' ' ' ILE . 36.5 m-85 -60.67 109.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 110.926 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.41 -36.66 69.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.538 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.5 132.68 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.019 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.63 134.09 49.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.794 HG12 HG22 ' A' ' 32' ' ' VAL . 29.2 m -115.51 148.21 18.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.9 t -148.7 138.69 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.24 115.98 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 -71.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.733 0.301 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.402 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -80.06 -60.0 0.51 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.783 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -78.48 -168.41 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.579 2.186 . . . . 0.0 112.355 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.927 HG12 HD12 ' A' ' 52' ' ' ILE . 21.5 t -148.33 95.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -123.13 148.37 45.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.794 HG22 HG12 ' A' ' 24' ' ' VAL . 19.6 t -90.22 126.63 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.004 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -95.29 -42.61 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -119.33 145.18 46.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.61 144.62 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 37.9 tttt -66.14 114.38 5.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.87 139.44 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t0 59.17 30.05 19.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.76 -158.7 8.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.23 85.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.758 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.08 -47.33 68.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.07 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -48.2 76.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -30.41 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.83 62.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.455 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.42 34.6 11.78 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 41' ' ' ALA . 14.0 p -79.93 158.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 46' ' ' VAL . 14.9 mt-30 -125.66 138.05 53.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.823 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 t -70.34 130.45 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.93 47.96 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.672 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -88.32 138.35 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.68 135.33 33.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.927 HD12 HG12 ' A' ' 30' ' ' VAL . 18.6 mt -94.31 125.24 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 83' ' ' GLN . 33.9 mt -98.68 -34.97 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -142.99 142.02 31.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 52' ' ' ILE . 21.4 t -125.13 117.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 59.41 30.77 20.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.5 27.3 67.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.547 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 58' ' ' THR . 8.5 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.096 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.81 ' O ' HG23 ' A' ' 69' ' ' VAL . 34.0 t-80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.757 0.313 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.82 -43.16 76.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.799 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -62.58 -44.1 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.401 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.846 HG12 HD11 ' A' ' 72' ' ' ILE . 25.5 t -64.16 -46.66 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.118 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 65' ' ' HIS . 35.2 t -60.67 -43.23 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.137 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -65.71 -38.37 89.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.66 81.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.846 HD11 HG12 ' A' ' 68' ' ' VAL . 9.4 mt -70.79 -36.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.739 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -74.27 -20.59 60.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -27.9 5.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.73 147.57 18.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.51 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 p -59.63 -43.65 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.4 m-85 -102.97 115.24 30.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 78' ' ' VAL . 12.7 p -114.88 113.42 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.181 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.1 104.46 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD12 HG13 ' A' ' 82' ' ' VAL . 3.6 pp -123.11 134.03 54.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -84.65 122.63 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' A' ' 52' ' ' ILE . 12.7 m -116.81 169.19 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.294 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.714 ' HB2' HD11 ' A' ' 53' ' ' ILE . 6.6 tt0 -135.43 134.63 39.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.647 -179.909 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.833 0.349 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -122.45 154.3 37.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.846 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -139.49 130.28 26.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.0 108.11 19.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.014 HG21 HG22 ' A' ' 46' ' ' VAL . 9.3 p -96.97 143.66 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.7 mm -119.27 95.42 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.053 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.608 HD13 HD21 ' A' ' 22' ' ' LEU . 3.3 mt -86.34 130.01 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.35 127.36 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.838 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -65.26 131.64 47.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -102.5 -169.1 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.814 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -59.5 -29.87 68.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.22 -29.97 15.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.24 -118.66 3.33 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.447 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 72' ' ' ILE . 48.0 m-85 -116.42 115.54 26.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.56 -44.19 73.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.596 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.608 HD21 HD13 ' A' ' 13' ' ' ILE . 4.1 pp -59.73 139.43 57.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -112.58 137.4 50.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.838 HG12 ' HA ' ' A' ' 32' ' ' VAL . 30.1 m -129.31 142.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.258 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -149.49 132.02 15.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.11 140.46 4.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.605 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -73.7 -74.21 0.19 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.778 0.323 . . . . 0.0 110.805 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.24 -56.79 0.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.691 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.03 -168.15 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.571 2.18 . . . . 0.0 112.176 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.813 HG13 ' HB ' ' A' ' 52' ' ' ILE . 8.6 p -155.71 106.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -127.69 154.85 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.838 ' HA ' HG12 ' A' ' 24' ' ' VAL . 4.5 t -91.19 120.34 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -89.42 -31.08 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 144.33 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 46' ' ' VAL . 31.2 m -132.35 139.36 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -62.54 107.82 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -73.46 130.53 40.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.69 30.42 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.1 -157.42 8.85 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -39.33 89.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -66.02 -47.35 74.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.6 tpt -69.33 -41.74 76.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -67.95 -29.69 68.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.689 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -75.4 -15.92 60.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.324 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.37 46.24 3.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.491 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.014 HG22 HG21 ' A' ' 11' ' ' VAL . 16.2 t -106.92 143.84 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.832 0.348 . . . . 0.0 111.042 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -110.06 163.14 13.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 116.98 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.24 37.13 11.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.598 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.574 ' OD2' HG11 ' A' ' 82' ' ' VAL . 8.9 p-10 -96.83 154.02 17.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -95.42 137.31 34.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.813 ' HB ' HG13 ' A' ' 30' ' ' VAL . 12.8 mt -99.7 117.48 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.082 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.69 -42.5 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 147.06 30.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 52' ' ' ILE . 21.5 t -118.77 111.64 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.96 41.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.83 73.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.729 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 67' ' ' GLU . 3.0 pp -55.24 -43.07 74.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.766 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.42 -44.02 97.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.993 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 72' ' ' ILE . 24.9 t -62.78 -46.67 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.114 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.9 t -61.7 -44.13 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.564 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.9 -39.74 90.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -45.9 73.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.462 HG13 HG21 ' A' ' 78' ' ' VAL . 20.5 tt -68.76 -35.76 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -70.43 -32.37 69.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.76 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.8 t -71.59 73.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.82 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.75 144.34 4.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.539 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.22 -30.78 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -108.85 132.99 53.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.4 p -129.94 112.43 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.45 103.48 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.62 HD12 HG13 ' A' ' 82' ' ' VAL . 3.1 pp -121.07 124.76 45.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.3 m -79.24 126.93 31.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.62 HG13 HD12 ' A' ' 80' ' ' LEU . 30.6 m -118.59 169.71 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.33 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -142.8 144.05 32.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.59 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.824 0.345 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.32 129.96 50.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -127.82 137.96 52.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.28 143.33 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.505 HG21 HG22 ' A' ' 46' ' ' VAL . 25.5 m -133.43 126.4 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.97 107.23 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.49 HD12 ' H ' ' A' ' 13' ' ' ILE . 4.0 mp -94.04 138.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 3.1 mp0 -102.07 124.8 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -71.58 133.59 45.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -99.51 -170.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.67 -31.56 69.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -88.58 -44.23 10.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.63 -158.54 23.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.509 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.43 ' CD2' HG12 ' A' ' 72' ' ' ILE . 68.7 m-85 -86.72 118.13 25.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.51 -26.98 58.21 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 pp -58.47 138.95 56.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -107.0 134.26 50.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 68' ' ' VAL . 30.8 t -115.61 135.55 55.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.402 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 37.3 t -149.42 132.17 15.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.04 125.41 0.92 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.94 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -78.78 -61.06 0.54 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.3 Cg_endo -76.61 -167.9 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.848 HG12 HD12 ' A' ' 52' ' ' ILE . 21.4 t -140.86 110.84 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 23.1 p90 -136.39 150.25 48.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.644 ' CG2' HD11 ' A' ' 52' ' ' ILE . 21.5 t -91.11 120.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -72.34 -58.97 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 t -122.59 157.97 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.681 HG11 HG12 ' A' ' 46' ' ' VAL . 32.4 m -135.04 145.33 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.0 ttpm? -56.84 98.95 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 140.09 54.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER 55.59 29.89 14.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -136.5 -160.12 8.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.689 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.4 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.532 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . . . -69.29 -47.71 63.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.634 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 39' ' ' GLY . 2.4 ppp? -70.6 -34.73 72.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -31.81 70.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.72 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.375 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 27.29 11.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.52 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.681 HG12 HG11 ' A' ' 35' ' ' VAL . 16.3 t -88.54 144.51 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 111.046 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.71 158.02 19.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.68 122.06 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.21 43.24 39.97 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.407 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -98.79 156.76 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.848 HD12 HG12 ' A' ' 30' ' ' VAL . 19.7 mt -103.47 124.4 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.5 mp -97.8 -32.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -137.68 141.91 41.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 55' ' ' VAL . 26.3 m -124.59 104.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.516 ' OD1' HG23 ' A' ' 78' ' ' VAL . 97.8 m-20 61.03 43.98 10.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.81 28.21 69.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.18 -179.763 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 24' ' ' VAL . 11.1 t-80 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.78 0.324 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 69' ' ' VAL . 3.0 mt -55.46 -43.03 75.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.741 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.0 mm-40 -66.08 -38.8 89.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 24' ' ' VAL . 30.0 t -66.9 -46.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.502 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.505 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.8 p -66.16 -41.43 89.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.167 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 69' ' ' VAL . 14.1 ttmm -66.33 -39.46 89.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.366 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.8 mm? -68.9 -46.94 67.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.553 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 68' ' ' VAL . 2.3 tt -67.97 -35.67 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.893 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 59.9 p -66.62 78.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.73 145.97 6.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -71.04 -46.66 61.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CZ ' ' HG2' ' A' ' 14' ' ' GLN . 2.4 m-85 -95.76 121.11 37.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.516 HG23 ' OD1' ' A' ' 56' ' ' ASN . 11.6 p -117.14 141.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.83 117.82 14.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.2 pp -135.98 134.35 38.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.8 m -75.75 123.94 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 52' ' ' ILE . 10.3 m -123.45 175.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.216 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.656 ' HB2' HD11 ' A' ' 53' ' ' ILE . 36.6 tt0 -142.81 135.6 27.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.554 179.968 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -120.6 152.29 38.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 130.3 41.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.89 103.3 13.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -93.66 129.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.87 106.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.61 129.4 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 77' ' ' TYR . 3.5 pt20 -97.0 127.42 42.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.791 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -65.27 132.34 48.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -96.25 -170.92 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -60.7 -32.36 71.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -92.99 -36.54 12.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.0 -105.75 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.502 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 72' ' ' ILE . 94.9 m-85 -129.78 111.4 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.375 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.76 68.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.61 140.42 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 m -101.31 137.5 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.471 HG12 HG22 ' A' ' 32' ' ' VAL . 20.3 m -134.14 138.43 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.07 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.2 t -148.76 132.62 17.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.86 117.55 0.56 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.23 -77.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-80 -79.33 -61.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.7 Cg_endo -76.42 -168.34 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.543 2.162 . . . . 0.0 112.326 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.559 HG12 HD12 ' A' ' 52' ' ' ILE . 14.7 t -145.53 110.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -138.27 154.09 49.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.174 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 24' ' ' VAL . 15.5 t -95.92 139.14 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.06 -35.27 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.12 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -133.75 153.81 51.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.069 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 14.2 m -136.37 139.86 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -56.21 117.49 3.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.55 126.46 29.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t0 55.34 30.37 14.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.37 -149.23 7.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 14' ' ' GLN . . . -60.97 -37.55 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -71.13 -47.51 57.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.315 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.04 -44.6 96.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -31.36 72.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.49 -15.88 60.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.479 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.48 33.06 40.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 47' ' ' GLN . 21.7 t -71.14 158.99 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.036 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' HG12 ' A' ' 46' ' ' VAL . 2.2 mt-30 -123.06 119.61 30.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.748 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.81 131.15 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 30.99 56.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.515 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -94.38 152.36 18.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -97.03 134.07 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.57 ' CG1' HG12 ' A' ' 82' ' ' VAL . 5.9 mt -101.3 123.92 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 83' ' ' GLN . 2.3 mt -97.84 -38.65 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -129.07 149.3 50.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.026 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.917 HG12 HD23 ' A' ' 80' ' ' LEU . 29.9 m -119.18 112.29 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.039 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.46 38.56 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.86 27.0 73.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.336 . . . . 0.0 110.956 -179.896 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.807 ' O ' HG23 ' A' ' 69' ' ' VAL . 20.3 t-80 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.769 0.319 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.27 -43.21 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -44.26 94.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.826 HG12 HD11 ' A' ' 72' ' ' ILE . 27.3 t -62.82 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.127 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.5 t -61.73 -45.23 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.192 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -62.66 -38.3 89.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.129 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -42.71 74.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 HG12 ' A' ' 68' ' ' VAL . 15.2 mt -68.96 -36.02 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.773 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -31.45 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.693 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.78 78.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.91 145.43 5.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -78.09 -44.87 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -106.93 112.74 25.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.91 136.66 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.12 106.43 10.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.073 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.917 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -106.64 127.32 53.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.1 m -75.1 112.85 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.57 HG12 ' CG1' ' A' ' 52' ' ' ILE . 29.9 m -112.91 175.74 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.653 ' HB2' HD11 ' A' ' 53' ' ' ILE . 6.0 tt0 -142.67 141.49 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.513 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.879 0.371 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -124.52 149.61 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.06 135.57 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.47 131.99 34.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 44' ' ' ALA . 4.4 m -135.1 115.83 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.96 119.17 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -89.53 135.35 26.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.082 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -113.15 121.4 44.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -72.34 145.07 48.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.24 -168.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.814 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.65 -30.52 65.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -87.51 -32.72 19.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.06 -175.71 25.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -62.43 103.61 0.42 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.28 79.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.607 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.2 pp -59.58 133.92 56.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 129.14 47.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.3 141.69 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.9 m -149.34 132.15 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.38 119.5 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -58.99 -74.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.29 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -79.96 -61.49 0.45 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.941 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -76.28 -168.3 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.459 2.106 . . . . 0.0 112.246 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.857 HG12 HD12 ' A' ' 52' ' ' ILE . 6.3 t -150.46 100.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.033 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -123.37 144.03 49.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.22 123.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -86.37 -48.48 8.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -130.11 155.9 45.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 46' ' ' VAL . 22.3 m -136.39 137.53 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 113.42 3.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.76 134.89 47.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 58.43 28.55 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.19 -162.1 10.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.425 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.83 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.46 56.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.218 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -34.73 63.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.45 -31.39 65.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -74.25 -15.82 60.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.401 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.06 26.91 11.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 35' ' ' VAL . 17.1 t -86.61 148.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.704 0.288 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -125.81 147.66 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 48' ' ' THR . 1.2 t -67.22 131.04 44.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.25 38.54 33.97 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.538 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.67 27.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.65 130.34 38.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.857 HD12 HG12 ' A' ' 30' ' ' VAL . 13.4 mt -94.21 121.87 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.991 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.694 HD11 ' HB2' ' A' ' 83' ' ' GLN . 31.0 mt -88.07 -48.32 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -136.72 161.98 34.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 80' ' ' LEU . 25.5 t -136.36 109.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 61.56 49.28 5.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.427 . . . . 0.0 110.774 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.59 26.52 59.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.772 ' O ' HG23 ' A' ' 69' ' ' VAL . 8.9 t-80 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.888 0.375 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.1 -42.73 73.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.617 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -61.72 -44.03 97.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.082 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.32 -46.62 95.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.087 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.1 t -60.86 -44.49 97.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.41 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -38.35 88.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.327 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -67.14 -47.59 70.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.489 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.53 HG13 HG11 ' A' ' 78' ' ' VAL . 16.4 tt -68.15 -35.95 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.684 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE2' HG12 ' A' ' 69' ' ' VAL . 6.0 mttm -71.64 -29.32 64.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -64.37 80.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.989 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.64 146.66 7.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.529 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -69.76 -54.14 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.15 129.86 43.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.856 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.53 HG11 HG13 ' A' ' 72' ' ' ILE . 10.3 p -147.12 118.48 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.34 142.79 35.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.73 HD23 HG21 ' A' ' 52' ' ' ILE . 2.1 mp -143.69 108.04 4.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -77.36 112.21 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.588 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 52' ' ' ILE . 30.5 m -112.58 165.82 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.463 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.694 ' HB2' HD11 ' A' ' 53' ' ' ILE . 47.5 tt0 -142.81 150.48 40.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.34 145.07 47.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.9 ttm-85 -142.44 133.0 25.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.73 120.91 24.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 44' ' ' ALA . 12.4 p -114.41 119.46 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.067 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mt -106.92 105.61 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.591 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . 3.5 mt -87.89 132.35 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -67.52 149.97 49.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -115.28 -172.78 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.82 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.86 -31.28 69.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.71 -49.04 7.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.88 176.0 14.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.422 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CE1' HG22 ' A' ' 13' ' ' ILE . 16.2 m-85 -64.43 108.04 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.346 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.87 -37.37 94.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.499 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -59.46 142.08 53.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.802 0.334 . . . . 0.0 110.913 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.56 140.62 49.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.78 148.48 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 4.7 t -149.39 132.04 15.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.56 122.33 0.6 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.482 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.3 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.951 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.66 -60.34 0.88 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.851 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.4 -169.48 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.286 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.562 HG12 HD12 ' A' ' 52' ' ' ILE . 4.2 t -150.57 115.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 4.7 p90 -136.06 144.61 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.18 120.83 28.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -89.31 -45.85 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -126.75 151.85 47.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.42 129.89 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.54 99.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.35 130.76 44.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 58.46 36.75 25.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.67 -144.78 4.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.455 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . . . -60.97 -45.84 93.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.116 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.746 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -62.55 -47.39 84.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.121 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -29.85 70.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.79 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -72.24 -37.79 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -74.05 -15.78 61.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.389 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.31 27.45 33.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 41' ' ' ALA . 11.4 p -85.16 147.11 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.704 0.287 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -113.45 164.65 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -79.75 126.63 31.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 38.45 27.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 152.74 20.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 134.35 39.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.562 HD12 HG12 ' A' ' 30' ' ' VAL . 7.8 mt -107.01 114.42 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 83' ' ' GLN . 4.1 mp -78.7 -47.13 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 150.86 43.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG12 ' CB ' ' A' ' 80' ' ' LEU . 4.5 m -132.76 111.6 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 60.35 28.86 18.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.03 24.3 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.662 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.749 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.857 0.36 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.767 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.13 -44.14 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.13 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 72' ' ' ILE . 4.4 t -62.74 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.199 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 65' ' ' HIS . 31.8 t -62.09 -44.63 99.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.214 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -63.21 -38.43 91.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.222 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.57 -36.38 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.562 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 68' ' ' VAL . 55.2 mt -73.55 -41.86 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -74.24 -25.96 59.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.43 77.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.925 0.393 . . . . 0.0 110.888 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.93 153.46 8.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.545 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -78.44 -36.3 45.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -106.05 141.45 37.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.1 p -137.26 125.81 34.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.065 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 111.09 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.7 HD12 HG13 ' A' ' 82' ' ' VAL . 2.5 pp -137.09 124.72 22.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.4 m -74.51 124.49 26.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 80' ' ' LEU . 30.5 m -117.27 175.59 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.755 ' HB2' HD11 ' A' ' 53' ' ' ILE . 5.7 tt0 -137.64 138.81 39.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.391 -179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.769 0.318 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.51 126.37 52.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.89 148.75 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.59 159.57 26.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.901 HG21 HG22 ' A' ' 46' ' ' VAL . 10.4 p -146.18 108.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.075 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.08 111.89 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 22' ' ' LEU . 6.5 mt -89.24 144.44 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -109.37 128.41 55.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 12.7 ttmt -82.46 115.32 21.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -90.33 -168.22 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.775 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.51 -30.33 65.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.21 -46.81 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.33 -118.08 1.73 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.554 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 39.6 m-85 -124.29 113.73 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.61 60.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.774 HD23 HG12 ' A' ' 35' ' ' VAL . 4.7 mp -53.81 122.37 9.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 m -101.31 122.28 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.46 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 32' ' ' VAL . 35.7 m -124.1 149.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.373 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -149.33 132.08 15.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.86 111.69 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.587 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.3 -73.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -74.65 -60.68 1.26 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 73.8 Cg_endo -75.51 -168.13 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.55 2.166 . . . . 0.0 112.102 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 HD12 ' A' ' 52' ' ' ILE . 4.9 p -159.46 104.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -134.25 154.24 51.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.782 ' HA ' HG12 ' A' ' 24' ' ' VAL . 10.5 t -92.03 137.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.59 -52.2 2.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.8 t -122.48 149.43 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.774 HG12 HD23 ' A' ' 22' ' ' LEU . 27.2 m -136.41 153.39 31.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 94.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.842 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.13 139.3 58.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 58.29 30.98 20.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.15 -147.76 5.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.498 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.86 96.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -64.03 -47.43 80.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.044 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.34 -35.12 79.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -74.21 -31.49 62.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.53 -15.71 59.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.22 52.6 3.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.901 HG22 HG21 ' A' ' 11' ' ' VAL . 8.8 t -92.45 160.55 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 110.972 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 46' ' ' VAL . 14.2 mp0 -128.9 114.78 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.694 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.91 131.13 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.23 30.82 58.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.627 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -97.8 154.21 17.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 110.976 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -92.21 142.46 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.711 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 30' ' ' VAL . 36.3 mt -106.86 115.4 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.657 HD11 ' HG3' ' A' ' 83' ' ' GLN . 3.2 mp -80.27 -47.3 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 144.57 32.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 71' ' ' LEU . 6.9 m -121.93 111.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' OD1' HG23 ' A' ' 78' ' ' VAL . 0.8 OUTLIER 60.15 30.0 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.895 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.06 -24.71 30.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.639 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.845 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.184 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -43.19 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.741 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -62.62 -44.1 97.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.343 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.05 -46.5 93.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.114 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 65' ' ' HIS . 22.0 t -60.92 -44.43 97.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -65.69 -38.35 88.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.099 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.493 HD13 ' CG2' ' A' ' 55' ' ' VAL . 3.8 mt -66.55 -47.29 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.529 ' CD1' HG11 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -68.61 -35.93 72.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.819 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -29.32 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.41 80.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.38 153.59 11.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.601 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -67.8 -42.21 81.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.64 150.27 25.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.947 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 72' ' ' ILE . 11.4 p -145.88 122.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.5 109.49 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -125.03 139.95 53.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m -90.34 124.21 34.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.634 HG12 HG12 ' A' ' 52' ' ' ILE . 30.0 m -118.92 172.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.657 ' HG3' HD11 ' A' ' 53' ' ' ILE . 21.5 mt-30 -142.83 136.37 28.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.549 -179.921 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.91 0.385 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -122.69 133.39 54.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.778 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 136.56 21.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.158 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.42 142.91 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 m -142.85 134.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.277 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 79' ' ' ALA . 21.1 mt -96.1 117.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.037 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.885 HD13 HD21 ' A' ' 22' ' ' LEU . 20.8 mt -86.32 127.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.23 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -101.9 130.31 48.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.74 150.06 44.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.32 -168.13 1.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.734 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -30.03 65.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -100.58 -35.72 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.83 -137.27 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.519 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.42 97.31 9.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.44 -27.86 63.97 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 13' ' ' ILE . 3.6 pp -63.93 133.69 53.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -103.33 137.54 41.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 32' ' ' VAL . 27.0 m -132.5 142.92 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -149.52 132.13 15.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.56 112.93 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.83 -54.78 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 6.4 m-20 -98.46 -63.9 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -79.99 -166.42 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.437 2.092 . . . . 0.0 112.278 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.931 HG12 HD12 ' A' ' 52' ' ' ILE . 18.4 t -143.55 110.55 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.06 155.03 48.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.022 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.787 ' HA ' HG12 ' A' ' 24' ' ' VAL . 23.2 t -92.56 120.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -31.07 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.48 148.46 39.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.581 HG11 ' CG1' ' A' ' 46' ' ' VAL . 18.0 m -136.49 148.51 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.023 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -61.16 105.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.36 135.3 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 62.05 25.37 15.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.09 -150.08 6.29 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.3 95.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -61.5 -46.81 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.093 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.02 84.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ttp85 -62.03 -33.39 74.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.968 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.35 -15.88 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 31.75 19.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.546 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.581 ' CG1' HG11 ' A' ' 35' ' ' VAL . 21.3 t -82.38 157.21 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.458 ' N ' HG12 ' A' ' 46' ' ' VAL . 7.3 mt-30 -122.8 145.53 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 123.73 25.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 34.31 22.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.24 147.53 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.788 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -90.94 140.47 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.931 HD12 HG12 ' A' ' 30' ' ' VAL . 29.8 mt -104.93 130.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -102.94 -49.11 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.066 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -125.03 142.08 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.898 HG12 HD23 ' A' ' 80' ' ' LEU . 27.5 m -114.68 107.33 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.181 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.401 ' CG ' HG13 ' A' ' 78' ' ' VAL . 3.7 t-20 59.94 43.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.52 27.96 71.81 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.96 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.787 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.8 t-160 . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.838 0.352 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.8 mt -55.08 -43.09 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.731 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.91 -44.11 97.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.123 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.469 HG12 HD11 ' A' ' 72' ' ' ILE . 23.3 t -63.77 -46.75 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.128 0.489 . . . . 0.0 110.102 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 65' ' ' HIS . 32.1 t -60.07 -44.5 95.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.25 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -65.85 -38.47 88.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.185 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.2 -47.7 75.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.602 ' O ' HG21 ' A' ' 78' ' ' VAL . 32.5 mt -68.04 -42.38 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.617 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -74.64 -14.9 60.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 p -48.22 -28.22 2.9 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.678 0.275 . . . . 0.0 111.402 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.99 150.02 20.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.621 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 p -64.23 -51.24 64.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.835 0.35 . . . . 0.0 110.78 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.7 112.62 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.618 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 72' ' ' ILE . 21.7 t -131.26 129.49 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.354 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.576 ' HB2' HG12 ' A' ' 12' ' ' ILE . . . -110.91 103.46 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.898 HD23 HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -110.05 128.76 55.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.07 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -79.74 121.84 25.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.438 HG12 HG12 ' A' ' 52' ' ' ILE . 15.9 m -112.6 172.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -141.93 137.84 31.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.513 -179.949 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.794 0.33 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 129.64 52.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -120.93 137.66 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 t -82.7 123.94 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 44' ' ' ALA . 17.4 m -112.0 126.9 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.3 mt -98.13 104.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.758 HG21 HD21 ' A' ' 22' ' ' LEU . 18.5 mt -86.89 116.09 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.41 135.9 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 146.41 54.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -112.48 -174.19 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.82 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -60.05 -30.66 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.78 -42.55 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.2 72.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 63.21 144.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.81 -27.15 3.61 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.557 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -59.3 138.41 57.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.2 m -102.9 126.4 50.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 31' ' ' PHE . 12.3 p -125.43 137.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 p -149.45 132.16 15.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.52 126.97 1.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.525 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.82 -77.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.449 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -88.21 -52.3 0.39 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.582 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 6.9 Cg_exo -73.21 -166.75 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.826 2.35 . . . . 0.0 111.846 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.838 HG12 HD12 ' A' ' 52' ' ' ILE . 21.8 t -154.29 95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 24' ' ' VAL . 7.6 p90 -119.95 146.8 45.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.409 ' CG2' HD11 ' A' ' 52' ' ' ILE . 21.2 t -90.47 120.67 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.421 ' O ' HG22 ' A' ' 48' ' ' THR . 3.0 tt0 -79.37 -55.15 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -126.6 157.91 37.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.657 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 18.2 m -136.33 139.86 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tptp -59.74 109.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.81 131.73 44.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t70 59.92 31.45 20.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.27 -150.67 6.23 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.517 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.95 87.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.816 0.341 . . . . 0.0 111.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -67.29 -47.26 71.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.151 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.9 tpt -64.32 -49.07 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -31.58 70.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.514 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -72.24 -15.77 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.45 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.492 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.491 HG22 HG21 ' A' ' 11' ' ' VAL . 20.5 t -79.1 158.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' HG12 ' A' ' 46' ' ' VAL . 10.8 mp0 -125.31 141.99 51.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.04 128.1 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.61 48.4 56.64 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.2 p30 -100.92 174.67 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.58 133.31 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.838 HD12 HG12 ' A' ' 30' ' ' VAL . 31.1 mt -105.68 114.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.16 -30.09 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -135.82 143.1 44.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.559 HG12 HD23 ' A' ' 80' ' ' LEU . 16.6 m -126.71 107.18 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.783 ' CG ' HG23 ' A' ' 78' ' ' VAL . 15.2 t30 60.4 32.54 20.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.85 26.25 71.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.145 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.759 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 t-80 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.888 0.375 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.32 -43.07 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.136 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.777 HG12 HD11 ' A' ' 72' ' ' ILE . 25.3 t -62.61 -46.57 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.9 t -61.45 -46.88 95.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.339 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -62.24 -38.3 88.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 71' ' ' LEU . 6.2 tt -68.32 -41.83 80.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.437 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.777 HD11 HG12 ' A' ' 68' ' ' VAL . 15.7 mt -70.63 -35.99 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.803 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -27.52 62.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.32 80.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.19 147.21 7.14 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.403 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.0 m -59.53 -61.39 2.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.81 128.47 56.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.853 HG13 HD11 ' A' ' 80' ' ' LEU . 10.4 p -113.09 140.23 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.29 101.77 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.853 HD11 HG13 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -113.78 126.89 55.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.6 m -71.49 112.8 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.771 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 83' ' ' GLN . 11.9 p -113.48 159.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 82' ' ' VAL . 48.4 tt0 -132.48 144.46 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.502 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.886 0.374 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.63 133.34 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.4 ttp85 -144.82 130.89 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.3 m -80.57 144.36 32.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.17 137.46 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.6 mp -116.59 117.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.73 143.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.576 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 31.5 mt-30 -112.92 128.71 56.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -65.45 143.84 57.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.02 -170.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -59.69 -29.21 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.999 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.06 -50.17 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.29 -128.07 2.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 62.0 m-85 -117.34 114.13 23.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.44 -29.96 65.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.418 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 41' ' ' ALA . 1.9 mp -55.52 113.45 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 m -101.2 122.35 43.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 31' ' ' PHE . 9.2 p -130.14 141.5 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -149.34 135.67 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.43 138.89 3.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.71 -79.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.29 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -78.2 -61.26 0.59 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' O ' HG13 ' A' ' 30' ' ' VAL . 72.4 Cg_endo -76.4 -167.43 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.126 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.754 HG23 ' HB ' ' A' ' 52' ' ' ILE . 3.0 m -157.53 104.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.214 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.762 ' O ' HG23 ' A' ' 24' ' ' VAL . 18.0 p90 -123.05 136.71 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 22' ' ' LEU . 26.3 t -81.98 120.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -87.27 -29.29 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 148.32 51.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.242 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.433 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 31.6 m -136.67 153.48 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 7.9 tttp -68.73 116.56 9.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.9 134.9 35.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 55.76 32.97 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.975 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -137.17 -144.63 4.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -61.04 -44.68 97.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.776 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -64.4 -47.28 79.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -38.66 91.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -71.22 -30.75 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . -75.18 -15.82 60.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.415 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.12 38.85 12.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.582 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 41' ' ' ALA . 11.5 p -96.32 153.99 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 110.95 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -120.19 141.44 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -60.97 132.39 53.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.34 47.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.188 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.53 146.92 26.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -92.15 132.5 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.787 ' HA ' HG12 ' A' ' 82' ' ' VAL . 4.0 mt -97.08 123.86 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.105 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 81' ' ' THR . 4.3 mt -91.94 -42.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.026 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HG3' HG22 ' A' ' 53' ' ' ILE . 25.1 mttp -148.42 142.99 26.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.83 118.87 58.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.78 32.62 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.16 26.87 69.71 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.651 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 -179.933 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.721 0.296 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.7 pp -55.38 -43.61 75.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.101 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.45 ' N ' HD12 ' A' ' 66' ' ' LEU . 3.0 tp10 -65.5 -39.34 91.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.279 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.536 ' O ' HG22 ' A' ' 72' ' ' ILE . 30.2 t -65.62 -46.84 88.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.1 p -65.39 -41.42 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.197 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 2.5 mptp? -66.06 -40.46 90.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.261 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' HG3' ' A' ' 67' ' ' GLU . 2.3 mm? -67.66 -47.48 69.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 68' ' ' VAL . 7.2 tt -68.48 -35.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.869 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -73.24 -28.81 62.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 p -68.83 72.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.819 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.14 144.01 7.71 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.0 p -70.15 -30.92 68.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -95.98 117.39 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.89 133.24 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.82 113.1 10.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.746 HD12 HG13 ' A' ' 82' ' ' VAL . 3.3 pp -126.32 133.59 51.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.433 HG22 HD12 ' A' ' 53' ' ' ILE . 60.8 m -76.02 126.08 30.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 52' ' ' ILE . 14.7 m -127.1 175.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -134.17 132.54 39.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -97.53 138.26 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.791 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -141.41 139.38 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.1 m -106.62 142.6 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.668 ' CG1' HG22 ' A' ' 46' ' ' VAL . 15.8 m -128.17 137.05 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.529 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 32.3 mt -128.08 92.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.995 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 22' ' ' LEU . 4.0 mt -86.33 142.76 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.626 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 21.1 mt-30 -112.99 137.46 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.89 135.44 45.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -103.7 -163.15 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.603 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.47 56.1 2.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.795 0.331 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 174.8 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.59 -169.28 24.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.444 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.47 ' CE2' HG22 ' A' ' 72' ' ' ILE . 63.2 m-85 -79.04 130.5 35.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.9 -33.77 23.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' CD2' HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -58.6 148.63 28.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -112.19 122.94 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 11.2 p -118.58 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.7 132.1 15.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.64 99.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.677 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.88 -69.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.409 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.421 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 t-20 -82.71 -55.12 0.55 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.182 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.6 Cg_endo -86.87 -164.66 0.22 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.818 2.345 . . . . 0.0 111.909 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.058 HG22 HD12 ' A' ' 52' ' ' ILE . 5.6 p -147.92 97.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 110.94 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -133.75 149.26 51.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.9 120.2 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.35 -67.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG23 ' A' ' 48' ' ' THR . 30.7 m -134.71 171.4 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.099 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.616 HG11 ' CG1' ' A' ' 46' ' ' VAL . 5.9 m -135.91 153.47 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.34 123.25 22.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -75.3 146.62 40.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 55.08 24.05 5.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.81 -161.17 11.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.626 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -60.99 -40.26 92.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.319 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.707 ' HB3' ' HG2' ' A' ' 36' ' ' LYS . . . -68.0 -47.71 67.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.093 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -63.4 -39.28 94.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 0.0 110.712 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -69.88 -31.88 69.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.529 ' HB1' ' H ' ' A' ' 12' ' ' ILE . . . -71.01 -15.77 62.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.453 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.12 29.07 26.45 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.537 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.668 HG22 ' CG1' ' A' ' 11' ' ' VAL . 11.9 t -78.05 149.9 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -110.03 163.01 13.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -82.82 123.77 29.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.22 44.64 65.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.536 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -93.71 146.51 23.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.738 0.304 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -84.48 138.45 32.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.6 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.058 HD12 HG22 ' A' ' 30' ' ' VAL . 29.5 mt -100.93 114.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.171 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 83' ' ' GLN . 7.2 mt -78.71 -42.01 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.028 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -156.32 142.07 17.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 80' ' ' LEU . 21.4 t -108.43 125.56 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.199 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 59.81 37.01 22.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.21 27.93 63.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.585 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.767 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.4 t-160 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.725 0.298 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.35 -43.13 74.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.562 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.1 -43.97 97.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.174 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.758 HG12 HD11 ' A' ' 72' ' ' ILE . 6.3 t -62.15 -46.69 95.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.047 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.0 t -62.18 -46.2 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.322 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.42 75.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.456 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.758 HD11 HG12 ' A' ' 68' ' ' VAL . 20.3 mt -69.71 -36.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.844 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HD3' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -73.75 -31.53 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.922 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -67.88 80.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 173.37 13.42 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -98.51 -42.73 7.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.86 120.54 39.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 72' ' ' ILE . 12.0 p -116.36 120.46 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.96 104.91 10.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.737 HD12 HG13 ' A' ' 82' ' ' VAL . 2.9 pp -120.65 132.87 55.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.811 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.458 HG22 HD12 ' A' ' 53' ' ' ILE . 63.6 m -79.97 122.86 27.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.737 HG13 HD12 ' A' ' 80' ' ' LEU . 26.8 m -116.11 169.09 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.03 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.619 ' HB2' HD11 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -134.83 142.78 46.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.2 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.875 0.369 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -131.98 133.8 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.72 130.18 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -88.99 118.07 28.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 11' ' ' VAL . 24.5 m -128.27 108.28 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 130.63 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 46' ' ' VAL . 23.6 mm -108.36 137.36 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.062 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 13.9 mt-30 -110.31 134.42 52.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -67.82 123.82 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -86.93 -169.93 2.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -59.46 -31.18 69.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.52 1.72 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.348 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.33 -160.27 14.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.545 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.434 ' CE2' HG22 ' A' ' 72' ' ' ILE . 14.0 m-85 -80.06 114.62 19.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.719 0.295 . . . . 0.0 110.855 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -29.77 75.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.604 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.18 137.54 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.38 136.78 40.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 31' ' ' PHE . 12.3 p -133.36 134.05 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -149.4 137.0 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.41 130.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.523 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.6 -71.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.417 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 3.9 m-20 -82.6 -61.86 0.32 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.786 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 80.1 Cg_endo -77.64 -167.99 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.542 2.161 . . . . 0.0 112.151 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.813 HG22 HD12 ' A' ' 52' ' ' ILE . 8.2 p -152.96 104.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.743 ' O ' HG23 ' A' ' 24' ' ' VAL . 47.0 p90 -130.89 155.64 46.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -92.17 120.87 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -31.43 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -135.28 147.8 49.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.608 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 15.8 m -129.89 145.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 105.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.48 133.12 44.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 60.22 30.94 20.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.77 -147.8 5.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.48 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.608 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -64.76 -47.37 78.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 tpt -63.1 -41.59 99.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -36.99 86.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.83 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 36.51 25.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.593 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 13' ' ' ILE . 18.5 t -88.08 149.05 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 111.072 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -112.11 153.3 27.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -69.04 130.6 43.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.57 31.94 43.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.405 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' HG11 ' A' ' 82' ' ' VAL . 3.4 p30 -84.24 138.55 32.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.72 141.4 28.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.655 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.813 HD12 HG22 ' A' ' 30' ' ' VAL . 17.0 mt -102.77 137.77 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mm -113.32 -38.79 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -137.63 157.77 45.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 55' ' ' VAL . 18.5 m -139.48 104.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.89 43.57 17.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.68 26.79 66.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.504 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 55' ' ' VAL . 16.0 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.952 0.406 . . . . 0.0 110.886 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -38.68 88.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.222 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.22 -44.34 79.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.717 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 72' ' ' ILE . 7.5 p -68.29 -41.63 83.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 65' ' ' HIS . 95.1 t -65.13 -43.77 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.929 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -65.99 -41.18 91.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.2 mt -65.34 -50.41 65.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.763 ' CD1' HG22 ' A' ' 68' ' ' VAL . 26.5 mt -65.51 -35.89 76.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.573 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.55 -25.68 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -63.92 80.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.11 144.13 10.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.438 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.99 -42.96 89.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.399 . . . . 0.0 111.022 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.0 m-85 -102.54 113.73 27.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -137.12 127.77 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.209 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.81 148.55 22.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -143.65 116.32 8.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.081 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -79.47 115.22 18.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 ' OD1' ' A' ' 50' ' ' ASP . 17.8 m -115.18 170.53 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -131.9 140.95 49.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.442 ' O ' HG11 ' A' ' 7' ' ' VAL . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.568 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.743 0.306 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.16 151.87 29.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -148.52 146.49 28.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.3 m -90.19 132.86 35.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 11' ' ' VAL . 29.6 m -130.43 100.35 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.552 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.9 mp -84.93 108.81 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.24 124.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HG2' ' CD1' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -101.46 134.35 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.795 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -65.35 131.48 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.09 -170.83 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -30.71 69.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -103.07 -34.36 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.38 -160.36 24.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.53 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 72' ' ' ILE . 59.4 m-85 -81.53 121.72 26.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.973 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.61 -30.94 42.42 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.545 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -60.04 134.97 57.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -104.57 137.0 43.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 32' ' ' VAL . 6.7 m -129.4 136.53 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 t -149.42 132.12 15.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.012 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.92 117.41 0.61 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.05 -74.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 110.816 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.7 m120 -81.75 -61.48 0.37 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 71.7 Cg_endo -77.06 -168.05 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.52 2.146 . . . . 0.0 112.317 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.607 HG12 HG13 ' A' ' 52' ' ' ILE . 25.5 t -144.08 111.99 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 2.7 p90 -139.6 152.97 47.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.716 ' HA ' HG12 ' A' ' 24' ' ' VAL . 11.2 t -92.75 120.99 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.036 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -73.09 -67.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.98 163.03 17.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.652 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 23.3 m -136.32 140.04 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -59.28 120.41 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.73 131.08 39.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.3 30.82 20.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.45 -152.35 7.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.538 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.81 87.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.187 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -68.64 -47.37 66.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -63.67 -48.76 75.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -34.41 72.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.982 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.553 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -71.68 -15.95 62.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.432 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.99 40.73 13.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.456 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.446 ' CG1' HG11 ' A' ' 35' ' ' VAL . 19.2 t -90.36 140.16 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.81 148.04 26.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.25 119.8 13.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 44.98 12.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 32' ' ' VAL . 57.0 p30 -93.38 161.99 14.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -98.72 137.88 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.023 HD13 HG12 ' A' ' 82' ' ' VAL . 25.4 mm -96.21 138.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.019 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 83' ' ' GLN . 5.8 mt -113.61 -48.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.059 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -136.07 141.96 44.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.631 HG23 HD11 ' A' ' 80' ' ' LEU . 9.7 p -125.71 112.36 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.643 ' OD1' HG23 ' A' ' 78' ' ' VAL . 54.6 m-20 59.25 38.19 23.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.013 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 24.31 71.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.783 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 C--N 1.331 -0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.26 -179.943 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.213 0 CA-C-O 120.749 0.309 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.9 mm? -55.46 -43.3 75.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.652 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.753 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.9 mp0 -65.37 -39.14 91.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.304 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.655 HG12 HD11 ' A' ' 72' ' ' ILE . 22.8 t -66.26 -46.79 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.599 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.2 p -65.98 -41.22 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.194 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.82 -38.32 88.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.6 mm? -68.56 -43.22 77.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.305 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.737 HG23 HG11 ' A' ' 78' ' ' VAL . 19.4 mt -71.32 -41.67 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -74.43 -18.87 60.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.103 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -28.62 6.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.48 161.64 29.03 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 p -68.56 -48.2 64.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 14' ' ' GLN . 57.4 m-85 -95.8 114.75 26.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 72' ' ' ILE . 12.8 p -128.52 139.47 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.01 114.31 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.883 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.642 ' CD1' HG22 ' A' ' 78' ' ' VAL . 7.8 mp -119.27 119.74 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -77.78 113.62 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.023 HG12 HD13 ' A' ' 52' ' ' ILE . 34.1 m -112.39 172.95 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.586 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.792 ' HB2' HD11 ' A' ' 53' ' ' ILE . 23.0 tt0 -135.49 137.09 41.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.765 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.956 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.781 0.324 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -128.61 138.96 52.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -135.51 149.8 49.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.6 p -99.37 104.9 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 11' ' ' VAL . 12.9 p -85.52 115.49 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -88.11 99.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.702 HG22 ' CD1' ' A' ' 20' ' ' PHE . 28.8 mt -86.42 112.65 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -102.16 131.52 48.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.96 119.61 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.43 -168.96 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -30.71 66.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 -38.39 13.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.61 178.43 20.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.702 ' CD1' HG22 ' A' ' 13' ' ' ILE . 25.1 m-85 -60.05 112.78 2.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.5 8.41 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.636 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -50.74 146.84 5.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 111.19 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 148.78 41.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.804 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.629 HG12 HG22 ' A' ' 32' ' ' VAL . 30.9 m -135.34 140.07 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 t -149.51 132.09 15.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.27 109.95 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -57.61 -68.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 2.0 t30 -89.51 -51.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 2.2 Cg_endo -84.61 -161.37 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.98 2.453 . . . . 0.0 112.19 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.029 HG12 HD12 ' A' ' 52' ' ' ILE . 10.1 t -150.4 97.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -133.8 149.73 51.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.147 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.629 HG22 HG12 ' A' ' 24' ' ' VAL . 25.7 t -83.65 128.36 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -92.64 -49.49 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.68 158.02 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HB ' HG11 ' A' ' 46' ' ' VAL . 17.6 m -136.49 153.11 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -81.79 111.69 18.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.2 138.01 39.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t0 58.58 30.62 20.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.6 -158.99 8.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.554 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.79 72.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB1' HG11 ' A' ' 46' ' ' VAL . . . -71.31 -47.36 57.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.214 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tpt -67.42 -42.24 83.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -32.72 74.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.75 58.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.461 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 52.95 3.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.479 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.611 HG11 ' HB1' ' A' ' 41' ' ' ALA . 14.9 p -88.59 158.95 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -128.13 115.86 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.867 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.32 130.83 36.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 32.67 45.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.434 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -94.68 147.71 23.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.926 0.393 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.56 142.61 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.707 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.029 HD12 HG12 ' A' ' 30' ' ' VAL . 39.1 mt -98.51 115.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.763 HD12 HG22 ' A' ' 81' ' ' THR . 20.0 mt -78.72 -47.09 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -156.86 161.91 39.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.002 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.937 HG23 ' CD2' ' A' ' 80' ' ' LEU . 9.4 p -121.13 114.79 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.181 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 56.6 55.56 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.91 27.5 62.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.546 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.842 -179.957 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.814 ' O ' HG23 ' A' ' 69' ' ' VAL . 12.0 t-80 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.786 0.327 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 66' ' ' LEU . 6.5 mp -55.32 -43.19 74.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.29 -43.97 96.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.192 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.822 HG12 HD11 ' A' ' 72' ' ' ILE . 6.4 t -63.32 -46.56 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.053 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 65' ' ' HIS . 23.4 t -62.55 -45.08 99.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -38.42 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.492 HD23 HG11 ' A' ' 55' ' ' VAL . 5.9 tp -68.17 -45.48 73.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.707 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.822 HD11 HG12 ' A' ' 68' ' ' VAL . 18.1 mt -70.14 -36.09 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -74.37 -28.88 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.9 p -64.29 80.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.932 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.68 143.94 5.41 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.578 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 m -71.68 -55.7 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 m-85 -96.06 116.17 28.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.05 145.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.203 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.83 112.38 16.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.937 ' CD2' HG23 ' A' ' 55' ' ' VAL . 3.3 mt -112.96 116.67 30.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.763 HG22 HD12 ' A' ' 53' ' ' ILE . 89.5 m -77.47 111.15 12.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.688 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 52' ' ' ILE . 12.4 m -117.43 175.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.325 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.96 130.04 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.67 -179.81 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.782 0.325 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -105.47 139.88 39.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -148.49 137.93 21.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.98 107.25 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.07 143.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.1 105.21 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.713 HD11 HD11 ' A' ' 72' ' ' ILE . 32.7 pt -105.06 137.76 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.254 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.51 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 8.2 tt0 -106.61 119.18 38.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.754 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -67.31 145.5 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -112.99 -169.34 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -60.37 -31.18 70.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -41.27 13.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 -155.45 20.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -88.85 111.08 21.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.97 -38.67 96.38 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.605 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -54.59 136.81 44.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -101.25 131.64 47.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 32' ' ' VAL . 29.0 m -129.64 134.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 p -147.67 132.16 17.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.23 119.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.28 -77.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -84.28 -48.25 0.68 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -84.65 -168.81 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.538 2.159 . . . . 0.0 112.476 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.702 HG12 HD12 ' A' ' 52' ' ' ILE . 21.3 t -149.4 102.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -132.2 153.3 50.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 24' ' ' VAL . 24.4 t -88.78 124.81 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.0 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -34.85 22.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.62 158.81 43.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 46' ' ' VAL . 8.9 m -136.08 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.156 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 13.3 ptmt -55.93 122.56 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.1 mt-10 -77.33 151.43 34.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.974 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.28 29.85 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HE2' ' A' ' 36' ' ' LYS . . . -141.04 -166.65 10.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -52.35 -44.72 65.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.777 0.322 . . . . 0.0 111.405 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -59.9 -47.61 85.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -67.26 -50.96 58.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -59.14 -31.95 69.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.03 -15.82 62.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.399 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.55 35.51 28.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.544 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.693 ' HB ' HG11 ' A' ' 35' ' ' VAL . 17.9 t -85.08 141.21 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.282 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -105.77 156.83 17.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.88 125.14 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.23 30.59 45.48 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -80.7 145.49 31.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.04 133.89 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.702 HD12 HG12 ' A' ' 30' ' ' VAL . 5.6 mt -101.27 133.93 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mt -110.77 -47.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -122.02 156.5 33.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.58 HG13 ' CD2' ' A' ' 80' ' ' LEU . 22.1 t -133.66 104.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 t30 59.0 41.44 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.15 73.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.587 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.786 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.1 t-80 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.851 0.358 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.25 -43.26 74.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.97 -44.12 96.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 72' ' ' ILE . 17.4 t -62.74 -46.51 96.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.9 t -62.31 -44.3 99.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 13.9 mtpp -66.09 -38.37 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.794 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -40.48 70.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.888 HD12 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -73.93 -36.87 46.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.038 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.55 -20.57 59.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -68.6 72.14 0.22 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.879 0.371 . . . . 0.0 110.8 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 150.24 7.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.438 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -46.67 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 114.39 26.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.728 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -131.47 144.47 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.66 111.35 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -112.18 134.34 53.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.6 m -82.64 113.78 20.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -112.59 169.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -142.78 128.0 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.647 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.774 -179.891 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.872 0.368 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -128.62 143.65 50.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -143.51 140.52 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 128.75 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 44' ' ' ALA . 12.4 p -126.2 114.72 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.19 114.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.758 HD13 HD21 ' A' ' 22' ' ' LEU . 12.0 mt -98.09 145.05 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.13 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -114.97 126.2 54.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -66.13 120.4 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 33.9 m-20 -87.57 -173.05 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -29.82 67.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.12 -30.38 14.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.94 -161.67 12.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.514 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 72' ' ' ILE . 4.3 m-85 -79.38 94.49 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.48 -32.12 80.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 13' ' ' ILE . 4.2 pp -59.87 131.39 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 m -102.22 132.92 47.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 HG22 ' A' ' 32' ' ' VAL . 31.3 m -116.88 143.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.54 132.51 17.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.02 132.26 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.365 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -58.03 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.672 0.272 . . . . 0.0 110.839 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.439 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 7.6 m-20 -85.24 -61.49 0.27 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.766 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 92.1 Cg_endo -80.07 -167.44 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.524 2.149 . . . . 0.0 112.194 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.64 120.72 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 2.9 t80 -128.42 135.39 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.702 HG22 HG12 ' A' ' 24' ' ' VAL . 20.6 t -93.75 122.99 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -97.0 -49.83 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.281 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.54 148.66 42.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.191 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.603 HG11 HG12 ' A' ' 46' ' ' VAL . 29.4 m -136.46 145.56 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.99 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.89 121.06 15.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.008 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.02 138.94 31.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t0 59.11 30.73 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.34 -149.66 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . . . -59.78 -45.55 91.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.76 0.314 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . -61.7 -47.41 85.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.82 85.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -32.72 73.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -71.25 -15.72 62.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.404 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.3 26.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.567 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.603 HG12 HG11 ' A' ' 35' ' ' VAL . 24.4 t -78.8 158.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.731 0.301 . . . . 0.0 110.992 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.482 ' N ' HG12 ' A' ' 46' ' ' VAL . 13.2 mt-30 -132.3 144.65 50.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.42 125.11 23.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 78.32 46.6 8.88 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.429 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.7 139.65 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -92.05 152.08 20.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.973 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.808 HD13 HG12 ' A' ' 82' ' ' VAL . 13.4 mm -106.94 133.37 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.0 mm -107.45 -33.82 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.2 157.28 42.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.752 HG12 ' HB3' ' A' ' 80' ' ' LEU . 4.7 m -140.62 110.46 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.496 HD21 HG23 ' A' ' 78' ' ' VAL . 84.4 m-20 60.75 41.98 14.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 26.25 71.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.87 0.367 . . . . 0.0 110.952 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.827 0.346 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.468 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 tp -55.29 -43.47 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.87 -40.14 94.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.256 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.48 ' O ' HG22 ' A' ' 72' ' ' ILE . 22.6 t -65.68 -46.78 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.2 p -65.02 -41.29 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.019 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -38.37 87.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.102 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -47.39 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.453 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.513 HD11 ' CE2' ' A' ' 20' ' ' PHE . 2.0 tt -68.7 -37.89 78.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.64 -26.6 59.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.023 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 t -64.23 80.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.96 144.56 9.13 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 m -69.8 -49.26 54.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 120.49 36.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG23 HD21 ' A' ' 56' ' ' ASN . 11.1 p -136.06 133.87 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.93 117.44 30.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.752 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -131.03 127.56 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -70.02 131.23 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.808 HG12 HD13 ' A' ' 52' ' ' ILE . 27.0 m -126.86 169.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -140.61 127.87 21.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.627 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.835 0.35 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.74 138.58 40.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.7 154.17 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.33 139.75 37.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.79 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.4 m -134.05 144.29 35.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 79' ' ' ALA . 24.3 mm -113.67 107.32 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.691 HD11 HD21 ' A' ' 80' ' ' LEU . 15.9 pt -106.02 126.07 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.41 139.35 38.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 128.67 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.703 ' OD2' ' HB2' ' A' ' 40' ' ' ALA . 18.0 m-20 -103.99 -169.59 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.81 -36.35 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.29 -43.84 66.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.14 76.06 1.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.561 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.641 ' CE2' HD12 ' A' ' 13' ' ' ILE . 8.8 m-85 61.39 115.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.11 -44.97 4.91 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.553 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 142.79 36.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.337 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m -101.32 122.26 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.401 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 10.0 p -118.97 137.18 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.8 p -149.53 132.03 15.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.26 120.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.461 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.7 -73.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.5 t-20 -84.66 -53.04 0.5 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 86.2 Cg_endo -84.27 -167.49 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.725 2.284 . . . . 0.0 112.378 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.098 HG12 HD12 ' A' ' 52' ' ' ILE . 19.5 t -145.49 94.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.006 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -127.31 141.02 51.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.92 128.69 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.05 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.73 -30.33 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.17 146.25 47.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.951 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.61 HG13 ' HB1' ' A' ' 41' ' ' ALA . 40.4 t -134.6 129.71 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -66.92 110.55 3.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.806 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.4 pm0 -91.81 44.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.43 35.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.591 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.47 -145.82 4.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.849 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . . . -60.99 -38.88 87.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.726 0.298 . . . . 0.0 111.401 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -59.29 -47.47 85.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.416 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 3.8 tpt -72.42 -43.14 64.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.801 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -30.8 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 13' ' ' ILE . . . -83.51 -15.85 47.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.73 56.96 3.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 47' ' ' GLN . 24.6 t -98.39 158.5 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.481 ' N ' HG12 ' A' ' 46' ' ' VAL . 1.5 mp0 -118.88 148.68 42.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.04 129.11 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 33.42 32.8 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.586 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.95 133.93 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.846 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.098 HD12 HG12 ' A' ' 30' ' ' VAL . 24.3 mt -96.89 124.41 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.69 -43.85 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.181 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -138.29 150.36 46.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.955 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 80' ' ' LEU . 5.2 m -136.19 106.19 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.173 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.29 43.6 10.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.803 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.98 27.56 70.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.495 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.727 ' O ' HG23 ' A' ' 69' ' ' VAL . 19.2 t-80 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.806 0.336 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 mt -55.2 -42.91 73.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.662 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.57 -44.04 97.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 HD11 ' A' ' 72' ' ' ILE . 21.1 t -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.8 t -61.69 -43.72 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -65.43 -38.41 89.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.342 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -41.87 79.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.785 HD11 HG12 ' A' ' 68' ' ' VAL . 14.9 mt -71.61 -38.04 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -74.49 -27.13 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 85.2 p -63.33 80.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.44 144.41 4.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.584 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.7 p -71.63 -54.02 11.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -95.75 118.77 33.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 72' ' ' ILE . 20.5 t -125.86 123.42 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.282 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -115.27 101.82 9.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.691 HD21 HD11 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -113.31 137.43 51.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.022 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 m -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 80' ' ' LEU . 5.8 m -112.59 170.05 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -130.0 143.9 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.588 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -114.23 160.0 19.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.853 0.358 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.2 m80 60.34 167.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.59 -75.03 0.52 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.37 -43.75 97.86 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 tp 60.2 30.74 20.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.895 0.378 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.24 130.69 54.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.88 146.39 49.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -129.1 130.25 46.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.883 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.9 p -80.59 129.75 34.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 45' ' ' GLY . 5.1 m -141.69 104.92 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mt -83.78 126.88 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.101 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.442 HG22 ' CE1' ' A' ' 20' ' ' PHE . 26.4 mm -98.02 140.36 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.029 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.51 127.56 56.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.35 140.8 43.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -115.23 -171.67 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.816 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -31.64 70.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -90.32 -37.17 14.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 177.86 16.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.444 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.52 ' CE2' HG22 ' A' ' 72' ' ' ILE . 26.7 m-85 -60.09 123.84 18.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 110.934 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.68 -45.9 9.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.524 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 22' ' ' LEU . 4.0 pp -58.11 141.78 49.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.378 . . . . 0.0 110.967 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.83 144.74 50.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.936 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.795 HG12 ' HA ' ' A' ' 32' ' ' VAL . 30.3 m -122.1 156.38 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.995 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -149.49 132.13 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.54 124.09 0.71 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.31 -78.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 110.74 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.412 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 5.0 m-20 -74.97 -60.64 1.17 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.667 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 74.2 Cg_endo -75.33 -168.08 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.673 2.249 . . . . 0.0 112.184 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.533 HG12 HG13 ' A' ' 52' ' ' ILE . 30.4 t -152.95 111.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.001 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.74 141.79 44.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.839 HG23 HD11 ' A' ' 52' ' ' ILE . 23.7 t -77.28 124.75 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.134 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.526 ' O ' HG22 ' A' ' 48' ' ' THR . 24.4 pt20 -94.45 -42.54 8.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.978 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 p -122.85 153.25 39.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.44 142.62 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.4 tptt -68.69 99.23 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -69.0 129.77 40.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.83 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.6 t0 60.05 32.7 21.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.786 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.65 -152.14 6.52 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.528 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.46 85.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.95 -47.31 72.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -36.3 81.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.821 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.13 -31.09 62.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.969 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 13' ' ' ILE . . . -78.21 -15.82 58.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.429 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' HG11 ' A' ' 11' ' ' VAL . . . 85.58 51.76 3.56 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.59 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -103.53 147.26 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -119.44 149.22 42.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.975 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -73.17 128.12 34.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.962 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.01 34.84 36.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.425 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.76 150.54 21.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 mtt85 -90.69 136.47 33.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.84 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.903 HD13 HG12 ' A' ' 82' ' ' VAL . 18.5 mm -98.29 121.11 48.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.76 -49.21 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.76 161.56 34.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.61 HG12 HD12 ' A' ' 80' ' ' LEU . 5.3 m -120.33 111.28 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 1.9 t30 59.94 41.33 17.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.907 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.73 27.66 73.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.529 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.2 m -134.38 115.14 13.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mp -60.71 148.95 36.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.815 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 t -107.33 111.78 37.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.3 p -114.74 179.14 4.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 61.78 152.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.24 108.66 21.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.35 103.35 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.78 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 t-80 -59.6 -38.64 81.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.819 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.492 HD23 ' HG3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -55.42 -42.67 74.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.634 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -62.51 -43.97 97.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.277 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.659 HG12 HD11 ' A' ' 72' ' ' ILE . 24.5 t -63.85 -46.7 93.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.002 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 65' ' ' HIS . 29.8 t -60.63 -45.66 97.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.254 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HG3' HD23 ' A' ' 66' ' ' LEU . 5.5 mtmp? -64.47 -38.27 90.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.008 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.73 -44.63 85.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.303 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.659 HD11 HG12 ' A' ' 68' ' ' VAL . 15.5 mt -68.96 -43.22 82.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.655 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -74.4 -12.97 60.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.369 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.0 p -44.35 -30.17 0.79 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.816 0.341 . . . . 0.0 111.597 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.23 156.88 27.01 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.547 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.8 m -57.09 -57.31 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 110.756 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -100.75 112.6 25.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -134.13 128.19 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 56' ' ' ASN . . . -70.28 143.89 51.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.908 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.61 HD12 HG12 ' A' ' 55' ' ' VAL . 4.1 tp -136.29 93.4 2.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.02 110.11 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.903 HG12 HD13 ' A' ' 52' ' ' ILE . 27.5 m -112.58 173.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.36 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -135.98 138.49 42.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.91 135.45 2.13 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.426 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -105.92 115.74 60.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.531 0.205 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -51.88 171.25 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.415 2.077 . . . . 0.0 112.348 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.17 175.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.551 2.167 . . . . 0.0 112.241 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -132.35 27.89 3.52 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.526 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.938 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.511 -0.235 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -61.38 93.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.77 0.319 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -155.81 107.16 2.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.793 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 37.1 mtt -70.28 -55.38 9.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.775 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.7 54.76 13.61 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.15 36.59 4.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.79 0.329 . . . . 0.0 110.79 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -108.58 146.56 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.23 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG2' HD13 ' A' ' 53' ' ' ILE . 1.4 mt-30 -125.22 154.35 41.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.97 130.24 17.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 103.62 11.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 11' ' ' VAL . 31.4 m -98.12 114.19 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.41 100.68 10.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.141 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.424 HG22 ' CE1' ' A' ' 20' ' ' PHE . 3.6 mp -91.34 133.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -106.31 124.3 49.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.88 137.58 56.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -116.0 -171.47 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -60.2 -31.48 70.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -81.98 -36.97 27.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.72 166.48 22.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.423 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 72' ' ' ILE . 23.8 m-85 -60.33 109.27 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.07 -29.78 64.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.501 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.76 126.39 29.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.78 139.08 38.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 32' ' ' VAL . 25.2 m -119.13 135.77 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.37 132.48 16.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.18 123.95 0.97 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.451 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.61 -76.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.752 0.311 . . . . 0.0 110.782 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -80.53 -60.56 0.46 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.823 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.0 Cg_endo -78.7 -168.05 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.56 2.173 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.81 HG12 HD12 ' A' ' 52' ' ' ILE . 19.8 t -145.89 96.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.0 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -125.51 145.11 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.935 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 24' ' ' VAL . 12.1 t -76.46 120.2 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.35 -49.23 8.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.49 143.97 46.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.826 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.511 HG11 HG22 ' A' ' 46' ' ' VAL . 28.4 m -136.42 136.18 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' CB ' ' HB3' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -64.59 114.45 4.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.709 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -97.27 40.79 1.14 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.983 0.42 . . . . 0.0 110.988 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -176.36 34.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.683 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.65 -139.64 2.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.687 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.76 93.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.77 0.319 . . . . 0.0 111.324 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.778 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -59.29 -47.38 85.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.058 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -41.8 95.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.784 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -71.94 -29.95 64.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.4 -15.87 61.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.11 33.77 35.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.712 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 41' ' ' ALA . 12.2 p -90.22 147.86 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 0.0 111.024 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.72 163.21 14.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.05 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.56 126.52 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.728 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.88 29.06 35.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.372 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -80.2 141.08 35.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -93.82 134.62 35.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.825 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.81 HD12 HG12 ' A' ' 30' ' ' VAL . 25.0 mt -101.97 118.39 48.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.223 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.8 mp -85.9 -43.95 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.63 148.2 28.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.763 HG12 ' CB ' ' A' ' 80' ' ' LEU . 29.3 m -125.38 118.55 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 57.74 48.01 14.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.72 28.2 72.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.454 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.3 m -134.27 104.19 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.767 0.318 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 59' ' ' LEU . 0.3 OUTLIER -61.91 170.28 2.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG21 HG23 ' A' ' 30' ' ' VAL . 9.6 p -103.63 145.79 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.97 -47.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.36 31.22 1.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.5 m -89.69 126.95 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.839 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.7 t-20 -96.65 -173.11 2.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.894 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.8 t-80 -57.49 -52.58 64.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.85 -43.13 76.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.744 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -62.18 -44.13 97.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.386 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 64' ' ' ASN . 34.4 t -64.08 -46.73 92.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.06 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 65' ' ' HIS . 19.1 t -60.56 -43.64 94.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.22 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -65.97 -39.39 90.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.284 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -47.92 75.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.381 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.698 HD11 HG12 ' A' ' 68' ' ' VAL . 14.7 mt -68.97 -40.55 81.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.699 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -74.64 -19.68 60.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.199 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.1 t -50.9 -28.94 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.322 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.53 158.35 27.63 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.616 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -64.46 -46.8 81.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 0.0 110.862 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.1 m-85 -95.76 112.72 24.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.592 HG11 HG23 ' A' ' 72' ' ' ILE . 12.6 p -116.46 123.52 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.201 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.66 111.18 18.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.763 ' CB ' HG12 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -126.84 133.87 50.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.983 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.4 m -79.33 116.29 19.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG12 HG12 ' A' ' 52' ' ' ILE . 28.0 m -113.55 175.76 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.239 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.707 ' HB2' HD11 ' A' ' 53' ' ' ILE . 35.0 tt0 -132.69 130.88 40.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 155.79 163.51 12.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.528 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 144.38 31.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.551 0.215 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.54 129.64 12.98 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.497 2.131 . . . . 0.0 112.258 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.53 133.14 21.78 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.344 2.029 . . . . 0.0 112.414 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.69 41.28 2.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.518 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.802 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.62 179.1 4.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.759 0.314 . . . . 0.0 110.833 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -117.99 -40.71 2.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 43.3 mtm 60.85 82.34 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.56 -88.25 2.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp -164.84 94.17 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 7' ' ' VAL . 22.4 m -133.22 118.09 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.3 154.71 33.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -139.12 134.99 33.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.3 135.27 33.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.59 142.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 ' HB2' ' A' ' 79' ' ' ALA . 22.6 mt -118.16 113.89 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.14 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.515 HG22 ' CB ' ' A' ' 44' ' ' ALA . 27.6 pt -104.75 143.87 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.063 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 19.3 mt-30 -106.15 143.14 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 138.34 33.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -102.8 -168.94 1.59 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -58.51 -34.44 70.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.79 -35.47 12.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.862 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.62 -109.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.495 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 72' ' ' ILE . 32.0 m-85 -125.71 132.99 52.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.886 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -39.87 36.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 pp -61.48 139.58 58.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.792 0.329 . . . . 0.0 111.043 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 m -103.22 130.77 50.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 32' ' ' VAL . 33.7 m -119.07 140.7 42.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.351 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.6 131.88 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.808 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.75 112.49 0.36 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.624 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.63 -74.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -80.17 -60.94 0.46 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.734 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 85.8 Cg_endo -78.03 -169.46 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.541 2.161 . . . . 0.0 112.324 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.991 HG12 HD12 ' A' ' 52' ' ' ILE . 21.7 t -144.0 103.83 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.025 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -138.41 148.6 44.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 24' ' ' VAL . 25.2 t -84.81 132.74 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -93.65 -34.81 13.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.051 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.87 152.27 40.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 46' ' ' VAL . 30.4 m -135.98 135.38 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 6.4 tptp -59.8 113.88 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.648 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -92.46 44.12 1.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.976 0.417 . . . . 0.0 111.022 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -177.15 35.69 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -164.99 -148.63 5.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.558 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.54 79.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.737 0.304 . . . . 0.0 111.244 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . . . -59.7 -47.42 85.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.7 tpt -69.9 -50.8 38.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -30.48 70.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.003 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' A' ' 13' ' ' ILE . . . -71.34 -15.82 62.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.38 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.06 28.93 32.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.445 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 35' ' ' VAL . 9.4 t -84.79 151.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.98 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.71 145.19 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 48' ' ' THR . 1.3 t -69.25 131.43 44.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 30.28 36.01 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -93.81 149.36 21.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -96.43 142.52 28.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.991 HD12 HG12 ' A' ' 30' ' ' VAL . 32.2 mt -106.75 125.56 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.57 HD12 HG22 ' A' ' 81' ' ' THR . 4.0 mt -92.43 -49.12 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.02 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -151.07 157.07 42.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.53 HG13 ' HB3' ' A' ' 80' ' ' LEU . 30.1 t -128.44 114.31 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.084 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 58.87 53.14 5.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.15 27.59 60.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.35 128.84 8.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.831 0.348 . . . . 0.0 110.939 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -170.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.912 HG21 ' CG2' ' A' ' 30' ' ' VAL . 16.1 m -98.45 34.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.9 m 67.63 -70.21 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -176.8 -65.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.006 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.8 m -142.16 -163.15 1.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 69.95 111.86 0.05 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.684 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.6 t-80 -65.57 -36.13 82.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.978 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.84 -41.27 70.54 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.54 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -42.47 97.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.866 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.78 HG12 ' CD1' ' A' ' 72' ' ' ILE . 31.4 t -63.92 -46.63 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.212 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.9 t -63.19 -44.15 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.509 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -65.8 -38.41 88.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.475 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.01 -45.27 70.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.6 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.78 ' CD1' HG12 ' A' ' 68' ' ' VAL . 19.8 mt -69.69 -35.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.776 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mttp -72.8 -29.33 63.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.3 m -64.7 80.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.55 144.32 6.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -54.45 14.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.3 m-85 -98.28 119.82 37.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.8 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.0 p -124.79 115.38 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB2' HG12 ' A' ' 12' ' ' ILE . . . -105.86 105.36 15.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -112.07 139.92 47.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.009 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.57 HG22 HD12 ' A' ' 53' ' ' ILE . 63.6 m -84.97 121.09 27.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 52' ' ' ILE . 4.2 m -114.53 175.27 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.211 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.539 ' HB2' HD11 ' A' ' 53' ' ' ILE . 25.3 tt0 -138.39 150.4 46.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 172.71 136.26 2.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.523 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.81 127.95 26.37 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.554 0.216 . . . . 0.0 110.884 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.48 107.16 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.563 2.176 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.0 -61.39 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.521 2.147 . . . . 0.0 112.276 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.43 27.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.558 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.922 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.3 t -124.58 155.0 39.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -72.61 65.26 0.67 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.2 ttm -113.76 -35.57 5.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.07 -32.88 0.15 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.85 112.73 13.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 0.0 110.87 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.26 111.95 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -121.44 144.36 48.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.81 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -148.5 146.59 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 p -107.36 137.28 45.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.25 125.76 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -103.03 108.44 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.079 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.75 137.42 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.441 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 0.5 OUTLIER -109.76 139.97 44.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -72.67 143.05 48.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -110.91 -171.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -61.62 -31.43 71.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -96.05 -35.35 11.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.5 179.2 15.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.533 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.512 ' CE2' HG22 ' A' ' 72' ' ' ILE . 36.5 m-85 -60.67 109.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 0.0 110.926 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.41 -36.66 69.62 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.538 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.5 132.68 54.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.019 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.63 134.09 49.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.794 HG12 HG22 ' A' ' 32' ' ' VAL . 29.2 m -115.51 148.21 18.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.137 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.9 t -148.7 138.69 22.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.24 115.98 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 -71.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.733 0.301 . . . . 0.0 110.853 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.402 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.2 m-20 -80.06 -60.0 0.51 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.783 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -78.48 -168.41 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.579 2.186 . . . . 0.0 112.355 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.927 HG12 HD12 ' A' ' 52' ' ' ILE . 21.5 t -148.33 95.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -123.13 148.37 45.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.794 HG22 HG12 ' A' ' 24' ' ' VAL . 19.6 t -90.22 126.63 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.004 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -95.29 -42.61 8.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.0 p -119.33 145.18 46.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.019 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.61 144.62 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 37.9 tttt -66.14 114.38 5.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.934 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.87 139.44 33.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.791 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t0 59.17 30.05 19.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.76 -158.7 8.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.23 85.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 111.211 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.758 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.08 -47.33 68.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.07 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -48.2 76.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -30.41 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.14 -15.83 62.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.455 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.42 34.6 11.78 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.501 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 41' ' ' ALA . 14.0 p -79.93 158.99 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.759 0.314 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' HG22 ' A' ' 46' ' ' VAL . 14.9 mt-30 -125.66 138.05 53.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.823 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 t -70.34 130.45 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.964 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.87 26.93 47.96 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.672 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -88.32 138.35 31.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.68 135.33 33.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.927 HD12 HG12 ' A' ' 30' ' ' VAL . 18.6 mt -94.31 125.24 46.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.11 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 83' ' ' GLN . 33.9 mt -98.68 -34.97 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -142.99 142.02 31.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 52' ' ' ILE . 21.4 t -125.13 117.11 49.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 59.41 30.77 20.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.5 27.3 67.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.547 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 58' ' ' THR . 8.5 m -121.12 23.24 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.096 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 49.05 -168.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.234 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 60' ' ' VAL . 11.0 p -159.3 115.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.998 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 p -97.75 -67.0 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.942 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.78 130.39 4.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.991 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 m -162.8 156.29 20.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.808 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.8 m-80 -86.19 178.89 7.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.81 ' O ' HG23 ' A' ' 69' ' ' VAL . 34.0 t-80 -59.53 -49.88 76.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 mp -55.82 -43.16 76.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.799 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -62.58 -44.1 97.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.401 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.846 HG12 HD11 ' A' ' 72' ' ' ILE . 25.5 t -64.16 -46.66 92.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.118 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 65' ' ' HIS . 35.2 t -60.67 -43.23 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.137 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -65.71 -38.37 89.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -43.66 81.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.468 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.846 HD11 HG12 ' A' ' 68' ' ' VAL . 9.4 mt -70.79 -36.59 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.739 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -74.27 -20.59 60.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.122 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.85 -27.9 5.76 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.171 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.73 147.57 18.7 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.51 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.4 p -59.63 -43.65 93.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.804 0.335 . . . . 0.0 110.805 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.441 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.4 m-85 -102.97 115.24 30.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 78' ' ' VAL . 12.7 p -114.88 113.42 43.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.181 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.1 104.46 14.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD12 HG13 ' A' ' 82' ' ' VAL . 3.6 pp -123.11 134.03 54.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.997 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -84.65 122.63 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.791 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' A' ' 52' ' ' ILE . 12.7 m -116.81 169.19 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.294 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.714 ' HB2' HD11 ' A' ' 53' ' ' ILE . 6.6 tt0 -135.43 134.63 39.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.755 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.86 -51.47 9.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.647 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 62.54 143.0 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.637 0.256 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.491 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 44.7 Cg_exo -55.15 -49.07 17.7 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.535 2.156 . . . . 0.0 112.673 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 73.0 Cg_endo -75.99 -174.52 2.09 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.253 1.969 . . . . 0.0 112.419 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -100.53 -38.14 3.55 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.525 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.878 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -140.06 104.28 4.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.881 0.372 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.83 32.81 20.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.6 mtm -116.46 99.9 7.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 153.76 -64.32 0.35 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.13 87.82 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 0.0 110.766 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m -107.3 123.74 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.217 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -122.45 154.3 37.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.846 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -139.49 130.28 26.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.5 m -89.0 108.11 19.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.014 HG21 HG22 ' A' ' 46' ' ' VAL . 9.3 p -96.97 143.66 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.166 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.7 mm -119.27 95.42 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.053 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.608 HD13 HD21 ' A' ' 22' ' ' LEU . 3.3 mt -86.34 130.01 37.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.35 127.36 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.838 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -65.26 131.64 47.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -102.5 -169.1 1.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.814 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -59.5 -29.87 68.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.22 -29.97 15.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.24 -118.66 3.33 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.447 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 72' ' ' ILE . 48.0 m-85 -116.42 115.54 26.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.824 0.345 . . . . 0.0 110.92 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.56 -44.19 73.3 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.596 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.608 HD21 HD13 ' A' ' 13' ' ' ILE . 4.1 pp -59.73 139.43 57.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 m -112.58 137.4 50.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.838 HG12 ' HA ' ' A' ' 32' ' ' VAL . 30.1 m -129.31 142.0 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.258 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -149.49 132.02 15.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.11 140.46 4.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.605 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -73.7 -74.21 0.19 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.778 0.323 . . . . 0.0 110.805 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.24 -56.79 0.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.691 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.03 -168.15 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.571 2.18 . . . . 0.0 112.176 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.813 HG13 ' HB ' ' A' ' 52' ' ' ILE . 8.6 p -155.71 106.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -127.69 154.85 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.798 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.838 ' HA ' HG12 ' A' ' 24' ' ' VAL . 4.5 t -91.19 120.34 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -89.42 -31.08 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -132.27 144.33 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 46' ' ' VAL . 31.2 m -132.35 139.36 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -62.54 107.82 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -73.46 130.53 40.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.69 30.42 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.1 -157.42 8.85 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.05 -39.33 89.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 111.14 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -66.02 -47.35 74.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.128 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.6 tpt -69.33 -41.74 76.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 ttp-105 -67.95 -29.69 68.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.689 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -75.4 -15.92 60.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.324 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.37 46.24 3.06 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.491 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.014 HG22 HG21 ' A' ' 11' ' ' VAL . 16.2 t -106.92 143.84 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.832 0.348 . . . . 0.0 111.042 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' HG11 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -110.06 163.14 13.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.16 116.98 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.24 37.13 11.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.598 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.574 ' OD2' HG11 ' A' ' 82' ' ' VAL . 8.9 p-10 -96.83 154.02 17.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -95.42 137.31 34.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.813 ' HB ' HG13 ' A' ' 30' ' ' VAL . 12.8 mt -99.7 117.48 44.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.082 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.69 -42.5 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 147.06 30.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG22 HG21 ' A' ' 52' ' ' ILE . 21.5 t -118.77 111.64 34.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.96 41.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.995 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.83 28.83 73.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.3 m -128.09 90.8 3.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.74 -49.33 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.3 m -75.01 -177.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.062 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 62' ' ' HIS . 0.2 OUTLIER 63.12 -165.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.407 ' H ' HG22 ' A' ' 61' ' ' THR . 50.1 m80 61.99 151.61 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.4 p -168.88 -43.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -97.33 155.15 17.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.729 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -62.92 -36.45 83.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 67' ' ' GLU . 3.0 pp -55.24 -43.07 74.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.766 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.42 -44.02 97.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.993 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 72' ' ' ILE . 24.9 t -62.78 -46.67 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.114 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.9 t -61.7 -44.13 98.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.564 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.9 -39.74 90.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.55 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -45.9 73.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.628 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG13 HG21 ' A' ' 78' ' ' VAL . 20.5 tt -68.76 -35.76 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.773 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -70.43 -32.37 69.94 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.76 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.8 t -71.59 73.33 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.82 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.75 144.34 4.89 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.539 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.22 -30.78 60.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.819 0.342 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -108.85 132.99 53.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.4 p -129.94 112.43 23.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.011 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.45 103.48 13.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.114 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.62 HD12 HG13 ' A' ' 82' ' ' VAL . 3.1 pp -121.07 124.76 45.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.3 m -79.24 126.93 31.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.755 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.62 HG13 HD12 ' A' ' 80' ' ' LEU . 30.6 m -118.59 169.71 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.33 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -142.8 144.05 32.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.792 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.29 117.13 0.73 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.59 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.432 ' CB ' ' HD3' ' A' ' 86' ' ' PRO . 3.2 ttp180 -94.23 -53.89 0.24 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.563 0.221 . . . . 0.0 111.159 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.446 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 31.5 Cg_exo -57.74 -47.31 21.69 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.499 2.133 . . . . 0.0 112.656 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 96.2 Cg_endo -80.89 177.15 8.27 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.327 2.018 . . . . 0.0 112.438 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.32 -48.59 0.54 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.565 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.951 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.98 31.46 2.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.805 0.336 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.54 31.66 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.924 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 mtm -128.14 159.09 36.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 -24.6 29.79 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.554 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.7 29.8 3.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.755 0.312 . . . . 0.0 110.937 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG21 ' CD ' ' A' ' 85' ' ' ARG . 5.4 m -122.95 115.33 45.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.054 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -103.32 129.96 50.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -127.82 137.96 52.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.28 143.33 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.505 HG21 HG22 ' A' ' 46' ' ' VAL . 25.5 m -133.43 126.4 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.97 107.23 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.49 HD12 ' H ' ' A' ' 13' ' ' ILE . 4.0 mp -94.04 138.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HG2' ' CZ ' ' A' ' 77' ' ' TYR . 3.1 mp0 -102.07 124.8 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.963 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -71.58 133.59 45.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -99.51 -170.5 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -59.67 -31.56 69.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -88.58 -44.23 10.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.63 -158.54 23.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.509 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.43 ' CD2' HG12 ' A' ' 72' ' ' ILE . 68.7 m-85 -86.72 118.13 25.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.51 -26.98 58.21 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.549 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 pp -58.47 138.95 56.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -107.0 134.26 50.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 68' ' ' VAL . 30.8 t -115.61 135.55 55.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.402 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 37.3 t -149.42 132.17 15.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.933 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.04 125.41 0.92 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.94 -79.71 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.778 0.323 . . . . 0.0 110.867 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -78.78 -61.06 0.54 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.851 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.3 Cg_endo -76.61 -167.9 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.848 HG12 HD12 ' A' ' 52' ' ' ILE . 21.4 t -140.86 110.84 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.402 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 23.1 p90 -136.39 150.25 48.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.644 ' CG2' HD11 ' A' ' 52' ' ' ILE . 21.5 t -91.11 120.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.064 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -72.34 -58.97 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.022 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.8 t -122.59 157.97 30.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.016 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.681 HG11 HG12 ' A' ' 46' ' ' VAL . 32.4 m -135.04 145.33 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.117 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 4.0 ttpm? -56.84 98.95 0.03 OUTLIER 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.986 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.44 140.09 54.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.712 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 42' ' ' MET . 0.7 OUTLIER 55.59 29.89 14.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -136.5 -160.12 8.62 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.689 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.18 -28.4 69.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.724 0.297 . . . . 0.0 111.532 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . . . -69.29 -47.71 63.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.634 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 39' ' ' GLY . 2.4 ppp? -70.6 -34.73 72.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.848 0.356 . . . . 0.0 110.908 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -31.81 70.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.72 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.375 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 27.29 11.2 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.52 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.681 HG12 HG11 ' A' ' 35' ' ' VAL . 16.3 t -88.54 144.51 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 111.046 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.71 158.02 19.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.68 122.06 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.21 43.24 39.97 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.407 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -98.79 156.76 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 110.949 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.848 HD12 HG12 ' A' ' 30' ' ' VAL . 19.7 mt -103.47 124.4 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.08 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 83' ' ' GLN . 3.5 mp -97.8 -32.7 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 59' ' ' LEU . 26.2 ttpt -137.68 141.91 41.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 55' ' ' VAL . 26.3 m -124.59 104.09 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.516 ' OD1' HG23 ' A' ' 78' ' ' VAL . 97.8 m-20 61.03 43.98 10.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.81 28.21 69.35 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.6 m -133.62 84.5 2.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 111.18 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.4 pt? -94.87 27.61 3.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.206 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 61' ' ' THR . 21.3 t -136.3 158.86 38.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.258 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 60' ' ' VAL . 8.4 m 60.56 99.73 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -70.69 155.24 41.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.927 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.02 178.46 7.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.733 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.3 t-20 -94.59 -175.15 3.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 24' ' ' VAL . 11.1 t-80 -59.53 -45.1 92.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 69' ' ' VAL . 3.0 mt -55.46 -43.03 75.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.741 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.0 mm-40 -66.08 -38.8 89.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.341 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 64' ' ' ASN . 30.0 t -66.9 -46.89 84.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.502 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.505 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.8 p -66.16 -41.43 89.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.167 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 69' ' ' VAL . 14.1 ttmm -66.33 -39.46 89.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.366 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.8 mm? -68.9 -46.94 67.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.553 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 68' ' ' VAL . 2.3 tt -67.97 -35.67 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.893 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.777 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 59.9 p -66.62 78.03 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.73 145.97 6.9 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.7 t -71.04 -46.66 61.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.411 ' CZ ' ' HG2' ' A' ' 14' ' ' GLN . 2.4 m-85 -95.76 121.11 37.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.516 HG23 ' OD1' ' A' ' 56' ' ' ASN . 11.6 p -117.14 141.95 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.83 117.82 14.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.094 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.2 pp -135.98 134.35 38.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.8 m -75.75 123.94 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 52' ' ' ILE . 10.3 m -123.45 175.62 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.216 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.656 ' HB2' HD11 ' A' ' 53' ' ' ILE . 36.6 tt0 -142.81 135.6 27.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.28 -96.97 0.1 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.554 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.457 ' CD ' HG21 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 62.32 78.43 0.3 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.297 . . . . 0.0 110.87 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.3 169.9 21.17 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.554 2.17 . . . . 0.0 112.28 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.0 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.511 2.14 . . . . 0.0 112.343 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.06 -43.99 2.37 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.483 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.93 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.151 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.3 p -99.19 31.54 3.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -150.99 78.4 1.29 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttt -150.26 153.93 37.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.924 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.17 78.57 0.3 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.496 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.436 HD23 ' OE1' ' A' ' 83' ' ' GLN . 9.2 mt 60.78 104.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 0.0 110.84 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.99 121.28 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -120.6 152.29 38.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 130.3 41.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -83.89 103.3 13.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.882 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 m -93.66 129.27 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.87 106.19 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.61 129.4 47.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.429 ' HB3' ' CE1' ' A' ' 77' ' ' TYR . 3.5 pt20 -97.0 127.42 42.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.791 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -65.27 132.34 48.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -96.25 -170.92 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -60.7 -32.36 71.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.008 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -92.99 -36.54 12.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.0 -105.75 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.502 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.759 ' CE2' HG22 ' A' ' 72' ' ' ILE . 94.9 m-85 -129.78 111.4 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.375 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.76 68.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.468 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.61 140.42 55.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.797 0.332 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.9 m -101.31 137.5 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.471 HG12 HG22 ' A' ' 32' ' ' VAL . 20.3 m -134.14 138.43 50.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.07 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.2 t -148.76 132.62 17.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -179.86 117.55 0.56 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.427 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.23 -77.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 4.1 m-80 -79.33 -61.07 0.5 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.845 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.7 Cg_endo -76.42 -168.34 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.543 2.162 . . . . 0.0 112.326 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.559 HG12 HD12 ' A' ' 52' ' ' ILE . 14.7 t -145.53 110.88 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -138.27 154.09 49.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.174 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.471 HG22 HG12 ' A' ' 24' ' ' VAL . 15.5 t -95.92 139.14 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.06 -35.27 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.12 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 t -133.75 153.81 51.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.069 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 14.2 m -136.37 139.86 44.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.043 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' N ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -56.21 117.49 3.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.55 126.46 29.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.7 t0 55.34 30.37 14.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.37 -149.23 7.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 14' ' ' GLN . . . -60.97 -37.55 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.307 . . . . 0.0 111.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -71.13 -47.51 57.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.315 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.04 -44.6 96.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -31.36 72.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.917 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.49 -15.88 60.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.479 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.48 33.06 40.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 47' ' ' GLN . 21.7 t -71.14 158.99 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.036 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' HG12 ' A' ' 46' ' ' VAL . 2.2 mt-30 -123.06 119.61 30.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.748 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.81 131.15 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 30.99 56.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.515 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 p30 -94.38 152.36 18.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.6 mtp85 -97.03 134.07 40.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.57 ' CG1' HG12 ' A' ' 82' ' ' VAL . 5.9 mt -101.3 123.92 54.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 83' ' ' GLN . 2.3 mt -97.84 -38.65 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.64 ' HG2' HD12 ' A' ' 59' ' ' LEU . 23.4 mtmt -129.07 149.3 50.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.026 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.917 HG12 HD23 ' A' ' 80' ' ' LEU . 29.9 m -119.18 112.29 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.039 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 61.46 38.56 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.86 27.0 73.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.6 m -133.31 115.03 14.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.336 . . . . 0.0 110.956 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD12 ' HG2' ' A' ' 54' ' ' LYS . 1.3 tp -64.21 -175.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.03 142.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 t -152.39 152.44 32.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -84.85 165.95 17.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 p -98.03 36.87 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.978 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.423 ' O ' HG23 ' A' ' 68' ' ' VAL . 4.1 m120 -140.61 129.81 23.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.807 ' O ' HG23 ' A' ' 69' ' ' VAL . 20.3 t-80 -60.96 -39.23 88.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.822 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mt -56.27 -43.21 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -44.26 94.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.826 HG12 HD11 ' A' ' 72' ' ' ILE . 27.3 t -62.82 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.127 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.5 t -61.73 -45.23 99.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.192 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -62.66 -38.3 89.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.129 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -42.71 74.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.488 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 HG12 ' A' ' 68' ' ' VAL . 15.2 mt -68.96 -36.02 71.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.773 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -31.45 70.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.693 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.78 78.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.808 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.91 145.43 5.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -78.09 -44.87 25.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -106.93 112.74 25.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 p -120.91 136.66 57.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.082 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.12 106.43 10.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.073 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.917 HD23 HG12 ' A' ' 55' ' ' VAL . 2.8 mp -106.64 127.32 53.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.1 m -75.1 112.85 11.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.57 HG12 ' CG1' ' A' ' 52' ' ' ILE . 29.9 m -112.91 175.74 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.653 ' HB2' HD11 ' A' ' 53' ' ' ILE . 6.0 tt0 -142.67 141.49 31.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.978 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.46 101.07 1.26 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.513 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.14 82.13 30.61 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.436 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 2.9 Cg_endo -42.06 -57.46 1.54 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.973 2.449 . . . . 0.0 112.68 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 42.0 Cg_endo -67.68 158.6 56.46 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.238 1.959 . . . . 0.0 112.167 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.55 66.05 3.85 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.542 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.862 179.949 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -168.86 -44.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.819 0.342 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -154.03 105.96 2.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.7 ttt -122.06 2.66 9.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.402 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.38 24.84 7.28 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.611 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mp -146.63 75.05 1.38 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.769 0.319 . . . . 0.0 110.766 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.62 127.27 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.19 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -124.52 149.61 46.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.763 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.06 135.57 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -84.47 131.99 34.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 44' ' ' ALA . 4.4 m -135.1 115.83 19.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.96 119.17 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.038 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 80' ' ' LEU . 3.8 mt -89.53 135.35 26.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.082 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -113.15 121.4 44.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -72.34 145.07 48.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.24 -168.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.814 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.65 -30.52 65.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -87.51 -32.72 19.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.06 -175.71 25.26 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -62.43 103.61 0.42 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.847 0.356 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.48 -38.28 79.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.607 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 22' ' ' LEU . 3.2 pp -59.58 133.92 56.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -101.43 129.14 47.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.3 141.69 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.9 m -149.34 132.15 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.874 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 172.38 119.5 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -58.99 -74.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.708 0.29 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -79.96 -61.49 0.45 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.941 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 72.6 Cg_endo -76.28 -168.3 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.459 2.106 . . . . 0.0 112.246 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.857 HG12 HD12 ' A' ' 52' ' ' ILE . 6.3 t -150.46 100.03 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.033 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -123.37 144.03 49.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.22 123.61 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -86.37 -48.48 8.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.9 m -130.11 155.9 45.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 46' ' ' VAL . 22.3 m -136.39 137.53 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 113.42 3.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.76 134.89 47.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.807 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.1 t0 58.43 28.55 17.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.19 -162.1 10.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.425 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.0 -32.83 68.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.36 -47.46 56.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.218 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -34.73 63.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.45 -31.39 65.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.884 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -74.25 -15.82 60.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.401 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.06 26.91 11.59 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 35' ' ' VAL . 17.1 t -86.61 148.61 4.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.704 0.288 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -125.81 147.66 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 48' ' ' THR . 1.2 t -67.22 131.04 44.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.25 38.54 33.97 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.538 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.67 27.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.78 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.65 130.34 38.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.857 HD12 HG12 ' A' ' 30' ' ' VAL . 13.4 mt -94.21 121.87 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.991 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.694 HD11 ' HB2' ' A' ' 83' ' ' GLN . 31.0 mt -88.07 -48.32 15.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.244 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -136.72 161.98 34.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.138 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 80' ' ' LEU . 25.5 t -136.36 109.29 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 61.56 49.28 5.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.427 . . . . 0.0 110.774 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.59 26.52 59.93 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 60' ' ' VAL . 9.9 m -148.21 119.87 8.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.942 0.401 . . . . 0.0 110.823 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.86 -30.19 65.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 58' ' ' THR . 21.5 t 64.23 144.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.6 t -61.17 124.25 20.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.772 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -65.38 -177.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 t 62.34 159.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.002 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.68 97.0 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.138 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.772 ' O ' HG23 ' A' ' 69' ' ' VAL . 8.9 t-80 -66.07 -36.27 82.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.722 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.1 -42.73 73.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.617 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -61.72 -44.03 97.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.082 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.32 -46.62 95.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.087 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.1 t -60.86 -44.49 97.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.41 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -38.35 88.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.327 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -67.14 -47.59 70.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.489 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.53 HG13 HG11 ' A' ' 78' ' ' VAL . 16.4 tt -68.15 -35.95 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.684 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE2' HG12 ' A' ' 69' ' ' VAL . 6.0 mttm -71.64 -29.32 64.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 t -64.37 80.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.989 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.64 146.66 7.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.529 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.2 m -69.76 -54.14 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -96.15 129.86 43.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.856 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG11 HG13 ' A' ' 72' ' ' ILE . 10.3 p -147.12 118.48 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.19 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.34 142.79 35.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.73 HD23 HG21 ' A' ' 52' ' ' ILE . 2.1 mp -143.69 108.04 4.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -77.36 112.21 13.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.588 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 52' ' ' ILE . 30.5 m -112.58 165.82 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.463 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.694 ' HB2' HD11 ' A' ' 53' ' ' ILE . 47.5 tt0 -142.81 150.48 40.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.667 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.58 175.42 45.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' NH1' ' HB2' ' A' ' 85' ' ' ARG . 9.0 mtp-105 -136.74 112.57 9.81 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.507 0.194 . . . . 0.0 110.699 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.79 104.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.627 2.218 . . . . 0.0 112.582 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.72 -178.68 4.58 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.65 2.233 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 57.09 56.43 25.06 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.603 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.87 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -103.32 -179.99 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -154.26 -173.58 4.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.822 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -81.59 -31.71 32.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.947 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.22 -28.76 1.81 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.547 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 tp -103.11 97.5 7.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.4 m -116.31 124.43 72.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -120.34 145.07 47.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.9 ttm-85 -142.44 133.0 25.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.73 120.91 24.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 44' ' ' ALA . 12.4 p -114.41 119.46 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.067 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mt -106.92 105.61 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.591 ' HA ' ' HB2' ' A' ' 44' ' ' ALA . 3.5 mt -87.89 132.35 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -101.85 119.25 38.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -67.52 149.97 49.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -115.28 -172.78 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.82 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.86 -31.28 69.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.71 -49.04 7.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.88 176.0 14.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.422 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.493 ' CE1' HG22 ' A' ' 13' ' ' ILE . 16.2 m-85 -64.43 108.04 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.346 . . . . 0.0 110.936 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.87 -37.37 94.23 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.499 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -59.46 142.08 53.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.802 0.334 . . . . 0.0 110.913 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.56 140.62 49.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.78 148.48 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 4.7 t -149.39 132.04 15.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 166.56 122.33 0.6 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.482 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.3 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 110.951 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.66 -60.34 0.88 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.851 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.4 -169.48 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 112.286 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.562 HG12 HD12 ' A' ' 52' ' ' ILE . 4.2 t -150.57 115.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.998 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 4.7 p90 -136.06 144.61 45.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.986 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.18 120.83 28.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -89.31 -45.85 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -126.75 151.85 47.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.97 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.42 129.89 46.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -58.54 99.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -65.35 130.76 44.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 t0 58.46 36.75 25.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -141.67 -144.78 4.43 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.455 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . . . -60.97 -45.84 93.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.116 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.746 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -62.55 -47.39 84.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.121 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -29.85 70.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.79 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -72.24 -37.79 69.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -74.05 -15.78 61.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.389 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.31 27.45 33.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.585 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 41' ' ' ALA . 11.4 p -85.16 147.11 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.704 0.287 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -113.45 164.65 13.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -79.75 126.63 31.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.914 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 38.45 27.66 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 152.74 20.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.873 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.5 134.35 39.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.709 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.562 HD12 HG12 ' A' ' 30' ' ' VAL . 7.8 mt -107.01 114.42 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 83' ' ' GLN . 4.1 mp -78.7 -47.13 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.21 150.86 43.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG12 ' CB ' ' A' ' 80' ' ' LEU . 4.5 m -132.76 111.6 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 60.35 28.86 18.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.03 24.3 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.662 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.23 100.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.824 0.345 . . . . 0.0 110.819 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 59' ' ' LEU . 1.9 pp -114.19 33.04 5.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 61' ' ' THR . 11.1 p -117.88 157.76 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.014 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.475 ' N ' HG22 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -63.88 81.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.949 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.85 175.45 10.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 96.1 p -145.84 -173.79 4.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.9 OUTLIER 63.21 105.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.749 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -61.23 -38.23 85.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.767 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -63.13 -44.14 96.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.13 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 64' ' ' ASN . 4.4 t -62.74 -46.66 95.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.199 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.749 HG23 ' O ' ' A' ' 65' ' ' HIS . 31.8 t -62.09 -44.63 99.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.214 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -63.21 -38.43 91.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.222 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.57 -36.38 73.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.562 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 68' ' ' VAL . 55.2 mt -73.55 -41.86 55.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -74.24 -25.96 59.95 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.43 77.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.925 0.393 . . . . 0.0 110.888 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.93 153.46 8.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.545 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.3 m -78.44 -36.3 45.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.322 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -106.05 141.45 37.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.1 p -137.26 125.81 34.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.065 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.69 111.09 20.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.7 HD12 HG13 ' A' ' 82' ' ' VAL . 2.5 pp -137.09 124.72 22.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.4 m -74.51 124.49 26.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 80' ' ' LEU . 30.5 m -117.27 175.59 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.204 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.755 ' HB2' HD11 ' A' ' 53' ' ' ILE . 5.7 tt0 -137.64 138.81 39.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.83 133.09 5.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.391 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.94 141.14 11.79 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.542 0.211 . . . . 0.0 110.818 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.478 ' N ' ' HD2' ' A' ' 87' ' ' PRO . 45.5 Cg_exo -54.72 -49.11 17.89 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.35 2.033 . . . . 0.0 112.616 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 86' ' ' PRO . 73.5 Cg_endo -75.66 164.19 32.58 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.282 1.988 . . . . 0.0 112.298 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.7 -46.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.56 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.882 -179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 p -165.52 -65.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.709 0.29 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.28 -68.9 0.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.3 mmt 60.19 101.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.919 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.74 -77.63 0.19 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.487 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.01 52.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 0.0 110.834 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.68 118.93 31.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.175 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.51 126.37 52.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.787 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.89 148.75 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.964 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.59 159.57 26.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.878 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.901 HG21 HG22 ' A' ' 46' ' ' VAL . 10.4 p -146.18 108.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.075 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.08 111.89 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 22' ' ' LEU . 6.5 mt -89.24 144.44 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.08 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -109.37 128.41 55.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 12.7 ttmt -82.46 115.32 21.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -90.33 -168.22 2.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.775 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.51 -30.33 65.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.21 -46.81 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.33 -118.08 1.73 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.554 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 39.6 m-85 -124.29 113.73 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.783 0.325 . . . . 0.0 110.873 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.9 -27.61 60.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.487 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.774 HD23 HG12 ' A' ' 35' ' ' VAL . 4.7 mp -53.81 122.37 9.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.3 m -101.31 122.28 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.46 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 32' ' ' VAL . 35.7 m -124.1 149.06 28.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.373 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.4 m -149.33 132.08 15.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 168.86 111.69 0.25 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.587 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.3 -73.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 0.0 110.713 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.41 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -74.65 -60.68 1.26 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.626 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 73.8 Cg_endo -75.51 -168.13 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.55 2.166 . . . . 0.0 112.102 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 HD12 ' A' ' 52' ' ' ILE . 4.9 p -159.46 104.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -134.25 154.24 51.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.746 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.782 ' HA ' HG12 ' A' ' 24' ' ' VAL . 10.5 t -92.03 137.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.59 -52.2 2.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.8 t -122.48 149.43 43.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.017 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.774 HG12 HD23 ' A' ' 22' ' ' LEU . 27.2 m -136.41 153.39 31.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 94.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.842 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.13 139.3 58.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.927 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 58.29 30.98 20.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -140.15 -147.76 5.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.498 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.86 96.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 111.185 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -64.03 -47.43 80.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.044 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.9 tpt -66.34 -35.12 79.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -74.21 -31.49 62.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.53 -15.71 59.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.459 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.22 52.6 3.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.666 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.901 HG22 HG21 ' A' ' 11' ' ' VAL . 8.8 t -92.45 160.55 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 110.972 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 46' ' ' VAL . 14.2 mp0 -128.9 114.78 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.694 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.91 131.13 48.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.985 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.23 30.82 58.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.627 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -97.8 154.21 17.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 110.976 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -92.21 142.46 27.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.711 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 30' ' ' VAL . 36.3 mt -106.86 115.4 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.221 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.657 HD11 ' HG3' ' A' ' 83' ' ' GLN . 3.2 mp -80.27 -47.3 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.138 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 144.57 32.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 71' ' ' LEU . 6.9 m -121.93 111.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.131 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' OD1' HG23 ' A' ' 78' ' ' VAL . 0.8 OUTLIER 60.15 30.0 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.895 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.61 ' O ' HD23 ' A' ' 59' ' ' LEU . . . 101.06 -24.71 30.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.639 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.68 85.62 1.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 57' ' ' GLY . 0.4 OUTLIER -83.32 -23.4 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -53.88 148.59 2.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.403 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 61' ' ' THR . 3.8 t -126.93 101.19 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.53 38.63 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.02 -169.62 2.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -120.09 -173.13 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.845 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -60.08 -37.71 80.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -43.19 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.741 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -62.62 -44.1 97.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.343 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.2 t -64.05 -46.5 93.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.114 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 65' ' ' HIS . 22.0 t -60.92 -44.43 97.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.371 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -65.69 -38.35 88.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.099 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.493 HD13 ' CG2' ' A' ' 55' ' ' VAL . 3.8 mt -66.55 -47.29 73.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.529 ' CD1' HG11 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -68.61 -35.93 72.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.819 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -29.32 62.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.41 80.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.38 153.59 11.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.601 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -67.8 -42.21 81.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -105.64 150.27 25.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.947 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 72' ' ' ILE . 11.4 p -145.88 122.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.5 109.49 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.929 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -125.03 139.95 53.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.3 m -90.34 124.21 34.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.705 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.634 HG12 HG12 ' A' ' 52' ' ' ILE . 30.0 m -118.92 172.52 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.657 ' HG3' HD11 ' A' ' 53' ' ' ILE . 21.5 mt-30 -142.83 136.37 28.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.76 32.85 6.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.549 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -96.76 109.06 46.75 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.539 0.209 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.63 118.96 5.79 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.43 2.087 . . . . 0.0 112.278 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.95 -50.73 13.03 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.457 2.105 . . . . 0.0 112.312 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.88 -69.9 3.15 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.444 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.92 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.7 m -117.67 31.55 6.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -125.9 121.22 32.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.86 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.2 95.96 10.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.47 25.64 11.99 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.604 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.705 HD12 ' HD3' ' A' ' 85' ' ' ARG . 74.1 mt 65.18 -73.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.791 0.329 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.01 112.67 41.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -122.69 133.39 54.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.778 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 136.56 21.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.158 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.42 142.91 41.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.3 m -142.85 134.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.277 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.576 HG12 ' HB2' ' A' ' 79' ' ' ALA . 21.1 mt -96.1 117.34 40.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.037 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.885 HD13 HD21 ' A' ' 22' ' ' LEU . 20.8 mt -86.32 127.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.23 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -101.9 130.31 48.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.74 150.06 44.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -122.32 -168.13 1.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.734 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -30.03 65.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -100.58 -35.72 9.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.83 -137.27 9.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.519 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -95.42 97.31 9.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.44 -27.86 63.97 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.885 HD21 HD13 ' A' ' 13' ' ' ILE . 3.6 pp -63.93 133.69 53.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.885 0.374 . . . . 0.0 110.964 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -103.33 137.54 41.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 32' ' ' VAL . 27.0 m -132.5 142.92 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.095 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.5 t -149.52 132.13 15.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.56 112.93 0.47 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.505 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.83 -54.78 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 6.4 m-20 -98.46 -63.9 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 91.1 Cg_endo -79.99 -166.42 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.437 2.092 . . . . 0.0 112.278 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.931 HG12 HD12 ' A' ' 52' ' ' ILE . 18.4 t -143.55 110.55 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.059 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.06 155.03 48.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.022 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.787 ' HA ' HG12 ' A' ' 24' ' ' VAL . 23.2 t -92.56 120.31 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.057 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.41 -31.07 17.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.48 148.46 39.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.821 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.581 HG11 ' CG1' ' A' ' 46' ' ' VAL . 18.0 m -136.49 148.51 27.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.023 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -61.16 105.21 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.36 135.3 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.3 t0 62.05 25.37 15.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.142 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.09 -150.08 6.29 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.42 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.3 95.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.803 0.335 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -61.5 -46.81 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.093 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -45.02 84.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 ttp85 -62.03 -33.39 74.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.968 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.35 -15.88 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.483 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.9 31.75 19.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.546 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.581 ' CG1' HG11 ' A' ' 35' ' ' VAL . 21.3 t -82.38 157.21 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' N ' HG12 ' A' ' 46' ' ' VAL . 7.3 mt-30 -122.8 145.53 48.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.23 123.73 25.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.831 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 34.31 22.39 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.24 147.53 23.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.749 0.309 . . . . 0.0 110.788 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -90.94 140.47 29.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.931 HD12 HG12 ' A' ' 30' ' ' VAL . 29.8 mt -104.93 130.11 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 24.6 mm -102.94 -49.11 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.066 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -125.03 142.08 51.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.898 HG12 HD23 ' A' ' 80' ' ' LEU . 27.5 m -114.68 107.33 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.181 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.401 ' CG ' HG13 ' A' ' 78' ' ' VAL . 3.7 t-20 59.94 43.84 14.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.52 27.96 71.81 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.502 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 m -136.24 114.11 11.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.751 0.31 . . . . 0.0 110.96 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.83 79.78 3.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.828 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.65 140.07 42.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.111 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 t -109.56 -24.99 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.02 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' A' ' 71' ' ' LEU . 31.0 m-70 61.8 178.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.775 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 71.0 m -100.68 -75.34 0.58 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -74.14 146.35 43.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.062 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.787 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.8 t-160 -63.65 -36.37 83.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.857 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.8 mt -55.08 -43.09 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.731 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.91 -44.11 97.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.123 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 62' ' ' HIS . 23.3 t -63.77 -46.75 93.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.128 0.489 . . . . 0.0 110.102 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 65' ' ' HIS . 32.1 t -60.07 -44.5 95.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.25 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -65.85 -38.47 88.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.185 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.633 HD13 ' CE1' ' A' ' 62' ' ' HIS . 1.0 OUTLIER -65.2 -47.7 75.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.602 ' O ' HG21 ' A' ' 78' ' ' VAL . 32.5 mt -68.04 -42.38 85.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.617 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -74.64 -14.9 60.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.5 p -48.22 -28.22 2.9 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.678 0.275 . . . . 0.0 111.402 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.99 150.02 20.45 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.621 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 p -64.23 -51.24 64.64 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.835 0.35 . . . . 0.0 110.78 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.7 112.62 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.618 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.602 HG21 ' O ' ' A' ' 72' ' ' ILE . 21.7 t -131.26 129.49 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.354 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.576 ' HB2' HG12 ' A' ' 12' ' ' ILE . . . -110.91 103.46 11.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.898 HD23 HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -110.05 128.76 55.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.07 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 m -79.74 121.84 25.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.604 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.438 HG12 HG12 ' A' ' 52' ' ' ILE . 15.9 m -112.6 172.12 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -141.93 137.84 31.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -107.13 104.19 2.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.513 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.705 ' HD3' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.66 91.72 4.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.907 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 51.8 Cg_exo -53.09 -45.02 44.09 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.434 2.089 . . . . 0.0 112.564 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 86' ' ' PRO . 23.8 Cg_exo -63.82 -160.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.405 2.07 . . . . 0.0 112.182 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -120.53 47.04 1.06 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.382 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.7 p . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.997 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.32 33.68 20.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 110.945 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -121.92 -43.1 2.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.0 mtp -90.93 -61.79 1.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.23 65.25 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.432 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 tp -137.44 47.13 2.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.25 115.33 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.168 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.8 129.64 52.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -120.93 137.66 54.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 t -82.7 123.94 29.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 44' ' ' ALA . 17.4 m -112.0 126.9 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.057 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.3 mt -98.13 104.3 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.758 HG21 HD21 ' A' ' 22' ' ' LEU . 18.5 mt -86.89 116.09 28.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.069 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.41 135.9 33.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 146.41 54.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -112.48 -174.19 2.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.82 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -60.05 -30.66 69.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -93.78 -42.55 9.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.2 72.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 63.21 144.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.746 0.308 . . . . 0.0 110.93 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.81 -27.15 3.61 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.557 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -59.3 138.41 57.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.2 m -102.9 126.4 50.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 31' ' ' PHE . 12.3 p -125.43 137.24 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.7 p -149.45 132.16 15.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.52 126.97 1.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.525 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.82 -77.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 0.0 110.662 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.449 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -88.21 -52.3 0.39 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.582 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 6.9 Cg_exo -73.21 -166.75 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.826 2.35 . . . . 0.0 111.846 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.838 HG12 HD12 ' A' ' 52' ' ' ILE . 21.8 t -154.29 95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 24' ' ' VAL . 7.6 p90 -119.95 146.8 45.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.409 ' CG2' HD11 ' A' ' 52' ' ' ILE . 21.2 t -90.47 120.67 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.095 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.421 ' O ' HG22 ' A' ' 48' ' ' THR . 3.0 tt0 -79.37 -55.15 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -126.6 157.91 37.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.657 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 18.2 m -136.33 139.86 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 tptp -59.74 109.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.81 131.73 44.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 t70 59.92 31.45 20.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -134.27 -150.67 6.23 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.517 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.95 87.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.816 0.341 . . . . 0.0 111.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -67.29 -47.26 71.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.151 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.9 tpt -64.32 -49.07 73.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -31.58 70.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.514 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -72.24 -15.77 61.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.45 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.6 28.36 39.42 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.492 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.491 HG22 HG21 ' A' ' 11' ' ' VAL . 20.5 t -79.1 158.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' HG12 ' A' ' 46' ' ' VAL . 10.8 mp0 -125.31 141.99 51.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.04 128.1 34.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.894 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.61 48.4 56.64 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.559 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.2 p30 -100.92 174.67 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.58 133.31 54.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.742 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.838 HD12 HG12 ' A' ' 30' ' ' VAL . 31.1 mt -105.68 114.71 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.485 ' O ' HG22 ' A' ' 60' ' ' VAL . 3.7 mp -95.16 -30.09 4.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -135.82 143.1 44.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.988 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 59' ' ' LEU . 16.6 m -126.71 107.18 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.783 ' CG ' HG23 ' A' ' 78' ' ' VAL . 15.2 t30 60.4 32.54 20.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.85 26.25 71.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.578 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.3 m -123.04 23.6 9.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.767 0.318 . . . . 0.0 111.145 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.645 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER 54.84 173.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.108 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.528 HG12 HG13 ' A' ' 55' ' ' VAL . 23.6 m -117.76 64.09 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.072 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.36 31.12 3.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -108.6 -178.08 3.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.6 p -147.15 -50.34 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' HG23 ' A' ' 68' ' ' VAL . 2.4 m120 -60.52 126.03 25.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.759 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 t-80 -60.06 -41.3 92.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.772 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.32 -43.07 74.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.95 -43.86 97.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.136 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.777 HG12 HD11 ' A' ' 72' ' ' ILE . 25.3 t -62.61 -46.57 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.988 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.9 t -61.45 -46.88 95.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.339 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -62.24 -38.3 88.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.194 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 71' ' ' LEU . 6.2 tt -68.32 -41.83 80.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.437 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.777 HD11 HG12 ' A' ' 68' ' ' VAL . 15.7 mt -70.63 -35.99 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.803 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -27.52 62.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.32 80.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.19 147.21 7.14 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.403 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.0 m -59.53 -61.39 2.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.81 128.47 56.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.853 HG13 HD11 ' A' ' 80' ' ' LEU . 10.4 p -113.09 140.23 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.29 101.77 11.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.013 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.853 HD11 HG13 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -113.78 126.89 55.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.909 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.6 m -71.49 112.8 7.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.771 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 83' ' ' GLN . 11.9 p -113.48 159.14 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 82' ' ' VAL . 48.4 tt0 -132.48 144.46 50.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -129.13 120.19 3.17 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.502 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -140.8 139.14 19.2 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.611 0.244 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.55 109.99 3.01 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.468 2.112 . . . . 0.0 112.292 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.77 154.14 73.94 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.466 2.11 . . . . 0.0 112.296 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -96.42 29.15 10.71 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.573 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.019 179.939 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m -121.91 171.31 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -35.82 32.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.8 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.6 tpt -63.11 83.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.63 -50.76 0.21 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mp -144.88 113.59 6.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.36 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.39 123.87 71.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.135 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.63 133.34 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.4 ttp85 -144.82 130.89 19.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.3 m -80.57 144.36 32.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.17 137.46 46.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.074 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.6 mp -116.59 117.23 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.73 143.36 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.576 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 31.5 mt-30 -112.92 128.71 56.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -65.45 143.84 57.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.02 -170.42 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -59.69 -29.21 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.999 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.06 -50.17 6.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.29 -128.07 2.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.503 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 62.0 m-85 -117.34 114.13 23.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 0.0 110.895 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.44 -29.96 65.24 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.418 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 41' ' ' ALA . 1.9 mp -55.52 113.45 1.44 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.82 0.343 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.2 m -101.2 122.35 43.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.679 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 31' ' ' PHE . 9.2 p -130.14 141.5 46.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.188 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 m -149.34 135.67 19.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 177.43 138.89 3.14 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.546 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.71 -79.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.708 0.29 . . . . 0.0 110.819 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -78.2 -61.26 0.59 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' O ' HG13 ' A' ' 30' ' ' VAL . 72.4 Cg_endo -76.4 -167.43 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.545 2.163 . . . . 0.0 112.126 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.754 HG23 ' HB ' ' A' ' 52' ' ' ILE . 3.0 m -157.53 104.2 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.214 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.762 ' O ' HG23 ' A' ' 24' ' ' VAL . 18.0 p90 -123.05 136.71 54.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.677 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 22' ' ' LEU . 26.3 t -81.98 120.23 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -87.27 -29.29 21.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.075 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -134.04 148.32 51.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.242 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.433 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 31.6 m -136.67 153.48 30.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 7.9 tttp -68.73 116.56 9.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.9 134.9 35.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 t70 55.76 32.97 20.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.975 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -137.17 -144.63 4.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.576 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -61.04 -44.68 97.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.776 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -64.4 -47.28 79.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -38.66 91.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -71.22 -30.75 66.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . -75.18 -15.82 60.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.415 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.12 38.85 12.28 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.582 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 41' ' ' ALA . 11.5 p -96.32 153.99 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 110.95 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -120.19 141.44 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -60.97 132.39 53.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.21 31.34 47.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.188 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -86.53 146.92 26.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -92.15 132.5 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.787 ' HA ' HG12 ' A' ' 82' ' ' VAL . 4.0 mt -97.08 123.86 49.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.105 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 81' ' ' THR . 4.3 mt -91.94 -42.84 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.026 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.401 ' HG3' HG22 ' A' ' 53' ' ' ILE . 25.1 mttp -148.42 142.99 26.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.83 118.87 58.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.188 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 60.78 32.62 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.16 26.87 69.71 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.651 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.5 t -143.52 104.39 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 53' ' ' ILE . 32.1 tp -109.9 152.18 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.26 172.28 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.52 -44.95 48.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -117.65 124.97 49.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.858 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.7 p -142.13 -58.35 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.018 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.78 ' O ' HG23 ' A' ' 68' ' ' VAL . 1.5 t30 73.86 -178.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.937 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -66.0 -42.54 89.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.412 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 69' ' ' VAL . 1.7 pp -55.38 -43.61 75.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.101 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.45 ' N ' HD12 ' A' ' 66' ' ' LEU . 3.0 tp10 -65.5 -39.34 91.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.016 0.436 . . . . 0.0 110.279 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 64' ' ' ASN . 30.2 t -65.62 -46.84 88.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.601 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.515 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.1 p -65.39 -41.42 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.197 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 66' ' ' LEU . 2.5 mptp? -66.06 -40.46 90.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.261 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' HG3' ' A' ' 67' ' ' GLU . 2.3 mm? -67.66 -47.48 69.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.563 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 68' ' ' VAL . 7.2 tt -68.48 -35.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.869 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -73.24 -28.81 62.36 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 55.7 p -68.83 72.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.819 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.14 144.01 7.71 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.427 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.0 p -70.15 -30.92 68.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.813 0.339 . . . . 0.0 110.94 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -95.98 117.39 30.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -126.89 133.24 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.82 113.1 10.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.059 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.746 HD12 HG13 ' A' ' 82' ' ' VAL . 3.3 pp -126.32 133.59 51.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.433 HG22 HD12 ' A' ' 53' ' ' ILE . 60.8 m -76.02 126.08 30.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' A' ' 52' ' ' ILE . 14.7 m -127.1 175.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.137 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -134.17 132.54 39.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.43 105.44 0.56 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -176.3 96.58 0.25 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.572 0.225 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.92 171.49 11.07 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.419 2.079 . . . . 0.0 112.135 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.5 172.84 7.3 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.549 2.166 . . . . 0.0 112.208 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -100.1 19.66 52.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.647 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.012 179.891 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m -129.0 -64.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -89.43 167.62 12.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.5 ttm 61.65 152.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.64 68.52 0.85 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.549 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.19 35.83 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.346 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t -108.3 112.24 39.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.107 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -97.53 138.26 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.791 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -141.41 139.38 33.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.996 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 89.1 m -106.62 142.6 36.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.861 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.668 ' CG1' HG22 ' A' ' 46' ' ' VAL . 15.8 m -128.17 137.05 58.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.153 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.529 ' H ' ' HB1' ' A' ' 44' ' ' ALA . 32.3 mt -128.08 92.99 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.995 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 22' ' ' LEU . 4.0 mt -86.33 142.76 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.114 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.626 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 21.1 mt-30 -112.99 137.46 51.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.752 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.89 135.44 45.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -103.7 -163.15 0.96 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.603 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.47 56.1 2.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.795 0.331 . . . . 0.0 110.936 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 174.8 -39.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.59 -169.28 24.41 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.444 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.47 ' CE2' HG22 ' A' ' 72' ' ' ILE . 63.2 m-85 -79.04 130.5 35.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.816 0.341 . . . . 0.0 110.937 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.9 -33.77 23.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.54 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' CD2' HG21 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -58.6 148.63 28.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -112.19 122.94 49.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 11.2 p -118.58 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.7 132.1 15.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.64 99.67 0.16 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.677 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.88 -69.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.409 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.421 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.3 t-20 -82.71 -55.12 0.55 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.182 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 79.6 Cg_endo -86.87 -164.66 0.22 Allowed 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.818 2.345 . . . . 0.0 111.909 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.058 HG22 HD12 ' A' ' 52' ' ' ILE . 5.6 p -147.92 97.99 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 110.94 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -133.75 149.26 51.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.866 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -86.9 120.2 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.012 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.35 -67.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.081 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.429 ' HA ' HG23 ' A' ' 48' ' ' THR . 30.7 m -134.71 171.4 14.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.099 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.616 HG11 ' CG1' ' A' ' 46' ' ' VAL . 5.9 m -135.91 153.47 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.707 ' HG2' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.34 123.25 22.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 0.7 OUTLIER -75.3 146.62 40.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.3 t0 55.08 24.05 5.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.81 -161.17 11.06 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.503 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.626 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -60.99 -40.26 92.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.319 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.707 ' HB3' ' HG2' ' A' ' 36' ' ' LYS . . . -68.0 -47.71 67.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.093 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.432 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -63.4 -39.28 94.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 0.0 110.712 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -69.88 -31.88 69.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' HB1' ' H ' ' A' ' 12' ' ' ILE . . . -71.01 -15.77 62.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.453 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.12 29.07 26.45 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.537 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.668 HG22 ' CG1' ' A' ' 11' ' ' VAL . 11.9 t -78.05 149.9 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 0.0 110.971 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -110.03 163.01 13.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -82.82 123.77 29.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.22 44.64 65.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.536 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.1 p-10 -93.71 146.51 23.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.738 0.304 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.6 mtp85 -84.48 138.45 32.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.6 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.058 HD12 HG22 ' A' ' 30' ' ' VAL . 29.5 mt -100.93 114.44 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.171 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 83' ' ' GLN . 7.2 mt -78.71 -42.01 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.028 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 pttm -156.32 142.07 17.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.784 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 80' ' ' LEU . 21.4 t -108.43 125.56 65.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.199 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 59.81 37.01 22.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.21 27.93 63.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.585 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.8 t -145.37 103.44 3.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.7 mp -63.8 163.8 11.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.004 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -136.21 109.04 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.073 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 t -98.4 138.49 35.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.3 t60 60.16 39.49 19.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.861 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 73.3 m -111.79 174.71 5.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 68' ' ' VAL . 57.9 m-20 -125.26 -179.82 4.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.767 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.4 t-160 -61.58 -37.39 83.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.965 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.35 -43.13 74.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.562 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.1 -43.97 97.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.174 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.758 HG12 HD11 ' A' ' 72' ' ' ILE . 6.3 t -62.15 -46.69 95.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.047 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.0 t -62.18 -46.2 97.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.322 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -38.43 90.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -43.42 75.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.456 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.758 HD11 HG12 ' A' ' 68' ' ' VAL . 20.3 mt -69.71 -36.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.844 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HD3' HG12 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -73.75 -31.53 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.922 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -67.88 80.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.58 173.37 13.42 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 m -98.51 -42.73 7.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.832 0.349 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -99.86 120.54 39.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 72' ' ' ILE . 12.0 p -116.36 120.46 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.147 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.96 104.91 10.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.737 HD12 HG13 ' A' ' 82' ' ' VAL . 2.9 pp -120.65 132.87 55.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.811 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.458 HG22 HD12 ' A' ' 53' ' ' ILE . 63.6 m -79.97 122.86 27.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.019 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.737 HG13 HD12 ' A' ' 80' ' ' LEU . 26.8 m -116.11 169.09 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.03 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.619 ' HB2' HD11 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -134.83 142.78 46.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.76 159.71 27.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 29.9 ptt85 -158.57 149.94 16.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.704 0.287 . . . . 0.0 110.868 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.97 175.18 9.46 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.593 2.195 . . . . 0.0 112.322 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.18 -170.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.518 2.145 . . . . 0.0 112.227 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.43 -36.25 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.46 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.97 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -132.93 -175.84 3.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -74.63 -12.55 60.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.263 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.37 105.39 0.13 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 110.996 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.5 61.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 tt -104.45 -46.56 4.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.771 0.319 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.2 p -119.39 116.9 52.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -131.98 133.8 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.72 130.18 31.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.888 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -88.99 118.07 28.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 11' ' ' VAL . 24.5 m -128.27 108.28 17.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.58 130.63 35.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.158 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 46' ' ' VAL . 23.6 mm -108.36 137.36 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.062 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HG2' ' CE2' ' A' ' 77' ' ' TYR . 13.9 mt-30 -110.31 134.42 52.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -67.82 123.82 21.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.814 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -86.93 -169.93 2.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -59.46 -31.18 69.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.52 1.72 17.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.348 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.33 -160.27 14.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.545 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.434 ' CE2' HG22 ' A' ' 72' ' ' ILE . 14.0 m-85 -80.06 114.62 19.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.719 0.295 . . . . 0.0 110.855 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.98 -29.77 75.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.604 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.18 137.54 58.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.38 136.78 40.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 31' ' ' PHE . 12.3 p -133.36 134.05 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.075 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t -149.4 137.0 20.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 178.41 130.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.523 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.6 -71.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.417 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 3.9 m-20 -82.6 -61.86 0.32 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.786 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 80.1 Cg_endo -77.64 -167.99 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.542 2.161 . . . . 0.0 112.151 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.813 HG22 HD12 ' A' ' 52' ' ' ILE . 8.2 p -152.96 104.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.743 ' O ' HG23 ' A' ' 24' ' ' VAL . 47.0 p90 -130.89 155.64 46.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.814 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -92.17 120.87 42.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.104 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.7 -31.43 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -135.28 147.8 49.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.915 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.608 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 15.8 m -129.89 145.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 105.77 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.48 133.12 44.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t0 60.22 30.94 20.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -136.77 -147.8 5.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.48 93.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 111.137 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.608 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -64.76 -47.37 78.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.4 tpt -63.1 -41.59 99.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -36.99 86.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.07 -15.83 62.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.408 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 36.51 25.01 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.593 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 13' ' ' ILE . 18.5 t -88.08 149.05 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 0.0 111.072 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -112.11 153.3 27.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -69.04 130.6 43.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.021 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.57 31.94 43.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.405 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' HG11 ' A' ' 82' ' ' VAL . 3.4 p30 -84.24 138.55 32.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.738 0.304 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.72 141.4 28.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.655 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.813 HD12 HG22 ' A' ' 30' ' ' VAL . 17.0 mt -102.77 137.77 29.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.8 mm -113.32 -38.79 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -137.63 157.77 45.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 55' ' ' VAL . 18.5 m -139.48 104.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.075 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.89 43.57 17.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.68 26.79 66.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.504 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 55' ' ' VAL . 16.0 m -124.74 94.46 4.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.83 104.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 58' ' ' THR . 21.5 t -93.59 135.25 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.0 t -130.66 -48.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.872 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.77 97.05 3.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.835 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.3 m -145.25 -178.53 6.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.07 173.69 6.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.818 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -62.36 -40.92 97.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -38.68 88.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.222 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.22 -44.34 79.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.717 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 72' ' ' ILE . 7.5 p -68.29 -41.63 83.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 65' ' ' HIS . 95.1 t -65.13 -43.77 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.929 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -65.99 -41.18 91.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.2 mt -65.34 -50.41 65.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.763 ' CD1' HG22 ' A' ' 68' ' ' VAL . 26.5 mt -65.51 -35.89 76.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.573 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.55 -25.68 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -63.92 80.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.11 144.13 10.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.438 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.99 -42.96 89.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.939 0.399 . . . . 0.0 111.022 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.42 ' CE2' ' HG2' ' A' ' 14' ' ' GLN . 5.0 m-85 -102.54 113.73 27.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -137.12 127.77 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.209 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.81 148.55 22.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.427 HD21 HG12 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -143.65 116.32 8.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.081 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 m -79.47 115.22 18.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.649 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 ' OD1' ' A' ' 50' ' ' ASP . 17.8 m -115.18 170.53 5.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -131.9 140.95 49.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.66 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.442 ' O ' HG11 ' A' ' 7' ' ' VAL . . . -114.39 76.1 0.25 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.568 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.39 94.1 25.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.625 0.25 . . . . 0.0 110.809 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.13 171.24 12.91 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.476 2.117 . . . . 0.0 112.245 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.69 -168.28 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.571 2.181 . . . . 0.0 112.316 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -96.5 37.24 3.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.893 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p -157.95 38.21 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.816 0.341 . . . . 0.0 110.933 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 60.75 33.89 20.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.97 122.16 22.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.0 -80.26 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 mp 58.68 27.54 16.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.832 0.348 . . . . 0.0 110.991 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.478 HG21 ' HG3' ' A' ' 85' ' ' ARG . 5.0 m -123.67 112.14 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.156 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -112.16 151.87 29.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.968 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -148.52 146.49 28.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.3 m -90.19 132.86 35.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 11' ' ' VAL . 29.6 m -130.43 100.35 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.552 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.9 mp -84.93 108.81 17.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.24 124.05 48.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.082 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HG2' ' CD1' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -101.46 134.35 44.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.795 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -65.35 131.48 46.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.939 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -95.09 -170.83 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -30.71 69.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -103.07 -34.36 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.38 -160.36 24.71 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.53 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.437 ' CE2' HG22 ' A' ' 72' ' ' ILE . 59.4 m-85 -81.53 121.72 26.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.973 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.61 -30.94 42.42 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.545 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 pp -60.04 134.97 57.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -104.57 137.0 43.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 32' ' ' VAL . 6.7 m -129.4 136.53 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.8 t -149.42 132.12 15.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.012 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.92 117.41 0.61 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.483 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -61.05 -74.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.679 0.276 . . . . 0.0 110.816 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 1.7 m120 -81.75 -61.48 0.37 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.96 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 28' ' ' ASN . 71.7 Cg_endo -77.06 -168.05 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.52 2.146 . . . . 0.0 112.317 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.607 HG12 HG13 ' A' ' 52' ' ' ILE . 25.5 t -144.08 111.99 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 2.7 p90 -139.6 152.97 47.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.999 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.716 ' HA ' HG12 ' A' ' 24' ' ' VAL . 11.2 t -92.75 120.99 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.036 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -73.09 -67.28 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.065 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.98 163.03 17.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.652 ' HB ' ' HB1' ' A' ' 41' ' ' ALA . 23.3 m -136.32 140.04 44.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -59.28 120.41 9.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.73 131.08 39.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 58.3 30.82 20.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.45 -152.35 7.39 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.538 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.81 87.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.187 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -68.64 -47.37 66.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.1 tpt -63.67 -48.76 75.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -34.41 72.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.982 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.553 ' O ' HG12 ' A' ' 11' ' ' VAL . . . -71.68 -15.95 62.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.432 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.99 40.73 13.56 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.456 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.446 ' CG1' HG11 ' A' ' 35' ' ' VAL . 19.2 t -90.36 140.16 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 111.117 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.81 148.04 26.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.25 119.8 13.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.875 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 44.98 12.65 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.529 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 32' ' ' VAL . 57.0 p30 -93.38 161.99 14.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.788 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -98.72 137.88 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.921 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.023 HD13 HG12 ' A' ' 82' ' ' VAL . 25.4 mm -96.21 138.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.019 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 83' ' ' GLN . 5.8 mt -113.61 -48.93 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.059 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 19.3 ttmt -136.07 141.96 44.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.631 HG23 HD11 ' A' ' 80' ' ' LEU . 9.7 p -125.71 112.36 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.643 ' OD1' HG23 ' A' ' 78' ' ' VAL . 54.6 m-20 59.25 38.19 23.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.013 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 24.31 71.47 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.783 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.4 p -131.77 88.14 2.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.877 0.37 . . . . 0.0 111.26 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 60' ' ' VAL . 2.5 pp -47.48 169.45 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.295 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.739 ' O ' HD12 ' A' ' 59' ' ' LEU . 21.5 t -60.1 132.05 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.8 p -140.14 -68.3 0.42 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.946 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.47 88.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.3 m -151.68 146.56 25.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.866 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.723 ' O ' HG23 ' A' ' 68' ' ' VAL . 54.2 m-20 -96.36 -174.44 3.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.916 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.34 -45.17 84.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.9 mm? -55.46 -43.3 75.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.652 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.753 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.9 mp0 -65.37 -39.14 91.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.304 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 64' ' ' ASN . 22.8 t -66.26 -46.79 86.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.599 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 66' ' ' LEU . 7.2 p -65.98 -41.22 89.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.194 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.82 -38.32 88.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.917 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 67' ' ' GLU . 3.6 mm? -68.56 -43.22 77.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.305 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.737 HG23 HG11 ' A' ' 78' ' ' VAL . 19.4 mt -71.32 -41.67 74.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -74.43 -18.87 60.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.103 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.86 -28.62 6.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.307 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.48 161.64 29.03 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.1 p -68.56 -48.2 64.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 14' ' ' GLN . 57.4 m-85 -95.8 114.75 26.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.715 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 72' ' ' ILE . 12.8 p -128.52 139.47 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.01 114.31 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.883 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.642 ' CD1' HG22 ' A' ' 78' ' ' VAL . 7.8 mp -119.27 119.74 34.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.169 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 m -77.78 113.62 15.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.023 HG12 HD13 ' A' ' 52' ' ' ILE . 34.1 m -112.39 172.95 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.586 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.792 ' HB2' HD11 ' A' ' 53' ' ' ILE . 23.0 tt0 -135.49 137.09 41.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.765 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.91 134.27 1.61 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.458 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.478 ' HG3' HG21 ' A' ' 7' ' ' VAL . 4.0 ttp180 -92.05 136.6 25.8 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.507 0.194 . . . . 0.0 110.846 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 142.18 55.99 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.398 2.065 . . . . 0.0 112.197 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -74.1 -175.91 2.4 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.432 2.088 . . . . 0.0 112.296 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -77.6 -28.17 57.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.433 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.866 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.417 ' C ' HG12 ' A' ' 7' ' ' VAL . 32.5 m -129.76 33.91 4.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.795 0.331 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.74 83.0 1.03 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -162.58 -47.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.98 -54.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -114.52 109.68 18.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.759 0.314 . . . . 0.0 110.984 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG12 ' C ' ' A' ' 2' ' ' SER . 31.1 m -107.52 134.18 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.118 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -128.61 138.96 52.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -135.51 149.8 49.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.6 p -99.37 104.9 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.91 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 11' ' ' VAL . 12.9 p -85.52 115.49 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.2 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.7 mm -88.11 99.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.106 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.702 HG22 ' CD1' ' A' ' 20' ' ' PHE . 28.8 mt -86.42 112.65 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.094 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER -102.16 131.52 48.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.96 119.61 19.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -98.43 -168.96 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -30.71 66.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.852 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 -38.39 13.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.814 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.61 178.43 20.17 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.513 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.702 ' CD1' HG22 ' A' ' 13' ' ' ILE . 25.1 m-85 -60.05 112.78 2.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.38 -41.5 8.41 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.535 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.636 ' C ' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -50.74 146.84 5.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.026 0.441 . . . . 0.0 111.19 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.07 148.78 41.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.804 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.629 HG12 HG22 ' A' ' 32' ' ' VAL . 30.9 m -135.34 140.07 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.4 t -149.51 132.09 15.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.27 109.95 0.35 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -57.61 -68.15 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 2.0 t30 -89.51 -51.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 2.2 Cg_endo -84.61 -161.37 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.98 2.453 . . . . 0.0 112.19 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.029 HG12 HD12 ' A' ' 52' ' ' ILE . 10.1 t -150.4 97.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -133.8 149.73 51.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.147 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.629 HG22 HG12 ' A' ' 24' ' ' VAL . 25.7 t -83.65 128.36 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -92.64 -49.49 6.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.145 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.68 158.02 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HB ' HG11 ' A' ' 46' ' ' VAL . 17.6 m -136.49 153.11 30.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.064 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -81.79 111.69 18.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.2 138.01 39.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.7 t0 58.58 30.62 20.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -133.6 -158.99 8.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.554 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.79 72.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.804 0.335 . . . . 0.0 111.076 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.611 ' HB1' HG11 ' A' ' 46' ' ' VAL . . . -71.31 -47.36 57.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.214 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tpt -67.42 -42.24 83.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.955 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -32.72 74.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.75 58.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.461 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.99 52.95 3.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.479 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.611 HG11 ' HB1' ' A' ' 41' ' ' ALA . 14.9 p -88.59 158.95 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 0.0 111.073 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -128.13 115.86 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.867 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.32 130.83 36.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.71 32.67 45.1 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.434 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -94.68 147.71 23.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.926 0.393 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -87.56 142.61 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.707 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.029 HD12 HG12 ' A' ' 30' ' ' VAL . 39.1 mt -98.51 115.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.763 HD12 HG22 ' A' ' 81' ' ' THR . 20.0 mt -78.72 -47.09 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.001 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.64 ' HB3' HD23 ' A' ' 59' ' ' LEU . 5.1 pttt -156.86 161.91 39.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.002 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.937 HG23 ' CD2' ' A' ' 80' ' ' LEU . 9.4 p -121.13 114.79 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.181 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 56.6 55.56 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.91 27.5 62.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.546 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 m -129.78 118.03 21.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.842 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.64 HD23 ' HB3' ' A' ' 54' ' ' LYS . 4.7 mt -85.2 57.17 4.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.47 HG12 HG12 ' A' ' 55' ' ' VAL . 12.1 p -87.39 141.0 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.07 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 m -112.17 -66.49 1.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.981 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 57.9 -171.56 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.62 47.15 1.03 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 68' ' ' VAL . 24.2 m-20 -147.86 115.89 6.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.814 ' O ' HG23 ' A' ' 69' ' ' VAL . 12.0 t-80 -60.4 -40.28 90.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 66' ' ' LEU . 6.5 mp -55.32 -43.19 74.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.29 -43.97 96.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.192 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.822 HG12 HD11 ' A' ' 72' ' ' ILE . 6.4 t -63.32 -46.56 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.053 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.814 HG23 ' O ' ' A' ' 65' ' ' HIS . 23.4 t -62.55 -45.08 99.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.513 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -38.42 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.496 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.492 HD23 HG11 ' A' ' 55' ' ' VAL . 5.9 tp -68.17 -45.48 73.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.707 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.822 HD11 HG12 ' A' ' 68' ' ' VAL . 18.1 mt -70.14 -36.09 66.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.802 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -74.37 -28.88 61.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.9 p -64.29 80.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.932 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.68 143.94 5.41 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.578 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 m -71.68 -55.7 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 m-85 -96.06 116.17 28.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.2 p -128.05 145.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.203 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.83 112.38 16.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.971 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.937 ' CD2' HG23 ' A' ' 55' ' ' VAL . 3.3 mt -112.96 116.67 30.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.763 HG22 HD12 ' A' ' 53' ' ' ILE . 89.5 m -77.47 111.15 12.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.688 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 52' ' ' ILE . 12.4 m -117.43 175.84 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.325 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -139.96 130.04 24.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.719 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.01 -149.33 24.93 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.67 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 63.78 65.34 1.22 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.14 137.73 80.96 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.56 2.173 . . . . 0.0 112.137 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.35 134.42 15.61 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.423 2.082 . . . . 0.0 112.414 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.97 -54.08 4.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.565 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.924 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.627 -0.189 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.29 -69.55 0.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.801 0.334 . . . . 0.0 110.975 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -95.65 -39.96 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.807 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -98.55 32.66 2.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -136.65 -50.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.575 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.623 HD22 HE21 ' A' ' 83' ' ' GLN . 32.7 mt -134.56 101.34 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 0.0 110.937 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.5 m -101.57 119.15 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.175 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -105.47 139.88 39.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -148.49 137.93 21.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.98 107.25 19.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.877 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.07 143.88 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.5 mp -123.1 105.21 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.03 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.713 HD11 HD11 ' A' ' 72' ' ' ILE . 32.7 pt -105.06 137.76 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.254 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.51 ' H ' ' HB1' ' A' ' 40' ' ' ALA . 8.2 tt0 -106.61 119.18 38.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.754 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -67.31 145.5 55.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.003 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -112.99 -169.34 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -60.37 -31.18 70.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -41.27 13.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.858 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 -155.45 20.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -88.85 111.08 21.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.856 0.36 . . . . 0.0 110.836 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.97 -38.67 96.38 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.605 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 pp -54.59 136.81 44.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.771 0.32 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 m -101.25 131.64 47.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 32' ' ' VAL . 29.0 m -129.64 134.85 62.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 p -147.67 132.16 17.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.23 119.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.432 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.28 -77.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -84.28 -48.25 0.68 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 89.5 Cg_endo -84.65 -168.81 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.538 2.159 . . . . 0.0 112.476 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.702 HG12 HD12 ' A' ' 52' ' ' ILE . 21.3 t -149.4 102.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -132.2 153.3 50.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.733 ' HA ' HG12 ' A' ' 24' ' ' VAL . 24.4 t -88.78 124.81 41.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.0 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.08 -34.85 22.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.004 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.62 158.81 43.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.693 HG11 ' HB ' ' A' ' 46' ' ' VAL . 8.9 m -136.08 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.156 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.557 ' HG3' ' HB3' ' A' ' 41' ' ' ALA . 13.3 ptmt -55.93 122.56 11.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.1 mt-10 -77.33 151.43 34.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.974 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.28 29.85 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' HA3' ' HE2' ' A' ' 36' ' ' LYS . . . -141.04 -166.65 10.8 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB1' ' H ' ' A' ' 14' ' ' GLN . . . -52.35 -44.72 65.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.777 0.322 . . . . 0.0 111.405 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -59.9 -47.61 85.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 111.062 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -67.26 -50.96 58.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -59.14 -31.95 69.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.03 -15.82 62.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.399 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.55 35.51 28.86 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.544 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.693 ' HB ' HG11 ' A' ' 35' ' ' VAL . 17.9 t -85.08 141.21 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.282 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -105.77 156.83 17.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.88 125.14 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.23 30.59 45.48 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.525 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -80.7 145.49 31.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.04 133.89 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.787 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.702 HD12 HG12 ' A' ' 30' ' ' VAL . 5.6 mt -101.27 133.93 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.4 mt -110.77 -47.58 6.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.086 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -122.02 156.5 33.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.58 HG13 ' CD2' ' A' ' 80' ' ' LEU . 22.1 t -133.66 104.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 t30 59.0 41.44 20.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.14 27.15 73.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.587 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.58 84.33 1.98 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.686 0.279 . . . . 0.0 110.845 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.71 152.13 23.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 61' ' ' THR . 9.4 p -132.85 158.3 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.039 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.482 ' N ' HG22 ' A' ' 60' ' ' VAL . 73.4 p -99.11 -58.95 1.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -177.15 138.97 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.973 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.8 m -158.79 -78.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -179.33 162.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.786 ' O ' HG23 ' A' ' 69' ' ' VAL . 10.1 t-80 -59.3 -38.6 80.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 mt -55.25 -43.26 74.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.653 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -62.97 -44.12 96.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 72' ' ' ILE . 17.4 t -62.74 -46.51 96.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 65' ' ' HIS . 24.9 t -62.31 -44.3 99.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 13.9 mtpp -66.09 -38.37 88.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.794 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -40.48 70.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.888 HD12 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -73.93 -36.87 46.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.038 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -74.55 -20.57 59.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -68.6 72.14 0.22 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.879 0.371 . . . . 0.0 110.8 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.63 150.24 7.51 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.438 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -46.67 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 114.39 26.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.728 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 p -131.47 144.47 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.183 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.66 111.35 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.89 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -112.18 134.34 53.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.082 -179.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.6 m -82.64 113.78 20.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.8 m -112.59 169.3 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.408 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.623 HE21 HD22 ' A' ' 6' ' ' LEU . 1.2 tt0 -142.78 128.0 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.647 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.25 174.95 20.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.774 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.74 78.05 0.31 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.836 0.35 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.18 112.18 3.43 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.671 2.247 . . . . 0.0 112.365 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.39 -160.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.511 2.141 . . . . 0.0 112.196 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.85 -46.08 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.423 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.5 p . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.91 -179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 p 50.08 88.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.68 0.276 . . . . 0.0 111.225 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -123.79 146.57 48.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 35.3 mtp 60.33 78.99 0.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.81 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.82 -49.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.53 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 mt -118.21 104.78 11.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.08 147.46 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -128.62 143.65 50.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -143.51 140.52 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.0 128.75 33.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 44' ' ' ALA . 12.4 p -126.2 114.72 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.19 114.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.758 HD13 HD21 ' A' ' 22' ' ' LEU . 12.0 mt -98.09 145.05 10.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.13 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -114.97 126.2 54.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -66.13 120.4 13.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 33.9 m-20 -87.57 -173.05 4.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.92 -29.82 67.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.12 -30.38 14.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.94 -161.67 12.99 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.514 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 72' ' ' ILE . 4.3 m-85 -79.38 94.49 5.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.48 -32.12 80.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 13' ' ' ILE . 4.2 pp -59.87 131.39 50.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.889 0.376 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 m -102.22 132.92 47.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.702 HG12 HG22 ' A' ' 32' ' ' VAL . 31.3 m -116.88 143.69 26.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.54 132.51 17.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.02 132.26 2.31 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.365 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -58.03 -79.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.672 0.272 . . . . 0.0 110.839 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 7.6 m-20 -85.24 -61.49 0.27 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.766 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD3' ' CB ' ' A' ' 28' ' ' ASN . 92.1 Cg_endo -80.07 -167.44 0.51 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.524 2.149 . . . . 0.0 112.194 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.64 120.72 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CZ ' ' HA2' ' A' ' 49' ' ' GLY . 2.9 t80 -128.42 135.39 49.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.702 HG22 HG12 ' A' ' 24' ' ' VAL . 20.6 t -93.75 122.99 45.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -97.0 -49.83 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.281 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.54 148.66 42.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.191 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.603 HG11 HG12 ' A' ' 46' ' ' VAL . 29.4 m -136.46 145.56 30.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.99 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.89 121.06 15.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.008 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.02 138.94 31.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.964 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 t0 59.11 30.73 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.999 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -139.34 -149.66 5.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . . . -59.78 -45.55 91.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.76 0.314 . . . . 0.0 111.059 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . -61.7 -47.41 85.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.991 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -43.82 85.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -32.72 73.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -71.25 -15.72 62.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.404 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.1 27.3 26.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.567 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.603 HG12 HG11 ' A' ' 35' ' ' VAL . 24.4 t -78.8 158.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.731 0.301 . . . . 0.0 110.992 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.482 ' N ' HG12 ' A' ' 46' ' ' VAL . 13.2 mt-30 -132.3 144.65 50.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.42 125.11 23.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 31' ' ' PHE . . . 78.32 46.6 8.88 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.429 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.7 139.65 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.3 mtm180 -92.05 152.08 20.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.973 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.808 HD13 HG12 ' A' ' 82' ' ' VAL . 13.4 mm -106.94 133.37 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.056 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.0 mm -107.45 -33.82 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.054 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -150.2 157.28 42.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.805 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.752 HG12 ' HB3' ' A' ' 80' ' ' LEU . 4.7 m -140.62 110.46 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.178 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.496 HD21 HG23 ' A' ' 78' ' ' VAL . 84.4 m-20 60.75 41.98 14.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 26.25 71.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p -139.32 116.45 11.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.87 0.367 . . . . 0.0 110.952 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.72 -75.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.62 112.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 61' ' ' THR . 16.9 m -120.42 32.12 6.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.831 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -169.44 106.79 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.913 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.4 t -171.48 161.74 6.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.619 ' O ' HG23 ' A' ' 68' ' ' VAL . 18.3 t-20 -92.21 168.36 11.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -59.41 -42.23 91.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.468 ' HA ' HG12 ' A' ' 69' ' ' VAL . 4.9 tp -55.29 -43.47 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -64.87 -40.14 94.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.256 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 64' ' ' ASN . 22.6 t -65.68 -46.78 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.609 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 72' ' ' ILE . 7.2 p -65.02 -41.29 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.019 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -38.37 87.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.102 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -47.39 68.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.453 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.513 HD11 ' CE2' ' A' ' 20' ' ' PHE . 2.0 tt -68.7 -37.89 78.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.64 -26.6 59.98 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.023 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.6 t -64.23 80.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.96 144.56 9.13 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 m -69.8 -49.26 54.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 120.49 36.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG23 HD21 ' A' ' 56' ' ' ASN . 11.1 p -136.06 133.87 50.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -114.93 117.44 30.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.752 ' HB3' HG12 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -131.03 127.56 38.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.961 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -70.02 131.23 44.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.808 HG12 HD13 ' A' ' 52' ' ' ILE . 27.0 m -126.86 169.37 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -140.61 127.87 21.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.759 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.96 -169.26 11.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.627 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.27 92.27 3.02 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.646 0.26 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.39 110.42 2.03 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.487 2.124 . . . . 0.0 112.343 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.41 -44.9 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.415 2.077 . . . . 0.0 112.369 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.87 49.36 0.85 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.617 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 112.379 -0.288 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -107.17 46.7 0.92 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.921 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -156.44 31.19 0.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.4 ttm -65.9 -32.18 73.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.73 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -129.65 -80.64 0.25 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.468 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.28 -76.37 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 110.762 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.72 131.14 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.135 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -104.74 138.58 40.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.7 154.17 50.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.33 139.75 37.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.79 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.4 m -134.05 144.29 35.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.121 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 79' ' ' ALA . 24.3 mm -113.67 107.32 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.691 HD11 HD21 ' A' ' 80' ' ' LEU . 15.9 pt -106.02 126.07 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.41 139.35 38.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.2 128.67 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.703 ' OD2' ' HB2' ' A' ' 40' ' ' ALA . 18.0 m-20 -103.99 -169.59 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.81 -36.35 74.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.29 -43.84 66.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.14 76.06 1.25 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.561 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.641 ' CE2' HD12 ' A' ' 13' ' ' ILE . 8.8 m-85 61.39 115.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.11 -44.97 4.91 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.553 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.35 142.79 36.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.337 . . . . 0.0 111.049 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m -101.32 122.26 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.401 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 10.0 p -118.97 137.18 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.092 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.8 p -149.53 132.03 15.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -173.26 120.86 0.83 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.461 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -59.7 -73.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.77 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.407 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 1.5 t-20 -84.66 -53.04 0.5 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 28' ' ' ASN . 86.2 Cg_endo -84.27 -167.49 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.725 2.284 . . . . 0.0 112.378 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.098 HG12 HD12 ' A' ' 52' ' ' ILE . 19.5 t -145.49 94.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.006 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -127.31 141.02 51.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.999 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.92 128.69 40.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.05 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -98.73 -30.33 12.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.17 146.25 47.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.951 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.61 HG13 ' HB1' ' A' ' 41' ' ' ALA . 40.4 t -134.6 129.71 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -66.92 110.55 3.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.806 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 42' ' ' MET . 2.4 pm0 -91.81 44.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.43 35.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.591 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.47 -145.82 4.5 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.849 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . . . -60.99 -38.88 87.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.726 0.298 . . . . 0.0 111.401 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -59.29 -47.47 85.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.107 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.416 ' HB2' ' HA ' ' A' ' 37' ' ' GLU . 3.8 tpt -72.42 -43.14 64.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.801 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -30.8 69.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 13' ' ' ILE . . . -83.51 -15.85 47.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.355 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.73 56.96 3.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.58 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 47' ' ' GLN . 24.6 t -98.39 158.5 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.791 0.329 . . . . 0.0 111.068 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.481 ' N ' HG12 ' A' ' 46' ' ' VAL . 1.5 mp0 -118.88 148.68 42.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.04 129.11 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.1 33.42 32.8 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.586 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.95 133.93 33.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 110.846 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 mtp85 -89.33 131.67 35.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.098 HD12 HG12 ' A' ' 30' ' ' VAL . 24.3 mt -96.89 124.41 49.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.046 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.69 -43.85 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.181 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -138.29 150.36 46.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.955 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 80' ' ' LEU . 5.2 m -136.19 106.19 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.173 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 61.29 43.6 10.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.803 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.98 27.56 70.23 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.495 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.42 79.66 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 0.0 110.948 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -61.68 -30.56 70.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.12 151.59 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.133 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -134.64 171.72 13.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -119.51 178.54 4.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.99 -30.16 21.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.72 122.89 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.727 ' O ' HG23 ' A' ' 69' ' ' VAL . 19.2 t-80 -66.02 -36.5 83.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.834 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 mt -55.2 -42.91 73.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.662 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.57 -44.04 97.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.152 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.785 HG12 HD11 ' A' ' 72' ' ' ILE . 21.1 t -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 65' ' ' HIS . 34.8 t -61.69 -43.72 97.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -65.43 -38.41 89.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.342 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -41.87 79.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.563 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.785 HD11 HG12 ' A' ' 68' ' ' VAL . 14.9 mt -71.61 -38.04 65.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.778 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -74.49 -27.13 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 85.2 p -63.33 80.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.44 144.41 4.74 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.584 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.7 p -71.63 -54.02 11.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.77 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -95.75 118.77 33.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.704 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 72' ' ' ILE . 20.5 t -125.86 123.42 64.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.282 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -115.27 101.82 9.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.812 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.691 HD21 HD11 ' A' ' 13' ' ' ILE . 0.4 OUTLIER -113.31 137.43 51.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.022 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 71.3 m -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 80' ' ' LEU . 5.8 m -112.59 170.05 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -130.0 143.9 51.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.82 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.43 -178.11 42.69 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.588 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -137.92 119.17 10.53 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.612 0.244 . . . . 0.0 110.799 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.481 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 42.0 Cg_exo -55.79 -45.37 39.51 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.499 2.132 . . . . 0.0 112.428 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 86' ' ' PRO . 44.6 Cg_exo -56.44 164.5 5.41 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.397 2.065 . . . . 0.0 112.23 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.71 -64.35 3.87 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.522 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.898 -179.969 . . . . . . . . 0 0 . 1 stop_ save_